id	sid	tid	token	lemma	pos
aiua-10711	1	1	stesura	stesura	PROPN
aiua-10711	1	2	seveso	seveso	PROPN
aiua-10711	1	3	archivio	archivio	PROPN
aiua-10711	1	4	italiano	italiano	X
aiua-10711	1	5	di	di	X
aiua-10711	1	6	urologia	urologia	PROPN
aiua-10711	1	7	e	e	PROPN
aiua-10711	1	8	andrologia	andrologia	PROPN
aiua-10711	1	9	2022	2022	NUM
aiua-10711	1	10	;	;	PUNCT
aiua-10711	1	11	94	94	NUM
aiua-10711	1	12	,	,	PUNCT
aiua-10711	1	13	2252	2252	NUM
aiua-10711	1	14	review	review	VERB
aiua-10711	1	15	no	no	DET
aiua-10711	1	16	conflict	conflict	NOUN
aiua-10711	1	17	of	of	ADP
aiua-10711	1	18	interest	interest	NOUN
aiua-10711	1	19	declared	declare	VERB
aiua-10711	1	20	.	.	PUNCT
aiua-10711	2	1	introduction	introduction	NOUN
aiua-10711	2	2	alpha	alpha	NOUN
aiua-10711	2	3	adrenergic	adrenergic	ADJ
aiua-10711	2	4	receptor	receptor	NOUN
aiua-10711	2	5	(	(	PUNCT
aiua-10711	2	6	or	or	CCONJ
aiua-10711	2	7	adrenoreceptor	adrenoreceptor	NOUN
aiua-10711	2	8	)	)	PUNCT
aiua-10711	2	9	antagonists	antagonist	NOUN
aiua-10711	2	10	,	,	PUNCT
aiua-10711	2	11	also	also	ADV
aiua-10711	2	12	known	know	VERB
aiua-10711	2	13	as	as	ADP
aiua-10711	2	14	alpha	alpha	NOUN
aiua-10711	2	15	-	-	PUNCT
aiua-10711	2	16	blockers	blocker	NOUN
aiua-10711	2	17	,	,	PUNCT
aiua-10711	2	18	are	be	AUX
aiua-10711	2	19	a	a	DET
aiua-10711	2	20	class	class	NOUN
aiua-10711	2	21	of	of	ADP
aiua-10711	2	22	pharmacological	pharmacological	ADJ
aiua-10711	2	23	agents	agent	NOUN
aiua-10711	2	24	acting	act	VERB
aiua-10711	2	25	as	as	ADP
aiua-10711	2	26	antagonists	antagonist	NOUN
aiua-10711	2	27	on	on	ADP
aiua-10711	2	28	various	various	ADJ
aiua-10711	2	29	alphaadrenergic	alphaadrenergic	ADJ
aiua-10711	2	30	receptors	receptor	NOUN
aiua-10711	2	31	.	.	PUNCT
aiua-10711	3	1	depending	depend	VERB
aiua-10711	3	2	on	on	ADP
aiua-10711	3	3	receptor	receptor	NOUN
aiua-10711	3	4	specificity	specificity	NOUN
aiua-10711	3	5	,	,	PUNCT
aiua-10711	3	6	they	they	PRON
aiua-10711	3	7	bind	bind	VERB
aiua-10711	3	8	and	and	CCONJ
aiua-10711	3	9	inhibit	inhibit	VERB
aiua-10711	3	10	alpha1	alpha1	NOUN
aiua-10711	3	11	-	-	PUNCT
aiua-10711	3	12	receptors	receptor	NOUN
aiua-10711	3	13	,	,	PUNCT
aiua-10711	3	14	alpha2	alpha2	NOUN
aiua-10711	3	15	-	-	PUNCT
aiua-10711	3	16	receptors	receptor	NOUN
aiua-10711	3	17	,	,	PUNCT
aiua-10711	3	18	or	or	CCONJ
aiua-10711	3	19	both	both	DET
aiua-10711	3	20	(	(	PUNCT
aiua-10711	3	21	1	1	NUM
aiua-10711	3	22	)	)	PUNCT
aiua-10711	3	23	.	.	PUNCT
aiua-10711	4	1	alpha-1	alpha-1	PRON
aiua-10711	4	2	adrenergic	adrenergic	ADJ
aiua-10711	4	3	antagonists	antagonist	NOUN
aiua-10711	4	4	bind	bind	VERB
aiua-10711	4	5	to	to	ADP
aiua-10711	4	6	type-1	type-1	NUM
aiua-10711	4	7	alphaadrenergic	alphaadrenergic	ADJ
aiua-10711	4	8	receptors	receptor	NOUN
aiua-10711	4	9	,	,	PUNCT
aiua-10711	4	10	thus	thus	ADV
aiua-10711	4	11	inhibiting	inhibit	VERB
aiua-10711	4	12	smooth	smooth	ADJ
aiua-10711	4	13	muscle	muscle	NOUN
aiua-10711	4	14	contraction	contraction	NOUN
aiua-10711	4	15	.	.	PUNCT
aiua-10711	5	1	several	several	ADJ
aiua-10711	5	2	subtypes	subtype	NOUN
aiua-10711	5	3	of	of	ADP
aiua-10711	5	4	postsynaptic	postsynaptic	ADJ
aiua-10711	5	5	alpha1	alpha1	NOUN
aiua-10711	5	6	receptors	receptor	NOUN
aiua-10711	5	7	are	be	AUX
aiua-10711	5	8	present	present	ADJ
aiua-10711	5	9	in	in	ADP
aiua-10711	5	10	vascular	vascular	ADJ
aiua-10711	5	11	and	and	CCONJ
aiua-10711	5	12	nonvascular	nonvascular	ADJ
aiua-10711	5	13	smooth	smooth	ADJ
aiua-10711	5	14	muscle	muscle	NOUN
aiua-10711	5	15	.	.	PUNCT
aiua-10711	6	1	alpha	alpha	NOUN
aiua-10711	6	2	1a	1a	PROPN
aiua-10711	6	3	receptors	receptor	NOUN
aiua-10711	6	4	are	be	AUX
aiua-10711	6	5	predominantly	predominantly	ADV
aiua-10711	6	6	located	locate	VERB
aiua-10711	6	7	in	in	ADP
aiua-10711	6	8	the	the	DET
aiua-10711	6	9	smooth	smooth	ADJ
aiua-10711	6	10	muscle	muscle	NOUN
aiua-10711	6	11	of	of	ADP
aiua-10711	6	12	the	the	DET
aiua-10711	6	13	genitourinary	genitourinary	ADJ
aiua-10711	6	14	tract	tract	NOUN
aiua-10711	6	15	,	,	PUNCT
aiua-10711	6	16	where	where	SCONJ
aiua-10711	6	17	they	they	PRON
aiua-10711	6	18	regulate	regulate	VERB
aiua-10711	6	19	the	the	DET
aiua-10711	6	20	tone	tone	NOUN
aiua-10711	6	21	of	of	ADP
aiua-10711	6	22	the	the	DET
aiua-10711	6	23	bladder	bladder	NOUN
aiua-10711	6	24	neck	neck	NOUN
aiua-10711	6	25	and	and	CCONJ
aiua-10711	6	26	of	of	ADP
aiua-10711	6	27	the	the	DET
aiua-10711	6	28	smooth	smooth	ADJ
aiua-10711	6	29	muscle	muscle	NOUN
aiua-10711	6	30	fibers	fiber	NOUN
aiua-10711	6	31	within	within	ADP
aiua-10711	6	32	the	the	DET
aiua-10711	6	33	prostate	prostate	NOUN
aiua-10711	6	34	.	.	PUNCT
aiua-10711	7	1	alpha	alpha	NOUN
aiua-10711	7	2	1b	1b	NUM
aiua-10711	7	3	receptors	receptor	NOUN
aiua-10711	7	4	are	be	AUX
aiua-10711	7	5	more	more	ADV
aiua-10711	7	6	represented	represent	VERB
aiua-10711	7	7	in	in	ADP
aiua-10711	7	8	the	the	DET
aiua-10711	7	9	vascular	vascular	ADJ
aiua-10711	7	10	smooth	smooth	ADJ
aiua-10711	7	11	muscle	muscle	NOUN
aiua-10711	7	12	,	,	PUNCT
aiua-10711	7	13	and	and	CCONJ
aiua-10711	7	14	are	be	AUX
aiua-10711	7	15	involved	involve	VERB
aiua-10711	7	16	in	in	ADP
aiua-10711	7	17	the	the	DET
aiua-10711	7	18	regulation	regulation	NOUN
aiua-10711	7	19	of	of	ADP
aiua-10711	7	20	the	the	DET
aiua-10711	7	21	vascular	vascular	ADJ
aiua-10711	7	22	tone	tone	NOUN
aiua-10711	7	23	.	.	PUNCT
aiua-10711	8	1	receptors	receptor	NOUN
aiua-10711	8	2	belonging	belong	VERB
aiua-10711	8	3	to	to	ADP
aiua-10711	8	4	the	the	DET
aiua-10711	8	5	alpha1d	alpha1d	NOUN
aiua-10711	8	6	subtype	subtype	NOUN
aiua-10711	8	7	regulate	regulate	VERB
aiua-10711	8	8	the	the	DET
aiua-10711	8	9	contraction	contraction	NOUN
aiua-10711	8	10	of	of	ADP
aiua-10711	8	11	the	the	DET
aiua-10711	8	12	urinary	urinary	ADJ
aiua-10711	8	13	bladder	bladder	NOUN
aiua-10711	8	14	(	(	PUNCT
aiua-10711	8	15	2	2	NUM
aiua-10711	8	16	)	)	PUNCT
aiua-10711	8	17	.	.	PUNCT
aiua-10711	9	1	the	the	DET
aiua-10711	9	2	effects	effect	NOUN
aiua-10711	9	3	of	of	ADP
aiua-10711	9	4	alphabackground	alphabackground	NOUN
aiua-10711	9	5	:	:	PUNCT
aiua-10711	9	6	alpha	alpha	NOUN
aiua-10711	9	7	-	-	PUNCT
aiua-10711	9	8	adrenoreceptor	adrenoreceptor	NOUN
aiua-10711	9	9	antagonists	antagonist	NOUN
aiua-10711	9	10	or	or	CCONJ
aiua-10711	9	11	alpha	alpha	NOUN
aiua-10711	9	12	-	-	PUNCT
aiua-10711	9	13	blockers	blocker	NOUN
aiua-10711	9	14	are	be	AUX
aiua-10711	9	15	used	use	VERB
aiua-10711	9	16	in	in	ADP
aiua-10711	9	17	the	the	DET
aiua-10711	9	18	treatment	treatment	NOUN
aiua-10711	9	19	of	of	ADP
aiua-10711	9	20	hypertension	hypertension	NOUN
aiua-10711	9	21	,	,	PUNCT
aiua-10711	9	22	in	in	ADP
aiua-10711	9	23	the	the	DET
aiua-10711	9	24	therapy	therapy	NOUN
aiua-10711	9	25	of	of	ADP
aiua-10711	9	26	benign	benign	ADJ
aiua-10711	9	27	prostatic	prostatic	ADJ
aiua-10711	9	28	hyperplasia	hyperplasia	NOUN
aiua-10711	9	29	and	and	CCONJ
aiua-10711	9	30	in	in	ADP
aiua-10711	9	31	medical	medical	ADJ
aiua-10711	9	32	expulsive	expulsive	ADJ
aiua-10711	9	33	treatment	treatment	NOUN
aiua-10711	9	34	of	of	ADP
aiua-10711	9	35	ureteral	ureteral	ADJ
aiua-10711	9	36	stones	stone	NOUN
aiua-10711	9	37	.	.	PUNCT
aiua-10711	10	1	these	these	DET
aiua-10711	10	2	agents	agent	NOUN
aiua-10711	10	3	may	may	AUX
aiua-10711	10	4	affect	affect	VERB
aiua-10711	10	5	the	the	DET
aiua-10711	10	6	sexual	sexual	ADJ
aiua-10711	10	7	function	function	NOUN
aiua-10711	10	8	,	,	PUNCT
aiua-10711	10	9	with	with	ADP
aiua-10711	10	10	differences	difference	NOUN
aiua-10711	10	11	between	between	ADP
aiua-10711	10	12	drugs	drug	NOUN
aiua-10711	10	13	within	within	ADP
aiua-10711	10	14	the	the	DET
aiua-10711	10	15	same	same	ADJ
aiua-10711	10	16	class	class	NOUN
aiua-10711	10	17	,	,	PUNCT
aiua-10711	10	18	depending	depend	VERB
aiua-10711	10	19	on	on	ADP
aiua-10711	10	20	their	their	PRON
aiua-10711	10	21	selectivity	selectivity	NOUN
aiua-10711	10	22	for	for	ADP
aiua-10711	10	23	receptor	receptor	NOUN
aiua-10711	10	24	subtypes	subtype	NOUN
aiua-10711	10	25	.	.	PUNCT
aiua-10711	11	1	the	the	DET
aiua-10711	11	2	aim	aim	NOUN
aiua-10711	11	3	of	of	ADP
aiua-10711	11	4	this	this	DET
aiua-10711	11	5	review	review	NOUN
aiua-10711	11	6	was	be	AUX
aiua-10711	11	7	to	to	PART
aiua-10711	11	8	analyze	analyze	VERB
aiua-10711	11	9	the	the	DET
aiua-10711	11	10	effects	effect	NOUN
aiua-10711	11	11	of	of	ADP
aiua-10711	11	12	alpha	alpha	NOUN
aiua-10711	11	13	-	-	PUNCT
aiua-10711	11	14	blockers	blocker	NOUN
aiua-10711	11	15	on	on	ADP
aiua-10711	11	16	sexual	sexual	ADJ
aiua-10711	11	17	function	function	NOUN
aiua-10711	11	18	.	.	PUNCT
aiua-10711	12	1	materials	material	NOUN
aiua-10711	12	2	and	and	CCONJ
aiua-10711	12	3	methods	method	NOUN
aiua-10711	12	4	:	:	PUNCT
aiua-10711	12	5	we	we	PRON
aiua-10711	12	6	conducted	conduct	VERB
aiua-10711	12	7	a	a	DET
aiua-10711	12	8	systematic	systematic	ADJ
aiua-10711	12	9	review	review	NOUN
aiua-10711	12	10	and	and	CCONJ
aiua-10711	12	11	meta	meta	NOUN
aiua-10711	12	12	-	-	PUNCT
aiua-10711	12	13	analysis	analysis	NOUN
aiua-10711	12	14	by	by	ADP
aiua-10711	12	15	searching	search	VERB
aiua-10711	12	16	pubmed	pubmed	PROPN
aiua-10711	12	17	,	,	PUNCT
aiua-10711	12	18	embase	embase	NOUN
aiua-10711	12	19	and	and	CCONJ
aiua-10711	12	20	other	other	ADJ
aiua-10711	12	21	databases	database	NOUN
aiua-10711	12	22	for	for	ADP
aiua-10711	12	23	randomized	randomized	ADJ
aiua-10711	12	24	controlled	control	VERB
aiua-10711	12	25	trials	trial	NOUN
aiua-10711	12	26	(	(	PUNCT
aiua-10711	12	27	rcts	rct	NOUN
aiua-10711	12	28	)	)	PUNCT
aiua-10711	12	29	reporting	report	VERB
aiua-10711	12	30	sexual	sexual	ADJ
aiua-10711	12	31	adverse	adverse	ADJ
aiua-10711	12	32	effects	effect	NOUN
aiua-10711	12	33	in	in	ADP
aiua-10711	12	34	patients	patient	NOUN
aiua-10711	12	35	treated	treat	VERB
aiua-10711	12	36	with	with	ADP
aiua-10711	12	37	alpha	alpha	NOUN
aiua-10711	12	38	-	-	PUNCT
aiua-10711	12	39	blockers	blocker	NOUN
aiua-10711	12	40	.	.	PUNCT
aiua-10711	13	1	odds	odd	NOUN
aiua-10711	13	2	ratios	ratio	NOUN
aiua-10711	13	3	for	for	ADP
aiua-10711	13	4	sexual	sexual	ADJ
aiua-10711	13	5	dysfunction	dysfunction	NOUN
aiua-10711	13	6	were	be	AUX
aiua-10711	13	7	calculated	calculate	VERB
aiua-10711	13	8	using	use	VERB
aiua-10711	13	9	random	random	ADJ
aiua-10711	13	10	effects	effect	NOUN
aiua-10711	13	11	mantel	mantel	NOUN
aiua-10711	13	12	-	-	PUNCT
aiua-10711	13	13	haenszel	haenszel	ADJ
aiua-10711	13	14	statistics	statistic	NOUN
aiua-10711	13	15	.	.	PUNCT
aiua-10711	14	1	results	result	NOUN
aiua-10711	14	2	:	:	PUNCT
aiua-10711	14	3	out	out	ADP
aiua-10711	14	4	of	of	ADP
aiua-10711	14	5	608	608	NUM
aiua-10711	14	6	records	record	NOUN
aiua-10711	14	7	retrieved	retrieve	VERB
aiua-10711	14	8	,	,	PUNCT
aiua-10711	14	9	75	75	NUM
aiua-10711	14	10	eligible	eligible	ADJ
aiua-10711	14	11	rcts	rct	NOUN
aiua-10711	14	12	were	be	AUX
aiua-10711	14	13	included	include	VERB
aiua-10711	14	14	in	in	ADP
aiua-10711	14	15	the	the	DET
aiua-10711	14	16	meta	meta	ADJ
aiua-10711	14	17	-	-	PUNCT
aiua-10711	14	18	analysis	analysis	NOUN
aiua-10711	14	19	.	.	PUNCT
aiua-10711	15	1	compared	compare	VERB
aiua-10711	15	2	with	with	ADP
aiua-10711	15	3	placebo	placebo	NOUN
aiua-10711	15	4	,	,	PUNCT
aiua-10711	15	5	alphablockers	alphablocker	NOUN
aiua-10711	15	6	were	be	AUX
aiua-10711	15	7	associated	associate	VERB
aiua-10711	15	8	with	with	ADP
aiua-10711	15	9	increased	increase	VERB
aiua-10711	15	10	odds	odd	NOUN
aiua-10711	15	11	of	of	ADP
aiua-10711	15	12	ejaculatory	ejaculatory	ADJ
aiua-10711	15	13	disorders	disorder	NOUN
aiua-10711	15	14	both	both	CCONJ
aiua-10711	15	15	in	in	ADP
aiua-10711	15	16	patients	patient	NOUN
aiua-10711	15	17	with	with	ADP
aiua-10711	15	18	lower	low	ADJ
aiua-10711	15	19	urinary	urinary	ADJ
aiua-10711	15	20	tract	tract	NOUN
aiua-10711	15	21	symptoms	symptom	NOUN
aiua-10711	15	22	(	(	PUNCT
aiua-10711	15	23	luts	luts	PROPN
aiua-10711	15	24	)	)	PUNCT
aiua-10711	15	25	associated	associate	VERB
aiua-10711	15	26	to	to	ADP
aiua-10711	15	27	benign	benign	ADJ
aiua-10711	15	28	prostatic	prostatic	ADJ
aiua-10711	15	29	hyperplasia	hyperplasia	NOUN
aiua-10711	15	30	(	(	PUNCT
aiua-10711	15	31	bph	bph	NOUN
aiua-10711	15	32	)	)	PUNCT
aiua-10711	15	33	(	(	PUNCT
aiua-10711	15	34	or	or	CCONJ
aiua-10711	15	35	:	:	PUNCT
aiua-10711	15	36	7.53	7.53	NUM
aiua-10711	15	37	,	,	PUNCT
aiua-10711	15	38	95	95	NUM
aiua-10711	15	39	%	%	NOUN
aiua-10711	15	40	ci	ci	NOUN
aiua-10711	15	41	:	:	PUNCT
aiua-10711	15	42	3.77	3.77	NUM
aiua-10711	15	43	-	-	SYM
aiua-10711	15	44	15.02	15.02	NUM
aiua-10711	15	45	,	,	PUNCT
aiua-10711	15	46	z	z	NOUN
aiua-10711	15	47	=	=	NUM
aiua-10711	15	48	5.73	5.73	NUM
aiua-10711	15	49	,	,	PUNCT
aiua-10711	15	50	p	p	X
aiua-10711	15	51	<	<	X
aiua-10711	15	52	0.00001	0.00001	NUM
aiua-10711	15	53	,	,	PUNCT
aiua-10711	15	54	i2	i2	NOUN
aiua-10711	15	55	=	=	NOUN
aiua-10711	15	56	55	55	NUM
aiua-10711	15	57	%	%	NOUN
aiua-10711	15	58	)	)	PUNCT
aiua-10711	15	59	and	and	CCONJ
aiua-10711	15	60	in	in	ADP
aiua-10711	15	61	patients	patient	NOUN
aiua-10711	15	62	with	with	ADP
aiua-10711	15	63	ureteral	ureteral	ADJ
aiua-10711	15	64	stones	stone	NOUN
aiua-10711	15	65	(	(	PUNCT
aiua-10711	15	66	or	or	CCONJ
aiua-10711	15	67	:	:	PUNCT
aiua-10711	15	68	2.88	2.88	NUM
aiua-10711	15	69	,	,	PUNCT
aiua-10711	15	70	95	95	NUM
aiua-10711	15	71	%	%	NOUN
aiua-10711	15	72	ci	ci	NOUN
aiua-10711	15	73	:	:	PUNCT
aiua-10711	15	74	1.50	1.50	NUM
aiua-10711	15	75	-	-	SYM
aiua-10711	15	76	5.44	5.44	NUM
aiua-10711	15	77	,	,	PUNCT
aiua-10711	15	78	z	z	NOUN
aiua-10711	15	79	=	=	SYM
aiua-10711	15	80	3.19	3.19	NUM
aiua-10711	15	81	,	,	PUNCT
aiua-10711	15	82	p	p	X
aiua-10711	15	83	<	<	X
aiua-10711	15	84	0.001	0.001	NUM
aiua-10711	15	85	,	,	PUNCT
aiua-10711	15	86	i2	i2	NOUN
aiua-10711	15	87	=	=	PUNCT
aiua-10711	15	88	31	31	NUM
aiua-10711	15	89	%	%	NOUN
aiua-10711	15	90	)	)	PUNCT
aiua-10711	15	91	.	.	PUNCT
aiua-10711	16	1	uroselective	uroselective	ADJ
aiua-10711	16	2	alpha	alpha	NOUN
aiua-10711	16	3	-	-	PUNCT
aiua-10711	16	4	blockers	blocker	NOUN
aiua-10711	16	5	showed	show	VERB
aiua-10711	16	6	higher	high	ADJ
aiua-10711	16	7	odds	odd	NOUN
aiua-10711	16	8	of	of	ADP
aiua-10711	16	9	ejaculatory	ejaculatory	ADJ
aiua-10711	16	10	disorders	disorder	NOUN
aiua-10711	16	11	.	.	PUNCT
aiua-10711	17	1	conversely	conversely	ADV
aiua-10711	17	2	,	,	PUNCT
aiua-10711	17	3	nonselective	nonselective	ADJ
aiua-10711	17	4	alpha	alpha	NOUN
aiua-10711	17	5	-	-	PUNCT
aiua-10711	17	6	blockers	blocker	NOUN
aiua-10711	17	7	were	be	AUX
aiua-10711	17	8	not	not	PART
aiua-10711	17	9	associated	associate	VERB
aiua-10711	17	10	with	with	ADP
aiua-10711	17	11	higher	high	ADJ
aiua-10711	17	12	odds	odd	NOUN
aiua-10711	17	13	of	of	ADP
aiua-10711	17	14	ejaculatory	ejaculatory	ADJ
aiua-10711	17	15	dysfunction	dysfunction	NOUN
aiua-10711	17	16	.	.	PUNCT
aiua-10711	18	1	silodosin	silodosin	PROPN
aiua-10711	18	2	was	be	AUX
aiua-10711	18	3	associated	associate	VERB
aiua-10711	18	4	with	with	ADP
aiua-10711	18	5	increased	increase	VERB
aiua-10711	18	6	odds	odd	NOUN
aiua-10711	18	7	of	of	ADP
aiua-10711	18	8	ejaculatory	ejaculatory	ADJ
aiua-10711	18	9	dysfunction	dysfunction	NOUN
aiua-10711	18	10	compared	compare	VERB
aiua-10711	18	11	with	with	ADP
aiua-10711	18	12	tamsulosin	tamsulosin	NOUN
aiua-10711	18	13	(	(	PUNCT
aiua-10711	18	14	or	or	CCONJ
aiua-10711	18	15	:	:	PUNCT
aiua-10711	18	16	3.52	3.52	NUM
aiua-10711	18	17	,	,	PUNCT
aiua-10711	18	18	95	95	NUM
aiua-10711	18	19	%	%	NOUN
aiua-10711	18	20	ci	ci	NOUN
aiua-10711	18	21	:	:	PUNCT
aiua-10711	18	22	2.18	2.18	NUM
aiua-10711	18	23	-	-	SYM
aiua-10711	18	24	5.68	5.68	NUM
aiua-10711	18	25	,	,	PUNCT
aiua-10711	18	26	15	15	NUM
aiua-10711	18	27	series	series	NOUN
aiua-10711	18	28	,	,	PUNCT
aiua-10711	18	29	1512	1512	NUM
aiua-10711	18	30	participants	participant	NOUN
aiua-10711	18	31	,	,	PUNCT
aiua-10711	18	32	z	z	NOUN
aiua-10711	18	33	=	=	NUM
aiua-10711	18	34	5.15	5.15	NUM
aiua-10711	18	35	,	,	PUNCT
aiua-10711	18	36	p	p	X
aiua-10711	18	37	<	<	X
aiua-10711	18	38	0.00001	0.00001	NUM
aiua-10711	18	39	,	,	PUNCT
aiua-10711	18	40	i2	i2	NOUN
aiua-10711	18	41	=	=	SYM
aiua-10711	18	42	0	0	NUM
aiua-10711	18	43	%	%	NOUN
aiua-10711	18	44	)	)	PUNCT
aiua-10711	18	45	.	.	PUNCT
aiua-10711	19	1	naftopidil	naftopidil	NOUN
aiua-10711	19	2	and	and	CCONJ
aiua-10711	19	3	alfuzosin	alfuzosin	NOUN
aiua-10711	19	4	showed	show	VERB
aiua-10711	19	5	lower	low	ADJ
aiua-10711	19	6	odds	odd	NOUN
aiua-10711	19	7	of	of	ADP
aiua-10711	19	8	ejaculatory	ejaculatory	ADJ
aiua-10711	19	9	dysfunction	dysfunction	NOUN
aiua-10711	19	10	compared	compare	VERB
aiua-10711	19	11	to	to	ADP
aiua-10711	19	12	uroselective	uroselective	ADJ
aiua-10711	19	13	alpha	alpha	NOUN
aiua-10711	19	14	-	-	PUNCT
aiua-10711	19	15	blockers	blocker	NOUN
aiua-10711	19	16	.	.	PUNCT
aiua-10711	20	1	effect	effect	NOUN
aiua-10711	20	2	of	of	ADP
aiua-10711	20	3	alpha	alpha	NOUN
aiua-10711	20	4	-	-	PUNCT
aiua-10711	20	5	adrenoceptor	adrenoceptor	NOUN
aiua-10711	20	6	antagonists	antagonist	NOUN
aiua-10711	20	7	on	on	ADP
aiua-10711	20	8	sexual	sexual	ADJ
aiua-10711	20	9	function	function	NOUN
aiua-10711	20	10	.	.	PUNCT
aiua-10711	21	1	a	a	DET
aiua-10711	21	2	systematic	systematic	ADJ
aiua-10711	21	3	review	review	NOUN
aiua-10711	21	4	and	and	CCONJ
aiua-10711	21	5	meta	meta	ADJ
aiua-10711	21	6	-	-	PUNCT
aiua-10711	21	7	analysis	analysis	NOUN
aiua-10711	21	8	rawa	rawa	PROPN
aiua-10711	21	9	bapir	bapir	VERB
aiua-10711	21	10	1	1	NUM
aiua-10711	21	11	,	,	PUNCT
aiua-10711	21	12	13	13	NUM
aiua-10711	21	13	,	,	PUNCT
aiua-10711	21	14	kamran	kamran	PROPN
aiua-10711	21	15	hassan	hassan	PROPN
aiua-10711	21	16	bhatti	bhatti	PROPN
aiua-10711	21	17	2	2	NUM
aiua-10711	21	18	,	,	PUNCT
aiua-10711	21	19	13	13	NUM
aiua-10711	21	20	,	,	PUNCT
aiua-10711	21	21	ahmed	ahmed	PROPN
aiua-10711	21	22	eliwa	eliwa	VERB
aiua-10711	21	23	3	3	NUM
aiua-10711	21	24	,	,	PUNCT
aiua-10711	21	25	13	13	NUM
aiua-10711	21	26	,	,	PUNCT
aiua-10711	21	27	herney	herney	NOUN
aiua-10711	21	28	andrés	andrés	PROPN
aiua-10711	21	29	garcía	garcía	PROPN
aiua-10711	21	30	-	-	PUNCT
aiua-10711	21	31	perdomo	perdomo	NOUN
aiua-10711	21	32	4	4	NUM
aiua-10711	21	33	,	,	PUNCT
aiua-10711	21	34	13	13	NUM
aiua-10711	21	35	,	,	PUNCT
aiua-10711	21	36	nazim	nazim	PROPN
aiua-10711	21	37	gherabi	gherabi	PROPN
aiua-10711	21	38	5	5	NUM
aiua-10711	21	39	,	,	PUNCT
aiua-10711	21	40	13	13	NUM
aiua-10711	21	41	,	,	PUNCT
aiua-10711	21	42	derek	derek	PROPN
aiua-10711	21	43	hennessey	hennessey	PROPN
aiua-10711	21	44	6	6	NUM
aiua-10711	21	45	,	,	PUNCT
aiua-10711	21	46	13	13	NUM
aiua-10711	21	47	,	,	PUNCT
aiua-10711	21	48	vittorio	vittorio	NOUN
aiua-10711	21	49	magri	magri	VERB
aiua-10711	21	50	7	7	NUM
aiua-10711	21	51	,	,	PUNCT
aiua-10711	21	52	13	13	NUM
aiua-10711	21	53	,	,	PUNCT
aiua-10711	21	54	panagiotis	panagiotis	NOUN
aiua-10711	21	55	mourmouris	mourmouris	VERB
aiua-10711	21	56	8	8	NUM
aiua-10711	21	57	,	,	PUNCT
aiua-10711	21	58	13	13	NUM
aiua-10711	21	59	,	,	PUNCT
aiua-10711	21	60	adama	adama	PROPN
aiua-10711	21	61	ouattara	ouattara	NOUN
aiua-10711	21	62	9	9	NUM
aiua-10711	21	63	,	,	PUNCT
aiua-10711	21	64	13	13	NUM
aiua-10711	21	65	,	,	PUNCT
aiua-10711	21	66	gianpaolo	gianpaolo	NOUN
aiua-10711	21	67	perletti	perletti	NOUN
aiua-10711	21	68	10	10	NUM
aiua-10711	21	69	,	,	PUNCT
aiua-10711	21	70	13	13	NUM
aiua-10711	21	71	,	,	PUNCT
aiua-10711	21	72	joseph	joseph	PROPN
aiua-10711	21	73	philipraj	philipraj	PROPN
aiua-10711	21	74	11	11	NUM
aiua-10711	21	75	,	,	PUNCT
aiua-10711	21	76	13	13	NUM
aiua-10711	21	77	,	,	PUNCT
aiua-10711	21	78	alberto	alberto	PROPN
aiua-10711	21	79	trinchieri	trinchieri	PROPN
aiua-10711	21	80	12	12	NUM
aiua-10711	21	81	,	,	PUNCT
aiua-10711	21	82	13	13	NUM
aiua-10711	21	83	,	,	PUNCT
aiua-10711	21	84	noor	noor	PROPN
aiua-10711	21	85	buchholz	buchholz	PROPN
aiua-10711	21	86	13	13	NUM
aiua-10711	21	87	1	1	NUM
aiua-10711	21	88	smart	smart	ADJ
aiua-10711	21	89	health	health	NOUN
aiua-10711	21	90	tower	tower	NOUN
aiua-10711	21	91	,	,	PUNCT
aiua-10711	21	92	sulaymaniyah	sulaymaniyah	NOUN
aiua-10711	21	93	,	,	PUNCT
aiua-10711	21	94	kurdistan	kurdistan	PROPN
aiua-10711	21	95	region	region	NOUN
aiua-10711	21	96	,	,	PUNCT
aiua-10711	21	97	iraq	iraq	PROPN
aiua-10711	21	98	;	;	PUNCT
aiua-10711	21	99	2	2	NUM
aiua-10711	21	100	urology	urology	NOUN
aiua-10711	21	101	department	department	NOUN
aiua-10711	21	102	,	,	PUNCT
aiua-10711	21	103	hmc	hmc	PROPN
aiua-10711	21	104	,	,	PUNCT
aiua-10711	21	105	hamad	hamad	PROPN
aiua-10711	21	106	medical	medical	PROPN
aiua-10711	21	107	corporation	corporation	PROPN
aiua-10711	21	108	,	,	PUNCT
aiua-10711	21	109	qatar	qatar	PROPN
aiua-10711	21	110	;	;	PUNCT
aiua-10711	21	111	3	3	NUM
aiua-10711	21	112	department	department	NOUN
aiua-10711	21	113	of	of	ADP
aiua-10711	21	114	urology	urology	NOUN
aiua-10711	21	115	,	,	PUNCT
aiua-10711	21	116	zagazig	zagazig	PROPN
aiua-10711	21	117	university	university	PROPN
aiua-10711	21	118	,	,	PUNCT
aiua-10711	21	119	zagazig	zagazig	PROPN
aiua-10711	21	120	,	,	PUNCT
aiua-10711	21	121	sharkia	sharkia	PROPN
aiua-10711	21	122	,	,	PUNCT
aiua-10711	21	123	egypt	egypt	PROPN
aiua-10711	21	124	;	;	PUNCT
aiua-10711	21	125	4	4	NUM
aiua-10711	21	126	universidad	universidad	PROPN
aiua-10711	21	127	del	del	PROPN
aiua-10711	21	128	valle	valle	PROPN
aiua-10711	21	129	,	,	PUNCT
aiua-10711	21	130	cali	cali	PROPN
aiua-10711	21	131	,	,	PUNCT
aiua-10711	21	132	colombia	colombia	PROPN
aiua-10711	21	133	;	;	PUNCT
aiua-10711	21	134	5	5	NUM
aiua-10711	21	135	faculty	faculty	NOUN
aiua-10711	21	136	of	of	ADP
aiua-10711	21	137	medicine	medicine	NOUN
aiua-10711	21	138	algiers	algiers	PROPN
aiua-10711	21	139	1	1	NUM
aiua-10711	21	140	,	,	PUNCT
aiua-10711	21	141	algiers	algiers	PROPN
aiua-10711	21	142	,	,	PUNCT
aiua-10711	21	143	algeria	algeria	PROPN
aiua-10711	21	144	;	;	PUNCT
aiua-10711	21	145	6	6	NUM
aiua-10711	21	146	department	department	NOUN
aiua-10711	21	147	of	of	ADP
aiua-10711	21	148	urology	urology	NOUN
aiua-10711	21	149	,	,	PUNCT
aiua-10711	21	150	mercy	mercy	NOUN
aiua-10711	21	151	university	university	NOUN
aiua-10711	21	152	hospital	hospital	NOUN
aiua-10711	21	153	,	,	PUNCT
aiua-10711	21	154	cork	cork	NOUN
aiua-10711	21	155	,	,	PUNCT
aiua-10711	21	156	ireland	ireland	NOUN
aiua-10711	21	157	;	;	PUNCT
aiua-10711	21	158	7	7	NUM
aiua-10711	21	159	asst	asst	NOUN
aiua-10711	21	160	nord	nord	PROPN
aiua-10711	21	161	milano	milano	PROPN
aiua-10711	21	162	,	,	PUNCT
aiua-10711	21	163	milan	milan	PROPN
aiua-10711	21	164	,	,	PUNCT
aiua-10711	21	165	italy	italy	PROPN
aiua-10711	21	166	;	;	PUNCT
aiua-10711	21	167	8	8	NUM
aiua-10711	21	168	2nd	2nd	ADJ
aiua-10711	21	169	department	department	NOUN
aiua-10711	21	170	of	of	ADP
aiua-10711	21	171	urology	urology	NOUN
aiua-10711	21	172	,	,	PUNCT
aiua-10711	21	173	national	national	ADJ
aiua-10711	21	174	and	and	CCONJ
aiua-10711	21	175	kapodistrian	kapodistrian	ADJ
aiua-10711	21	176	university	university	PROPN
aiua-10711	21	177	of	of	ADP
aiua-10711	21	178	athens	athens	PROPN
aiua-10711	21	179	,	,	PUNCT
aiua-10711	21	180	sismanoglio	sismanoglio	PROPN
aiua-10711	21	181	hospital	hospital	PROPN
aiua-10711	21	182	,	,	PUNCT
aiua-10711	21	183	athens	athens	PROPN
aiua-10711	21	184	,	,	PUNCT
aiua-10711	21	185	greece	greece	PROPN
aiua-10711	21	186	;	;	PUNCT
aiua-10711	21	187	9	9	NUM
aiua-10711	21	188	division	division	NOUN
aiua-10711	21	189	of	of	ADP
aiua-10711	21	190	urology	urology	NOUN
aiua-10711	21	191	,	,	PUNCT
aiua-10711	21	192	souro	souro	NOUN
aiua-10711	21	193	sanou	sanou	PROPN
aiua-10711	21	194	university	university	NOUN
aiua-10711	21	195	teaching	teaching	NOUN
aiua-10711	21	196	hospital	hospital	NOUN
aiua-10711	21	197	,	,	PUNCT
aiua-10711	21	198	bobo	bobo	NOUN
aiua-10711	21	199	-	-	PUNCT
aiua-10711	21	200	dioulasso	dioulasso	PROPN
aiua-10711	21	201	,	,	PUNCT
aiua-10711	21	202	burkina	burkina	PROPN
aiua-10711	21	203	faso	faso	PROPN
aiua-10711	21	204	;	;	PUNCT
aiua-10711	21	205	10	10	NUM
aiua-10711	21	206	department	department	NOUN
aiua-10711	21	207	of	of	ADP
aiua-10711	21	208	biotechnology	biotechnology	NOUN
aiua-10711	21	209	and	and	CCONJ
aiua-10711	21	210	life	life	NOUN
aiua-10711	21	211	sciences	science	NOUN
aiua-10711	21	212	,	,	PUNCT
aiua-10711	21	213	section	section	NOUN
aiua-10711	21	214	of	of	ADP
aiua-10711	21	215	medical	medical	ADJ
aiua-10711	21	216	and	and	CCONJ
aiua-10711	21	217	surgical	surgical	ADJ
aiua-10711	21	218	sciences	science	NOUN
aiua-10711	21	219	,	,	PUNCT
aiua-10711	21	220	university	university	NOUN
aiua-10711	21	221	of	of	ADP
aiua-10711	21	222	insubria	insubria	PROPN
aiua-10711	21	223	,	,	PUNCT
aiua-10711	21	224	varese	varese	PROPN
aiua-10711	21	225	,	,	PUNCT
aiua-10711	21	226	italy	italy	PROPN
aiua-10711	21	227	;	;	PUNCT
aiua-10711	21	228	11	11	NUM
aiua-10711	21	229	department	department	NOUN
aiua-10711	21	230	of	of	ADP
aiua-10711	21	231	urology	urology	NOUN
aiua-10711	21	232	,	,	PUNCT
aiua-10711	21	233	mahatma	mahatma	PROPN
aiua-10711	21	234	gandhi	gandhi	PROPN
aiua-10711	21	235	medical	medical	PROPN
aiua-10711	21	236	college	college	PROPN
aiua-10711	21	237	and	and	CCONJ
aiua-10711	21	238	research	research	PROPN
aiua-10711	21	239	institute	institute	PROPN
aiua-10711	21	240	,	,	PUNCT
aiua-10711	21	241	sri	sri	PROPN
aiua-10711	21	242	balaji	balaji	PROPN
aiua-10711	21	243	vidyapeeth	vidyapeeth	PROPN
aiua-10711	21	244	,	,	PUNCT
aiua-10711	21	245	puducherry	puducherry	PROPN
aiua-10711	21	246	,	,	PUNCT
aiua-10711	21	247	india	india	PROPN
aiua-10711	21	248	;	;	PUNCT
aiua-10711	21	249	12	12	NUM
aiua-10711	21	250	urology	urology	NOUN
aiua-10711	21	251	school	school	NOUN
aiua-10711	21	252	,	,	PUNCT
aiua-10711	21	253	university	university	PROPN
aiua-10711	21	254	of	of	ADP
aiua-10711	21	255	milan	milan	PROPN
aiua-10711	21	256	,	,	PUNCT
aiua-10711	21	257	milan	milan	PROPN
aiua-10711	21	258	,	,	PUNCT
aiua-10711	21	259	italy	italy	PROPN
aiua-10711	21	260	;	;	PUNCT
aiua-10711	21	261	13	13	NUM
aiua-10711	21	262	u	u	NOUN
aiua-10711	21	263	-	-	ADJ
aiua-10711	21	264	merge	merge	PROPN
aiua-10711	21	265	ltd	ltd	PROPN
aiua-10711	21	266	.	.	PUNCT
aiua-10711	22	1	(	(	PUNCT
aiua-10711	22	2	urology	urology	NOUN
aiua-10711	22	3	for	for	ADP
aiua-10711	22	4	emerging	emerge	VERB
aiua-10711	22	5	countries	country	NOUN
aiua-10711	22	6	)	)	PUNCT
aiua-10711	22	7	,	,	PUNCT
aiua-10711	22	8	london	london	PROPN
aiua-10711	22	9	-	-	PUNCT
aiua-10711	22	10	athens	athens	PROPN
aiua-10711	22	11	-	-	PUNCT
aiua-10711	22	12	dubai	dubai	NOUN
aiua-10711	22	13	*	*	PUNCT
aiua-10711	22	14	.	.	PUNCT
aiua-10711	23	1	authors	author	NOUN
aiua-10711	23	2	1	1	NUM
aiua-10711	23	3	-	-	SYM
aiua-10711	23	4	12	12	NUM
aiua-10711	23	5	have	have	AUX
aiua-10711	23	6	equally	equally	ADV
aiua-10711	23	7	contributed	contribute	VERB
aiua-10711	23	8	to	to	ADP
aiua-10711	23	9	the	the	DET
aiua-10711	23	10	paper	paper	NOUN
aiua-10711	23	11	and	and	CCONJ
aiua-10711	23	12	share	share	VERB
aiua-10711	23	13	first	first	ADJ
aiua-10711	23	14	authorship	authorship	NOUN
aiua-10711	23	15	.	.	PUNCT
aiua-10711	24	1	*	*	PUNCT
aiua-10711	24	2	u	u	VERB
aiua-10711	24	3	-	-	ADJ
aiua-10711	24	4	merge	merge	ADJ
aiua-10711	24	5	ltd	ltd	PROPN
aiua-10711	24	6	.	.	PUNCT
aiua-10711	25	1	(	(	PUNCT
aiua-10711	25	2	urology	urology	NOUN
aiua-10711	25	3	for	for	ADP
aiua-10711	25	4	emerging	emerge	VERB
aiua-10711	25	5	countries	country	NOUN
aiua-10711	25	6	)	)	PUNCT
aiua-10711	25	7	is	be	AUX
aiua-10711	25	8	an	an	DET
aiua-10711	25	9	academic	academic	ADJ
aiua-10711	25	10	urological	urological	ADJ
aiua-10711	25	11	platform	platform	NOUN
aiua-10711	25	12	dedicated	dedicate	VERB
aiua-10711	25	13	to	to	PART
aiua-10711	25	14	facilitate	facilitate	VERB
aiua-10711	25	15	knowledge	knowledge	NOUN
aiua-10711	25	16	transfer	transfer	NOUN
aiua-10711	25	17	in	in	ADP
aiua-10711	25	18	urology	urology	NOUN
aiua-10711	25	19	on	on	ADP
aiua-10711	25	20	all	all	DET
aiua-10711	25	21	levels	level	NOUN
aiua-10711	25	22	from	from	ADP
aiua-10711	25	23	developed	develop	VERB
aiua-10711	25	24	to	to	ADP
aiua-10711	25	25	emerging	emerge	VERB
aiua-10711	25	26	countries	country	NOUN
aiua-10711	25	27	.	.	PUNCT
aiua-10711	26	1	u	u	ADJ
aiua-10711	26	2	-	-	ADJ
aiua-10711	26	3	merge	merge	PROPN
aiua-10711	26	4	ltd	ltd	PROPN
aiua-10711	26	5	.	.	PROPN
aiua-10711	26	6	is	be	AUX
aiua-10711	26	7	registered	register	VERB
aiua-10711	26	8	with	with	ADP
aiua-10711	26	9	the	the	DET
aiua-10711	26	10	companies	company	NOUN
aiua-10711	26	11	house	house	VERB
aiua-10711	26	12	in	in	ADP
aiua-10711	26	13	london/	london/	NUM
aiua-10711	26	14	uk	uk	PROPN
aiua-10711	26	15	.	.	PUNCT
aiua-10711	27	1	www.u-merge.com	www.u-merge.com	PROPN
aiua-10711	27	2	.	.	PUNCT
aiua-10711	28	1	doi	doi	NOUN
aiua-10711	28	2	:	:	PUNCT
aiua-10711	28	3	10.4081	10.4081	NUM
aiua-10711	28	4	/	/	SYM
aiua-10711	28	5	aiua.2022.2.252	aiua.2022.2.252	PROPN
aiua-10711	28	6	summary	summary	NOUN
aiua-10711	28	7	no	no	DET
aiua-10711	28	8	statistically	statistically	ADV
aiua-10711	28	9	significant	significant	ADJ
aiua-10711	28	10	differences	difference	NOUN
aiua-10711	28	11	in	in	ADP
aiua-10711	28	12	the	the	DET
aiua-10711	28	13	odds	odd	NOUN
aiua-10711	28	14	of	of	ADP
aiua-10711	28	15	erectile	erectile	ADJ
aiua-10711	28	16	dysfunction	dysfunction	NOUN
aiua-10711	28	17	were	be	AUX
aiua-10711	28	18	observed	observe	VERB
aiua-10711	28	19	when	when	SCONJ
aiua-10711	28	20	alpha	alpha	NOUN
aiua-10711	28	21	-	-	PUNCT
aiua-10711	28	22	blockers	blocker	NOUN
aiua-10711	28	23	were	be	AUX
aiua-10711	28	24	compared	compare	VERB
aiua-10711	28	25	to	to	ADP
aiua-10711	28	26	placebo	placebo	NOUN
aiua-10711	28	27	.	.	PUNCT
aiua-10711	29	1	key	key	ADJ
aiua-10711	29	2	words	word	NOUN
aiua-10711	29	3	:	:	PUNCT
aiua-10711	29	4	alpha	alpha	NOUN
aiua-10711	29	5	-	-	PUNCT
aiua-10711	29	6	blockers	blocker	NOUN
aiua-10711	29	7	;	;	PUNCT
aiua-10711	29	8	ejaculation	ejaculation	NOUN
aiua-10711	29	9	;	;	PUNCT
aiua-10711	29	10	erectile	erectile	ADJ
aiua-10711	29	11	dysfunction	dysfunction	NOUN
aiua-10711	29	12	;	;	PUNCT
aiua-10711	29	13	silodosin	silodosin	NOUN
aiua-10711	29	14	;	;	PUNCT
aiua-10711	29	15	tamsulosin	tamsulosin	NOUN
aiua-10711	29	16	;	;	PUNCT
aiua-10711	29	17	alfuzosin	alfuzosin	NOUN
aiua-10711	29	18	;	;	PUNCT
aiua-10711	29	19	doxazosin	doxazosin	VERB
aiua-10711	29	20	;	;	PUNCT
aiua-10711	29	21	terazosin	terazosin	NOUN
aiua-10711	29	22	.	.	PUNCT
aiua-10711	29	23	submitted	submit	VERB
aiua-10711	29	24	11	11	NUM
aiua-10711	29	25	february	february	NOUN
aiua-10711	29	26	2022	2022	NUM
aiua-10711	29	27	;	;	PUNCT
aiua-10711	29	28	accepted	accept	VERB
aiua-10711	29	29	24	24	NUM
aiua-10711	29	30	march	march	NOUN
aiua-10711	29	31	2022	2022	NUM
aiua-10711	29	32	253archivio	253archivio	PROPN
aiua-10711	29	33	italiano	italiano	ADJ
aiua-10711	29	34	di	di	NOUN
aiua-10711	29	35	urologia	urologia	PROPN
aiua-10711	29	36	e	e	PROPN
aiua-10711	29	37	andrologia	andrologia	PROPN
aiua-10711	29	38	2022	2022	NUM
aiua-10711	29	39	;	;	PUNCT
aiua-10711	29	40	94	94	NUM
aiua-10711	29	41	,	,	PUNCT
aiua-10711	29	42	2	2	NUM
aiua-10711	29	43	sexual	sexual	ADJ
aiua-10711	29	44	function	function	NOUN
aiua-10711	29	45	and	and	CCONJ
aiua-10711	29	46	alpha	alpha	NOUN
aiua-10711	29	47	-	-	PUNCT
aiua-10711	29	48	blockers	blocker	NOUN
aiua-10711	29	49	adrenergic	adrenergic	ADJ
aiua-10711	29	50	blocking	block	VERB
aiua-10711	29	51	agents	agent	NOUN
aiua-10711	29	52	depend	depend	VERB
aiua-10711	29	53	on	on	ADP
aiua-10711	29	54	their	their	PRON
aiua-10711	29	55	selectivity	selectivity	NOUN
aiua-10711	29	56	(	(	PUNCT
aiua-10711	29	57	or	or	CCONJ
aiua-10711	29	58	non	non	ADJ
aiua-10711	29	59	-	-	ADJ
aiua-10711	29	60	selectivity	selectivity	ADJ
aiua-10711	29	61	)	)	PUNCT
aiua-10711	29	62	for	for	ADP
aiua-10711	29	63	specific	specific	ADJ
aiua-10711	29	64	receptor	receptor	NOUN
aiua-10711	29	65	subtypes	subtype	NOUN
aiua-10711	29	66	.	.	PUNCT
aiua-10711	30	1	nonselective	nonselective	ADJ
aiua-10711	30	2	alpha-1	alpha-1	NOUN
aiua-10711	30	3	-	-	PUNCT
aiua-10711	30	4	adrenergic	adrenergic	ADJ
aiua-10711	30	5	antagonists	antagonist	NOUN
aiua-10711	30	6	have	have	AUX
aiua-10711	30	7	been	be	AUX
aiua-10711	30	8	used	use	VERB
aiua-10711	30	9	for	for	ADP
aiua-10711	30	10	decades	decade	NOUN
aiua-10711	30	11	against	against	ADP
aiua-10711	30	12	hypertension	hypertension	NOUN
aiua-10711	30	13	.	.	PUNCT
aiua-10711	31	1	blockade	blockade	NOUN
aiua-10711	31	2	of	of	ADP
aiua-10711	31	3	alpha1b	alpha1b	NOUN
aiua-10711	31	4	receptors	receptor	NOUN
aiua-10711	31	5	can	can	AUX
aiua-10711	31	6	decrease	decrease	VERB
aiua-10711	31	7	vascular	vascular	ADJ
aiua-10711	31	8	resistance	resistance	NOUN
aiua-10711	31	9	in	in	ADP
aiua-10711	31	10	peripheral	peripheral	ADJ
aiua-10711	31	11	arterioles	arteriole	NOUN
aiua-10711	31	12	and	and	CCONJ
aiua-10711	31	13	increase	increase	VERB
aiua-10711	31	14	venous	venous	ADJ
aiua-10711	31	15	capacitance	capacitance	NOUN
aiua-10711	31	16	,	,	PUNCT
aiua-10711	31	17	ultimately	ultimately	ADV
aiua-10711	31	18	lowering	lower	VERB
aiua-10711	31	19	blood	blood	NOUN
aiua-10711	31	20	pressure	pressure	NOUN
aiua-10711	31	21	(	(	PUNCT
aiua-10711	31	22	3	3	NUM
aiua-10711	31	23	)	)	PUNCT
aiua-10711	31	24	.	.	PUNCT
aiua-10711	32	1	at	at	ADP
aiua-10711	32	2	present	present	ADJ
aiua-10711	32	3	,	,	PUNCT
aiua-10711	32	4	alpha1	alpha1	NOUN
aiua-10711	32	5	adrenergic	adrenergic	ADJ
aiua-10711	32	6	antagonists	antagonist	NOUN
aiua-10711	32	7	are	be	AUX
aiua-10711	32	8	no	no	ADV
aiua-10711	32	9	longer	long	ADV
aiua-10711	32	10	recommended	recommend	VERB
aiua-10711	32	11	as	as	ADP
aiua-10711	32	12	monotherapy	monotherapy	NOUN
aiua-10711	32	13	,	,	PUNCT
aiua-10711	32	14	but	but	CCONJ
aiua-10711	32	15	only	only	ADV
aiua-10711	32	16	as	as	ADP
aiua-10711	32	17	adjunctive	adjunctive	ADJ
aiua-10711	32	18	treatment	treatment	NOUN
aiua-10711	32	19	of	of	ADP
aiua-10711	32	20	hypertension	hypertension	NOUN
aiua-10711	32	21	(	(	PUNCT
aiua-10711	32	22	4	4	NUM
aiua-10711	32	23	)	)	PUNCT
aiua-10711	32	24	.	.	PUNCT
aiua-10711	33	1	alpha-1	alpha-1	NOUN
aiua-10711	33	2	-	-	PUNCT
aiua-10711	33	3	blockers	blocker	NOUN
aiua-10711	33	4	are	be	AUX
aiua-10711	33	5	used	use	VERB
aiua-10711	33	6	for	for	ADP
aiua-10711	33	7	the	the	DET
aiua-10711	33	8	treatment	treatment	NOUN
aiua-10711	33	9	of	of	ADP
aiua-10711	33	10	symptoms	symptom	NOUN
aiua-10711	33	11	of	of	ADP
aiua-10711	33	12	urinary	urinary	ADJ
aiua-10711	33	13	obstruction	obstruction	NOUN
aiua-10711	33	14	due	due	ADP
aiua-10711	33	15	to	to	ADP
aiua-10711	33	16	benign	benign	ADJ
aiua-10711	33	17	prostatic	prostatic	ADJ
aiua-10711	33	18	hyperplasia	hyperplasia	NOUN
aiua-10711	33	19	because	because	SCONJ
aiua-10711	33	20	they	they	PRON
aiua-10711	33	21	can	can	AUX
aiua-10711	33	22	relax	relax	VERB
aiua-10711	33	23	the	the	DET
aiua-10711	33	24	smooth	smooth	ADJ
aiua-10711	33	25	muscle	muscle	NOUN
aiua-10711	33	26	fiber	fiber	NOUN
aiua-10711	33	27	in	in	ADP
aiua-10711	33	28	the	the	DET
aiua-10711	33	29	bladder	bladder	NOUN
aiua-10711	33	30	neck	neck	NOUN
aiua-10711	33	31	and	and	CCONJ
aiua-10711	33	32	in	in	ADP
aiua-10711	33	33	the	the	DET
aiua-10711	33	34	prostate	prostate	NOUN
aiua-10711	33	35	acting	act	VERB
aiua-10711	33	36	on	on	ADP
aiua-10711	33	37	alpha1a	alpha1a	NOUN
aiua-10711	33	38	receptors	receptor	NOUN
aiua-10711	33	39	.	.	PUNCT
aiua-10711	34	1	initially	initially	ADV
aiua-10711	34	2	,	,	PUNCT
aiua-10711	34	3	nonselective	nonselective	ADJ
aiua-10711	34	4	alpha-1	alpha-1	NOUN
aiua-10711	34	5	adrenergic	adrenergic	ADJ
aiua-10711	34	6	antagonists	antagonist	NOUN
aiua-10711	34	7	such	such	ADJ
aiua-10711	34	8	as	as	ADP
aiua-10711	34	9	doxazosin	doxazosin	NOUN
aiua-10711	34	10	,	,	PUNCT
aiua-10711	34	11	terazosin	terazosin	NOUN
aiua-10711	34	12	and	and	CCONJ
aiua-10711	34	13	alfuzosin	alfuzosin	NOUN
aiua-10711	34	14	were	be	AUX
aiua-10711	34	15	used	use	VERB
aiua-10711	34	16	for	for	ADP
aiua-10711	34	17	the	the	DET
aiua-10711	34	18	management	management	NOUN
aiua-10711	34	19	of	of	ADP
aiua-10711	34	20	bladder	bladder	NOUN
aiua-10711	34	21	neck	neck	NOUN
aiua-10711	34	22	obstruction	obstruction	NOUN
aiua-10711	34	23	(	(	PUNCT
aiua-10711	34	24	5	5	NUM
aiua-10711	34	25	)	)	PUNCT
aiua-10711	34	26	.	.	PUNCT
aiua-10711	35	1	selective	selective	ADJ
aiua-10711	35	2	alpha1a	alpha1a	NOUN
aiua-10711	35	3	blockers	blocker	NOUN
aiua-10711	35	4	with	with	ADP
aiua-10711	35	5	high	high	ADJ
aiua-10711	35	6	affinity	affinity	NOUN
aiua-10711	35	7	for	for	ADP
aiua-10711	35	8	the	the	DET
aiua-10711	35	9	alpha1a	alpha1a	NOUN
aiua-10711	35	10	adrenergic	adrenergic	ADJ
aiua-10711	35	11	receptor	receptor	NOUN
aiua-10711	35	12	,	,	PUNCT
aiua-10711	35	13	as	as	ADP
aiua-10711	35	14	tamsulosin	tamsulosin	NOUN
aiua-10711	35	15	and	and	CCONJ
aiua-10711	35	16	silodosin	silodosin	NOUN
aiua-10711	35	17	,	,	PUNCT
aiua-10711	35	18	have	have	AUX
aiua-10711	35	19	been	be	AUX
aiua-10711	35	20	subsequently	subsequently	ADV
aiua-10711	35	21	developed	develop	VERB
aiua-10711	35	22	to	to	PART
aiua-10711	35	23	be	be	AUX
aiua-10711	35	24	specifically	specifically	ADV
aiua-10711	35	25	used	use	VERB
aiua-10711	35	26	in	in	ADP
aiua-10711	35	27	benign	benign	ADJ
aiua-10711	35	28	prostatic	prostatic	ADJ
aiua-10711	35	29	hyperplasia	hyperplasia	NOUN
aiua-10711	35	30	.	.	PUNCT
aiua-10711	36	1	selectivity	selectivity	NOUN
aiua-10711	36	2	of	of	ADP
aiua-10711	36	3	these	these	DET
aiua-10711	36	4	agents	agent	NOUN
aiua-10711	36	5	was	be	AUX
aiua-10711	36	6	aimed	aim	VERB
aiua-10711	36	7	at	at	ADP
aiua-10711	36	8	decreasing	decrease	VERB
aiua-10711	36	9	their	their	PRON
aiua-10711	36	10	effect	effect	NOUN
aiua-10711	36	11	on	on	ADP
aiua-10711	36	12	blood	blood	NOUN
aiua-10711	36	13	pressure	pressure	NOUN
aiua-10711	36	14	and	and	CCONJ
aiua-10711	36	15	at	at	ADP
aiua-10711	36	16	reducing	reduce	VERB
aiua-10711	36	17	the	the	DET
aiua-10711	36	18	risk	risk	NOUN
aiua-10711	36	19	of	of	ADP
aiua-10711	36	20	unwanted	unwanted	ADJ
aiua-10711	36	21	effects	effect	NOUN
aiua-10711	36	22	,	,	PUNCT
aiua-10711	36	23	such	such	ADJ
aiua-10711	36	24	as	as	ADP
aiua-10711	36	25	postural	postural	ADJ
aiua-10711	36	26	hypotension	hypotension	NOUN
aiua-10711	36	27	.	.	PUNCT
aiua-10711	37	1	alpha1d	alpha1d	NOUN
aiua-10711	37	2	-	-	PUNCT
aiua-10711	37	3	adrenoceptor	adrenoceptor	NOUN
aiua-10711	37	4	antagonists	antagonist	NOUN
aiua-10711	37	5	have	have	AUX
aiua-10711	37	6	also	also	ADV
aiua-10711	37	7	been	be	AUX
aiua-10711	37	8	shown	show	VERB
aiua-10711	37	9	to	to	PART
aiua-10711	37	10	be	be	AUX
aiua-10711	37	11	effective	effective	ADJ
aiua-10711	37	12	in	in	ADP
aiua-10711	37	13	alleviating	alleviate	VERB
aiua-10711	37	14	both	both	CCONJ
aiua-10711	37	15	voiding	void	VERB
aiua-10711	37	16	and	and	CCONJ
aiua-10711	37	17	storage	storage	NOUN
aiua-10711	37	18	luts	luts	PROPN
aiua-10711	37	19	associated	associate	VERB
aiua-10711	37	20	with	with	ADP
aiua-10711	37	21	bph	bph	NOUN
aiua-10711	37	22	.	.	PUNCT
aiua-10711	38	1	naftopidil	naftopidil	NOUN
aiua-10711	38	2	is	be	AUX
aiua-10711	38	3	an	an	DET
aiua-10711	38	4	alpha-1	alpha-1	NUM
aiua-10711	38	5	adrenoceptor	adrenoceptor	NOUN
aiua-10711	38	6	antagonist	antagonist	NOUN
aiua-10711	38	7	with	with	ADP
aiua-10711	38	8	a	a	DET
aiua-10711	38	9	distinct	distinct	ADJ
aiua-10711	38	10	selectivity	selectivity	NOUN
aiua-10711	38	11	for	for	ADP
aiua-10711	38	12	the	the	DET
aiua-10711	38	13	alpha1d	alpha1d	NOUN
aiua-10711	38	14	receptor	receptor	NOUN
aiua-10711	38	15	showing	show	VERB
aiua-10711	38	16	a	a	DET
aiua-10711	38	17	threefold	threefold	ADJ
aiua-10711	38	18	selectivity	selectivity	NOUN
aiua-10711	38	19	for	for	ADP
aiua-10711	38	20	the	the	DET
aiua-10711	38	21	alpha1d	alpha1d	NOUN
aiua-10711	38	22	-	-	PUNCT
aiua-10711	38	23	adrenoceptor	adrenoceptor	NOUN
aiua-10711	38	24	compared	compare	VERB
aiua-10711	38	25	to	to	ADP
aiua-10711	38	26	the	the	DET
aiua-10711	38	27	alpha1a	alpha1a	NOUN
aiua-10711	38	28	-	-	PUNCT
aiua-10711	38	29	adrenoceptor	adrenoceptor	NOUN
aiua-10711	38	30	(	(	PUNCT
aiua-10711	38	31	6	6	NUM
aiua-10711	38	32	)	)	PUNCT
aiua-10711	38	33	.	.	PUNCT
aiua-10711	39	1	it	it	PRON
aiua-10711	39	2	is	be	AUX
aiua-10711	39	3	used	use	VERB
aiua-10711	39	4	for	for	ADP
aiua-10711	39	5	bph	bph	NOUN
aiua-10711	39	6	management	management	NOUN
aiua-10711	39	7	in	in	ADP
aiua-10711	39	8	japan	japan	PROPN
aiua-10711	39	9	because	because	SCONJ
aiua-10711	39	10	of	of	ADP
aiua-10711	39	11	its	its	PRON
aiua-10711	39	12	fewer	few	ADJ
aiua-10711	39	13	side	side	NOUN
aiua-10711	39	14	effects	effect	NOUN
aiua-10711	39	15	,	,	PUNCT
aiua-10711	39	16	but	but	CCONJ
aiua-10711	39	17	there	there	PRON
aiua-10711	39	18	is	be	VERB
aiua-10711	39	19	limited	limited	ADJ
aiua-10711	39	20	evidence	evidence	NOUN
aiua-10711	39	21	of	of	ADP
aiua-10711	39	22	its	its	PRON
aiua-10711	39	23	effectiveness	effectiveness	NOUN
aiua-10711	39	24	in	in	ADP
aiua-10711	39	25	other	other	ADJ
aiua-10711	39	26	populations	population	NOUN
aiua-10711	39	27	(	(	PUNCT
aiua-10711	39	28	7	7	NUM
aiua-10711	39	29	)	)	PUNCT
aiua-10711	39	30	.	.	PUNCT
aiua-10711	40	1	alpha-1	alpha-1	NOUN
aiua-10711	40	2	-	-	PUNCT
aiua-10711	40	3	adrenergic	adrenergic	ADJ
aiua-10711	40	4	antagonists	antagonist	NOUN
aiua-10711	40	5	are	be	AUX
aiua-10711	40	6	also	also	ADV
aiua-10711	40	7	used	use	VERB
aiua-10711	40	8	to	to	PART
aiua-10711	40	9	facilitate	facilitate	VERB
aiua-10711	40	10	the	the	DET
aiua-10711	40	11	spontaneous	spontaneous	ADJ
aiua-10711	40	12	passage	passage	NOUN
aiua-10711	40	13	of	of	ADP
aiua-10711	40	14	stones	stone	NOUN
aiua-10711	40	15	in	in	ADP
aiua-10711	40	16	the	the	DET
aiua-10711	40	17	distal	distal	ADJ
aiua-10711	40	18	ureter	ureter	NOUN
aiua-10711	40	19	.	.	PUNCT
aiua-10711	41	1	when	when	SCONJ
aiua-10711	41	2	alpha-1	alpha-1	NOUN
aiua-10711	41	3	-	-	PUNCT
aiua-10711	41	4	adrenergic	adrenergic	ADJ
aiua-10711	41	5	antagonists	antagonist	NOUN
aiua-10711	41	6	are	be	AUX
aiua-10711	41	7	administered	administer	VERB
aiua-10711	41	8	for	for	ADP
aiua-10711	41	9	benign	benign	ADJ
aiua-10711	41	10	prostatic	prostatic	ADJ
aiua-10711	41	11	hyperplasia	hyperplasia	NOUN
aiua-10711	41	12	and	and	CCONJ
aiua-10711	41	13	for	for	ADP
aiua-10711	41	14	medical	medical	ADJ
aiua-10711	41	15	expulsive	expulsive	PROPN
aiua-10711	41	16	therapy	therapy	NOUN
aiua-10711	41	17	,	,	PUNCT
aiua-10711	41	18	their	their	PRON
aiua-10711	41	19	effect	effect	NOUN
aiua-10711	41	20	at	at	ADP
aiua-10711	41	21	various	various	ADJ
aiua-10711	41	22	sites	site	NOUN
aiua-10711	41	23	of	of	ADP
aiua-10711	41	24	the	the	DET
aiua-10711	41	25	uro	uro	NOUN
aiua-10711	41	26	-	-	PUNCT
aiua-10711	41	27	genital	genital	ADJ
aiua-10711	41	28	tract	tract	NOUN
aiua-10711	41	29	may	may	AUX
aiua-10711	41	30	affect	affect	VERB
aiua-10711	41	31	sexual	sexual	ADJ
aiua-10711	41	32	function	function	NOUN
aiua-10711	41	33	,	,	PUNCT
aiua-10711	41	34	with	with	ADP
aiua-10711	41	35	differences	difference	NOUN
aiua-10711	41	36	between	between	ADP
aiua-10711	41	37	drugs	drug	NOUN
aiua-10711	41	38	within	within	ADP
aiua-10711	41	39	the	the	DET
aiua-10711	41	40	same	same	ADJ
aiua-10711	41	41	class	class	NOUN
aiua-10711	41	42	.	.	PUNCT
aiua-10711	42	1	the	the	DET
aiua-10711	42	2	aim	aim	NOUN
aiua-10711	42	3	of	of	ADP
aiua-10711	42	4	this	this	DET
aiua-10711	42	5	study	study	NOUN
aiua-10711	42	6	is	be	AUX
aiua-10711	42	7	to	to	PART
aiua-10711	42	8	review	review	VERB
aiua-10711	42	9	the	the	DET
aiua-10711	42	10	existing	exist	VERB
aiua-10711	42	11	evidence	evidence	NOUN
aiua-10711	42	12	on	on	ADP
aiua-10711	42	13	the	the	DET
aiua-10711	42	14	effect	effect	NOUN
aiua-10711	42	15	of	of	ADP
aiua-10711	42	16	alpha-1	alpha-1	NOUN
aiua-10711	42	17	-	-	PUNCT
aiua-10711	42	18	adrenergic	adrenergic	ADJ
aiua-10711	42	19	antagonists	antagonist	NOUN
aiua-10711	42	20	on	on	ADP
aiua-10711	42	21	sexual	sexual	ADJ
aiua-10711	42	22	function	function	NOUN
aiua-10711	42	23	.	.	PUNCT
aiua-10711	43	1	materials	material	NOUN
aiua-10711	43	2	and	and	CCONJ
aiua-10711	43	3	methods	method	NOUN
aiua-10711	43	4	the	the	DET
aiua-10711	43	5	review	review	NOUN
aiua-10711	43	6	was	be	AUX
aiua-10711	43	7	conducted	conduct	VERB
aiua-10711	43	8	in	in	ADP
aiua-10711	43	9	accordance	accordance	NOUN
aiua-10711	43	10	with	with	ADP
aiua-10711	43	11	prisma	prisma	NOUN
aiua-10711	43	12	(	(	PUNCT
aiua-10711	43	13	preferred	prefer	VERB
aiua-10711	43	14	reporting	reporting	NOUN
aiua-10711	43	15	items	item	NOUN
aiua-10711	43	16	for	for	ADP
aiua-10711	43	17	systematic	systematic	ADJ
aiua-10711	43	18	reviews	review	NOUN
aiua-10711	43	19	and	and	CCONJ
aiua-10711	43	20	metaanalyses	metaanalyse	NOUN
aiua-10711	43	21	)	)	PUNCT
aiua-10711	43	22	guidelines	guideline	NOUN
aiua-10711	43	23	(	(	PUNCT
aiua-10711	43	24	8)	8)	NUM
aiua-10711	43	25	.	.	PUNCT
aiua-10711	44	1	it	it	PRON
aiua-10711	44	2	was	be	AUX
aiua-10711	44	3	registered	register	VERB
aiua-10711	44	4	on	on	ADP
aiua-10711	44	5	the	the	DET
aiua-10711	44	6	prospero	prospero	NOUN
aiua-10711	44	7	platform	platform	NOUN
aiua-10711	44	8	as	as	ADP
aiua-10711	44	9	crd42021283385	crd42021283385	NOUN
aiua-10711	44	10	.	.	PUNCT
aiua-10711	45	1	we	we	PRON
aiua-10711	45	2	included	include	VERB
aiua-10711	45	3	in	in	ADP
aiua-10711	45	4	this	this	DET
aiua-10711	45	5	review	review	NOUN
aiua-10711	45	6	randomized	randomize	VERB
aiua-10711	45	7	controlled	control	VERB
aiua-10711	45	8	trials	trial	NOUN
aiua-10711	45	9	(	(	PUNCT
aiua-10711	45	10	rcts	rct	NOUN
aiua-10711	45	11	)	)	PUNCT
aiua-10711	45	12	,	,	PUNCT
aiua-10711	45	13	with	with	ADP
aiua-10711	45	14	single	single	ADJ
aiua-10711	45	15	/	/	SYM
aiua-10711	45	16	double	double	ADJ
aiua-10711	45	17	blinded	blind	VERB
aiua-10711	45	18	design	design	NOUN
aiua-10711	45	19	involving	involve	VERB
aiua-10711	45	20	participants	participant	NOUN
aiua-10711	45	21	of	of	ADP
aiua-10711	45	22	any	any	DET
aiua-10711	45	23	age	age	NOUN
aiua-10711	45	24	or	or	CCONJ
aiua-10711	45	25	ethnicity	ethnicity	NOUN
aiua-10711	45	26	who	who	PRON
aiua-10711	45	27	were	be	AUX
aiua-10711	45	28	treated	treat	VERB
aiua-10711	45	29	with	with	ADP
aiua-10711	45	30	alpha	alpha	ADJ
aiua-10711	45	31	adrenergic	adrenergic	ADJ
aiua-10711	45	32	receptor	receptor	NOUN
aiua-10711	45	33	antagonists	antagonist	NOUN
aiua-10711	45	34	for	for	ADP
aiua-10711	45	35	different	different	ADJ
aiua-10711	45	36	conditions	condition	NOUN
aiua-10711	45	37	such	such	ADJ
aiua-10711	45	38	as	as	ADP
aiua-10711	45	39	arterial	arterial	ADJ
aiua-10711	45	40	hypertension	hypertension	NOUN
aiua-10711	45	41	,	,	PUNCT
aiua-10711	45	42	bladder	bladder	NOUN
aiua-10711	45	43	neck	neck	NOUN
aiua-10711	45	44	obstruction	obstruction	NOUN
aiua-10711	45	45	by	by	ADP
aiua-10711	45	46	benign	benign	ADJ
aiua-10711	45	47	prostatic	prostatic	ADJ
aiua-10711	45	48	hyperplasia	hyperplasia	NOUN
aiua-10711	45	49	(	(	PUNCT
aiua-10711	45	50	bph	bph	NOUN
aiua-10711	45	51	)	)	PUNCT
aiua-10711	45	52	or	or	CCONJ
aiua-10711	45	53	ureteral	ureteral	ADJ
aiua-10711	45	54	obstruction	obstruction	NOUN
aiua-10711	45	55	by	by	ADP
aiua-10711	45	56	ureteral	ureteral	ADJ
aiua-10711	45	57	stones	stone	NOUN
aiua-10711	45	58	(	(	PUNCT
aiua-10711	45	59	medical	medical	ADJ
aiua-10711	45	60	expulsive	expulsive	ADJ
aiua-10711	45	61	treatment	treatment	NOUN
aiua-10711	45	62	or	or	CCONJ
aiua-10711	45	63	met	meet	VERB
aiua-10711	45	64	)	)	PUNCT
aiua-10711	45	65	.	.	PUNCT
aiua-10711	46	1	the	the	DET
aiua-10711	46	2	following	follow	VERB
aiua-10711	46	3	outcomes	outcome	NOUN
aiua-10711	46	4	were	be	AUX
aiua-10711	46	5	considered	consider	VERB
aiua-10711	46	6	:	:	PUNCT
aiua-10711	46	7	(	(	PUNCT
aiua-10711	46	8	i	i	NOUN
aiua-10711	46	9	)	)	PUNCT
aiua-10711	46	10	rate	rate	NOUN
aiua-10711	46	11	of	of	ADP
aiua-10711	46	12	ejaculatory	ejaculatory	ADJ
aiua-10711	46	13	disorders	disorder	NOUN
aiua-10711	46	14	,	,	PUNCT
aiua-10711	46	15	(	(	PUNCT
aiua-10711	46	16	ii	ii	NOUN
aiua-10711	46	17	)	)	PUNCT
aiua-10711	46	18	rate	rate	NOUN
aiua-10711	46	19	of	of	ADP
aiua-10711	46	20	erectile	erectile	NOUN
aiua-10711	46	21	disorders	disorder	NOUN
aiua-10711	46	22	,	,	PUNCT
aiua-10711	46	23	(	(	PUNCT
aiua-10711	46	24	iii	iii	X
aiua-10711	46	25	)	)	PUNCT
aiua-10711	46	26	scores	score	NOUN
aiua-10711	46	27	of	of	ADP
aiua-10711	46	28	tests	test	NOUN
aiua-10711	46	29	measuring	measure	VERB
aiua-10711	46	30	erectile	erectile	NOUN
aiua-10711	46	31	(	(	PUNCT
aiua-10711	46	32	iief-5	iief-5	NUM
aiua-10711	46	33	)	)	PUNCT
aiua-10711	46	34	or	or	CCONJ
aiua-10711	46	35	ejaculatory	ejaculatory	NOUN
aiua-10711	46	36	activity	activity	NOUN
aiua-10711	46	37	(	(	PUNCT
aiua-10711	46	38	mshq	mshq	PROPN
aiua-10711	46	39	-	-	PUNCT
aiua-10711	46	40	ejd	ejd	PROPN
aiua-10711	46	41	,	,	PUNCT
aiua-10711	46	42	dan	dan	PROPN
aiua-10711	46	43	-	-	PUNCT
aiua-10711	46	44	psssex	psssex	PROPN
aiua-10711	46	45	)	)	PUNCT
aiua-10711	46	46	.	.	PUNCT
aiua-10711	47	1	two	two	NUM
aiua-10711	47	2	electronic	electronic	ADJ
aiua-10711	47	3	databases	database	NOUN
aiua-10711	47	4	(	(	PUNCT
aiua-10711	47	5	pubmed	pubmed	NOUN
aiua-10711	47	6	and	and	CCONJ
aiua-10711	47	7	embase	embase	NOUN
aiua-10711	47	8	)	)	PUNCT
aiua-10711	47	9	were	be	AUX
aiua-10711	47	10	searched	search	VERB
aiua-10711	47	11	for	for	ADP
aiua-10711	47	12	articles	article	NOUN
aiua-10711	47	13	published	publish	VERB
aiua-10711	47	14	up	up	ADP
aiua-10711	47	15	to	to	ADP
aiua-10711	47	16	september	september	PROPN
aiua-10711	47	17	30th	30th	NUM
aiua-10711	47	18	,	,	PUNCT
aiua-10711	47	19	2021	2021	NUM
aiua-10711	47	20	.	.	PUNCT
aiua-10711	48	1	database	database	NOUN
aiua-10711	48	2	interrogation	interrogation	NOUN
aiua-10711	48	3	was	be	AUX
aiua-10711	48	4	performed	perform	VERB
aiua-10711	48	5	using	use	VERB
aiua-10711	48	6	specific	specific	ADJ
aiua-10711	48	7	search	search	NOUN
aiua-10711	48	8	strings	string	NOUN
aiua-10711	48	9	;	;	PUNCT
aiua-10711	48	10	for	for	ADP
aiua-10711	48	11	example	example	NOUN
aiua-10711	48	12	,	,	PUNCT
aiua-10711	48	13	the	the	DET
aiua-10711	48	14	pubmed	pubmed	PROPN
aiua-10711	48	15	search	search	PROPN
aiua-10711	48	16	was	be	AUX
aiua-10711	48	17	preferentially	preferentially	ADV
aiua-10711	48	18	based	base	VERB
aiua-10711	48	19	on	on	ADP
aiua-10711	48	20	mesh	mesh	NOUN
aiua-10711	48	21	terms	term	NOUN
aiua-10711	48	22	{	{	PUNCT
aiua-10711	48	23	(	(	PUNCT
aiua-10711	48	24	'	'	PUNCT
aiua-10711	48	25	adrenergic	adrenergic	ADJ
aiua-10711	48	26	alphaantagonists'/exp	alphaantagonists'/exp	NOUN
aiua-10711	48	27	or	or	CCONJ
aiua-10711	48	28	'	'	PUNCT
aiua-10711	48	29	adrenergic	adrenergic	ADJ
aiua-10711	48	30	alpha	alpha	NOUN
aiua-10711	48	31	-	-	PUNCT
aiua-10711	48	32	antagonists	antagonist	NOUN
aiua-10711	48	33	'	'	PART
aiua-10711	48	34	or	or	CCONJ
aiua-10711	48	35	(	(	PUNCT
aiua-10711	48	36	adrenergic	adrenergic	ADJ
aiua-10711	48	37	and	and	CCONJ
aiua-10711	48	38	'	'	PUNCT
aiua-10711	48	39	alpha	alpha	NOUN
aiua-10711	48	40	antagonists	antagonist	NOUN
aiua-10711	48	41	'	'	PART
aiua-10711	48	42	)	)	PUNCT
aiua-10711	48	43	or	or	CCONJ
aiua-10711	48	44	'	'	PUNCT
aiua-10711	48	45	alfuzosin'/exp	alfuzosin'/exp	PRON
aiua-10711	48	46	or	or	CCONJ
aiua-10711	48	47	alfuzosin	alfuzosin	VERB
aiua-10711	48	48	or	or	CCONJ
aiua-10711	48	49	'	'	PUNCT
aiua-10711	48	50	silodosin'/exp	silodosin'/exp	NOUN
aiua-10711	48	51	or	or	CCONJ
aiua-10711	48	52	silodosin	silodosin	VERB
aiua-10711	48	53	or	or	CCONJ
aiua-10711	48	54	'	'	NUM
aiua-10711	48	55	tamsulosin'/exp	tamsulosin'/exp	NUM
aiua-10711	48	56	or	or	CCONJ
aiua-10711	48	57	tamsulosin	tamsulosin	NOUN
aiua-10711	48	58	)	)	PUNCT
aiua-10711	48	59	and	and	CCONJ
aiua-10711	48	60	(	(	PUNCT
aiua-10711	48	61	'	'	PUNCT
aiua-10711	48	62	ejaculation'/exp	ejaculation'/exp	NOUN
aiua-10711	48	63	or	or	CCONJ
aiua-10711	48	64	ejaculation	ejaculation	NOUN
aiua-10711	48	65	or	or	CCONJ
aiua-10711	48	66	'	'	PUNCT
aiua-10711	48	67	erectile	erectile	NOUN
aiua-10711	48	68	dysfunction'/exp	dysfunction'/exp	NOUN
aiua-10711	48	69	or	or	CCONJ
aiua-10711	48	70	'	'	PUNCT
aiua-10711	48	71	erectile	erectile	ADJ
aiua-10711	48	72	dysfunction	dysfunction	NOUN
aiua-10711	48	73	'	'	PUNCT
aiua-10711	48	74	or	or	CCONJ
aiua-10711	48	75	(	(	PUNCT
aiua-10711	48	76	erectile	erectile	NOUN
aiua-10711	48	77	and	and	CCONJ
aiua-10711	48	78	dysfunction	dysfunction	NOUN
aiua-10711	48	79	)	)	PUNCT
aiua-10711	48	80	)	)	PUNCT
aiua-10711	48	81	and	and	CCONJ
aiua-10711	49	1	[	[	X
aiua-10711	49	2	randomized	randomize	VERB
aiua-10711	49	3	controlled	control	VERB
aiua-10711	49	4	trial]/lim	trial]/lim	NOUN
aiua-10711	49	5	}	}	PUNCT
aiua-10711	49	6	.	.	PUNCT
aiua-10711	50	1	relevant	relevant	ADJ
aiua-10711	50	2	data	datum	NOUN
aiua-10711	50	3	were	be	AUX
aiua-10711	50	4	also	also	ADV
aiua-10711	50	5	hand	hand	AUX
aiua-10711	50	6	searched	search	VERB
aiua-10711	50	7	by	by	ADP
aiua-10711	50	8	browsing	browse	VERB
aiua-10711	50	9	various	various	ADJ
aiua-10711	50	10	sources	source	NOUN
aiua-10711	50	11	(	(	PUNCT
aiua-10711	50	12	e.g.	e.g.	ADV
aiua-10711	50	13	,	,	PUNCT
aiua-10711	50	14	reference	reference	NOUN
aiua-10711	50	15	lists	list	NOUN
aiua-10711	50	16	from	from	ADP
aiua-10711	50	17	reviews	review	NOUN
aiua-10711	50	18	and	and	CCONJ
aiua-10711	50	19	study	study	NOUN
aiua-10711	50	20	reports	report	NOUN
aiua-10711	50	21	,	,	PUNCT
aiua-10711	50	22	congress	congress	PROPN
aiua-10711	50	23	abstracts	abstract	VERB
aiua-10711	50	24	,	,	PUNCT
aiua-10711	50	25	clinical	clinical	ADJ
aiua-10711	50	26	trial	trial	NOUN
aiua-10711	50	27	registers	register	NOUN
aiua-10711	50	28	such	such	ADJ
aiua-10711	50	29	as	as	ADP
aiua-10711	50	30	www.clinicaltrials.gov	www.clinicaltrials.gov	NOUN
aiua-10711	50	31	,	,	PUNCT
aiua-10711	50	32	www.clinicaltrialsregister.eu	www.clinicaltrialsregister.eu	NOUN
aiua-10711	50	33	,	,	PUNCT
aiua-10711	50	34	etc	etc	X
aiua-10711	50	35	.	.	X
aiua-10711	50	36	)	)	PUNCT
aiua-10711	50	37	.	.	PUNCT
aiua-10711	51	1	title	title	NOUN
aiua-10711	51	2	and	and	CCONJ
aiua-10711	51	3	abstract	abstract	ADJ
aiua-10711	51	4	screening	screen	VERB
aiua-10711	51	5	to	to	PART
aiua-10711	51	6	exclude	exclude	VERB
aiua-10711	51	7	documents	document	NOUN
aiua-10711	51	8	that	that	PRON
aiua-10711	51	9	did	do	AUX
aiua-10711	51	10	not	not	PART
aiua-10711	51	11	meet	meet	VERB
aiua-10711	51	12	the	the	DET
aiua-10711	51	13	inclusion	inclusion	NOUN
aiua-10711	51	14	criteria	criterion	NOUN
aiua-10711	51	15	was	be	AUX
aiua-10711	51	16	performed	perform	VERB
aiua-10711	51	17	independently	independently	ADV
aiua-10711	51	18	by	by	ADP
aiua-10711	51	19	two	two	NUM
aiua-10711	51	20	authors	author	NOUN
aiua-10711	51	21	.	.	PUNCT
aiua-10711	52	1	duplicate	duplicate	ADJ
aiua-10711	52	2	references	reference	NOUN
aiua-10711	52	3	were	be	AUX
aiua-10711	52	4	deleted	delete	VERB
aiua-10711	52	5	.	.	PUNCT
aiua-10711	53	1	controversies	controversy	NOUN
aiua-10711	53	2	were	be	AUX
aiua-10711	53	3	resolved	resolve	VERB
aiua-10711	53	4	by	by	ADP
aiua-10711	53	5	a	a	DET
aiua-10711	53	6	third	third	ADJ
aiua-10711	53	7	researcher	researcher	NOUN
aiua-10711	53	8	.	.	PUNCT
aiua-10711	54	1	full	full	ADJ
aiua-10711	54	2	texts	text	NOUN
aiua-10711	54	3	were	be	AUX
aiua-10711	54	4	downloaded	download	VERB
aiua-10711	54	5	to	to	PART
aiua-10711	54	6	confirm	confirm	VERB
aiua-10711	54	7	or	or	CCONJ
aiua-10711	54	8	reject	reject	VERB
aiua-10711	54	9	inclusion	inclusion	NOUN
aiua-10711	54	10	and	and	CCONJ
aiua-10711	54	11	to	to	PART
aiua-10711	54	12	extract	extract	VERB
aiua-10711	54	13	relevant	relevant	ADJ
aiua-10711	54	14	information	information	NOUN
aiua-10711	54	15	.	.	PUNCT
aiua-10711	55	1	data	datum	NOUN
aiua-10711	55	2	extraction	extraction	NOUN
aiua-10711	55	3	was	be	AUX
aiua-10711	55	4	conducted	conduct	VERB
aiua-10711	55	5	by	by	ADP
aiua-10711	55	6	two	two	NUM
aiua-10711	55	7	authors	author	NOUN
aiua-10711	55	8	using	use	VERB
aiua-10711	55	9	a	a	DET
aiua-10711	55	10	standardized	standardized	ADJ
aiua-10711	55	11	form	form	NOUN
aiua-10711	55	12	.	.	PUNCT
aiua-10711	56	1	the	the	DET
aiua-10711	56	2	following	follow	VERB
aiua-10711	56	3	information	information	NOUN
aiua-10711	56	4	was	be	AUX
aiua-10711	56	5	obtained	obtain	VERB
aiua-10711	56	6	from	from	ADP
aiua-10711	56	7	each	each	DET
aiua-10711	56	8	study	study	NOUN
aiua-10711	56	9	:	:	PUNCT
aiua-10711	56	10	authors	author	NOUN
aiua-10711	56	11	,	,	PUNCT
aiua-10711	56	12	publication	publication	NOUN
aiua-10711	56	13	year	year	NOUN
aiua-10711	56	14	,	,	PUNCT
aiua-10711	56	15	study	study	NOUN
aiua-10711	56	16	design	design	NOUN
aiua-10711	56	17	,	,	PUNCT
aiua-10711	56	18	population	population	NOUN
aiua-10711	56	19	,	,	PUNCT
aiua-10711	56	20	intervention	intervention	NOUN
aiua-10711	56	21	,	,	PUNCT
aiua-10711	56	22	effect	effect	NOUN
aiua-10711	56	23	on	on	ADP
aiua-10711	56	24	sexual	sexual	ADJ
aiua-10711	56	25	function	function	NOUN
aiua-10711	56	26	(	(	PUNCT
aiua-10711	56	27	erectile	erectile	NOUN
aiua-10711	56	28	,	,	PUNCT
aiua-10711	56	29	ejaculatory	ejaculatory	NOUN
aiua-10711	56	30	)	)	PUNCT
aiua-10711	56	31	.	.	PUNCT
aiua-10711	57	1	in	in	ADP
aiua-10711	57	2	case	case	NOUN
aiua-10711	57	3	of	of	ADP
aiua-10711	57	4	missing	missing	ADJ
aiua-10711	57	5	or	or	CCONJ
aiua-10711	57	6	insufficient	insufficient	ADJ
aiua-10711	57	7	information	information	NOUN
aiua-10711	57	8	,	,	PUNCT
aiua-10711	57	9	we	we	PRON
aiua-10711	57	10	analyzed	analyze	VERB
aiua-10711	57	11	the	the	DET
aiua-10711	57	12	impact	impact	NOUN
aiua-10711	57	13	of	of	ADP
aiua-10711	57	14	missing	miss	VERB
aiua-10711	57	15	data	datum	NOUN
aiua-10711	57	16	on	on	ADP
aiua-10711	57	17	the	the	DET
aiua-10711	57	18	meta	meta	ADJ
aiua-10711	57	19	-	-	PUNCT
aiua-10711	57	20	analysis	analysis	NOUN
aiua-10711	57	21	results	result	NOUN
aiua-10711	57	22	and	and	CCONJ
aiua-10711	57	23	evaluated	evaluate	VERB
aiua-10711	57	24	the	the	DET
aiua-10711	57	25	potential	potential	ADJ
aiua-10711	57	26	risk	risk	NOUN
aiua-10711	57	27	of	of	ADP
aiua-10711	57	28	bias	bias	NOUN
aiua-10711	57	29	.	.	PUNCT
aiua-10711	58	1	two	two	NUM
aiua-10711	58	2	authors	author	NOUN
aiua-10711	58	3	independently	independently	ADV
aiua-10711	58	4	performed	perform	VERB
aiua-10711	58	5	the	the	DET
aiua-10711	58	6	quality	quality	NOUN
aiua-10711	58	7	assessment	assessment	NOUN
aiua-10711	58	8	by	by	ADP
aiua-10711	58	9	identifying	identify	VERB
aiua-10711	58	10	potential	potential	ADJ
aiua-10711	58	11	biases	bias	NOUN
aiua-10711	58	12	using	use	VERB
aiua-10711	58	13	the	the	DET
aiua-10711	58	14	risk	risk	NOUN
aiua-10711	58	15	of	of	ADP
aiua-10711	58	16	bias	bias	NOUN
aiua-10711	58	17	(	(	PUNCT
aiua-10711	58	18	rob)-2	rob)-2	NOUN
aiua-10711	58	19	assessment	assessment	NOUN
aiua-10711	58	20	tool	tool	NOUN
aiua-10711	58	21	of	of	ADP
aiua-10711	58	22	the	the	DET
aiua-10711	58	23	cochrane	cochrane	NOUN
aiua-10711	58	24	collaboration	collaboration	NOUN
aiua-10711	58	25	(	(	PUNCT
aiua-10711	58	26	9	9	NUM
aiua-10711	58	27	)	)	PUNCT
aiua-10711	58	28	.	.	PUNCT
aiua-10711	59	1	study	study	NOUN
aiua-10711	59	2	quality	quality	NOUN
aiua-10711	59	3	was	be	AUX
aiua-10711	59	4	evaluated	evaluate	VERB
aiua-10711	59	5	based	base	VERB
aiua-10711	59	6	on	on	ADP
aiua-10711	59	7	pre	pre	ADJ
aiua-10711	59	8	-	-	ADJ
aiua-10711	59	9	defined	define	VERB
aiua-10711	59	10	criteria	criterion	NOUN
aiua-10711	59	11	in	in	ADP
aiua-10711	59	12	relation	relation	NOUN
aiua-10711	59	13	to	to	ADP
aiua-10711	59	14	randomization	randomization	NOUN
aiua-10711	59	15	process	process	NOUN
aiua-10711	59	16	(	(	PUNCT
aiua-10711	59	17	d1	d1	NOUN
aiua-10711	59	18	)	)	PUNCT
aiua-10711	59	19	,	,	PUNCT
aiua-10711	59	20	deviations	deviation	NOUN
aiua-10711	59	21	from	from	ADP
aiua-10711	59	22	the	the	DET
aiua-10711	59	23	intended	intend	VERB
aiua-10711	59	24	interventions	intervention	NOUN
aiua-10711	59	25	(	(	PUNCT
aiua-10711	59	26	d1	d1	NOUN
aiua-10711	59	27	)	)	PUNCT
aiua-10711	59	28	,	,	PUNCT
aiua-10711	59	29	missing	miss	VERB
aiua-10711	59	30	outcome	outcome	NOUN
aiua-10711	59	31	data	datum	NOUN
aiua-10711	59	32	(	(	PUNCT
aiua-10711	59	33	d3	d3	PROPN
aiua-10711	59	34	)	)	PUNCT
aiua-10711	59	35	,	,	PUNCT
aiua-10711	59	36	measurement	measurement	NOUN
aiua-10711	59	37	of	of	ADP
aiua-10711	59	38	the	the	DET
aiua-10711	59	39	outcome	outcome	NOUN
aiua-10711	59	40	(	(	PUNCT
aiua-10711	59	41	d4	d4	PROPN
aiua-10711	59	42	)	)	PUNCT
aiua-10711	59	43	and	and	CCONJ
aiua-10711	59	44	selection	selection	NOUN
aiua-10711	59	45	of	of	ADP
aiua-10711	59	46	the	the	DET
aiua-10711	59	47	reported	report	VERB
aiua-10711	59	48	result	result	NOUN
aiua-10711	59	49	(	(	PUNCT
aiua-10711	59	50	d5	d5	NOUN
aiua-10711	59	51	)	)	PUNCT
aiua-10711	59	52	.	.	PUNCT
aiua-10711	60	1	for	for	ADP
aiua-10711	60	2	each	each	DET
aiua-10711	60	3	rob	rob	PROPN
aiua-10711	60	4	domain	domain	NOUN
aiua-10711	60	5	,	,	PUNCT
aiua-10711	60	6	an	an	DET
aiua-10711	60	7	evaluation	evaluation	NOUN
aiua-10711	60	8	was	be	AUX
aiua-10711	60	9	given	give	VERB
aiua-10711	60	10	,	,	PUNCT
aiua-10711	60	11	based	base	VERB
aiua-10711	60	12	on	on	ADP
aiua-10711	60	13	a	a	DET
aiua-10711	60	14	specific	specific	ADJ
aiua-10711	60	15	algorithm	algorithm	NOUN
aiua-10711	60	16	,	,	PUNCT
aiua-10711	60	17	resulting	result	VERB
aiua-10711	60	18	in	in	ADP
aiua-10711	60	19	the	the	DET
aiua-10711	60	20	following	following	ADJ
aiua-10711	60	21	rating	rating	NOUN
aiua-10711	60	22	:	:	PUNCT
aiua-10711	60	23	low	low	ADJ
aiua-10711	60	24	risk	risk	NOUN
aiua-10711	60	25	,	,	PUNCT
aiua-10711	60	26	some	some	DET
aiua-10711	60	27	concern	concern	NOUN
aiua-10711	60	28	,	,	PUNCT
aiua-10711	60	29	high	high	ADJ
aiua-10711	60	30	risk	risk	NOUN
aiua-10711	60	31	.	.	PUNCT
aiua-10711	61	1	disagreements	disagreement	NOUN
aiua-10711	61	2	were	be	AUX
aiua-10711	61	3	resolved	resolve	VERB
aiua-10711	61	4	by	by	ADP
aiua-10711	61	5	discussion	discussion	NOUN
aiua-10711	61	6	.	.	PUNCT
aiua-10711	62	1	the	the	DET
aiua-10711	62	2	presence	presence	NOUN
aiua-10711	62	3	of	of	ADP
aiua-10711	62	4	risk	risk	NOUN
aiua-10711	62	5	of	of	ADP
aiua-10711	62	6	bias	bias	NOUN
aiua-10711	62	7	did	do	AUX
aiua-10711	62	8	not	not	PART
aiua-10711	62	9	influence	influence	VERB
aiua-10711	62	10	the	the	DET
aiua-10711	62	11	decision	decision	NOUN
aiua-10711	62	12	to	to	PART
aiua-10711	62	13	include	include	VERB
aiua-10711	62	14	/	/	SYM
aiua-10711	62	15	exclude	exclude	VERB
aiua-10711	62	16	a	a	DET
aiua-10711	62	17	study	study	NOUN
aiua-10711	62	18	from	from	ADP
aiua-10711	62	19	quantitative	quantitative	ADJ
aiua-10711	62	20	analysis	analysis	NOUN
aiua-10711	62	21	.	.	PUNCT
aiua-10711	63	1	statistical	statistical	ADJ
aiua-10711	63	2	analysis	analysis	NOUN
aiua-10711	63	3	statistical	statistical	ADJ
aiua-10711	63	4	analysis	analysis	NOUN
aiua-10711	63	5	was	be	AUX
aiua-10711	63	6	performed	perform	VERB
aiua-10711	63	7	using	use	VERB
aiua-10711	63	8	the	the	DET
aiua-10711	63	9	revman5	revman5	PROPN
aiua-10711	63	10	software	software	NOUN
aiua-10711	63	11	.	.	PUNCT
aiua-10711	64	1	dichotomous	dichotomous	ADJ
aiua-10711	64	2	data	datum	NOUN
aiua-10711	64	3	(	(	PUNCT
aiua-10711	64	4	presence	presence	NOUN
aiua-10711	64	5	/	/	SYM
aiua-10711	64	6	absence	absence	NOUN
aiua-10711	64	7	of	of	ADP
aiua-10711	64	8	sexual	sexual	ADJ
aiua-10711	64	9	dysfunction	dysfunction	NOUN
aiua-10711	64	10	)	)	PUNCT
aiua-10711	64	11	and	and	CCONJ
aiua-10711	64	12	number	number	NOUN
aiua-10711	64	13	of	of	ADP
aiua-10711	64	14	per	per	ADP
aiua-10711	64	15	-	-	PUNCT
aiua-10711	64	16	protocol	protocol	NOUN
aiua-10711	64	17	or	or	CCONJ
aiua-10711	64	18	intent	intent	NOUN
aiua-10711	64	19	-	-	PUNCT
aiua-10711	64	20	totreat	totreat	NOUN
aiua-10711	64	21	patients	patient	NOUN
aiua-10711	64	22	were	be	AUX
aiua-10711	64	23	extracted	extract	VERB
aiua-10711	64	24	to	to	PART
aiua-10711	64	25	calculate	calculate	VERB
aiua-10711	64	26	odds	odd	NOUN
aiua-10711	64	27	ratios	ratio	NOUN
aiua-10711	64	28	(	(	PUNCT
aiua-10711	64	29	or	or	CCONJ
aiua-10711	64	30	)	)	PUNCT
aiua-10711	64	31	,	,	PUNCT
aiua-10711	64	32	95	95	NUM
aiua-10711	64	33	%	%	NOUN
aiua-10711	64	34	confidence	confidence	NOUN
aiua-10711	64	35	intervals	interval	NOUN
aiua-10711	64	36	(	(	PUNCT
aiua-10711	64	37	ci	ci	NOUN
aiua-10711	64	38	)	)	PUNCT
aiua-10711	64	39	to	to	ADP
aiua-10711	64	40	odds	odd	NOUN
aiua-10711	64	41	-	-	PUNCT
aiua-10711	64	42	ratios	ratio	NOUN
aiua-10711	64	43	,	,	PUNCT
aiua-10711	64	44	and	and	CCONJ
aiua-10711	64	45	z	z	NOUN
aiua-10711	64	46	statistics	statistic	NOUN
aiua-10711	64	47	(	(	PUNCT
aiua-10711	64	48	random	random	ADJ
aiua-10711	64	49	-	-	PUNCT
aiua-10711	64	50	effects	effect	NOUN
aiua-10711	64	51	model	model	NOUN
aiua-10711	64	52	,	,	PUNCT
aiua-10711	64	53	mantel	mantel	NOUN
aiua-10711	64	54	-	-	PUNCT
aiua-10711	64	55	haenszel	haenszel	NOUN
aiua-10711	64	56	method	method	NOUN
aiua-10711	64	57	)	)	PUNCT
aiua-10711	64	58	.	.	PUNCT
aiua-10711	65	1	study	study	NOUN
aiua-10711	65	2	heterogeneity	heterogeneity	NOUN
aiua-10711	65	3	was	be	AUX
aiua-10711	65	4	assessed	assess	VERB
aiua-10711	65	5	by	by	ADP
aiua-10711	65	6	calculating	calculate	VERB
aiua-10711	65	7	i^2	i^2	PROPN
aiua-10711	65	8	(	(	PUNCT
aiua-10711	65	9	and	and	CCONJ
aiua-10711	65	10	95	95	NUM
aiua-10711	65	11	%	%	NOUN
aiua-10711	65	12	ci	ci	NOUN
aiua-10711	65	13	)	)	PUNCT
aiua-10711	65	14	,	,	PUNCT
aiua-10711	65	15	which	which	PRON
aiua-10711	65	16	was	be	AUX
aiua-10711	65	17	interpreted	interpret	VERB
aiua-10711	65	18	as	as	ADP
aiua-10711	65	19	of	of	ADP
aiua-10711	65	20	lesser	less	ADJ
aiua-10711	65	21	importance	importance	NOUN
aiua-10711	65	22	(	(	PUNCT
aiua-10711	65	23	i^2	i^2	X
aiua-10711	65	24	≤	≤	NUM
aiua-10711	65	25	40	40	NUM
aiua-10711	65	26	%	%	NOUN
aiua-10711	65	27	)	)	PUNCT
aiua-10711	65	28	,	,	PUNCT
aiua-10711	65	29	moderate	moderate	ADJ
aiua-10711	65	30	(	(	PUNCT
aiua-10711	65	31	i^2	i^2	X
aiua-10711	65	32	=	=	PUNCT
aiua-10711	65	33	30%-60	30%-60	NUM
aiua-10711	65	34	%	%	NOUN
aiua-10711	65	35	)	)	PUNCT
aiua-10711	65	36	,	,	PUNCT
aiua-10711	65	37	substantial	substantial	ADJ
aiua-10711	65	38	(	(	PUNCT
aiua-10711	65	39	i^2	i^2	X
aiua-10711	65	40	=	=	PUNCT
aiua-10711	65	41	50%-90	50%-90	NUM
aiua-10711	65	42	%	%	NOUN
aiua-10711	65	43	)	)	PUNCT
aiua-10711	65	44	or	or	CCONJ
aiua-10711	65	45	considerable	considerable	ADJ
aiua-10711	65	46	(	(	PUNCT
aiua-10711	65	47	i^2	i^2	X
aiua-10711	65	48	≥	≥	NUM
aiua-10711	65	49	75	75	NUM
aiua-10711	65	50	%	%	NOUN
aiua-10711	65	51	)	)	PUNCT
aiua-10711	65	52	,	,	PUNCT
aiua-10711	65	53	according	accord	VERB
aiua-10711	65	54	to	to	ADP
aiua-10711	65	55	cochrane	cochrane	NOUN
aiua-10711	65	56	criteria	criterion	NOUN
aiua-10711	65	57	.	.	PUNCT
aiua-10711	66	1	funnel	funnel	NOUN
aiua-10711	66	2	plots	plot	NOUN
aiua-10711	66	3	were	be	AUX
aiua-10711	66	4	drawn	draw	VERB
aiua-10711	66	5	and	and	CCONJ
aiua-10711	66	6	visually	visually	ADV
aiua-10711	66	7	evaluated	evaluate	VERB
aiua-10711	66	8	to	to	PART
aiua-10711	66	9	detect	detect	VERB
aiua-10711	66	10	publication	publication	NOUN
aiua-10711	66	11	bias	bias	NOUN
aiua-10711	66	12	and	and	CCONJ
aiua-10711	66	13	small	small	ADJ
aiua-10711	66	14	study	study	NOUN
aiua-10711	66	15	effects	effect	NOUN
aiua-10711	66	16	.	.	PUNCT
aiua-10711	67	1	if	if	SCONJ
aiua-10711	67	2	publication	publication	NOUN
aiua-10711	67	3	bias	bias	NOUN
aiua-10711	67	4	was	be	AUX
aiua-10711	67	5	suspected	suspect	VERB
aiua-10711	67	6	,	,	PUNCT
aiua-10711	67	7	the	the	DET
aiua-10711	67	8	egger	egger	NOUN
aiua-10711	67	9	’s	’s	NOUN
aiua-10711	67	10	and	and	CCONJ
aiua-10711	67	11	begg	begg	PROPN
aiua-10711	67	12	’s	’s	PART
aiua-10711	67	13	tests	test	NOUN
aiua-10711	67	14	were	be	AUX
aiua-10711	67	15	implemented	implement	VERB
aiua-10711	67	16	to	to	PART
aiua-10711	67	17	assess	assess	VERB
aiua-10711	67	18	funnel	funnel	NOUN
aiua-10711	67	19	plot	plot	NOUN
aiua-10711	67	20	symmetry	symmetry	NOUN
aiua-10711	67	21	or	or	CCONJ
aiua-10711	67	22	asymmetry	asymmetry	NOUN
aiua-10711	67	23	.	.	PUNCT
aiua-10711	68	1	asymmetry	asymmetry	NOUN
aiua-10711	68	2	tests	test	NOUN
aiua-10711	68	3	were	be	AUX
aiua-10711	68	4	performed	perform	VERB
aiua-10711	68	5	using	use	VERB
aiua-10711	68	6	the	the	DET
aiua-10711	68	7	metaessentials1	metaessentials1	NOUN
aiua-10711	68	8	software	software	NOUN
aiua-10711	68	9	(	(	PUNCT
aiua-10711	68	10	rotterdam	rotterdam	PROPN
aiua-10711	68	11	school	school	NOUN
aiua-10711	68	12	of	of	ADP
aiua-10711	68	13	management	management	NOUN
aiua-10711	68	14	,	,	PUNCT
aiua-10711	68	15	erasmus	erasmus	PROPN
aiua-10711	68	16	university	university	PROPN
aiua-10711	68	17	,	,	PUNCT
aiua-10711	68	18	the	the	DET
aiua-10711	68	19	netherlands	netherlands	PROPN
aiua-10711	68	20	)	)	PUNCT
aiua-10711	68	21	.	.	PUNCT
aiua-10711	69	1	the	the	DET
aiua-10711	69	2	‘	'	PUNCT
aiua-10711	69	3	trim	trim	VERB
aiua-10711	69	4	and	and	CCONJ
aiua-10711	69	5	fill	fill	NOUN
aiua-10711	69	6	’	'	PUNCT
aiua-10711	69	7	missing	miss	VERB
aiua-10711	69	8	study	study	NOUN
aiua-10711	69	9	imputation	imputation	NOUN
aiua-10711	69	10	approach	approach	NOUN
aiua-10711	69	11	was	be	AUX
aiua-10711	69	12	applied	apply	VERB
aiua-10711	69	13	to	to	ADP
aiua-10711	69	14	funnel	funnel	NOUN
aiua-10711	69	15	plots	plot	NOUN
aiua-10711	69	16	;	;	PUNCT
aiua-10711	69	17	if	if	SCONJ
aiua-10711	69	18	archivio	archivio	NOUN
aiua-10711	69	19	italiano	italiano	NOUN
aiua-10711	69	20	di	di	X
aiua-10711	69	21	urologia	urologia	PROPN
aiua-10711	69	22	e	e	PROPN
aiua-10711	69	23	andrologia	andrologia	PROPN
aiua-10711	69	24	2022	2022	NUM
aiua-10711	69	25	;	;	PUNCT
aiua-10711	69	26	94	94	NUM
aiua-10711	69	27	,	,	PUNCT
aiua-10711	69	28	2	2	NUM
aiua-10711	69	29	r.	r.	NOUN
aiua-10711	69	30	bapir	bapir	NOUN
aiua-10711	69	31	,	,	PUNCT
aiua-10711	69	32	k.	k.	PROPN
aiua-10711	69	33	hassan	hassan	PROPN
aiua-10711	69	34	bhatti	bhatti	PROPN
aiua-10711	69	35	,	,	PUNCT
aiua-10711	69	36	a	a	PRON
aiua-10711	69	37	,	,	PUNCT
aiua-10711	69	38	eliwa	eliwa	NOUN
aiua-10711	69	39	,	,	PUNCT
aiua-10711	69	40	et	et	PROPN
aiua-10711	69	41	al	al	PROPN
aiua-10711	69	42	.	.	PROPN
aiua-10711	69	43	254	254	NUM
aiua-10711	69	44	missing	miss	VERB
aiua-10711	69	45	studies	study	NOUN
aiua-10711	69	46	were	be	AUX
aiua-10711	69	47	imputed	impute	VERB
aiua-10711	69	48	by	by	ADP
aiua-10711	69	49	this	this	DET
aiua-10711	69	50	procedure	procedure	NOUN
aiua-10711	69	51	,	,	PUNCT
aiua-10711	69	52	adjusted	adjust	VERB
aiua-10711	69	53	overall	overall	ADJ
aiua-10711	69	54	effect	effect	NOUN
aiua-10711	69	55	sizes	size	NOUN
aiua-10711	69	56	(	(	PUNCT
aiua-10711	69	57	odds	odd	NOUN
aiua-10711	69	58	ratios	ratio	NOUN
aiua-10711	69	59	)	)	PUNCT
aiua-10711	69	60	were	be	AUX
aiua-10711	69	61	calculated	calculate	VERB
aiua-10711	69	62	.	.	PUNCT
aiua-10711	70	1	results	result	VERB
aiua-10711	70	2	a	a	DET
aiua-10711	70	3	prisma	prisma	NOUN
aiua-10711	70	4	flow	flow	NOUN
aiua-10711	70	5	diagram	diagram	NOUN
aiua-10711	70	6	illustrates	illustrate	VERB
aiua-10711	70	7	the	the	DET
aiua-10711	70	8	results	result	NOUN
aiua-10711	70	9	of	of	ADP
aiua-10711	70	10	study	study	NOUN
aiua-10711	70	11	selection	selection	NOUN
aiua-10711	70	12	process	process	NOUN
aiua-10711	70	13	(	(	PUNCT
aiua-10711	70	14	figure	figure	NOUN
aiua-10711	70	15	1	1	NUM
aiua-10711	70	16	)	)	PUNCT
aiua-10711	70	17	.	.	PUNCT
aiua-10711	71	1	we	we	PRON
aiua-10711	71	2	retrieved	retrieve	VERB
aiua-10711	71	3	612	612	NUM
aiua-10711	71	4	records	record	NOUN
aiua-10711	71	5	(	(	PUNCT
aiua-10711	71	6	pubmed	pubmed	PROPN
aiua-10711	71	7	,	,	PUNCT
aiua-10711	71	8	152	152	NUM
aiua-10711	71	9	;	;	PUNCT
aiua-10711	71	10	embase	embase	NOUN
aiua-10711	71	11	,	,	PUNCT
aiua-10711	71	12	456	456	NUM
aiua-10711	71	13	;	;	PUNCT
aiua-10711	71	14	other	other	ADJ
aiua-10711	71	15	sources	source	NOUN
aiua-10711	71	16	,	,	PUNCT
aiua-10711	71	17	4	4	NUM
aiua-10711	71	18	)	)	PUNCT
aiua-10711	71	19	.	.	PUNCT
aiua-10711	72	1	after	after	ADP
aiua-10711	72	2	title	title	NOUN
aiua-10711	72	3	and	and	CCONJ
aiua-10711	72	4	abstract	abstract	ADJ
aiua-10711	72	5	screening	screening	NOUN
aiua-10711	72	6	,	,	PUNCT
aiua-10711	72	7	we	we	PRON
aiua-10711	72	8	selected	select	VERB
aiua-10711	72	9	125	125	NUM
aiua-10711	72	10	articles	article	NOUN
aiua-10711	72	11	by	by	ADP
aiua-10711	72	12	title	title	NOUN
aiua-10711	72	13	and	and	CCONJ
aiua-10711	72	14	abstract	abstract	ADJ
aiua-10711	72	15	screening	screening	NOUN
aiua-10711	72	16	(	(	PUNCT
aiua-10711	72	17	pubmed	pubmed	PROPN
aiua-10711	72	18	=	=	SYM
aiua-10711	72	19	45	45	NUM
aiua-10711	72	20	papers	paper	NOUN
aiua-10711	72	21	,	,	PUNCT
aiua-10711	72	22	embase	embase	NOUN
aiua-10711	72	23	=	=	PROPN
aiua-10711	72	24	80	80	NUM
aiua-10711	72	25	)	)	PUNCT
aiua-10711	72	26	.	.	PUNCT
aiua-10711	73	1	following	follow	VERB
aiua-10711	73	2	removal	removal	NOUN
aiua-10711	73	3	of	of	ADP
aiua-10711	73	4	23	23	NUM
aiua-10711	73	5	duplicates	duplicate	NOUN
aiua-10711	73	6	,	,	PUNCT
aiua-10711	73	7	the	the	DET
aiua-10711	73	8	full	full	ADJ
aiua-10711	73	9	text	text	NOUN
aiua-10711	73	10	of	of	ADP
aiua-10711	73	11	the	the	DET
aiua-10711	73	12	remaining	remain	VERB
aiua-10711	73	13	102	102	NUM
aiua-10711	73	14	articles	article	NOUN
aiua-10711	73	15	were	be	AUX
aiua-10711	73	16	examined	examine	VERB
aiua-10711	73	17	.	.	PUNCT
aiua-10711	74	1	twenty	twenty	NUM
aiua-10711	74	2	-	-	PUNCT
aiua-10711	74	3	seven	seven	NUM
aiua-10711	74	4	articles	article	NOUN
aiua-10711	74	5	were	be	AUX
aiua-10711	74	6	excluded	exclude	VERB
aiua-10711	74	7	(	(	PUNCT
aiua-10711	74	8	2	2	NUM
aiua-10711	74	9	because	because	SCONJ
aiua-10711	74	10	alpha	alpha	NOUN
aiua-10711	74	11	-	-	PUNCT
aiua-10711	74	12	blockers	blocker	NOUN
aiua-10711	74	13	were	be	AUX
aiua-10711	74	14	expressly	expressly	ADV
aiua-10711	74	15	used	use	VERB
aiua-10711	74	16	to	to	PART
aiua-10711	74	17	treat	treat	VERB
aiua-10711	74	18	premature	premature	ADJ
aiua-10711	74	19	ejaculation	ejaculation	NOUN
aiua-10711	74	20	or	or	CCONJ
aiua-10711	74	21	as	as	ADP
aiua-10711	74	22	male	male	ADJ
aiua-10711	74	23	oral	oral	ADJ
aiua-10711	74	24	contraceptives	contraceptive	NOUN
aiua-10711	74	25	,	,	PUNCT
aiua-10711	74	26	6	6	NUM
aiua-10711	74	27	open	open	ADJ
aiua-10711	74	28	-	-	PUNCT
aiua-10711	74	29	label	label	NOUN
aiua-10711	74	30	studies	study	NOUN
aiua-10711	74	31	,	,	PUNCT
aiua-10711	74	32	5	5	NUM
aiua-10711	74	33	non	non	ADJ
aiua-10711	74	34	-	-	ADJ
aiua-10711	74	35	controlled	control	VERB
aiua-10711	74	36	studies	study	NOUN
aiua-10711	74	37	,	,	PUNCT
aiua-10711	74	38	4	4	NUM
aiua-10711	74	39	studies	study	NOUN
aiua-10711	74	40	not	not	PART
aiua-10711	74	41	reported	report	VERB
aiua-10711	74	42	in	in	ADP
aiua-10711	74	43	english	english	PROPN
aiua-10711	74	44	,	,	PUNCT
aiua-10711	74	45	3	3	NUM
aiua-10711	74	46	reviews	review	NOUN
aiua-10711	74	47	,	,	PUNCT
aiua-10711	74	48	4	4	NUM
aiua-10711	74	49	short	short	ADJ
aiua-10711	74	50	term	term	NOUN
aiua-10711	74	51	experimental	experimental	ADJ
aiua-10711	74	52	studies	study	NOUN
aiua-10711	74	53	in	in	ADP
aiua-10711	74	54	healthy	healthy	ADJ
aiua-10711	74	55	subjects	subject	NOUN
aiua-10711	74	56	,	,	PUNCT
aiua-10711	74	57	3	3	NUM
aiua-10711	74	58	studies	study	NOUN
aiua-10711	74	59	not	not	PART
aiua-10711	74	60	reporting	report	VERB
aiua-10711	74	61	sexual	sexual	ADJ
aiua-10711	74	62	function	function	NOUN
aiua-10711	74	63	outcomes	outcome	NOUN
aiua-10711	74	64	)	)	PUNCT
aiua-10711	74	65	.	.	PUNCT
aiua-10711	75	1	the	the	DET
aiua-10711	75	2	remaining	remain	VERB
aiua-10711	75	3	75	75	NUM
aiua-10711	75	4	papers	paper	NOUN
aiua-10711	75	5	were	be	AUX
aiua-10711	75	6	included	include	VERB
aiua-10711	75	7	in	in	ADP
aiua-10711	75	8	three	three	NUM
aiua-10711	75	9	analyses	analysis	NOUN
aiua-10711	75	10	:	:	PUNCT
aiua-10711	75	11	alpha	alpha	NOUN
aiua-10711	75	12	-	-	PUNCT
aiua-10711	75	13	blockers	blocker	NOUN
aiua-10711	75	14	versus	versus	ADP
aiua-10711	75	15	placebo	placebo	NOUN
aiua-10711	75	16	(	(	PUNCT
aiua-10711	75	17	n=36	n=36	PROPN
aiua-10711	75	18	)	)	PUNCT
aiua-10711	75	19	(	(	PUNCT
aiua-10711	75	20	10	10	NUM
aiua-10711	75	21	-	-	SYM
aiua-10711	75	22	45	45	NUM
aiua-10711	75	23	)	)	PUNCT
aiua-10711	75	24	,	,	PUNCT
aiua-10711	75	25	comparison	comparison	NOUN
aiua-10711	75	26	of	of	ADP
aiua-10711	75	27	different	different	ADJ
aiua-10711	75	28	alpha	alpha	NOUN
aiua-10711	75	29	-	-	PUNCT
aiua-10711	75	30	blockers	blocker	NOUN
aiua-10711	75	31	(	(	PUNCT
aiua-10711	75	32	n=31	n=31	PROPN
aiua-10711	75	33	)	)	PUNCT
aiua-10711	75	34	(	(	PUNCT
aiua-10711	75	35	46	46	NUM
aiua-10711	75	36	-	-	SYM
aiua-10711	75	37	76	76	NUM
aiua-10711	75	38	)	)	PUNCT
aiua-10711	75	39	and	and	CCONJ
aiua-10711	75	40	comparison	comparison	NOUN
aiua-10711	75	41	of	of	ADP
aiua-10711	75	42	alpha	alpha	NOUN
aiua-10711	75	43	-	-	PUNCT
aiua-10711	75	44	blockers	blocker	NOUN
aiua-10711	75	45	administered	administer	VERB
aiua-10711	75	46	at	at	ADP
aiua-10711	75	47	different	different	ADJ
aiua-10711	75	48	dosages	dosage	NOUN
aiua-10711	75	49	(	(	PUNCT
aiua-10711	75	50	n=8	n=8	NUM
aiua-10711	75	51	)	)	PUNCT
aiua-10711	75	52	(	(	PUNCT
aiua-10711	75	53	77	77	NUM
aiua-10711	75	54	-	-	SYM
aiua-10711	75	55	84	84	NUM
aiua-10711	75	56	)	)	PUNCT
aiua-10711	75	57	(	(	PUNCT
aiua-10711	75	58	supplementary	supplementary	ADJ
aiua-10711	75	59	materials	material	NOUN
aiua-10711	75	60	pico	pico	NOUN
aiua-10711	75	61	tables	table	NOUN
aiua-10711	75	62	)	)	PUNCT
aiua-10711	75	63	.	.	PUNCT
aiua-10711	76	1	risk	risk	NOUN
aiua-10711	76	2	of	of	ADP
aiua-10711	76	3	bias	bias	NOUN
aiua-10711	76	4	among	among	ADP
aiua-10711	76	5	the	the	DET
aiua-10711	76	6	75	75	NUM
aiua-10711	76	7	studies	study	NOUN
aiua-10711	76	8	included	include	VERB
aiua-10711	76	9	in	in	ADP
aiua-10711	76	10	qualitative	qualitative	ADJ
aiua-10711	76	11	analysis	analysis	NOUN
aiua-10711	76	12	,	,	PUNCT
aiua-10711	76	13	the	the	DET
aiua-10711	76	14	method	method	NOUN
aiua-10711	76	15	of	of	ADP
aiua-10711	76	16	randomization	randomization	NOUN
aiua-10711	76	17	was	be	AUX
aiua-10711	76	18	deemed	deem	VERB
aiua-10711	76	19	to	to	PART
aiua-10711	76	20	be	be	AUX
aiua-10711	76	21	at	at	ADP
aiua-10711	76	22	low	low	ADJ
aiua-10711	76	23	risk	risk	NOUN
aiua-10711	76	24	of	of	ADP
aiua-10711	76	25	bias	bias	NOUN
aiua-10711	76	26	in	in	ADP
aiua-10711	76	27	46	46	NUM
aiua-10711	76	28	cases	case	NOUN
aiua-10711	76	29	,	,	PUNCT
aiua-10711	76	30	and	and	CCONJ
aiua-10711	76	31	to	to	ADP
aiua-10711	76	32	unclear	unclear	ADJ
aiua-10711	76	33	risk	risk	NOUN
aiua-10711	76	34	in	in	ADP
aiua-10711	76	35	29	29	NUM
aiua-10711	76	36	.	.	PUNCT
aiua-10711	77	1	the	the	DET
aiua-10711	77	2	risk	risk	NOUN
aiua-10711	77	3	of	of	ADP
aiua-10711	77	4	deviation	deviation	NOUN
aiua-10711	77	5	from	from	ADP
aiua-10711	77	6	the	the	DET
aiua-10711	77	7	intended	intend	VERB
aiua-10711	77	8	intervention	intervention	NOUN
aiua-10711	77	9	was	be	AUX
aiua-10711	77	10	rated	rate	VERB
aiua-10711	77	11	as	as	ADV
aiua-10711	77	12	low	low	ADJ
aiua-10711	77	13	in	in	ADP
aiua-10711	77	14	62	62	NUM
aiua-10711	77	15	studies	study	NOUN
aiua-10711	77	16	,	,	PUNCT
aiua-10711	77	17	unclear	unclear	ADJ
aiua-10711	77	18	in	in	ADP
aiua-10711	77	19	12	12	NUM
aiua-10711	77	20	and	and	CCONJ
aiua-10711	77	21	high	high	ADJ
aiua-10711	77	22	in	in	ADP
aiua-10711	77	23	one	one	NUM
aiua-10711	77	24	.	.	PUNCT
aiua-10711	78	1	the	the	DET
aiua-10711	78	2	rob	rob	PROPN
aiua-10711	78	3	associated	associate	VERB
aiua-10711	78	4	to	to	ADP
aiua-10711	78	5	missing	miss	VERB
aiua-10711	78	6	outcome	outcome	NOUN
aiua-10711	78	7	data	datum	NOUN
aiua-10711	78	8	was	be	AUX
aiua-10711	78	9	considered	consider	VERB
aiua-10711	78	10	to	to	PART
aiua-10711	78	11	be	be	AUX
aiua-10711	78	12	low	low	ADJ
aiua-10711	78	13	in	in	ADP
aiua-10711	78	14	63	63	NUM
aiua-10711	78	15	studies	study	NOUN
aiua-10711	78	16	and	and	CCONJ
aiua-10711	78	17	unclear	unclear	ADJ
aiua-10711	78	18	in	in	ADP
aiua-10711	78	19	12	12	NUM
aiua-10711	78	20	.	.	PUNCT
aiua-10711	79	1	the	the	DET
aiua-10711	79	2	risk	risk	NOUN
aiua-10711	79	3	of	of	ADP
aiua-10711	79	4	bias	bias	NOUN
aiua-10711	79	5	in	in	ADP
aiua-10711	79	6	measurement	measurement	NOUN
aiua-10711	79	7	of	of	ADP
aiua-10711	79	8	outcome	outcome	NOUN
aiua-10711	79	9	was	be	AUX
aiua-10711	79	10	considered	consider	VERB
aiua-10711	79	11	to	to	PART
aiua-10711	79	12	be	be	AUX
aiua-10711	79	13	low	low	ADJ
aiua-10711	79	14	in	in	ADP
aiua-10711	79	15	70	70	NUM
aiua-10711	79	16	studies	study	NOUN
aiua-10711	79	17	and	and	CCONJ
aiua-10711	79	18	unclear	unclear	ADJ
aiua-10711	79	19	in	in	ADP
aiua-10711	79	20	5	5	NUM
aiua-10711	79	21	.	.	PUNCT
aiua-10711	80	1	the	the	DET
aiua-10711	80	2	risk	risk	NOUN
aiua-10711	80	3	of	of	ADP
aiua-10711	80	4	bias	bias	NOUN
aiua-10711	80	5	generated	generate	VERB
aiua-10711	80	6	by	by	ADP
aiua-10711	80	7	selection	selection	NOUN
aiua-10711	80	8	of	of	ADP
aiua-10711	80	9	the	the	DET
aiua-10711	80	10	reported	report	VERB
aiua-10711	80	11	results	result	NOUN
aiua-10711	80	12	was	be	AUX
aiua-10711	80	13	rated	rate	VERB
aiua-10711	80	14	as	as	ADV
aiua-10711	80	15	low	low	ADJ
aiua-10711	80	16	in	in	ADP
aiua-10711	80	17	73	73	NUM
aiua-10711	80	18	studies	study	NOUN
aiua-10711	80	19	and	and	CCONJ
aiua-10711	80	20	as	as	ADV
aiua-10711	80	21	unclear	unclear	ADJ
aiua-10711	80	22	in	in	ADP
aiua-10711	80	23	2	2	NUM
aiua-10711	80	24	.	.	PUNCT
aiua-10711	81	1	in	in	ADP
aiua-10711	81	2	total	total	ADJ
aiua-10711	81	3	risk	risk	NOUN
aiua-10711	81	4	of	of	ADP
aiua-10711	81	5	bias	bias	NOUN
aiua-10711	81	6	was	be	AUX
aiua-10711	81	7	considered	consider	VERB
aiua-10711	81	8	low	low	ADJ
aiua-10711	81	9	in	in	ADP
aiua-10711	81	10	37	37	NUM
aiua-10711	81	11	studies	study	NOUN
aiua-10711	81	12	,	,	PUNCT
aiua-10711	81	13	unclear	unclear	ADJ
aiua-10711	81	14	in	in	ADP
aiua-10711	81	15	35	35	NUM
aiua-10711	81	16	and	and	CCONJ
aiua-10711	81	17	high	high	ADJ
aiua-10711	81	18	in	in	ADP
aiua-10711	81	19	3	3	NUM
aiua-10711	81	20	(	(	PUNCT
aiua-10711	81	21	supplementary	supplementary	ADJ
aiua-10711	81	22	materials	material	NOUN
aiua-10711	81	23	risk	risk	NOUN
aiua-10711	81	24	of	of	ADP
aiua-10711	81	25	bias	bias	NOUN
aiua-10711	81	26	)	)	PUNCT
aiua-10711	81	27	.	.	PUNCT
aiua-10711	82	1	analysis	analysis	NOUN
aiua-10711	82	2	of	of	ADP
aiua-10711	82	3	funnel	funnel	NOUN
aiua-10711	82	4	plots	plot	NOUN
aiua-10711	82	5	symmetry	symmetry	NOUN
aiua-10711	82	6	by	by	ADP
aiua-10711	82	7	egger	egger	NOUN
aiua-10711	82	8	’s	’s	PART
aiua-10711	82	9	and	and	CCONJ
aiua-10711	82	10	begg	begg	PROPN
aiua-10711	82	11	’s	’s	PART
aiua-10711	82	12	tests	test	NOUN
aiua-10711	82	13	,	,	PUNCT
aiua-10711	82	14	and	and	CCONJ
aiua-10711	82	15	adjusted	adjust	VERB
aiua-10711	82	16	odds	odd	NOUN
aiua-10711	82	17	ratios	ratio	NOUN
aiua-10711	82	18	when	when	SCONJ
aiua-10711	82	19	missing	miss	VERB
aiua-10711	82	20	studies	study	NOUN
aiua-10711	82	21	were	be	AUX
aiua-10711	82	22	imputed	impute	VERB
aiua-10711	82	23	by	by	ADP
aiua-10711	82	24	the	the	DET
aiua-10711	82	25	trim	trim	NOUN
aiua-10711	82	26	-	-	PUNCT
aiua-10711	82	27	and	and	CCONJ
aiua-10711	82	28	-	-	PUNCT
aiua-10711	82	29	fill	fill	NOUN
aiua-10711	82	30	procedure	procedure	NOUN
aiua-10711	82	31	are	be	AUX
aiua-10711	82	32	shown	show	VERB
aiua-10711	82	33	in	in	ADP
aiua-10711	82	34	the	the	DET
aiua-10711	82	35	(	(	PUNCT
aiua-10711	82	36	supplementary	supplementary	ADJ
aiua-10711	82	37	materials	material	NOUN
aiua-10711	82	38	funnel	funnel	NOUN
aiua-10711	82	39	plots	plot	NOUN
aiua-10711	82	40	&	&	CCONJ
aiua-10711	82	41	symmetry	symmetry	NOUN
aiua-10711	82	42	tests	test	NOUN
aiua-10711	82	43	)	)	PUNCT
aiua-10711	82	44	.	.	PUNCT
aiua-10711	83	1	significant	significant	ADJ
aiua-10711	83	2	asymmetry	asymmetry	NOUN
aiua-10711	83	3	was	be	AUX
aiua-10711	83	4	detected	detect	VERB
aiua-10711	83	5	by	by	ADP
aiua-10711	83	6	at	at	ADV
aiua-10711	83	7	least	least	ADV
aiua-10711	83	8	one	one	NUM
aiua-10711	83	9	test	test	NOUN
aiua-10711	83	10	for	for	ADP
aiua-10711	83	11	any	any	DET
aiua-10711	83	12	kind	kind	NOUN
aiua-10711	83	13	of	of	ADP
aiua-10711	83	14	alpha	alpha	ADJ
aiua-10711	83	15	blockers	blocker	NOUN
aiua-10711	83	16	(	(	PUNCT
aiua-10711	83	17	uroselective	uroselective	ADJ
aiua-10711	83	18	,	,	PUNCT
aiua-10711	83	19	nonuroselective	nonuroselective	ADJ
aiua-10711	83	20	or	or	CCONJ
aiua-10711	83	21	both	both	PRON
aiua-10711	83	22	)	)	PUNCT
aiua-10711	83	23	compared	compare	VERB
aiua-10711	83	24	to	to	ADP
aiua-10711	83	25	placebo	placebo	NOUN
aiua-10711	83	26	in	in	ADP
aiua-10711	83	27	bph	bph	NOUN
aiua-10711	83	28	patients	patient	NOUN
aiua-10711	83	29	(	(	PUNCT
aiua-10711	83	30	endpoint	endpoint	NOUN
aiua-10711	83	31	:	:	PUNCT
aiua-10711	83	32	ejaculation	ejaculation	NOUN
aiua-10711	83	33	)	)	PUNCT
aiua-10711	83	34	,	,	PUNCT
aiua-10711	83	35	in	in	ADP
aiua-10711	83	36	the	the	DET
aiua-10711	83	37	alpha	alpha	NOUN
aiua-10711	83	38	blockers	blocker	NOUN
aiua-10711	83	39	vs.	vs.	ADP
aiua-10711	83	40	standard	standard	PROPN
aiua-10711	83	41	care	care	PROPN
aiua-10711	83	42	comparison	comparison	NOUN
aiua-10711	83	43	in	in	ADP
aiua-10711	83	44	stone	stone	NOUN
aiua-10711	83	45	patients	patient	NOUN
aiua-10711	83	46	(	(	PUNCT
aiua-10711	83	47	endpoint	endpoint	NOUN
aiua-10711	83	48	:	:	PUNCT
aiua-10711	83	49	ejaculation	ejaculation	NOUN
aiua-10711	83	50	)	)	PUNCT
aiua-10711	83	51	,	,	PUNCT
aiua-10711	83	52	and	and	CCONJ
aiua-10711	83	53	in	in	ADP
aiua-10711	83	54	the	the	DET
aiua-10711	83	55	alpha	alpha	NOUN
aiua-10711	83	56	blockers	blocker	NOUN
aiua-10711	83	57	vs.	vs.	ADP
aiua-10711	83	58	standard	standard	ADJ
aiua-10711	83	59	care	care	NOUN
aiua-10711	83	60	or	or	CCONJ
aiua-10711	83	61	placebo	placebo	NOUN
aiua-10711	83	62	comparison	comparison	NOUN
aiua-10711	83	63	in	in	ADP
aiua-10711	83	64	stone	stone	NOUN
aiua-10711	83	65	patients	patient	NOUN
aiua-10711	83	66	(	(	PUNCT
aiua-10711	83	67	endpoint	endpoint	NOUN
aiua-10711	83	68	:	:	PUNCT
aiua-10711	83	69	ejaculation	ejaculation	NOUN
aiua-10711	83	70	)	)	PUNCT
aiua-10711	83	71	.	.	PUNCT
aiua-10711	84	1	imputation	imputation	NOUN
aiua-10711	84	2	of	of	ADP
aiua-10711	84	3	missing	miss	VERB
aiua-10711	84	4	studies	study	NOUN
aiua-10711	84	5	by	by	ADP
aiua-10711	84	6	the	the	DET
aiua-10711	84	7	trim	trim	NOUN
aiua-10711	84	8	-	-	PUNCT
aiua-10711	84	9	andfill	andfill	NOUN
aiua-10711	84	10	procedure	procedure	NOUN
aiua-10711	84	11	was	be	AUX
aiua-10711	84	12	implemented	implement	VERB
aiua-10711	84	13	in	in	ADP
aiua-10711	84	14	4	4	NUM
aiua-10711	84	15	comparisons	comparison	NOUN
aiua-10711	84	16	.	.	PUNCT
aiua-10711	85	1	in	in	ADP
aiua-10711	85	2	3	3	NUM
aiua-10711	85	3	cases	case	NOUN
aiua-10711	85	4	,	,	PUNCT
aiua-10711	85	5	the	the	DET
aiua-10711	85	6	significance	significance	NOUN
aiua-10711	85	7	or	or	CCONJ
aiua-10711	85	8	non	non	ADJ
aiua-10711	85	9	-	-	NOUN
aiua-10711	85	10	significance	significance	NOUN
aiua-10711	85	11	of	of	ADP
aiua-10711	85	12	adjusted	adjust	VERB
aiua-10711	85	13	odds	odd	NOUN
aiua-10711	85	14	ratios	ratio	NOUN
aiua-10711	85	15	was	be	AUX
aiua-10711	85	16	not	not	PART
aiua-10711	85	17	modified	modify	VERB
aiua-10711	85	18	by	by	ADP
aiua-10711	85	19	imputation	imputation	NOUN
aiua-10711	85	20	.	.	PUNCT
aiua-10711	86	1	conversely	conversely	ADV
aiua-10711	86	2	,	,	PUNCT
aiua-10711	86	3	the	the	DET
aiua-10711	86	4	adjusted	adjust	VERB
aiua-10711	86	5	odds	odd	NOUN
aiua-10711	86	6	ratio	ratio	NOUN
aiua-10711	86	7	for	for	ADP
aiua-10711	86	8	ejaculatory	ejaculatory	ADJ
aiua-10711	86	9	disorders	disorder	NOUN
aiua-10711	86	10	in	in	ADP
aiua-10711	86	11	stone	stone	NOUN
aiua-10711	86	12	patients	patient	NOUN
aiua-10711	86	13	treated	treat	VERB
aiua-10711	86	14	with	with	ADP
aiua-10711	86	15	alpha	alpha	NOUN
aiua-10711	86	16	adrenoceptor	adrenoceptor	NOUN
aiua-10711	86	17	blockers	blocker	NOUN
aiua-10711	86	18	compared	compare	VERB
aiua-10711	86	19	to	to	ADP
aiua-10711	86	20	placebo	placebo	NOUN
aiua-10711	86	21	lost	lose	VERB
aiua-10711	86	22	statistical	statistical	ADJ
aiua-10711	86	23	significance	significance	NOUN
aiua-10711	86	24	.	.	PUNCT
aiua-10711	87	1	alpha	alpha	NOUN
aiua-10711	87	2	-	-	PUNCT
aiua-10711	87	3	blockers	blocker	NOUN
aiua-10711	87	4	versus	versus	ADP
aiua-10711	87	5	placebo	placebo	NOUN
aiua-10711	87	6	a	a	DET
aiua-10711	87	7	total	total	NOUN
aiua-10711	87	8	of	of	ADP
aiua-10711	87	9	36	36	NUM
aiua-10711	87	10	studies	study	NOUN
aiua-10711	87	11	were	be	AUX
aiua-10711	87	12	included	include	VERB
aiua-10711	87	13	in	in	ADP
aiua-10711	87	14	this	this	DET
aiua-10711	87	15	analysis	analysis	NOUN
aiua-10711	87	16	:	:	PUNCT
aiua-10711	87	17	15	15	NUM
aiua-10711	87	18	studies	study	NOUN
aiua-10711	87	19	evaluated	evaluate	VERB
aiua-10711	87	20	ejaculatory	ejaculatory	ADJ
aiua-10711	87	21	disorders	disorder	NOUN
aiua-10711	87	22	secondary	secondary	ADJ
aiua-10711	87	23	to	to	ADP
aiua-10711	87	24	treatment	treatment	NOUN
aiua-10711	87	25	with	with	ADP
aiua-10711	87	26	alpha	alpha	NOUN
aiua-10711	87	27	-	-	PUNCT
aiua-10711	87	28	blockers	blocker	NOUN
aiua-10711	87	29	compared	compare	VERB
aiua-10711	87	30	to	to	ADP
aiua-10711	87	31	placebo	placebo	NOUN
aiua-10711	87	32	(	(	PUNCT
aiua-10711	87	33	9	9	NUM
aiua-10711	87	34	in	in	ADP
aiua-10711	87	35	patients	patient	NOUN
aiua-10711	87	36	with	with	ADP
aiua-10711	87	37	bph	bph	NOUN
aiua-10711	87	38	,	,	PUNCT
aiua-10711	87	39	1	1	NUM
aiua-10711	87	40	in	in	ADP
aiua-10711	87	41	patients	patient	NOUN
aiua-10711	87	42	with	with	ADP
aiua-10711	87	43	cp	cp	NOUN
aiua-10711	87	44	/	/	SYM
aiua-10711	87	45	cpps	cpps	NOUN
aiua-10711	87	46	,	,	PUNCT
aiua-10711	87	47	5	5	NUM
aiua-10711	87	48	in	in	ADP
aiua-10711	87	49	patients	patient	NOUN
aiua-10711	87	50	with	with	ADP
aiua-10711	87	51	ureteral	ureteral	ADJ
aiua-10711	87	52	stones	stone	NOUN
aiua-10711	87	53	)	)	PUNCT
aiua-10711	87	54	(	(	PUNCT
aiua-10711	87	55	10	10	NUM
aiua-10711	87	56	-	-	NUM
aiua-10711	87	57	24	24	NUM
aiua-10711	87	58	)	)	PUNCT
aiua-10711	87	59	.	.	PUNCT
aiua-10711	88	1	in	in	ADP
aiua-10711	88	2	7	7	NUM
aiua-10711	88	3	studies	study	NOUN
aiua-10711	88	4	ejaculatory	ejaculatory	ADJ
aiua-10711	88	5	disorders	disorder	NOUN
aiua-10711	88	6	were	be	AUX
aiua-10711	88	7	compared	compare	VERB
aiua-10711	88	8	in	in	ADP
aiua-10711	88	9	patients	patient	NOUN
aiua-10711	88	10	on	on	ADP
aiua-10711	88	11	treatment	treatment	NOUN
aiua-10711	88	12	with	with	ADP
aiua-10711	88	13	alpha	alpha	NOUN
aiua-10711	88	14	-	-	PUNCT
aiua-10711	88	15	blockers	blocker	NOUN
aiua-10711	88	16	compared	compare	VERB
aiua-10711	88	17	with	with	ADP
aiua-10711	88	18	standard	standard	ADJ
aiua-10711	88	19	conservative	conservative	ADJ
aiua-10711	88	20	treatment	treatment	NOUN
aiua-10711	88	21	of	of	ADP
aiua-10711	88	22	ureteral	ureteral	ADJ
aiua-10711	88	23	stones	stone	NOUN
aiua-10711	88	24	(	(	PUNCT
aiua-10711	88	25	25	25	NUM
aiua-10711	88	26	-	-	SYM
aiua-10711	88	27	31	31	NUM
aiua-10711	88	28	)	)	PUNCT
aiua-10711	88	29	.	.	PUNCT
aiua-10711	89	1	in	in	ADP
aiua-10711	89	2	9	9	NUM
aiua-10711	89	3	studies	study	NOUN
aiua-10711	89	4	,	,	PUNCT
aiua-10711	89	5	both	both	CCONJ
aiua-10711	89	6	ejaculatory	ejaculatory	ADJ
aiua-10711	89	7	and	and	CCONJ
aiua-10711	89	8	erectile	erectile	ADJ
aiua-10711	89	9	dysfunction	dysfunction	NOUN
aiua-10711	89	10	after	after	ADP
aiua-10711	89	11	treatment	treatment	NOUN
aiua-10711	89	12	with	with	ADP
aiua-10711	89	13	alpha	alpha	NOUN
aiua-10711	89	14	-	-	PUNCT
aiua-10711	89	15	blockers	blocker	NOUN
aiua-10711	89	16	were	be	AUX
aiua-10711	89	17	compared	compare	VERB
aiua-10711	89	18	to	to	ADP
aiua-10711	89	19	placebo	placebo	NOUN
aiua-10711	89	20	in	in	ADP
aiua-10711	89	21	patients	patient	NOUN
aiua-10711	89	22	with	with	ADP
aiua-10711	89	23	bph	bph	NOUN
aiua-10711	89	24	(	(	PUNCT
aiua-10711	89	25	32	32	NUM
aiua-10711	89	26	-	-	SYM
aiua-10711	89	27	40	40	NUM
aiua-10711	89	28	)	)	PUNCT
aiua-10711	89	29	.	.	PUNCT
aiua-10711	90	1	finally	finally	ADV
aiua-10711	90	2	,	,	PUNCT
aiua-10711	90	3	5	5	NUM
aiua-10711	90	4	studies	study	NOUN
aiua-10711	90	5	reported	report	VERB
aiua-10711	90	6	the	the	DET
aiua-10711	90	7	effect	effect	NOUN
aiua-10711	90	8	on	on	ADP
aiua-10711	90	9	erectile	erectile	ADJ
aiua-10711	90	10	function	function	NOUN
aiua-10711	90	11	of	of	ADP
aiua-10711	90	12	alphablockers	alphablocker	NOUN
aiua-10711	90	13	compared	compare	VERB
aiua-10711	90	14	to	to	ADP
aiua-10711	90	15	placebo	placebo	NOUN
aiua-10711	90	16	in	in	ADP
aiua-10711	90	17	bph	bph	NOUN
aiua-10711	90	18	patients	patient	NOUN
aiua-10711	90	19	(	(	PUNCT
aiua-10711	90	20	41	41	NUM
aiua-10711	90	21	-	-	SYM
aiua-10711	90	22	45	45	NUM
aiua-10711	90	23	)	)	PUNCT
aiua-10711	90	24	.	.	PUNCT
aiua-10711	91	1	endpoint	endpoint	NOUN
aiua-10711	91	2	:	:	PUNCT
aiua-10711	91	3	ejaculatory	ejaculatory	ADJ
aiua-10711	91	4	disorders	disorder	NOUN
aiua-10711	91	5	compared	compare	VERB
aiua-10711	91	6	to	to	ADP
aiua-10711	91	7	placebo	placebo	NOUN
aiua-10711	91	8	,	,	PUNCT
aiua-10711	91	9	alpha	alpha	NOUN
aiua-10711	91	10	-	-	PUNCT
aiua-10711	91	11	blockers	blocker	NOUN
aiua-10711	91	12	were	be	AUX
aiua-10711	91	13	associated	associate	VERB
aiua-10711	91	14	with	with	ADP
aiua-10711	91	15	significantly	significantly	ADV
aiua-10711	91	16	increased	increase	VERB
aiua-10711	91	17	odds	odd	NOUN
aiua-10711	91	18	of	of	ADP
aiua-10711	91	19	ejaculatory	ejaculatory	ADJ
aiua-10711	91	20	disorders	disorder	NOUN
aiua-10711	91	21	in	in	ADP
aiua-10711	91	22	patients	patient	NOUN
aiua-10711	91	23	with	with	ADP
aiua-10711	91	24	luts	luts	PROPN
aiua-10711	91	25	associated	associate	VERB
aiua-10711	91	26	to	to	ADP
aiua-10711	91	27	bph	bph	NOUN
aiua-10711	91	28	(	(	PUNCT
aiua-10711	91	29	or	or	CCONJ
aiua-10711	91	30	:	:	PUNCT
aiua-10711	91	31	7.53	7.53	NUM
aiua-10711	91	32	,	,	PUNCT
aiua-10711	91	33	95	95	NUM
aiua-10711	91	34	%	%	NOUN
aiua-10711	91	35	ci	ci	NOUN
aiua-10711	91	36	:	:	PUNCT
aiua-10711	91	37	3.77	3.77	NUM
aiua-10711	91	38	to	to	ADP
aiua-10711	91	39	15.02	15.02	NUM
aiua-10711	91	40	,	,	PUNCT
aiua-10711	91	41	23	23	NUM
aiua-10711	91	42	series	series	NOUN
aiua-10711	91	43	from	from	ADP
aiua-10711	91	44	19	19	NUM
aiua-10711	91	45	figure	figure	NOUN
aiua-10711	91	46	1	1	NUM
aiua-10711	91	47	.	.	PUNCT
aiua-10711	92	1	flow	flow	NOUN
aiua-10711	92	2	chart	chart	NOUN
aiua-10711	92	3	.	.	PUNCT
aiua-10711	93	1	255archivio	255archivio	PROPN
aiua-10711	93	2	italiano	italiano	NOUN
aiua-10711	93	3	di	di	X
aiua-10711	93	4	urologia	urologia	PROPN
aiua-10711	93	5	e	e	PROPN
aiua-10711	93	6	andrologia	andrologia	PROPN
aiua-10711	93	7	2022	2022	NUM
aiua-10711	93	8	;	;	PUNCT
aiua-10711	93	9	94	94	NUM
aiua-10711	93	10	,	,	PUNCT
aiua-10711	93	11	2	2	NUM
aiua-10711	93	12	sexual	sexual	ADJ
aiua-10711	93	13	function	function	NOUN
aiua-10711	93	14	and	and	CCONJ
aiua-10711	93	15	alpha	alpha	NOUN
aiua-10711	93	16	-	-	PUNCT
aiua-10711	93	17	blockers	blocker	NOUN
aiua-10711	93	18	studies	study	NOUN
aiua-10711	93	19	,	,	PUNCT
aiua-10711	93	20	13006	13006	NUM
aiua-10711	93	21	participants	participant	NOUN
aiua-10711	93	22	,	,	PUNCT
aiua-10711	93	23	z	z	NOUN
aiua-10711	93	24	=	=	NUM
aiua-10711	93	25	5.73	5.73	NUM
aiua-10711	93	26	,	,	PUNCT
aiua-10711	93	27	p	p	X
aiua-10711	93	28	<	<	X
aiua-10711	93	29	0.00001	0.00001	NUM
aiua-10711	93	30	,	,	PUNCT
aiua-10711	93	31	i2	i2	NOUN
aiua-10711	93	32	=	=	NOUN
aiua-10711	93	33	55	55	NUM
aiua-10711	93	34	%	%	NOUN
aiua-10711	93	35	)	)	PUNCT
aiua-10711	93	36	(	(	PUNCT
aiua-10711	93	37	figure	figure	NOUN
aiua-10711	93	38	2	2	NUM
aiua-10711	93	39	)	)	PUNCT
aiua-10711	93	40	.	.	PUNCT
aiua-10711	94	1	similarly	similarly	ADV
aiua-10711	94	2	,	,	PUNCT
aiua-10711	94	3	in	in	ADP
aiua-10711	94	4	patients	patient	NOUN
aiua-10711	94	5	with	with	ADP
aiua-10711	94	6	ureteral	ureteral	ADJ
aiua-10711	94	7	stones	stone	NOUN
aiua-10711	94	8	,	,	PUNCT
aiua-10711	94	9	patients	patient	NOUN
aiua-10711	94	10	taking	take	VERB
aiua-10711	94	11	alpha	alpha	NOUN
aiua-10711	94	12	-	-	PUNCT
aiua-10711	94	13	blockers	blocker	NOUN
aiua-10711	94	14	showed	show	VERB
aiua-10711	94	15	significantly	significantly	ADV
aiua-10711	94	16	higher	high	ADJ
aiua-10711	94	17	odds	odd	NOUN
aiua-10711	94	18	for	for	ADP
aiua-10711	94	19	ejaculatory	ejaculatory	ADJ
aiua-10711	94	20	disorders	disorder	NOUN
aiua-10711	94	21	,	,	PUNCT
aiua-10711	94	22	compared	compare	VERB
aiua-10711	94	23	to	to	ADP
aiua-10711	94	24	patients	patient	NOUN
aiua-10711	94	25	receiving	receive	VERB
aiua-10711	94	26	placebo	placebo	NOUN
aiua-10711	94	27	or	or	CCONJ
aiua-10711	94	28	standard	standard	ADJ
aiua-10711	94	29	care	care	NOUN
aiua-10711	94	30	(	(	PUNCT
aiua-10711	94	31	or	or	CCONJ
aiua-10711	94	32	:	:	PUNCT
aiua-10711	94	33	2.86	2.86	NUM
aiua-10711	94	34	,	,	PUNCT
aiua-10711	94	35	95	95	NUM
aiua-10711	94	36	%	%	NOUN
aiua-10711	94	37	ci	ci	NOUN
aiua-10711	94	38	:	:	PUNCT
aiua-10711	94	39	1.50	1.50	NUM
aiua-10711	94	40	to	to	ADP
aiua-10711	94	41	5.44	5.44	NUM
aiua-10711	94	42	,	,	PUNCT
aiua-10711	94	43	12	12	NUM
aiua-10711	94	44	series	series	NOUN
aiua-10711	94	45	from	from	ADP
aiua-10711	94	46	12	12	NUM
aiua-10711	94	47	studies	study	NOUN
aiua-10711	94	48	,	,	PUNCT
aiua-10711	94	49	3192	3192	NUM
aiua-10711	94	50	participants	participant	NOUN
aiua-10711	94	51	,	,	PUNCT
aiua-10711	94	52	z	z	NOUN
aiua-10711	94	53	=	=	SYM
aiua-10711	94	54	3.19	3.19	NUM
aiua-10711	94	55	,	,	PUNCT
aiua-10711	94	56	p	p	X
aiua-10711	94	57	<	<	X
aiua-10711	94	58	0.001	0.001	NUM
aiua-10711	94	59	,	,	PUNCT
aiua-10711	94	60	i2	i2	NOUN
aiua-10711	94	61	=	=	SYM
aiua-10711	94	62	31	31	NUM
aiua-10711	94	63	%	%	NOUN
aiua-10711	94	64	)	)	PUNCT
aiua-10711	94	65	(	(	PUNCT
aiua-10711	94	66	figure	figure	NOUN
aiua-10711	94	67	3	3	NUM
aiua-10711	94	68	)	)	PUNCT
aiua-10711	94	69	.	.	PUNCT
aiua-10711	95	1	significantly	significantly	ADV
aiua-10711	95	2	higher	high	ADJ
aiua-10711	95	3	odds	odd	NOUN
aiua-10711	95	4	for	for	ADP
aiua-10711	95	5	ejaculatory	ejaculatory	ADJ
aiua-10711	95	6	disorders	disorder	NOUN
aiua-10711	95	7	were	be	AUX
aiua-10711	95	8	confirmed	confirm	VERB
aiua-10711	95	9	in	in	ADP
aiua-10711	95	10	patients	patient	NOUN
aiua-10711	95	11	with	with	ADP
aiua-10711	95	12	ureteral	ureteral	ADJ
aiua-10711	95	13	stones	stone	NOUN
aiua-10711	95	14	taking	take	VERB
aiua-10711	95	15	alphablockers	alphablocker	NOUN
aiua-10711	95	16	compared	compare	VERB
aiua-10711	95	17	to	to	ADP
aiua-10711	95	18	patients	patient	NOUN
aiua-10711	95	19	either	either	CCONJ
aiua-10711	95	20	on	on	ADP
aiua-10711	95	21	placebo	placebo	NOUN
aiua-10711	95	22	or	or	CCONJ
aiua-10711	95	23	on	on	ADP
aiua-10711	95	24	standard	standard	ADJ
aiua-10711	95	25	treatment	treatment	NOUN
aiua-10711	95	26	(	(	PUNCT
aiua-10711	96	1	forest	forest	NOUN
aiua-10711	96	2	plots	plot	NOUN
aiua-10711	96	3	shown	show	VERB
aiua-10711	96	4	in	in	ADP
aiua-10711	96	5	supplementary	supplementary	ADJ
aiua-10711	96	6	materials	material	NOUN
aiua-10711	96	7	forest	forest	NOUN
aiua-10711	96	8	plots	plot	NOUN
aiua-10711	96	9	figures	figure	NOUN
aiua-10711	96	10	1	1	NUM
aiua-10711	96	11	-	-	SYM
aiua-10711	96	12	2	2	NUM
aiua-10711	96	13	)	)	PUNCT
aiua-10711	96	14	.	.	PUNCT
aiua-10711	97	1	compared	compare	VERB
aiua-10711	97	2	to	to	ADP
aiua-10711	97	3	placebo	placebo	NOUN
aiua-10711	97	4	,	,	PUNCT
aiua-10711	97	5	uroselective	uroselective	ADJ
aiua-10711	97	6	alpha	alpha	NOUN
aiua-10711	97	7	-	-	PUNCT
aiua-10711	97	8	blockers	blocker	NOUN
aiua-10711	97	9	showed	show	VERB
aiua-10711	97	10	significantly	significantly	ADV
aiua-10711	97	11	higher	high	ADJ
aiua-10711	97	12	odds	odd	NOUN
aiua-10711	97	13	of	of	ADP
aiua-10711	97	14	ejaculatory	ejaculatory	ADJ
aiua-10711	97	15	disorders	disorder	NOUN
aiua-10711	97	16	(	(	PUNCT
aiua-10711	97	17	or	or	CCONJ
aiua-10711	97	18	:	:	PUNCT
aiua-10711	97	19	11.46	11.46	NUM
aiua-10711	97	20	,	,	PUNCT
aiua-10711	97	21	95	95	NUM
aiua-10711	97	22	%	%	NOUN
aiua-10711	97	23	ci	ci	NOUN
aiua-10711	97	24	:	:	PUNCT
aiua-10711	97	25	5.58	5.58	NUM
aiua-10711	97	26	to	to	ADP
aiua-10711	97	27	23.54	23.54	NUM
aiua-10711	97	28	,	,	PUNCT
aiua-10711	97	29	16	16	NUM
aiua-10711	97	30	series	series	NOUN
aiua-10711	97	31	from	from	ADP
aiua-10711	97	32	13	13	NUM
aiua-10711	97	33	studies	study	NOUN
aiua-10711	97	34	,	,	PUNCT
aiua-10711	97	35	8580	8580	NUM
aiua-10711	97	36	participants	participant	NOUN
aiua-10711	97	37	,	,	PUNCT
aiua-10711	97	38	z	z	NOUN
aiua-10711	97	39	=	=	NUM
aiua-10711	98	1	6.64	6.64	NUM
aiua-10711	98	2	,	,	PUNCT
aiua-10711	98	3	p	p	X
aiua-10711	98	4	<	<	X
aiua-10711	98	5	0.00001	0.00001	NUM
aiua-10711	98	6	,	,	PUNCT
aiua-10711	98	7	i2	i2	NOUN
aiua-10711	98	8	=	=	SYM
aiua-10711	98	9	49	49	NUM
aiua-10711	98	10	%	%	NOUN
aiua-10711	98	11	(	(	PUNCT
aiua-10711	98	12	figure	figure	NOUN
aiua-10711	98	13	4	4	NUM
aiua-10711	98	14	)	)	PUNCT
aiua-10711	98	15	,	,	PUNCT
aiua-10711	98	16	whereas	whereas	SCONJ
aiua-10711	98	17	nonselective	nonselective	ADJ
aiua-10711	98	18	alpha	alpha	NOUN
aiua-10711	98	19	-	-	PUNCT
aiua-10711	98	20	blockers	blocker	NOUN
aiua-10711	98	21	were	be	AUX
aiua-10711	98	22	not	not	PART
aiua-10711	98	23	associated	associate	VERB
aiua-10711	98	24	with	with	ADP
aiua-10711	98	25	higher	high	ADJ
aiua-10711	98	26	figure	figure	NOUN
aiua-10711	98	27	2	2	NUM
aiua-10711	98	28	.	.	NOUN
aiua-10711	98	29	odds	odd	NOUN
aiua-10711	98	30	for	for	ADP
aiua-10711	98	31	ejaculatory	ejaculatory	ADJ
aiua-10711	98	32	disorders	disorder	NOUN
aiua-10711	98	33	in	in	ADP
aiua-10711	98	34	patients	patient	NOUN
aiua-10711	98	35	with	with	ADP
aiua-10711	98	36	luts	luts	PROPN
aiua-10711	98	37	associated	associate	VERB
aiua-10711	98	38	to	to	ADP
aiua-10711	98	39	bph	bph	NOUN
aiua-10711	98	40	taking	take	VERB
aiua-10711	98	41	alpha	alpha	NOUN
aiua-10711	98	42	-	-	PUNCT
aiua-10711	98	43	blockers	blocker	NOUN
aiua-10711	98	44	.	.	PUNCT
aiua-10711	99	1	data	datum	NOUN
aiua-10711	99	2	to	to	ADP
aiua-10711	99	3	the	the	DET
aiua-10711	99	4	right	right	NOUN
aiua-10711	99	5	of	of	ADP
aiua-10711	99	6	the	the	DET
aiua-10711	99	7	vertical	vertical	ADJ
aiua-10711	99	8	no	no	DET
aiua-10711	99	9	-	-	PUNCT
aiua-10711	99	10	effect	effect	NOUN
aiua-10711	99	11	axis	axis	NOUN
aiua-10711	99	12	indicate	indicate	VERB
aiua-10711	99	13	higher	high	ADJ
aiua-10711	99	14	odds	odd	NOUN
aiua-10711	99	15	for	for	ADP
aiua-10711	99	16	ejaculatory	ejaculatory	ADJ
aiua-10711	99	17	disorders	disorder	NOUN
aiua-10711	99	18	in	in	ADP
aiua-10711	99	19	patients	patient	NOUN
aiua-10711	99	20	treated	treat	VERB
aiua-10711	99	21	with	with	ADP
aiua-10711	99	22	alpha	alpha	NOUN
aiua-10711	99	23	adrenoceptor	adrenoceptor	NOUN
aiua-10711	99	24	blockers	blocker	NOUN
aiua-10711	99	25	(	(	PUNCT
aiua-10711	99	26	both	both	CCONJ
aiua-10711	99	27	uroselective	uroselective	ADJ
aiua-10711	99	28	and	and	CCONJ
aiua-10711	99	29	non	non	ADJ
aiua-10711	99	30	-	-	ADJ
aiua-10711	99	31	uroselective	uroselective	ADJ
aiua-10711	99	32	)	)	PUNCT
aiua-10711	99	33	,	,	PUNCT
aiua-10711	99	34	compared	compare	VERB
aiua-10711	99	35	to	to	ADP
aiua-10711	99	36	placebo	placebo	NOUN
aiua-10711	99	37	.	.	PUNCT
aiua-10711	100	1	figure	figure	VERB
aiua-10711	100	2	3	3	NUM
aiua-10711	100	3	.	.	NOUN
aiua-10711	100	4	odds	odd	NOUN
aiua-10711	100	5	for	for	ADP
aiua-10711	100	6	ejaculatory	ejaculatory	ADJ
aiua-10711	100	7	disorders	disorder	NOUN
aiua-10711	100	8	in	in	ADP
aiua-10711	100	9	patients	patient	NOUN
aiua-10711	100	10	with	with	ADP
aiua-10711	100	11	ureteral	ureteral	ADJ
aiua-10711	100	12	stones	stone	NOUN
aiua-10711	100	13	taking	take	VERB
aiua-10711	100	14	alpha	alpha	NOUN
aiua-10711	100	15	-	-	PUNCT
aiua-10711	100	16	blockers	blocker	NOUN
aiua-10711	100	17	for	for	ADP
aiua-10711	100	18	medical	medical	ADJ
aiua-10711	100	19	expulsive	expulsive	ADJ
aiua-10711	100	20	treatment	treatment	NOUN
aiua-10711	100	21	.	.	PUNCT
aiua-10711	101	1	data	datum	NOUN
aiua-10711	101	2	to	to	ADP
aiua-10711	101	3	the	the	DET
aiua-10711	101	4	right	right	NOUN
aiua-10711	101	5	of	of	ADP
aiua-10711	101	6	the	the	DET
aiua-10711	101	7	vertical	vertical	ADJ
aiua-10711	101	8	no	no	DET
aiua-10711	101	9	-	-	PUNCT
aiua-10711	101	10	effect	effect	NOUN
aiua-10711	101	11	axis	axis	NOUN
aiua-10711	101	12	indicate	indicate	VERB
aiua-10711	101	13	higher	high	ADJ
aiua-10711	101	14	odds	odd	NOUN
aiua-10711	101	15	for	for	ADP
aiua-10711	101	16	ejaculatory	ejaculatory	ADJ
aiua-10711	101	17	disorders	disorder	NOUN
aiua-10711	101	18	in	in	ADP
aiua-10711	101	19	patients	patient	NOUN
aiua-10711	101	20	treated	treat	VERB
aiua-10711	101	21	with	with	ADP
aiua-10711	101	22	alpha	alpha	NOUN
aiua-10711	101	23	adrenoceptor	adrenoceptor	NOUN
aiua-10711	101	24	blockers	blocker	NOUN
aiua-10711	101	25	compared	compare	VERB
aiua-10711	101	26	to	to	ADP
aiua-10711	101	27	placebo	placebo	NOUN
aiua-10711	101	28	or	or	CCONJ
aiua-10711	101	29	standard	standard	ADJ
aiua-10711	101	30	treatment	treatment	NOUN
aiua-10711	101	31	.	.	PUNCT
aiua-10711	102	1	archivio	archivio	NOUN
aiua-10711	102	2	italiano	italiano	PROPN
aiua-10711	102	3	di	di	PROPN
aiua-10711	102	4	urologia	urologia	PROPN
aiua-10711	102	5	e	e	PROPN
aiua-10711	102	6	andrologia	andrologia	PROPN
aiua-10711	102	7	2022	2022	NUM
aiua-10711	102	8	;	;	PUNCT
aiua-10711	102	9	94	94	NUM
aiua-10711	102	10	,	,	PUNCT
aiua-10711	102	11	2	2	NUM
aiua-10711	102	12	r.	r.	NOUN
aiua-10711	102	13	bapir	bapir	NOUN
aiua-10711	102	14	,	,	PUNCT
aiua-10711	102	15	k.	k.	PROPN
aiua-10711	102	16	hassan	hassan	PROPN
aiua-10711	102	17	bhatti	bhatti	PROPN
aiua-10711	102	18	,	,	PUNCT
aiua-10711	102	19	a	a	PRON
aiua-10711	102	20	,	,	PUNCT
aiua-10711	102	21	eliwa	eliwa	NOUN
aiua-10711	102	22	,	,	PUNCT
aiua-10711	102	23	et	et	PROPN
aiua-10711	102	24	al	al	PROPN
aiua-10711	102	25	.	.	PROPN
aiua-10711	103	1	256	256	NUM
aiua-10711	103	2	odds	odd	NOUN
aiua-10711	103	3	of	of	ADP
aiua-10711	103	4	ejaculatory	ejaculatory	ADJ
aiua-10711	103	5	dysfunction	dysfunction	NOUN
aiua-10711	103	6	(	(	PUNCT
aiua-10711	103	7	or	or	CCONJ
aiua-10711	103	8	:	:	PUNCT
aiua-10711	103	9	2.22	2.22	NUM
aiua-10711	103	10	,	,	PUNCT
aiua-10711	103	11	95	95	NUM
aiua-10711	103	12	%	%	NOUN
aiua-10711	103	13	ci	ci	NOUN
aiua-10711	103	14	:	:	PUNCT
aiua-10711	103	15	0.72	0.72	NUM
aiua-10711	103	16	to	to	ADP
aiua-10711	103	17	6.84	6.84	NUM
aiua-10711	103	18	,	,	PUNCT
aiua-10711	103	19	7	7	NUM
aiua-10711	103	20	series	series	NOUN
aiua-10711	103	21	,	,	PUNCT
aiua-10711	103	22	4426	4426	NUM
aiua-10711	103	23	participants	participant	NOUN
aiua-10711	103	24	,	,	PUNCT
aiua-10711	103	25	z	z	NOUN
aiua-10711	103	26	=	=	NUM
aiua-10711	103	27	1.38	1.38	NUM
aiua-10711	103	28	,	,	PUNCT
aiua-10711	103	29	p	p	X
aiua-10711	103	30	=	=	SYM
aiua-10711	103	31	0.17	0.17	NUM
aiua-10711	103	32	,	,	PUNCT
aiua-10711	103	33	i2	i2	PROPN
aiua-10711	103	34	=	=	NOUN
aiua-10711	103	35	12	12	NUM
aiua-10711	103	36	%	%	NOUN
aiua-10711	103	37	)	)	PUNCT
aiua-10711	103	38	(	(	PUNCT
aiua-10711	103	39	figure	figure	NOUN
aiua-10711	103	40	5	5	NUM
aiua-10711	103	41	)	)	PUNCT
aiua-10711	103	42	.	.	PUNCT
aiua-10711	104	1	endpoint	endpoint	NOUN
aiua-10711	104	2	:	:	PUNCT
aiua-10711	104	3	erectile	erectile	ADJ
aiua-10711	104	4	dysfunction	dysfunction	NOUN
aiua-10711	104	5	the	the	DET
aiua-10711	104	6	presence	presence	NOUN
aiua-10711	104	7	of	of	ADP
aiua-10711	104	8	erectile	erectile	ADJ
aiua-10711	104	9	dysfunction	dysfunction	NOUN
aiua-10711	104	10	in	in	ADP
aiua-10711	104	11	patients	patient	NOUN
aiua-10711	104	12	treated	treat	VERB
aiua-10711	104	13	with	with	ADP
aiua-10711	104	14	alpha	alpha	NOUN
aiua-10711	104	15	-	-	PUNCT
aiua-10711	104	16	blockers	blocker	NOUN
aiua-10711	104	17	was	be	AUX
aiua-10711	104	18	investigated	investigate	VERB
aiua-10711	104	19	in	in	ADP
aiua-10711	104	20	14	14	NUM
aiua-10711	104	21	studies	study	NOUN
aiua-10711	104	22	.	.	PUNCT
aiua-10711	105	1	eleven	eleven	NUM
aiua-10711	105	2	studies	study	NOUN
aiua-10711	105	3	(	(	PUNCT
aiua-10711	105	4	12	12	NUM
aiua-10711	105	5	series	series	NOUN
aiua-10711	105	6	)	)	PUNCT
aiua-10711	105	7	reported	report	VERB
aiua-10711	105	8	the	the	DET
aiua-10711	105	9	rates	rate	NOUN
aiua-10711	105	10	of	of	ADP
aiua-10711	105	11	erectile	erectile	ADJ
aiua-10711	105	12	dysfunction	dysfunction	NOUN
aiua-10711	105	13	in	in	ADP
aiua-10711	105	14	patients	patient	NOUN
aiua-10711	105	15	on	on	ADP
aiua-10711	105	16	treatment	treatment	NOUN
aiua-10711	105	17	with	with	ADP
aiua-10711	105	18	alpha	alpha	NOUN
aiua-10711	105	19	-	-	PUNCT
aiua-10711	105	20	blockers	blocker	NOUN
aiua-10711	105	21	(	(	PUNCT
aiua-10711	105	22	any	any	DET
aiua-10711	105	23	kind	kind	NOUN
aiua-10711	105	24	)	)	PUNCT
aiua-10711	105	25	in	in	ADP
aiua-10711	105	26	comparison	comparison	NOUN
aiua-10711	105	27	with	with	ADP
aiua-10711	105	28	placebo	placebo	NOUN
aiua-10711	105	29	(	(	PUNCT
aiua-10711	105	30	32	32	NUM
aiua-10711	105	31	-	-	SYM
aiua-10711	105	32	39	39	NUM
aiua-10711	105	33	,	,	PUNCT
aiua-10711	105	34	43	43	NUM
aiua-10711	105	35	-	-	SYM
aiua-10711	105	36	45	45	NUM
aiua-10711	105	37	)	)	PUNCT
aiua-10711	105	38	.	.	PUNCT
aiua-10711	106	1	there	there	PRON
aiua-10711	106	2	was	be	VERB
aiua-10711	106	3	no	no	DET
aiua-10711	106	4	statistically	statistically	ADV
aiua-10711	106	5	significant	significant	ADJ
aiua-10711	106	6	difference	difference	NOUN
aiua-10711	106	7	between	between	ADP
aiua-10711	106	8	the	the	DET
aiua-10711	106	9	odds	odd	NOUN
aiua-10711	106	10	of	of	ADP
aiua-10711	106	11	erectile	erectile	ADJ
aiua-10711	106	12	dysfunction	dysfunction	NOUN
aiua-10711	106	13	assessed	assess	VERB
aiua-10711	106	14	in	in	ADP
aiua-10711	106	15	the	the	DET
aiua-10711	106	16	alphablocker	alphablocker	ADJ
aiua-10711	106	17	treatment	treatment	NOUN
aiua-10711	106	18	arm	arm	NOUN
aiua-10711	106	19	compared	compare	VERB
aiua-10711	106	20	to	to	ADP
aiua-10711	106	21	placebo	placebo	NOUN
aiua-10711	106	22	(	(	PUNCT
aiua-10711	106	23	or	or	CCONJ
aiua-10711	106	24	:	:	PUNCT
aiua-10711	106	25	0.88	0.88	NUM
aiua-10711	106	26	,	,	PUNCT
aiua-10711	106	27	95	95	NUM
aiua-10711	106	28	%	%	NOUN
aiua-10711	106	29	ci	ci	NOUN
aiua-10711	106	30	:	:	PUNCT
aiua-10711	106	31	0.42	0.42	NUM
aiua-10711	106	32	to	to	ADP
aiua-10711	106	33	1.82	1.82	NUM
aiua-10711	106	34	,	,	PUNCT
aiua-10711	106	35	12	12	NUM
aiua-10711	106	36	series	series	NOUN
aiua-10711	106	37	,	,	PUNCT
aiua-10711	106	38	6631	6631	NUM
aiua-10711	106	39	participants	participant	NOUN
aiua-10711	106	40	,	,	PUNCT
aiua-10711	106	41	z	z	NOUN
aiua-10711	106	42	=	=	SYM
aiua-10711	106	43	0.35	0.35	NUM
aiua-10711	106	44	,	,	PUNCT
aiua-10711	106	45	p	p	X
aiua-10711	106	46	=	=	NOUN
aiua-10711	106	47	0.73	0.73	NUM
aiua-10711	106	48	,	,	PUNCT
aiua-10711	106	49	i2	i2	NOUN
aiua-10711	106	50	=	=	PUNCT
aiua-10711	106	51	36	36	NUM
aiua-10711	106	52	%	%	NOUN
aiua-10711	106	53	)	)	PUNCT
aiua-10711	106	54	(	(	PUNCT
aiua-10711	106	55	figure	figure	NOUN
aiua-10711	106	56	6	6	NUM
aiua-10711	106	57	)	)	PUNCT
aiua-10711	106	58	.	.	PUNCT
aiua-10711	107	1	the	the	DET
aiua-10711	107	2	lack	lack	NOUN
aiua-10711	107	3	of	of	ADP
aiua-10711	107	4	a	a	DET
aiua-10711	107	5	significant	significant	ADJ
aiua-10711	107	6	inter	inter	ADJ
aiua-10711	107	7	-	-	ADJ
aiua-10711	107	8	arm	arm	ADJ
aiua-10711	107	9	difference	difference	NOUN
aiua-10711	107	10	versus	versus	ADP
aiua-10711	107	11	placebo	placebo	NOUN
aiua-10711	107	12	was	be	AUX
aiua-10711	107	13	confirmed	confirm	VERB
aiua-10711	107	14	when	when	SCONJ
aiua-10711	107	15	uroselective	uroselective	ADJ
aiua-10711	107	16	and	and	CCONJ
aiua-10711	107	17	non	non	ADJ
aiua-10711	107	18	-	-	ADJ
aiua-10711	107	19	selective	selective	ADJ
aiua-10711	107	20	alpha	alpha	NOUN
aiua-10711	107	21	-	-	PUNCT
aiua-10711	107	22	blockers	blocker	NOUN
aiua-10711	107	23	were	be	AUX
aiua-10711	107	24	analyzed	analyze	VERB
aiua-10711	107	25	separately	separately	ADV
aiua-10711	107	26	(	(	PUNCT
aiua-10711	107	27	forest	forest	NOUN
aiua-10711	107	28	plots	plot	NOUN
aiua-10711	107	29	shown	show	VERB
aiua-10711	107	30	in	in	ADP
aiua-10711	107	31	supplementary	supplementary	ADJ
aiua-10711	107	32	materials	material	NOUN
aiua-10711	107	33	forest	forest	NOUN
aiua-10711	107	34	plots	plot	NOUN
aiua-10711	107	35	figures	figure	NOUN
aiua-10711	107	36	3	3	NUM
aiua-10711	107	37	,	,	PUNCT
aiua-10711	107	38	4	4	NUM
aiua-10711	107	39	)	)	PUNCT
aiua-10711	107	40	.	.	PUNCT
aiua-10711	108	1	in	in	ADP
aiua-10711	108	2	three	three	NUM
aiua-10711	108	3	of	of	ADP
aiua-10711	108	4	the	the	DET
aiua-10711	108	5	above	above	ADJ
aiua-10711	108	6	reported	report	VERB
aiua-10711	108	7	studies	study	NOUN
aiua-10711	108	8	,	,	PUNCT
aiua-10711	108	9	erectile	erectile	ADJ
aiua-10711	108	10	function	function	NOUN
aiua-10711	108	11	alterations	alteration	NOUN
aiua-10711	108	12	were	be	AUX
aiua-10711	108	13	also	also	ADV
aiua-10711	108	14	evaluated	evaluate	VERB
aiua-10711	108	15	by	by	ADP
aiua-10711	108	16	administering	administer	VERB
aiua-10711	108	17	questionnaires	questionnaire	NOUN
aiua-10711	108	18	to	to	ADP
aiua-10711	108	19	enrolled	enrol	VERB
aiua-10711	108	20	patients	patient	NOUN
aiua-10711	108	21	.	.	PUNCT
aiua-10711	109	1	hofner	hofner	PROPN
aiua-10711	109	2	et	et	PROPN
aiua-10711	109	3	al	al	PROPN
aiua-10711	109	4	.	.	PUNCT
aiua-10711	110	1	(	(	PUNCT
aiua-10711	110	2	33	33	NUM
aiua-10711	110	3	)	)	PUNCT
aiua-10711	110	4	evaluated	evaluate	VERB
aiua-10711	110	5	the	the	DET
aiua-10711	110	6	effect	effect	NOUN
aiua-10711	110	7	of	of	ADP
aiua-10711	110	8	alpha	alpha	NOUN
aiua-10711	110	9	-	-	PUNCT
aiua-10711	110	10	blockers	blocker	NOUN
aiua-10711	110	11	on	on	ADP
aiua-10711	110	12	sexual	sexual	ADJ
aiua-10711	110	13	function	function	NOUN
aiua-10711	110	14	by	by	ADP
aiua-10711	110	15	administering	administer	VERB
aiua-10711	110	16	a	a	DET
aiua-10711	110	17	quality	quality	NOUN
aiua-10711	110	18	-	-	PUNCT
aiua-10711	110	19	of	of	ADP
aiua-10711	110	20	-	-	PUNCT
aiua-10711	110	21	life	life	NOUN
aiua-10711	110	22	assessment	assessment	NOUN
aiua-10711	110	23	questionnaire	questionnaire	NOUN
aiua-10711	110	24	including	include	VERB
aiua-10711	110	25	three	three	NUM
aiua-10711	110	26	questions	question	NOUN
aiua-10711	110	27	on	on	ADP
aiua-10711	110	28	sexual	sexual	ADJ
aiua-10711	110	29	function	function	NOUN
aiua-10711	110	30	(	(	PUNCT
aiua-10711	110	31	interest	interest	NOUN
aiua-10711	110	32	in	in	ADP
aiua-10711	110	33	sex	sex	NOUN
aiua-10711	110	34	,	,	PUNCT
aiua-10711	110	35	erection	erection	NOUN
aiua-10711	110	36	,	,	PUNCT
aiua-10711	110	37	ejaculation	ejaculation	NOUN
aiua-10711	110	38	)	)	PUNCT
aiua-10711	110	39	.	.	PUNCT
aiua-10711	111	1	the	the	DET
aiua-10711	111	2	authors	author	NOUN
aiua-10711	111	3	reported	report	VERB
aiua-10711	111	4	the	the	DET
aiua-10711	111	5	overall	overall	ADJ
aiua-10711	111	6	evaluation	evaluation	NOUN
aiua-10711	111	7	of	of	ADP
aiua-10711	111	8	sexual	sexual	ADJ
aiua-10711	111	9	function	function	NOUN
aiua-10711	111	10	without	without	ADP
aiua-10711	111	11	showing	show	VERB
aiua-10711	111	12	the	the	DET
aiua-10711	111	13	results	result	NOUN
aiua-10711	111	14	of	of	ADP
aiua-10711	111	15	the	the	DET
aiua-10711	111	16	three	three	NUM
aiua-10711	111	17	separate	separate	ADJ
aiua-10711	111	18	domains	domain	NOUN
aiua-10711	111	19	.	.	PUNCT
aiua-10711	112	1	a	a	DET
aiua-10711	112	2	trend	trend	NOUN
aiua-10711	112	3	to	to	ADP
aiua-10711	112	4	improvement	improvement	NOUN
aiua-10711	112	5	of	of	ADP
aiua-10711	112	6	the	the	DET
aiua-10711	112	7	overall	overall	ADJ
aiua-10711	112	8	sexual	sexual	ADJ
aiua-10711	112	9	function	function	NOUN
aiua-10711	112	10	was	be	AUX
aiua-10711	112	11	observed	observe	VERB
aiua-10711	112	12	after	after	ADP
aiua-10711	112	13	tamsulosin	tamsulosin	NOUN
aiua-10711	112	14	(	(	PUNCT
aiua-10711	112	15	p	p	X
aiua-10711	112	16	=	=	NOUN
aiua-10711	112	17	0.042	0.042	NUM
aiua-10711	112	18	)	)	PUNCT
aiua-10711	112	19	,	,	PUNCT
aiua-10711	112	20	whereas	whereas	SCONJ
aiua-10711	112	21	no	no	DET
aiua-10711	112	22	differences	difference	NOUN
aiua-10711	112	23	were	be	AUX
aiua-10711	112	24	observed	observe	VERB
aiua-10711	112	25	when	when	SCONJ
aiua-10711	112	26	tamsulosin	tamsulosin	NOUN
aiua-10711	112	27	was	be	AUX
aiua-10711	112	28	compared	compare	VERB
aiua-10711	112	29	to	to	PART
aiua-10711	112	30	alfuzosin	alfuzosin	VERB
aiua-10711	112	31	.	.	PUNCT
aiua-10711	113	1	rosen	rosen	PROPN
aiua-10711	113	2	et	et	PROPN
aiua-10711	113	3	al	al	PROPN
aiua-10711	113	4	.	.	PROPN
aiua-10711	114	1	(	(	PUNCT
aiua-10711	114	2	39	39	NUM
aiua-10711	114	3	)	)	PUNCT
aiua-10711	114	4	reported	report	VERB
aiua-10711	114	5	changes	change	NOUN
aiua-10711	114	6	of	of	ADP
aiua-10711	114	7	the	the	DET
aiua-10711	114	8	dan	dan	PROPN
aiua-10711	114	9	-	-	PUNCT
aiua-10711	114	10	psssex	psssex	NOUN
aiua-10711	114	11	score	score	NOUN
aiua-10711	114	12	after	after	ADP
aiua-10711	114	13	alfuzosin	alfuzosin	NOUN
aiua-10711	114	14	treatment	treatment	NOUN
aiua-10711	114	15	.	.	PUNCT
aiua-10711	115	1	the	the	DET
aiua-10711	115	2	dan	dan	PROPN
aiua-10711	115	3	-	-	PUNCT
aiua-10711	115	4	psssex	psssex	NOUN
aiua-10711	115	5	tool	tool	NOUN
aiua-10711	115	6	includes	include	VERB
aiua-10711	115	7	questions	question	NOUN
aiua-10711	115	8	on	on	ADP
aiua-10711	115	9	erectile	erectile	NOUN
aiua-10711	115	10	and	and	CCONJ
aiua-10711	115	11	ejaculatory	ejaculatory	NOUN
aiua-10711	115	12	function	function	NOUN
aiua-10711	115	13	,	,	PUNCT
aiua-10711	115	14	and	and	CCONJ
aiua-10711	115	15	on	on	ADP
aiua-10711	115	16	bother	bother	NOUN
aiua-10711	115	17	associated	associate	VERB
aiua-10711	115	18	with	with	ADP
aiua-10711	115	19	these	these	DET
aiua-10711	115	20	two	two	NUM
aiua-10711	115	21	functions	function	NOUN
aiua-10711	115	22	.	.	PUNCT
aiua-10711	116	1	alfuzosin	alfuzosin	PROPN
aiua-10711	116	2	treatment	treatment	NOUN
aiua-10711	116	3	was	be	AUX
aiua-10711	116	4	associated	associate	VERB
aiua-10711	116	5	with	with	ADP
aiua-10711	116	6	a	a	DET
aiua-10711	116	7	significant	significant	ADJ
aiua-10711	116	8	improvement	improvement	NOUN
aiua-10711	116	9	of	of	ADP
aiua-10711	116	10	erectile	erectile	ADJ
aiua-10711	116	11	function	function	NOUN
aiua-10711	116	12	compared	compare	VERB
aiua-10711	116	13	with	with	ADP
aiua-10711	116	14	placebo	placebo	NOUN
aiua-10711	116	15	(	(	PUNCT
aiua-10711	116	16	p	p	NOUN
aiua-10711	116	17	=	=	NOUN
aiua-10711	116	18	0.02	0.02	NUM
aiua-10711	116	19	)	)	PUNCT
aiua-10711	116	20	,	,	PUNCT
aiua-10711	116	21	whereas	whereas	SCONJ
aiua-10711	116	22	treatment	treatment	NOUN
aiua-10711	116	23	did	do	AUX
aiua-10711	116	24	n’t	not	PART
aiua-10711	116	25	appear	appear	VERB
aiua-10711	116	26	to	to	PART
aiua-10711	116	27	influence	influence	VERB
aiua-10711	116	28	the	the	DET
aiua-10711	116	29	ejaculatory	ejaculatory	NOUN
aiua-10711	116	30	function	function	NOUN
aiua-10711	116	31	.	.	PUNCT
aiua-10711	117	1	shelbaia	shelbaia	PROPN
aiua-10711	117	2	et	et	PROPN
aiua-10711	117	3	al	al	PROPN
aiua-10711	117	4	.	.	PUNCT
aiua-10711	118	1	(	(	PUNCT
aiua-10711	118	2	44	44	NUM
aiua-10711	118	3	)	)	PUNCT
aiua-10711	118	4	observed	observe	VERB
aiua-10711	118	5	that	that	SCONJ
aiua-10711	118	6	the	the	DET
aiua-10711	118	7	use	use	NOUN
aiua-10711	118	8	of	of	ADP
aiua-10711	118	9	tamsulosin	tamsulosin	NOUN
aiua-10711	118	10	was	be	AUX
aiua-10711	118	11	associated	associate	VERB
aiua-10711	118	12	with	with	ADP
aiua-10711	118	13	increased	increase	VERB
aiua-10711	118	14	iief	iief	ADJ
aiua-10711	118	15	scores	score	NOUN
aiua-10711	118	16	(	(	PUNCT
aiua-10711	118	17	p	p	X
aiua-10711	118	18	=	=	NOUN
aiua-10711	118	19	0.047	0.047	NUM
aiua-10711	118	20	)	)	PUNCT
aiua-10711	118	21	in	in	ADP
aiua-10711	118	22	patients	patient	NOUN
aiua-10711	118	23	with	with	ADP
aiua-10711	118	24	luts	luts	PROPN
aiua-10711	118	25	and	and	CCONJ
aiua-10711	118	26	erectile	erectile	ADJ
aiua-10711	118	27	dysfunction	dysfunction	NOUN
aiua-10711	118	28	.	.	PUNCT
aiua-10711	119	1	three	three	NUM
aiua-10711	119	2	additional	additional	ADJ
aiua-10711	119	3	studies	study	NOUN
aiua-10711	119	4	were	be	AUX
aiua-10711	119	5	not	not	PART
aiua-10711	119	6	included	include	VERB
aiua-10711	119	7	in	in	ADP
aiua-10711	119	8	our	our	PRON
aiua-10711	119	9	quantitative	quantitative	ADJ
aiua-10711	119	10	analysis	analysis	NOUN
aiua-10711	119	11	.	.	PUNCT
aiua-10711	120	1	one	one	NUM
aiua-10711	120	2	study	study	NOUN
aiua-10711	120	3	evaluated	evaluate	VERB
aiua-10711	120	4	the	the	DET
aiua-10711	120	5	effects	effect	NOUN
aiua-10711	120	6	of	of	ADP
aiua-10711	120	7	the	the	DET
aiua-10711	120	8	oral	oral	ADJ
aiua-10711	120	9	administration	administration	NOUN
aiua-10711	120	10	of	of	ADP
aiua-10711	120	11	the	the	DET
aiua-10711	120	12	nonselective	nonselective	ADJ
aiua-10711	120	13	alphafigure	alphafigure	NOUN
aiua-10711	120	14	4	4	NUM
aiua-10711	120	15	.	.	NOUN
aiua-10711	120	16	odds	odd	NOUN
aiua-10711	120	17	for	for	ADP
aiua-10711	120	18	ejaculatory	ejaculatory	ADJ
aiua-10711	120	19	disorders	disorder	NOUN
aiua-10711	120	20	in	in	ADP
aiua-10711	120	21	patients	patient	NOUN
aiua-10711	120	22	in	in	ADP
aiua-10711	120	23	patients	patient	NOUN
aiua-10711	120	24	with	with	ADP
aiua-10711	120	25	luts	luts	PROPN
aiua-10711	120	26	associated	associate	VERB
aiua-10711	120	27	to	to	ADP
aiua-10711	120	28	bph	bph	NOUN
aiua-10711	120	29	taking	take	VERB
aiua-10711	120	30	uroselective	uroselective	ADJ
aiua-10711	120	31	alpha	alpha	NOUN
aiua-10711	120	32	-	-	PUNCT
aiua-10711	120	33	blockers	blocker	NOUN
aiua-10711	120	34	.	.	PUNCT
aiua-10711	121	1	data	datum	NOUN
aiua-10711	121	2	to	to	ADP
aiua-10711	121	3	the	the	DET
aiua-10711	121	4	right	right	NOUN
aiua-10711	121	5	of	of	ADP
aiua-10711	121	6	the	the	DET
aiua-10711	121	7	vertical	vertical	ADJ
aiua-10711	121	8	no	no	DET
aiua-10711	121	9	-	-	PUNCT
aiua-10711	121	10	effect	effect	NOUN
aiua-10711	121	11	axis	axis	NOUN
aiua-10711	121	12	indicate	indicate	VERB
aiua-10711	121	13	higher	high	ADJ
aiua-10711	121	14	odds	odd	NOUN
aiua-10711	121	15	for	for	ADP
aiua-10711	121	16	ejaculatory	ejaculatory	ADJ
aiua-10711	121	17	disorders	disorder	NOUN
aiua-10711	121	18	in	in	ADP
aiua-10711	121	19	patients	patient	NOUN
aiua-10711	121	20	treated	treat	VERB
aiua-10711	121	21	with	with	ADP
aiua-10711	121	22	uroselective	uroselective	ADJ
aiua-10711	121	23	alpha	alpha	NOUN
aiua-10711	121	24	adrenoceptor	adrenoceptor	NOUN
aiua-10711	121	25	blockers	blocker	NOUN
aiua-10711	121	26	compared	compare	VERB
aiua-10711	121	27	to	to	ADP
aiua-10711	121	28	placebo	placebo	NOUN
aiua-10711	121	29	.	.	PUNCT
aiua-10711	122	1	figure	figure	NOUN
aiua-10711	122	2	5	5	NUM
aiua-10711	122	3	.	.	PUNCT
aiua-10711	122	4	odds	odd	NOUN
aiua-10711	122	5	for	for	ADP
aiua-10711	122	6	ejaculatory	ejaculatory	ADJ
aiua-10711	122	7	disorders	disorder	NOUN
aiua-10711	122	8	in	in	ADP
aiua-10711	122	9	patients	patient	NOUN
aiua-10711	122	10	in	in	ADP
aiua-10711	122	11	patients	patient	NOUN
aiua-10711	122	12	with	with	ADP
aiua-10711	122	13	luts	luts	PROPN
aiua-10711	122	14	associated	associate	VERB
aiua-10711	122	15	to	to	ADP
aiua-10711	122	16	bph	bph	NOUN
aiua-10711	122	17	taking	take	VERB
aiua-10711	122	18	non	non	ADJ
aiua-10711	122	19	-	-	ADJ
aiua-10711	122	20	uroselective	uroselective	ADJ
aiua-10711	122	21	alpha	alpha	NOUN
aiua-10711	122	22	-	-	PUNCT
aiua-10711	122	23	blockers	blocker	NOUN
aiua-10711	122	24	.	.	PUNCT
aiua-10711	123	1	data	datum	NOUN
aiua-10711	123	2	to	to	ADP
aiua-10711	123	3	the	the	DET
aiua-10711	123	4	right	right	NOUN
aiua-10711	123	5	of	of	ADP
aiua-10711	123	6	the	the	DET
aiua-10711	123	7	vertical	vertical	ADJ
aiua-10711	123	8	no	no	DET
aiua-10711	123	9	-	-	PUNCT
aiua-10711	123	10	effect	effect	NOUN
aiua-10711	123	11	axis	axis	NOUN
aiua-10711	123	12	indicate	indicate	VERB
aiua-10711	123	13	higher	high	ADJ
aiua-10711	123	14	odds	odd	NOUN
aiua-10711	123	15	for	for	ADP
aiua-10711	123	16	ejaculatory	ejaculatory	ADJ
aiua-10711	123	17	disorders	disorder	NOUN
aiua-10711	123	18	in	in	ADP
aiua-10711	123	19	patients	patient	NOUN
aiua-10711	123	20	treated	treat	VERB
aiua-10711	123	21	with	with	ADP
aiua-10711	123	22	non	non	ADJ
aiua-10711	123	23	-	-	ADJ
aiua-10711	123	24	uroselective	uroselective	ADJ
aiua-10711	123	25	alpha	alpha	NOUN
aiua-10711	123	26	adrenoceptor	adrenoceptor	NOUN
aiua-10711	123	27	blockers	blocker	NOUN
aiua-10711	123	28	compared	compare	VERB
aiua-10711	123	29	to	to	ADP
aiua-10711	123	30	placebo	placebo	NOUN
aiua-10711	123	31	.	.	PUNCT
aiua-10711	124	1	257archivio	257archivio	PROPN
aiua-10711	124	2	italiano	italiano	NOUN
aiua-10711	124	3	di	di	X
aiua-10711	124	4	urologia	urologia	PROPN
aiua-10711	124	5	e	e	PROPN
aiua-10711	124	6	andrologia	andrologia	PROPN
aiua-10711	124	7	2022	2022	NUM
aiua-10711	124	8	;	;	PUNCT
aiua-10711	124	9	94	94	NUM
aiua-10711	124	10	,	,	PUNCT
aiua-10711	124	11	2	2	NUM
aiua-10711	124	12	sexual	sexual	ADJ
aiua-10711	124	13	function	function	NOUN
aiua-10711	124	14	and	and	CCONJ
aiua-10711	124	15	alpha	alpha	NOUN
aiua-10711	124	16	-	-	PUNCT
aiua-10711	124	17	blockers	blocker	NOUN
aiua-10711	124	18	adrenergic	adrenergic	ADJ
aiua-10711	124	19	antagonist	antagonist	NOUN
aiua-10711	124	20	phentolamine	phentolamine	NOUN
aiua-10711	124	21	in	in	ADP
aiua-10711	124	22	patients	patient	NOUN
aiua-10711	124	23	with	with	ADP
aiua-10711	124	24	erectile	erectile	ADJ
aiua-10711	124	25	dysfunction	dysfunction	NOUN
aiua-10711	124	26	.	.	PUNCT
aiua-10711	125	1	full	full	ADJ
aiua-10711	125	2	erection	erection	NOUN
aiua-10711	125	3	was	be	AUX
aiua-10711	125	4	achieved	achieve	VERB
aiua-10711	125	5	after	after	ADP
aiua-10711	125	6	ondemand	ondemand	NOUN
aiua-10711	125	7	administration	administration	NOUN
aiua-10711	125	8	of	of	ADP
aiua-10711	125	9	phentolamine	phentolamine	PROPN
aiua-10711	125	10	at	at	ADP
aiua-10711	125	11	different	different	ADJ
aiua-10711	125	12	doses	dose	NOUN
aiua-10711	125	13	(	(	PUNCT
aiua-10711	125	14	from	from	ADP
aiua-10711	125	15	20	20	NUM
aiua-10711	125	16	to	to	PART
aiua-10711	125	17	60	60	NUM
aiua-10711	125	18	mg	mg	NOUN
aiua-10711	125	19	)	)	PUNCT
aiua-10711	125	20	more	more	ADV
aiua-10711	125	21	frequently	frequently	ADV
aiua-10711	125	22	than	than	ADP
aiua-10711	125	23	after	after	ADP
aiua-10711	125	24	placebo	placebo	NOUN
aiua-10711	125	25	.	.	PUNCT
aiua-10711	126	1	however	however	ADV
aiua-10711	126	2	,	,	PUNCT
aiua-10711	126	3	the	the	DET
aiua-10711	126	4	sample	sample	NOUN
aiua-10711	126	5	size	size	NOUN
aiua-10711	126	6	was	be	AUX
aiua-10711	126	7	too	too	ADV
aiua-10711	126	8	small	small	ADJ
aiua-10711	126	9	for	for	ADP
aiua-10711	126	10	statistical	statistical	ADJ
aiua-10711	126	11	analysis	analysis	NOUN
aiua-10711	126	12	(	(	PUNCT
aiua-10711	126	13	41	41	NUM
aiua-10711	126	14	)	)	PUNCT
aiua-10711	126	15	.	.	PUNCT
aiua-10711	127	1	another	another	DET
aiua-10711	127	2	study	study	NOUN
aiua-10711	127	3	evaluated	evaluate	VERB
aiua-10711	127	4	the	the	DET
aiua-10711	127	5	effect	effect	NOUN
aiua-10711	127	6	of	of	ADP
aiua-10711	127	7	a	a	DET
aiua-10711	127	8	single	single	ADJ
aiua-10711	127	9	dose	dose	NOUN
aiua-10711	127	10	of	of	ADP
aiua-10711	127	11	the	the	DET
aiua-10711	127	12	selective	selective	ADJ
aiua-10711	127	13	,	,	PUNCT
aiua-10711	127	14	orally	orally	ADV
aiua-10711	127	15	-	-	PUNCT
aiua-10711	127	16	active	active	ADJ
aiua-10711	127	17	alpha1	alpha1	NOUN
aiua-10711	127	18	-	-	PUNCT
aiua-10711	127	19	aadrenoceptor	aadrenoceptor	NOUN
aiua-10711	127	20	antagonist	antagonist	NOUN
aiua-10711	127	21	ro70	ro70	PROPN
aiua-10711	127	22	-	-	PUNCT
aiua-10711	127	23	0004	0004	NUM
aiua-10711	127	24	on	on	ADP
aiua-10711	127	25	the	the	DET
aiua-10711	127	26	erectile	erectile	NOUN
aiua-10711	127	27	function	function	NOUN
aiua-10711	127	28	in	in	ADP
aiua-10711	127	29	a	a	DET
aiua-10711	127	30	group	group	NOUN
aiua-10711	127	31	of	of	ADP
aiua-10711	127	32	men	man	NOUN
aiua-10711	127	33	with	with	ADP
aiua-10711	127	34	erectile	erectile	ADJ
aiua-10711	127	35	dysfunction	dysfunction	NOUN
aiua-10711	127	36	.	.	PUNCT
aiua-10711	128	1	ro700004	ro700004	NOUN
aiua-10711	128	2	did	do	AUX
aiua-10711	128	3	not	not	PART
aiua-10711	128	4	improve	improve	VERB
aiua-10711	128	5	the	the	DET
aiua-10711	128	6	erectile	erectile	NOUN
aiua-10711	128	7	function	function	NOUN
aiua-10711	128	8	when	when	SCONJ
aiua-10711	128	9	compared	compare	VERB
aiua-10711	128	10	to	to	ADP
aiua-10711	128	11	placebo	placebo	NOUN
aiua-10711	128	12	(	(	PUNCT
aiua-10711	128	13	42	42	NUM
aiua-10711	128	14	)	)	PUNCT
aiua-10711	128	15	.	.	PUNCT
aiua-10711	129	1	finally	finally	ADV
aiua-10711	129	2	,	,	PUNCT
aiua-10711	129	3	in	in	ADP
aiua-10711	129	4	patients	patient	NOUN
aiua-10711	129	5	with	with	ADP
aiua-10711	129	6	painful	painful	ADJ
aiua-10711	129	7	ejaculation	ejaculation	NOUN
aiua-10711	129	8	,	,	PUNCT
aiua-10711	129	9	safarinejad	safarinejad	PROPN
aiua-10711	129	10	et	et	PROPN
aiua-10711	129	11	al	al	PROPN
aiua-10711	129	12	.	.	PUNCT
aiua-10711	130	1	(	(	PUNCT
aiua-10711	130	2	40	40	NUM
aiua-10711	130	3	)	)	PUNCT
aiua-10711	130	4	found	find	VERB
aiua-10711	130	5	that	that	SCONJ
aiua-10711	130	6	the	the	DET
aiua-10711	130	7	intercourse	intercourse	NOUN
aiua-10711	130	8	satisfaction	satisfaction	NOUN
aiua-10711	130	9	domain	domain	NOUN
aiua-10711	130	10	iief	iief	NOUN
aiua-10711	130	11	scores	score	NOUN
aiua-10711	130	12	were	be	AUX
aiua-10711	130	13	not	not	PART
aiua-10711	130	14	significantly	significantly	ADV
aiua-10711	130	15	improved	improve	VERB
aiua-10711	130	16	after	after	ADP
aiua-10711	130	17	tamsulosin	tamsulosin	NOUN
aiua-10711	130	18	(	(	PUNCT
aiua-10711	130	19	p	p	NOUN
aiua-10711	130	20	=	=	NOUN
aiua-10711	130	21	0.08	0.08	NUM
aiua-10711	130	22	)	)	PUNCT
aiua-10711	130	23	.	.	PUNCT
aiua-10711	131	1	other	other	ADJ
aiua-10711	131	2	endpoints	endpoint	NOUN
aiua-10711	131	3	few	few	ADJ
aiua-10711	131	4	studies	study	NOUN
aiua-10711	131	5	reported	report	VERB
aiua-10711	131	6	about	about	ADP
aiua-10711	131	7	the	the	DET
aiua-10711	131	8	alterations	alteration	NOUN
aiua-10711	131	9	of	of	ADP
aiua-10711	131	10	sexual	sexual	ADJ
aiua-10711	131	11	desire	desire	NOUN
aiua-10711	131	12	after	after	ADP
aiua-10711	131	13	administration	administration	NOUN
aiua-10711	131	14	of	of	ADP
aiua-10711	131	15	alpha	alpha	NOUN
aiua-10711	131	16	-	-	PUNCT
aiua-10711	131	17	blockers	blocker	NOUN
aiua-10711	131	18	.	.	PUNCT
aiua-10711	132	1	no	no	DET
aiua-10711	132	2	significant	significant	ADJ
aiua-10711	132	3	differences	difference	NOUN
aiua-10711	132	4	of	of	ADP
aiua-10711	132	5	desire	desire	NOUN
aiua-10711	132	6	after	after	ADP
aiua-10711	132	7	alfuzosin	alfuzosin	NOUN
aiua-10711	132	8	or	or	CCONJ
aiua-10711	132	9	tamsulosin	tamsulosin	NOUN
aiua-10711	132	10	and	and	CCONJ
aiua-10711	132	11	placebo	placebo	NOUN
aiua-10711	132	12	were	be	AUX
aiua-10711	132	13	reported	report	VERB
aiua-10711	132	14	.	.	PUNCT
aiua-10711	133	1	kirby	kirby	PROPN
aiua-10711	133	2	et	et	PROPN
aiua-10711	133	3	al	al	PROPN
aiua-10711	133	4	.	.	PROPN
aiua-10711	134	1	(	(	PUNCT
aiua-10711	134	2	34	34	NUM
aiua-10711	134	3	)	)	PUNCT
aiua-10711	134	4	reported	report	VERB
aiua-10711	134	5	similar	similar	ADJ
aiua-10711	134	6	decreases	decrease	NOUN
aiua-10711	134	7	of	of	ADP
aiua-10711	134	8	libido	libido	NOUN
aiua-10711	134	9	after	after	ADP
aiua-10711	134	10	alfuzosin	alfuzosin	NOUN
aiua-10711	134	11	or	or	CCONJ
aiua-10711	134	12	placebo	placebo	NOUN
aiua-10711	134	13	(	(	PUNCT
aiua-10711	134	14	-3.6	-3.6	PROPN
aiua-10711	134	15	%	%	NOUN
aiua-10711	134	16	vs	vs	ADP
aiua-10711	134	17	1.9	1.9	NUM
aiua-10711	134	18	%	%	NOUN
aiua-10711	134	19	,	,	PUNCT
aiua-10711	134	20	p	p	X
aiua-10711	134	21	=	=	NOUN
aiua-10711	134	22	0.58	0.58	NUM
aiua-10711	134	23	)	)	PUNCT
aiua-10711	134	24	.	.	PUNCT
aiua-10711	135	1	van	van	PROPN
aiua-10711	135	2	kerrebroeck	kerrebroeck	PROPN
aiua-10711	135	3	et	et	PROPN
aiua-10711	135	4	al	al	PROPN
aiua-10711	135	5	.	.	PROPN
aiua-10711	136	1	(	(	PUNCT
aiua-10711	136	2	45	45	NUM
aiua-10711	136	3	)	)	PUNCT
aiua-10711	136	4	reported	report	VERB
aiua-10711	136	5	no	no	DET
aiua-10711	136	6	cases	case	NOUN
aiua-10711	136	7	of	of	ADP
aiua-10711	136	8	decreased	decrease	VERB
aiua-10711	136	9	desire	desire	NOUN
aiua-10711	136	10	after	after	ADP
aiua-10711	136	11	alfuzosin	alfuzosin	NOUN
aiua-10711	136	12	10	10	NUM
aiua-10711	136	13	mg	mg	NUM
aiua-10711	136	14	/	/	SYM
aiua-10711	136	15	day	day	NOUN
aiua-10711	136	16	,	,	PUNCT
aiua-10711	136	17	0.7	0.7	NUM
aiua-10711	136	18	%	%	NOUN
aiua-10711	136	19	cases	case	NOUN
aiua-10711	136	20	after	after	ADP
aiua-10711	136	21	alfuzosin	alfuzosin	VERB
aiua-10711	136	22	2.5	2.5	NUM
aiua-10711	136	23	mg	mg	NOUN
aiua-10711	136	24	t.i.d	t.i.d	PROPN
aiua-10711	136	25	.	.	PUNCT
aiua-10711	137	1	and	and	CCONJ
aiua-10711	137	2	0.7	0.7	NUM
aiua-10711	137	3	%	%	NOUN
aiua-10711	137	4	cases	case	NOUN
aiua-10711	137	5	after	after	ADP
aiua-10711	137	6	placebo	placebo	NOUN
aiua-10711	137	7	.	.	PUNCT
aiua-10711	138	1	hofner	hofner	PROPN
aiua-10711	138	2	et	et	PROPN
aiua-10711	138	3	al	al	PROPN
aiua-10711	138	4	.	.	PUNCT
aiua-10711	139	1	(	(	PUNCT
aiua-10711	139	2	33	33	NUM
aiua-10711	139	3	)	)	PUNCT
aiua-10711	139	4	reported	report	VERB
aiua-10711	139	5	no	no	DET
aiua-10711	139	6	differences	difference	NOUN
aiua-10711	139	7	between	between	ADP
aiua-10711	139	8	tamsulosin	tamsulosin	NOUN
aiua-10711	139	9	and	and	CCONJ
aiua-10711	139	10	placebo	placebo	NOUN
aiua-10711	139	11	(	(	PUNCT
aiua-10711	139	12	0.8	0.8	NUM
aiua-10711	139	13	%	%	NOUN
aiua-10711	139	14	vs	vs	ADP
aiua-10711	139	15	0	0	NUM
aiua-10711	139	16	%	%	NOUN
aiua-10711	139	17	,	,	PUNCT
aiua-10711	139	18	p	p	NOUN
aiua-10711	139	19	=	=	NOUN
aiua-10711	139	20	0.306	0.306	NUM
aiua-10711	139	21	)	)	PUNCT
aiua-10711	139	22	and	and	CCONJ
aiua-10711	139	23	singh	singh	PROPN
aiua-10711	139	24	et	et	PROPN
aiua-10711	139	25	al	al	PROPN
aiua-10711	139	26	.	.	PROPN
aiua-10711	140	1	(	(	PUNCT
aiua-10711	140	2	19	19	NUM
aiua-10711	140	3	)	)	PUNCT
aiua-10711	140	4	no	no	DET
aiua-10711	140	5	cases	case	NOUN
aiua-10711	140	6	of	of	ADP
aiua-10711	140	7	decreased	decrease	VERB
aiua-10711	140	8	desire	desire	NOUN
aiua-10711	140	9	after	after	ADP
aiua-10711	140	10	both	both	PRON
aiua-10711	140	11	tamsulosin	tamsulosin	NOUN
aiua-10711	140	12	or	or	CCONJ
aiua-10711	140	13	placebo	placebo	NOUN
aiua-10711	140	14	.	.	PUNCT
aiua-10711	141	1	hofner	hofner	PROPN
aiua-10711	141	2	et	et	PROPN
aiua-10711	141	3	al	al	PROPN
aiua-10711	141	4	.	.	PUNCT
aiua-10711	142	1	(	(	PUNCT
aiua-10711	142	2	33	33	NUM
aiua-10711	142	3	)	)	PUNCT
aiua-10711	142	4	found	find	VERB
aiua-10711	142	5	no	no	DET
aiua-10711	142	6	cases	case	NOUN
aiua-10711	142	7	of	of	ADP
aiua-10711	142	8	decreased	decrease	VERB
aiua-10711	142	9	libido	libido	NOUN
aiua-10711	142	10	after	after	ADP
aiua-10711	142	11	tamsulosin	tamsulosin	NOUN
aiua-10711	142	12	or	or	CCONJ
aiua-10711	142	13	alfuzosin	alfuzosin	NOUN
aiua-10711	142	14	.	.	PUNCT
aiua-10711	143	1	comparisons	comparison	NOUN
aiua-10711	143	2	between	between	ADP
aiua-10711	143	3	alpha	alpha	NOUN
aiua-10711	143	4	-	-	PUNCT
aiua-10711	143	5	blockers	blocker	NOUN
aiua-10711	143	6	a	a	DET
aiua-10711	143	7	total	total	NOUN
aiua-10711	143	8	of	of	ADP
aiua-10711	143	9	31	31	NUM
aiua-10711	143	10	studies	study	NOUN
aiua-10711	143	11	compared	compare	VERB
aiua-10711	143	12	the	the	DET
aiua-10711	143	13	effect	effect	NOUN
aiua-10711	143	14	of	of	ADP
aiua-10711	143	15	different	different	ADJ
aiua-10711	143	16	alpha	alpha	NOUN
aiua-10711	143	17	-	-	PUNCT
aiua-10711	143	18	blockers	blocker	NOUN
aiua-10711	143	19	on	on	ADP
aiua-10711	143	20	sexual	sexual	ADJ
aiua-10711	143	21	function	function	NOUN
aiua-10711	143	22	(	(	PUNCT
aiua-10711	143	23	46	46	NUM
aiua-10711	143	24	-	-	SYM
aiua-10711	143	25	76	76	NUM
aiua-10711	143	26	)	)	PUNCT
aiua-10711	143	27	.	.	PUNCT
aiua-10711	144	1	out	out	ADP
aiua-10711	144	2	of	of	ADP
aiua-10711	144	3	31	31	NUM
aiua-10711	144	4	trials	trial	NOUN
aiua-10711	144	5	,	,	PUNCT
aiua-10711	144	6	15	15	NUM
aiua-10711	144	7	compared	compare	VERB
aiua-10711	144	8	the	the	DET
aiua-10711	144	9	risk	risk	NOUN
aiua-10711	144	10	of	of	ADP
aiua-10711	144	11	ejaculatory	ejaculatory	ADJ
aiua-10711	144	12	disorders	disorder	NOUN
aiua-10711	144	13	after	after	ADP
aiua-10711	144	14	figure	figure	NOUN
aiua-10711	144	15	7	7	NUM
aiua-10711	144	16	.	.	NOUN
aiua-10711	144	17	odds	odd	NOUN
aiua-10711	144	18	for	for	ADP
aiua-10711	144	19	ejaculatory	ejaculatory	ADJ
aiua-10711	144	20	disorders	disorder	NOUN
aiua-10711	144	21	in	in	ADP
aiua-10711	144	22	patients	patient	NOUN
aiua-10711	144	23	taking	take	VERB
aiua-10711	144	24	silodosin	silodosin	NOUN
aiua-10711	144	25	or	or	CCONJ
aiua-10711	144	26	tamsulosin	tamsulosin	NOUN
aiua-10711	144	27	.	.	PUNCT
aiua-10711	145	1	data	datum	NOUN
aiua-10711	145	2	to	to	ADP
aiua-10711	145	3	the	the	DET
aiua-10711	145	4	right	right	NOUN
aiua-10711	145	5	of	of	ADP
aiua-10711	145	6	the	the	DET
aiua-10711	145	7	vertical	vertical	ADJ
aiua-10711	145	8	no	no	DET
aiua-10711	145	9	-	-	PUNCT
aiua-10711	145	10	effect	effect	NOUN
aiua-10711	145	11	axis	axis	NOUN
aiua-10711	145	12	indicate	indicate	VERB
aiua-10711	145	13	higher	high	ADJ
aiua-10711	145	14	odds	odd	NOUN
aiua-10711	145	15	for	for	ADP
aiua-10711	145	16	ejaculatory	ejaculatory	ADJ
aiua-10711	145	17	disorders	disorder	NOUN
aiua-10711	145	18	in	in	ADP
aiua-10711	145	19	patients	patient	NOUN
aiua-10711	145	20	treated	treat	VERB
aiua-10711	145	21	with	with	ADP
aiua-10711	145	22	silodosin	silodosin	NOUN
aiua-10711	145	23	.	.	PUNCT
aiua-10711	146	1	figure	figure	VERB
aiua-10711	146	2	6	6	NUM
aiua-10711	146	3	.	.	PUNCT
aiua-10711	146	4	odds	odd	NOUN
aiua-10711	146	5	for	for	ADP
aiua-10711	146	6	erectile	erectile	ADJ
aiua-10711	146	7	dysfunction	dysfunction	NOUN
aiua-10711	146	8	in	in	ADP
aiua-10711	146	9	bph	bph	NOUN
aiua-10711	146	10	patients	patient	NOUN
aiua-10711	146	11	taking	take	VERB
aiua-10711	146	12	alpha	alpha	NOUN
aiua-10711	146	13	-	-	PUNCT
aiua-10711	146	14	blockers	blocker	NOUN
aiua-10711	146	15	.	.	PUNCT
aiua-10711	147	1	data	datum	NOUN
aiua-10711	147	2	to	to	ADP
aiua-10711	147	3	the	the	DET
aiua-10711	147	4	left	left	NOUN
aiua-10711	147	5	of	of	ADP
aiua-10711	147	6	the	the	DET
aiua-10711	147	7	vertical	vertical	ADJ
aiua-10711	147	8	no	no	DET
aiua-10711	147	9	-	-	PUNCT
aiua-10711	147	10	effect	effect	NOUN
aiua-10711	147	11	axis	axis	NOUN
aiua-10711	147	12	indicate	indicate	VERB
aiua-10711	147	13	lower	low	ADJ
aiua-10711	147	14	odds	odd	NOUN
aiua-10711	147	15	for	for	ADP
aiua-10711	147	16	erectile	erectile	ADJ
aiua-10711	147	17	dysfunction	dysfunction	NOUN
aiua-10711	147	18	in	in	ADP
aiua-10711	147	19	patients	patient	NOUN
aiua-10711	147	20	treated	treat	VERB
aiua-10711	147	21	with	with	ADP
aiua-10711	147	22	placebo	placebo	NOUN
aiua-10711	147	23	compared	compare	VERB
aiua-10711	147	24	to	to	ADP
aiua-10711	147	25	alpha	alpha	NOUN
aiua-10711	147	26	adrenoceptor	adrenoceptor	NOUN
aiua-10711	147	27	blockers	blocker	NOUN
aiua-10711	147	28	.	.	PUNCT
aiua-10711	148	1	archivio	archivio	NOUN
aiua-10711	148	2	italiano	italiano	PROPN
aiua-10711	148	3	di	di	X
aiua-10711	148	4	urologia	urologia	PROPN
aiua-10711	148	5	e	e	PROPN
aiua-10711	148	6	andrologia	andrologia	PROPN
aiua-10711	148	7	2022	2022	NUM
aiua-10711	148	8	;	;	PUNCT
aiua-10711	148	9	94	94	NUM
aiua-10711	148	10	,	,	PUNCT
aiua-10711	148	11	2	2	NUM
aiua-10711	148	12	r.	r.	NOUN
aiua-10711	148	13	bapir	bapir	NOUN
aiua-10711	148	14	,	,	PUNCT
aiua-10711	148	15	k.	k.	PROPN
aiua-10711	148	16	hassan	hassan	PROPN
aiua-10711	148	17	bhatti	bhatti	PROPN
aiua-10711	148	18	,	,	PUNCT
aiua-10711	148	19	a	a	PRON
aiua-10711	148	20	,	,	PUNCT
aiua-10711	148	21	eliwa	eliwa	NOUN
aiua-10711	148	22	,	,	PUNCT
aiua-10711	148	23	et	et	PROPN
aiua-10711	148	24	al	al	PROPN
aiua-10711	148	25	.	.	PROPN
aiua-10711	148	26	258	258	NUM
aiua-10711	148	27	tamsulosin	tamsulosin	NOUN
aiua-10711	148	28	compared	compare	VERB
aiua-10711	148	29	with	with	ADP
aiua-10711	148	30	silodosin	silodosin	NOUN
aiua-10711	148	31	(	(	PUNCT
aiua-10711	148	32	49	49	NUM
aiua-10711	148	33	-	-	SYM
aiua-10711	148	34	54	54	NUM
aiua-10711	148	35	,	,	PUNCT
aiua-10711	148	36	60	60	NUM
aiua-10711	148	37	,	,	PUNCT
aiua-10711	148	38	62	62	NUM
aiua-10711	148	39	,	,	PUNCT
aiua-10711	148	40	64	64	NUM
aiua-10711	148	41	,	,	PUNCT
aiua-10711	148	42	65	65	NUM
aiua-10711	148	43	,	,	PUNCT
aiua-10711	148	44	70	70	NUM
aiua-10711	148	45	,	,	PUNCT
aiua-10711	148	46	71	71	NUM
aiua-10711	148	47	,	,	PUNCT
aiua-10711	148	48	73	73	NUM
aiua-10711	148	49	-	-	SYM
aiua-10711	148	50	75	75	NUM
aiua-10711	148	51	)	)	PUNCT
aiua-10711	148	52	,	,	PUNCT
aiua-10711	148	53	5	5	NUM
aiua-10711	148	54	studies	study	NOUN
aiua-10711	148	55	evaluated	evaluate	VERB
aiua-10711	148	56	the	the	DET
aiua-10711	148	57	effect	effect	NOUN
aiua-10711	148	58	of	of	ADP
aiua-10711	148	59	naftopidil	naftopidil	NOUN
aiua-10711	148	60	compared	compare	VERB
aiua-10711	148	61	with	with	ADP
aiua-10711	148	62	a	a	DET
aiua-10711	148	63	uroselective	uroselective	ADJ
aiua-10711	148	64	alpha	alpha	NOUN
aiua-10711	148	65	-	-	NOUN
aiua-10711	148	66	blocker	blocker	NOUN
aiua-10711	148	67	on	on	ADP
aiua-10711	148	68	ejaculation	ejaculation	NOUN
aiua-10711	148	69	(	(	PUNCT
aiua-10711	148	70	including	include	VERB
aiua-10711	148	71	a	a	DET
aiua-10711	148	72	study	study	NOUN
aiua-10711	148	73	comparing	compare	VERB
aiua-10711	148	74	naftopidil	naftopidil	NOUN
aiua-10711	148	75	with	with	ADP
aiua-10711	148	76	both	both	PRON
aiua-10711	148	77	tamsulosin	tamsulosin	NOUN
aiua-10711	148	78	and	and	CCONJ
aiua-10711	148	79	silodosin	silodosin	NOUN
aiua-10711	148	80	)	)	PUNCT
aiua-10711	148	81	(	(	PUNCT
aiua-10711	148	82	59	59	NUM
aiua-10711	148	83	,	,	PUNCT
aiua-10711	148	84	61	61	NUM
aiua-10711	148	85	,	,	PUNCT
aiua-10711	148	86	68	68	NUM
aiua-10711	148	87	,	,	PUNCT
aiua-10711	148	88	72	72	NUM
aiua-10711	148	89	,	,	PUNCT
aiua-10711	148	90	73	73	NUM
aiua-10711	148	91	)	)	PUNCT
aiua-10711	148	92	,	,	PUNCT
aiua-10711	148	93	7	7	NUM
aiua-10711	148	94	studies	study	NOUN
aiua-10711	148	95	compared	compare	VERB
aiua-10711	148	96	alfuzosin	alfuzosin	NOUN
aiua-10711	148	97	with	with	ADP
aiua-10711	148	98	uroselective	uroselective	ADJ
aiua-10711	148	99	alphablockers	alphablocker	NOUN
aiua-10711	148	100	(	(	PUNCT
aiua-10711	148	101	46	46	NUM
aiua-10711	148	102	-	-	SYM
aiua-10711	148	103	48	48	NUM
aiua-10711	148	104	,	,	PUNCT
aiua-10711	148	105	55	55	NUM
aiua-10711	148	106	-	-	SYM
aiua-10711	148	107	57	57	NUM
aiua-10711	148	108	,	,	PUNCT
aiua-10711	148	109	60	60	NUM
aiua-10711	148	110	)	)	PUNCT
aiua-10711	148	111	,	,	PUNCT
aiua-10711	148	112	4	4	NUM
aiua-10711	148	113	studies	study	NOUN
aiua-10711	148	114	compared	compare	VERB
aiua-10711	148	115	terazosin	terazosin	NOUN
aiua-10711	148	116	or	or	CCONJ
aiua-10711	148	117	doxazosin	doxazosin	VERB
aiua-10711	148	118	with	with	ADP
aiua-10711	148	119	tamsulosin	tamsulosin	NOUN
aiua-10711	148	120	(	(	PUNCT
aiua-10711	148	121	58	58	NUM
aiua-10711	148	122	,	,	PUNCT
aiua-10711	148	123	63	63	NUM
aiua-10711	148	124	,	,	PUNCT
aiua-10711	148	125	66	66	NUM
aiua-10711	148	126	,	,	PUNCT
aiua-10711	148	127	76	76	NUM
aiua-10711	148	128	)	)	PUNCT
aiua-10711	148	129	and	and	CCONJ
aiua-10711	148	130	one	one	NUM
aiua-10711	148	131	study	study	NOUN
aiua-10711	148	132	terazosin	terazosin	NOUN
aiua-10711	148	133	with	with	ADP
aiua-10711	148	134	doxazosin	doxazosin	PROPN
aiua-10711	148	135	(	(	PUNCT
aiua-10711	148	136	67	67	NUM
aiua-10711	148	137	)	)	PUNCT
aiua-10711	148	138	.	.	PUNCT
aiua-10711	149	1	silodosin	silodosin	PROPN
aiua-10711	149	2	was	be	AUX
aiua-10711	149	3	associated	associate	VERB
aiua-10711	149	4	with	with	ADP
aiua-10711	149	5	significantly	significantly	ADV
aiua-10711	149	6	increased	increase	VERB
aiua-10711	149	7	odds	odd	NOUN
aiua-10711	149	8	of	of	ADP
aiua-10711	149	9	ejaculatory	ejaculatory	ADJ
aiua-10711	149	10	dysfunction	dysfunction	NOUN
aiua-10711	149	11	compared	compare	VERB
aiua-10711	149	12	with	with	ADP
aiua-10711	149	13	tamsulosin	tamsulosin	NOUN
aiua-10711	149	14	(	(	PUNCT
aiua-10711	149	15	or	or	CCONJ
aiua-10711	149	16	:	:	PUNCT
aiua-10711	149	17	3.52	3.52	NUM
aiua-10711	149	18	,	,	PUNCT
aiua-10711	149	19	95	95	NUM
aiua-10711	149	20	%	%	NOUN
aiua-10711	149	21	ci	ci	NOUN
aiua-10711	149	22	:	:	PUNCT
aiua-10711	149	23	2.18	2.18	NUM
aiua-10711	149	24	to	to	ADP
aiua-10711	149	25	5.68	5.68	NUM
aiua-10711	149	26	,	,	PUNCT
aiua-10711	149	27	15	15	NUM
aiua-10711	149	28	series	series	NOUN
aiua-10711	149	29	,	,	PUNCT
aiua-10711	149	30	1512	1512	NUM
aiua-10711	149	31	participants	participant	NOUN
aiua-10711	149	32	,	,	PUNCT
aiua-10711	149	33	z	z	NOUN
aiua-10711	149	34	=	=	NUM
aiua-10711	149	35	5.15	5.15	NUM
aiua-10711	149	36	,	,	PUNCT
aiua-10711	149	37	p	p	X
aiua-10711	149	38	<	<	X
aiua-10711	149	39	0.00001	0.00001	NUM
aiua-10711	149	40	,	,	PUNCT
aiua-10711	149	41	i2	i2	NOUN
aiua-10711	149	42	=	=	SYM
aiua-10711	149	43	0	0	NUM
aiua-10711	149	44	%	%	NOUN
aiua-10711	149	45	)	)	PUNCT
aiua-10711	149	46	(	(	PUNCT
aiua-10711	149	47	figure	figure	VERB
aiua-10711	149	48	7	7	NUM
aiua-10711	149	49	)	)	PUNCT
aiua-10711	149	50	.	.	PUNCT
aiua-10711	150	1	naftopidil	naftopidil	PROPN
aiua-10711	150	2	showed	show	VERB
aiua-10711	150	3	significantly	significantly	ADV
aiua-10711	150	4	lower	low	ADJ
aiua-10711	150	5	odds	odd	NOUN
aiua-10711	150	6	of	of	ADP
aiua-10711	150	7	ejaculatory	ejaculatory	ADJ
aiua-10711	150	8	dysfunction	dysfunction	NOUN
aiua-10711	150	9	compared	compare	VERB
aiua-10711	150	10	to	to	ADP
aiua-10711	150	11	uroselective	uroselective	ADJ
aiua-10711	150	12	alpha	alpha	NOUN
aiua-10711	150	13	-	-	PUNCT
aiua-10711	150	14	blockers	blocker	NOUN
aiua-10711	150	15	(	(	PUNCT
aiua-10711	150	16	or	or	CCONJ
aiua-10711	150	17	:	:	PUNCT
aiua-10711	150	18	0.29	0.29	NUM
aiua-10711	150	19	,	,	PUNCT
aiua-10711	150	20	95	95	NUM
aiua-10711	150	21	%	%	NOUN
aiua-10711	150	22	ci	ci	NOUN
aiua-10711	150	23	:	:	PUNCT
aiua-10711	150	24	0.13	0.13	NUM
aiua-10711	150	25	to	to	ADP
aiua-10711	150	26	0.64	0.64	NUM
aiua-10711	150	27	,	,	PUNCT
aiua-10711	150	28	6	6	NUM
aiua-10711	150	29	series	series	NOUN
aiua-10711	150	30	from	from	ADP
aiua-10711	150	31	5	5	NUM
aiua-10711	150	32	studies	study	NOUN
aiua-10711	150	33	,	,	PUNCT
aiua-10711	150	34	474	474	NUM
aiua-10711	150	35	participants	participant	NOUN
aiua-10711	150	36	,	,	PUNCT
aiua-10711	150	37	z	z	NOUN
aiua-10711	150	38	=	=	SYM
aiua-10711	150	39	3.04	3.04	NUM
aiua-10711	150	40	,	,	PUNCT
aiua-10711	150	41	p	p	X
aiua-10711	150	42	=	=	NOUN
aiua-10711	150	43	0.002	0.002	NUM
aiua-10711	150	44	,	,	PUNCT
aiua-10711	150	45	i2	i2	NOUN
aiua-10711	150	46	=	=	SYM
aiua-10711	150	47	0	0	NUM
aiua-10711	150	48	%	%	NOUN
aiua-10711	150	49	)	)	PUNCT
aiua-10711	150	50	(	(	PUNCT
aiua-10711	150	51	figure	figure	NOUN
aiua-10711	150	52	8)	8)	NUM
aiua-10711	150	53	.	.	PUNCT
aiua-10711	151	1	alfuzosin	alfuzosin	PROPN
aiua-10711	151	2	was	be	AUX
aiua-10711	151	3	associated	associate	VERB
aiua-10711	151	4	with	with	ADP
aiua-10711	151	5	significantly	significantly	ADV
aiua-10711	151	6	lower	low	ADJ
aiua-10711	151	7	odds	odd	NOUN
aiua-10711	151	8	of	of	ADP
aiua-10711	151	9	ejaculatory	ejaculatory	ADJ
aiua-10711	151	10	disorders	disorder	NOUN
aiua-10711	151	11	compared	compare	VERB
aiua-10711	151	12	to	to	ADP
aiua-10711	151	13	uroselective	uroselective	ADJ
aiua-10711	151	14	alphablockers	alphablocker	NOUN
aiua-10711	151	15	(	(	PUNCT
aiua-10711	151	16	or	or	CCONJ
aiua-10711	151	17	:	:	PUNCT
aiua-10711	151	18	0.17	0.17	NUM
aiua-10711	151	19	,	,	PUNCT
aiua-10711	151	20	95	95	NUM
aiua-10711	151	21	%	%	NOUN
aiua-10711	151	22	ci	ci	NOUN
aiua-10711	151	23	:	:	PUNCT
aiua-10711	151	24	0.07	0.07	NUM
aiua-10711	151	25	to	to	ADP
aiua-10711	151	26	0.38	0.38	NUM
aiua-10711	151	27	,	,	PUNCT
aiua-10711	151	28	8	8	NUM
aiua-10711	151	29	series	series	NOUN
aiua-10711	151	30	from	from	ADP
aiua-10711	151	31	7	7	NUM
aiua-10711	151	32	studies	study	NOUN
aiua-10711	151	33	,	,	PUNCT
aiua-10711	151	34	877	877	NUM
aiua-10711	151	35	participants	participant	NOUN
aiua-10711	151	36	,	,	PUNCT
aiua-10711	151	37	z	z	NOUN
aiua-10711	151	38	=	=	SYM
aiua-10711	151	39	4.27	4.27	NUM
aiua-10711	151	40	,	,	PUNCT
aiua-10711	151	41	p	p	X
aiua-10711	151	42	<	<	X
aiua-10711	151	43	0.0001	0.0001	NUM
aiua-10711	151	44	,	,	PUNCT
aiua-10711	151	45	i2	i2	NOUN
aiua-10711	151	46	=	=	SYM
aiua-10711	151	47	0	0	NUM
aiua-10711	151	48	%	%	NOUN
aiua-10711	151	49	)	)	PUNCT
aiua-10711	151	50	(	(	PUNCT
aiua-10711	151	51	figure	figure	NOUN
aiua-10711	151	52	9	9	NUM
aiua-10711	151	53	)	)	PUNCT
aiua-10711	151	54	.	.	PUNCT
aiua-10711	152	1	summary	summary	NOUN
aiua-10711	152	2	of	of	ADP
aiua-10711	152	3	findings	finding	NOUN
aiua-10711	152	4	summary	summary	NOUN
aiua-10711	152	5	of	of	ADP
aiua-10711	152	6	finding	find	VERB
aiua-10711	152	7	(	(	PUNCT
aiua-10711	152	8	sof	sof	VERB
aiua-10711	152	9	)	)	PUNCT
aiua-10711	152	10	tables	table	NOUN
aiua-10711	152	11	,	,	PUNCT
aiua-10711	152	12	containing	contain	VERB
aiua-10711	152	13	illustrative	illustrative	ADJ
aiua-10711	152	14	comparative	comparative	ADJ
aiua-10711	152	15	risks	risk	NOUN
aiua-10711	152	16	(	(	PUNCT
aiua-10711	152	17	assumed	assume	VERB
aiua-10711	152	18	control	control	NOUN
aiua-10711	152	19	risks	risk	NOUN
aiua-10711	152	20	and	and	CCONJ
aiua-10711	152	21	corresponding	correspond	VERB
aiua-10711	152	22	intervention	intervention	NOUN
aiua-10711	152	23	risks	risk	NOUN
aiua-10711	152	24	)	)	PUNCT
aiua-10711	152	25	and	and	CCONJ
aiua-10711	152	26	odds	odd	VERB
aiua-10711	152	27	ratios	ratio	NOUN
aiua-10711	152	28	relative	relative	ADJ
aiua-10711	152	29	to	to	ADP
aiua-10711	152	30	each	each	DET
aiua-10711	152	31	single	single	ADJ
aiua-10711	152	32	meta	meta	ADJ
aiua-10711	152	33	-	-	PUNCT
aiua-10711	152	34	analysis	analysis	NOUN
aiua-10711	152	35	are	be	AUX
aiua-10711	152	36	presented	present	VERB
aiua-10711	152	37	as	as	ADP
aiua-10711	152	38	supplementary	supplementary	ADJ
aiua-10711	152	39	materials	material	NOUN
aiua-10711	152	40	.	.	PUNCT
aiua-10711	153	1	sof	sof	PROPN
aiua-10711	153	2	tables	table	NOUN
aiua-10711	153	3	also	also	ADV
aiua-10711	153	4	contain	contain	VERB
aiua-10711	153	5	evaluations	evaluation	NOUN
aiua-10711	153	6	of	of	ADP
aiua-10711	153	7	the	the	DET
aiua-10711	153	8	quality	quality	NOUN
aiua-10711	153	9	of	of	ADP
aiua-10711	153	10	the	the	DET
aiua-10711	153	11	evidence	evidence	NOUN
aiua-10711	153	12	relative	relative	ADJ
aiua-10711	153	13	to	to	ADP
aiua-10711	153	14	each	each	DET
aiua-10711	153	15	meta	meta	ADJ
aiua-10711	153	16	-	-	PUNCT
aiua-10711	153	17	analysis	analysis	NOUN
aiua-10711	153	18	,	,	PUNCT
aiua-10711	153	19	rated	rate	VERB
aiua-10711	153	20	according	accord	VERB
aiua-10711	153	21	to	to	ADP
aiua-10711	153	22	grade	grade	NOUN
aiua-10711	153	23	criteria	criterion	NOUN
aiua-10711	153	24	.	.	PUNCT
aiua-10711	154	1	single	single	ADJ
aiua-10711	154	2	studies	study	NOUN
aiua-10711	154	3	not	not	PART
aiua-10711	154	4	included	include	VERB
aiua-10711	154	5	in	in	ADP
aiua-10711	154	6	quantitative	quantitative	ADJ
aiua-10711	154	7	analysis	analysis	NOUN
aiua-10711	154	8	zaytoun	zaytoun	NOUN
aiua-10711	154	9	et	et	PROPN
aiua-10711	154	10	al	al	PROPN
aiua-10711	154	11	.	.	PUNCT
aiua-10711	155	1	(	(	PUNCT
aiua-10711	155	2	2/50	2/50	NUM
aiua-10711	155	3	vs	vs	ADP
aiua-10711	155	4	0/50	0/50	NUM
aiua-10711	155	5	)	)	PUNCT
aiua-10711	155	6	(	(	PUNCT
aiua-10711	155	7	76	76	NUM
aiua-10711	155	8	)	)	PUNCT
aiua-10711	155	9	,	,	PUNCT
aiua-10711	155	10	pompeo	pompeo	PROPN
aiua-10711	155	11	et	et	PROPN
aiua-10711	155	12	al	al	PROPN
aiua-10711	155	13	.	.	PUNCT
aiua-10711	156	1	(	(	PUNCT
aiua-10711	156	2	4/83	4/83	NUM
aiua-10711	156	3	vs	vs	ADP
aiua-10711	156	4	2/82	2/82	NUM
aiua-10711	156	5	)	)	PUNCT
aiua-10711	156	6	(	(	PUNCT
aiua-10711	156	7	66	66	NUM
aiua-10711	156	8	)	)	PUNCT
aiua-10711	156	9	and	and	CCONJ
aiua-10711	156	10	kirby	kirby	PROPN
aiua-10711	156	11	et	et	PROPN
aiua-10711	156	12	al	al	PROPN
aiua-10711	156	13	.	.	PUNCT
aiua-10711	157	1	(	(	PUNCT
aiua-10711	157	2	2/50	2/50	NUM
aiua-10711	157	3	vs	vs	ADP
aiua-10711	157	4	0/48	0/48	NUM
aiua-10711	157	5	)	)	PUNCT
aiua-10711	157	6	(	(	PUNCT
aiua-10711	157	7	58	58	NUM
aiua-10711	157	8	)	)	PUNCT
aiua-10711	157	9	observed	observe	VERB
aiua-10711	157	10	more	more	ADV
aiua-10711	157	11	frequently	frequently	ADV
aiua-10711	157	12	ejaculatory	ejaculatory	ADJ
aiua-10711	157	13	disorders	disorder	NOUN
aiua-10711	157	14	after	after	ADP
aiua-10711	157	15	tamsulosin	tamsulosin	NOUN
aiua-10711	157	16	compared	compare	VERB
aiua-10711	157	17	to	to	PART
aiua-10711	157	18	doxazosin	doxazosin	VERB
aiua-10711	157	19	.	.	PUNCT
aiua-10711	158	1	narayan	narayan	PROPN
aiua-10711	158	2	et	et	PROPN
aiua-10711	158	3	al	al	PROPN
aiua-10711	158	4	.	.	PROPN
aiua-10711	159	1	(	(	PUNCT
aiua-10711	159	2	63	63	NUM
aiua-10711	159	3	)	)	PUNCT
aiua-10711	159	4	described	describe	VERB
aiua-10711	159	5	higher	high	ADJ
aiua-10711	159	6	rates	rate	NOUN
aiua-10711	159	7	of	of	ADP
aiua-10711	159	8	ejaculatory	ejaculatory	ADJ
aiua-10711	159	9	dysfunction	dysfunction	NOUN
aiua-10711	159	10	after	after	ADP
aiua-10711	159	11	tamsulosin	tamsulosin	NOUN
aiua-10711	159	12	compared	compare	VERB
aiua-10711	159	13	to	to	PART
aiua-10711	159	14	terazosin	terazosin	VERB
aiua-10711	160	1	[	[	X
aiua-10711	160	2	37/1002	37/1002	NUM
aiua-10711	160	3	(	(	PUNCT
aiua-10711	160	4	3.7	3.7	NUM
aiua-10711	160	5	%	%	NOUN
aiua-10711	160	6	)	)	PUNCT
aiua-10711	160	7	vs	vs	ADP
aiua-10711	160	8	3/981	3/981	NUM
aiua-10711	160	9	(	(	PUNCT
aiua-10711	160	10	0.3	0.3	NUM
aiua-10711	160	11	%	%	NOUN
aiua-10711	160	12	)	)	PUNCT
aiua-10711	160	13	]	]	PUNCT
aiua-10711	160	14	.	.	PUNCT
aiua-10711	161	1	samli	samli	PROPN
aiua-10711	161	2	et	et	PROPN
aiua-10711	161	3	al	al	PROPN
aiua-10711	161	4	.	.	PUNCT
aiua-10711	162	1	(	(	PUNCT
aiua-10711	162	2	67	67	NUM
aiua-10711	162	3	)	)	PUNCT
aiua-10711	162	4	observed	observe	VERB
aiua-10711	162	5	similar	similar	ADJ
aiua-10711	162	6	rates	rate	NOUN
aiua-10711	162	7	of	of	ADP
aiua-10711	162	8	erectile	erectile	ADJ
aiua-10711	162	9	dysfunction	dysfunction	NOUN
aiua-10711	162	10	after	after	ADP
aiua-10711	162	11	doxazosin	doxazosin	NOUN
aiua-10711	162	12	versus	versus	ADP
aiua-10711	162	13	terazosin	terazosin	NOUN
aiua-10711	162	14	(	(	PUNCT
aiua-10711	162	15	0/25	0/25	NUM
aiua-10711	162	16	vs	vs	ADP
aiua-10711	162	17	1/25	1/25	NUM
aiua-10711	162	18	)	)	PUNCT
aiua-10711	162	19	.	.	PUNCT
aiua-10711	163	1	comparison	comparison	NOUN
aiua-10711	163	2	between	between	ADP
aiua-10711	163	3	different	different	ADJ
aiua-10711	163	4	dosages	dosage	NOUN
aiua-10711	163	5	of	of	ADP
aiua-10711	163	6	alpha	alpha	NOUN
aiua-10711	163	7	-	-	PUNCT
aiua-10711	163	8	blockers	blocker	NOUN
aiua-10711	163	9	we	we	PRON
aiua-10711	163	10	retrieved	retrieve	VERB
aiua-10711	163	11	8	8	NUM
aiua-10711	163	12	studies	study	NOUN
aiua-10711	163	13	(	(	PUNCT
aiua-10711	163	14	77	77	NUM
aiua-10711	163	15	-	-	SYM
aiua-10711	163	16	84	84	NUM
aiua-10711	163	17	)	)	PUNCT
aiua-10711	163	18	designed	design	VERB
aiua-10711	163	19	to	to	PART
aiua-10711	163	20	compare	compare	VERB
aiua-10711	163	21	the	the	DET
aiua-10711	163	22	clinical	clinical	ADJ
aiua-10711	163	23	efficacy	efficacy	NOUN
aiua-10711	163	24	and	and	CCONJ
aiua-10711	163	25	tolerability	tolerability	NOUN
aiua-10711	163	26	of	of	ADP
aiua-10711	163	27	different	different	ADJ
aiua-10711	163	28	alpha	alpha	NOUN
aiua-10711	163	29	-	-	PUNCT
aiua-10711	163	30	blockers	blocker	NOUN
aiua-10711	163	31	administered	administer	VERB
aiua-10711	163	32	at	at	ADP
aiua-10711	163	33	different	different	ADJ
aiua-10711	163	34	doses	dose	NOUN
aiua-10711	163	35	and	and	CCONJ
aiua-10711	163	36	time	time	NOUN
aiua-10711	163	37	intervals	interval	NOUN
aiua-10711	163	38	.	.	PUNCT
aiua-10711	164	1	the	the	DET
aiua-10711	164	2	designs	design	NOUN
aiua-10711	164	3	of	of	ADP
aiua-10711	164	4	the	the	DET
aiua-10711	164	5	studies	study	NOUN
aiua-10711	164	6	were	be	AUX
aiua-10711	164	7	too	too	ADV
aiua-10711	164	8	heterogenous	heterogenous	ADJ
aiua-10711	164	9	for	for	ADP
aiua-10711	164	10	quantitative	quantitative	ADJ
aiua-10711	164	11	analysis	analysis	NOUN
aiua-10711	164	12	.	.	PUNCT
aiua-10711	165	1	no	no	DET
aiua-10711	165	2	differences	difference	NOUN
aiua-10711	165	3	in	in	ADP
aiua-10711	165	4	the	the	DET
aiua-10711	165	5	rate	rate	NOUN
aiua-10711	165	6	of	of	ADP
aiua-10711	165	7	ejaculatory	ejaculatory	ADJ
aiua-10711	165	8	disorders	disorder	NOUN
aiua-10711	165	9	were	be	AUX
aiua-10711	165	10	observed	observe	VERB
aiua-10711	165	11	with	with	ADP
aiua-10711	165	12	different	different	ADJ
aiua-10711	165	13	formulations	formulation	NOUN
aiua-10711	165	14	and	and	CCONJ
aiua-10711	165	15	different	different	ADJ
aiua-10711	165	16	doses	dose	NOUN
aiua-10711	165	17	figure	figure	VERB
aiua-10711	165	18	8	8	NUM
aiua-10711	165	19	.	.	PUNCT
aiua-10711	166	1	odds	odd	NOUN
aiua-10711	166	2	for	for	ADP
aiua-10711	166	3	ejaculatory	ejaculatory	ADJ
aiua-10711	166	4	disorders	disorder	NOUN
aiua-10711	166	5	in	in	ADP
aiua-10711	166	6	patients	patient	NOUN
aiua-10711	166	7	taking	take	VERB
aiua-10711	166	8	naftopidil	naftopidil	NOUN
aiua-10711	166	9	or	or	CCONJ
aiua-10711	166	10	uroselective	uroselective	ADJ
aiua-10711	166	11	alpha	alpha	NOUN
aiua-10711	166	12	-	-	PUNCT
aiua-10711	166	13	blockers	blocker	NOUN
aiua-10711	166	14	.	.	PUNCT
aiua-10711	167	1	data	datum	NOUN
aiua-10711	167	2	to	to	ADP
aiua-10711	167	3	the	the	DET
aiua-10711	167	4	left	left	NOUN
aiua-10711	167	5	of	of	ADP
aiua-10711	167	6	the	the	DET
aiua-10711	167	7	vertical	vertical	ADJ
aiua-10711	167	8	no	no	DET
aiua-10711	167	9	-	-	PUNCT
aiua-10711	167	10	effect	effect	NOUN
aiua-10711	167	11	axis	axis	NOUN
aiua-10711	167	12	indicate	indicate	VERB
aiua-10711	167	13	lower	low	ADJ
aiua-10711	167	14	odds	odd	NOUN
aiua-10711	167	15	for	for	ADP
aiua-10711	167	16	ejaculatory	ejaculatory	ADJ
aiua-10711	167	17	disorders	disorder	NOUN
aiua-10711	167	18	in	in	ADP
aiua-10711	167	19	patients	patient	NOUN
aiua-10711	167	20	treated	treat	VERB
aiua-10711	167	21	with	with	ADP
aiua-10711	167	22	naftopidil	naftopidil	NOUN
aiua-10711	167	23	compared	compare	VERB
aiua-10711	167	24	to	to	ADP
aiua-10711	167	25	uroselective	uroselective	ADJ
aiua-10711	167	26	alpha	alpha	NOUN
aiua-10711	167	27	adrenoceptor	adrenoceptor	NOUN
aiua-10711	167	28	blockers	blocker	NOUN
aiua-10711	167	29	.	.	PUNCT
aiua-10711	168	1	figure	figure	VERB
aiua-10711	168	2	9	9	NUM
aiua-10711	168	3	.	.	PUNCT
aiua-10711	168	4	odds	odd	NOUN
aiua-10711	168	5	for	for	ADP
aiua-10711	168	6	ejaculatory	ejaculatory	ADJ
aiua-10711	168	7	disorders	disorder	NOUN
aiua-10711	168	8	in	in	ADP
aiua-10711	168	9	patients	patient	NOUN
aiua-10711	168	10	taking	take	VERB
aiua-10711	168	11	alfuzosin	alfuzosin	NOUN
aiua-10711	168	12	compared	compare	VERB
aiua-10711	168	13	to	to	ADP
aiua-10711	168	14	uroselective	uroselective	ADJ
aiua-10711	168	15	alpha	alpha	NOUN
aiua-10711	168	16	-	-	PUNCT
aiua-10711	168	17	blockers	blocker	NOUN
aiua-10711	168	18	.	.	PUNCT
aiua-10711	169	1	data	datum	NOUN
aiua-10711	169	2	to	to	ADP
aiua-10711	169	3	the	the	DET
aiua-10711	169	4	left	left	NOUN
aiua-10711	169	5	of	of	ADP
aiua-10711	169	6	the	the	DET
aiua-10711	169	7	vertical	vertical	ADJ
aiua-10711	169	8	no	no	DET
aiua-10711	169	9	-	-	PUNCT
aiua-10711	169	10	effect	effect	NOUN
aiua-10711	169	11	axis	axis	NOUN
aiua-10711	169	12	indicate	indicate	VERB
aiua-10711	169	13	lower	low	ADJ
aiua-10711	169	14	odds	odd	NOUN
aiua-10711	169	15	for	for	ADP
aiua-10711	169	16	ejaculatory	ejaculatory	ADJ
aiua-10711	169	17	disorders	disorder	NOUN
aiua-10711	169	18	in	in	ADP
aiua-10711	169	19	patients	patient	NOUN
aiua-10711	169	20	treated	treat	VERB
aiua-10711	169	21	with	with	ADP
aiua-10711	169	22	alfuzosin	alfuzosin	NOUN
aiua-10711	169	23	.	.	PUNCT
aiua-10711	170	1	259archivio	259archivio	PROPN
aiua-10711	170	2	italiano	italiano	NOUN
aiua-10711	170	3	di	di	X
aiua-10711	170	4	urologia	urologia	PROPN
aiua-10711	170	5	e	e	PROPN
aiua-10711	170	6	andrologia	andrologia	PROPN
aiua-10711	170	7	2022	2022	NUM
aiua-10711	170	8	;	;	PUNCT
aiua-10711	170	9	94	94	NUM
aiua-10711	170	10	,	,	PUNCT
aiua-10711	170	11	2	2	NUM
aiua-10711	170	12	sexual	sexual	ADJ
aiua-10711	170	13	function	function	NOUN
aiua-10711	170	14	and	and	CCONJ
aiua-10711	170	15	alpha	alpha	NOUN
aiua-10711	170	16	-	-	PUNCT
aiua-10711	170	17	blockers	blocker	NOUN
aiua-10711	170	18	of	of	ADP
aiua-10711	170	19	doxazosin	doxazosin	NOUN
aiua-10711	170	20	(	(	PUNCT
aiua-10711	170	21	4	4	NUM
aiua-10711	170	22	mg	mg	NOUN
aiua-10711	170	23	vs	vs	ADP
aiua-10711	170	24	8	8	NUM
aiua-10711	170	25	mg	mg	NUM
aiua-10711	170	26	)	)	PUNCT
aiua-10711	170	27	(	(	PUNCT
aiua-10711	170	28	77	77	NUM
aiua-10711	170	29	,	,	PUNCT
aiua-10711	170	30	78	78	NUM
aiua-10711	170	31	)	)	PUNCT
aiua-10711	170	32	.	.	PUNCT
aiua-10711	171	1	the	the	DET
aiua-10711	171	2	improvement	improvement	NOUN
aiua-10711	171	3	in	in	ADP
aiua-10711	171	4	iief	iief	ADJ
aiua-10711	171	5	scores	score	NOUN
aiua-10711	171	6	after	after	ADP
aiua-10711	171	7	extended	extend	VERB
aiua-10711	171	8	-	-	PUNCT
aiua-10711	171	9	release	release	NOUN
aiua-10711	171	10	doxazosin	doxazosin	NOUN
aiua-10711	171	11	(	(	PUNCT
aiua-10711	171	12	4	4	NUM
aiua-10711	171	13	or	or	CCONJ
aiua-10711	171	14	8	8	NUM
aiua-10711	171	15	mg	mg	NOUN
aiua-10711	171	16	once	once	ADV
aiua-10711	171	17	daily	daily	ADV
aiua-10711	171	18	)	)	PUNCT
aiua-10711	171	19	was	be	AUX
aiua-10711	171	20	similar	similar	ADJ
aiua-10711	171	21	to	to	ADP
aiua-10711	171	22	the	the	DET
aiua-10711	171	23	one	one	NUM
aiua-10711	171	24	observed	observe	VERB
aiua-10711	171	25	after	after	ADP
aiua-10711	171	26	fastrelease	fastrelease	NOUN
aiua-10711	171	27	doxazosin	doxazosin	NOUN
aiua-10711	171	28	(	(	PUNCT
aiua-10711	171	29	1	1	NUM
aiua-10711	171	30	-	-	SYM
aiua-10711	171	31	8	8	NUM
aiua-10711	171	32	mg	mg	ADP
aiua-10711	171	33	once	once	ADV
aiua-10711	171	34	daily	daily	ADV
aiua-10711	171	35	)	)	PUNCT
aiua-10711	171	36	(	(	PUNCT
aiua-10711	171	37	78	78	NUM
aiua-10711	171	38	)	)	PUNCT
aiua-10711	171	39	.	.	PUNCT
aiua-10711	172	1	similarly	similarly	ADV
aiua-10711	172	2	,	,	PUNCT
aiua-10711	172	3	the	the	DET
aiua-10711	172	4	administration	administration	NOUN
aiua-10711	172	5	of	of	ADP
aiua-10711	172	6	tamsulosin	tamsulosin	NOUN
aiua-10711	172	7	at	at	ADP
aiua-10711	172	8	different	different	ADJ
aiua-10711	172	9	doses	dose	NOUN
aiua-10711	172	10	resulted	result	VERB
aiua-10711	172	11	in	in	ADP
aiua-10711	172	12	similar	similar	ADJ
aiua-10711	172	13	effects	effect	NOUN
aiua-10711	172	14	on	on	ADP
aiua-10711	172	15	ejaculatory	ejaculatory	ADJ
aiua-10711	172	16	function	function	NOUN
aiua-10711	172	17	(	(	PUNCT
aiua-10711	172	18	81	81	NUM
aiua-10711	172	19	-	-	SYM
aiua-10711	172	20	83	83	NUM
aiua-10711	172	21	)	)	PUNCT
aiua-10711	172	22	.	.	PUNCT
aiua-10711	173	1	rates	rate	NOUN
aiua-10711	173	2	of	of	ADP
aiua-10711	173	3	ejaculatory	ejaculatory	ADJ
aiua-10711	173	4	disorders	disorder	NOUN
aiua-10711	173	5	were	be	AUX
aiua-10711	173	6	not	not	PART
aiua-10711	173	7	different	different	ADJ
aiua-10711	173	8	after	after	ADP
aiua-10711	173	9	tamsulosin	tamsulosin	NOUN
aiua-10711	173	10	0.4	0.4	NUM
aiua-10711	173	11	mg	mg	PROPN
aiua-10711	173	12	versus	versus	ADP
aiua-10711	173	13	0.2	0.2	NUM
aiua-10711	173	14	mg	mg	PROPN
aiua-10711	173	15	(	(	PUNCT
aiua-10711	173	16	81	81	NUM
aiua-10711	173	17	,	,	PUNCT
aiua-10711	173	18	82	82	NUM
aiua-10711	173	19	)	)	PUNCT
aiua-10711	173	20	,	,	PUNCT
aiua-10711	173	21	or	or	CCONJ
aiua-10711	173	22	0.4	0.4	NUM
aiua-10711	173	23	mg	mg	NOUN
aiua-10711	173	24	once	once	ADV
aiua-10711	173	25	daily	daily	ADV
aiua-10711	173	26	every	every	DET
aiua-10711	173	27	other	other	ADJ
aiua-10711	173	28	day	day	NOUN
aiua-10711	173	29	(	(	PUNCT
aiua-10711	173	30	83	83	NUM
aiua-10711	173	31	)	)	PUNCT
aiua-10711	173	32	.	.	PUNCT
aiua-10711	174	1	the	the	DET
aiua-10711	174	2	timing	timing	NOUN
aiua-10711	174	3	of	of	ADP
aiua-10711	174	4	administration	administration	NOUN
aiua-10711	174	5	of	of	ADP
aiua-10711	174	6	silodosin	silodosin	PROPN
aiua-10711	174	7	appears	appear	VERB
aiua-10711	174	8	to	to	PART
aiua-10711	174	9	change	change	VERB
aiua-10711	174	10	the	the	DET
aiua-10711	174	11	effects	effect	NOUN
aiua-10711	174	12	of	of	ADP
aiua-10711	174	13	the	the	DET
aiua-10711	174	14	drug	drug	NOUN
aiua-10711	174	15	on	on	ADP
aiua-10711	174	16	sexual	sexual	ADJ
aiua-10711	174	17	function	function	NOUN
aiua-10711	174	18	.	.	PUNCT
aiua-10711	175	1	silodosin	silodosin	VERB
aiua-10711	175	2	4	4	NUM
aiua-10711	175	3	mg	mg	NOUN
aiua-10711	175	4	twice	twice	ADV
aiua-10711	175	5	-	-	PUNCT
aiua-10711	175	6	daily	daily	NOUN
aiua-10711	175	7	induced	induce	VERB
aiua-10711	175	8	a	a	DET
aiua-10711	175	9	higher	high	ADJ
aiua-10711	175	10	rate	rate	NOUN
aiua-10711	175	11	of	of	ADP
aiua-10711	175	12	ejaculatory	ejaculatory	ADJ
aiua-10711	175	13	disorders	disorder	NOUN
aiua-10711	175	14	compared	compare	VERB
aiua-10711	175	15	to	to	PART
aiua-10711	175	16	silodosin	silodosin	VERB
aiua-10711	175	17	4	4	NUM
aiua-10711	175	18	mg	mg	NOUN
aiua-10711	175	19	taken	take	VERB
aiua-10711	175	20	once	once	ADV
aiua-10711	175	21	a	a	DET
aiua-10711	175	22	day	day	NOUN
aiua-10711	175	23	(	(	PUNCT
aiua-10711	175	24	10/115	10/115	NUM
aiua-10711	175	25	vs	vs	ADP
aiua-10711	175	26	67/115	67/115	NUM
aiua-10711	175	27	)	)	PUNCT
aiua-10711	175	28	or	or	CCONJ
aiua-10711	175	29	silodosin	silodosin	VERB
aiua-10711	175	30	8	8	NUM
aiua-10711	175	31	mg	mg	NOUN
aiua-10711	175	32	administered	administer	VERB
aiua-10711	175	33	after	after	ADP
aiua-10711	175	34	breakfast	breakfast	NOUN
aiua-10711	175	35	(	(	PUNCT
aiua-10711	175	36	46/208	46/208	NOUN
aiua-10711	175	37	vs	vs	ADP
aiua-10711	175	38	32/212	32/212	NUM
aiua-10711	175	39	)	)	PUNCT
aiua-10711	175	40	(	(	PUNCT
aiua-10711	175	41	79	79	NUM
aiua-10711	175	42	,	,	PUNCT
aiua-10711	175	43	80	80	NUM
aiua-10711	175	44	)	)	PUNCT
aiua-10711	175	45	.	.	PUNCT
aiua-10711	176	1	discussion	discussion	NOUN
aiua-10711	176	2	alpha-1	alpha-1	NUM
aiua-10711	176	3	adrenoceptor	adrenoceptor	NOUN
aiua-10711	176	4	blockers	blocker	NOUN
aiua-10711	176	5	have	have	AUX
aiua-10711	176	6	been	be	AUX
aiua-10711	176	7	shown	show	VERB
aiua-10711	176	8	to	to	PART
aiua-10711	176	9	be	be	AUX
aiua-10711	176	10	very	very	ADV
aiua-10711	176	11	effective	effective	ADJ
aiua-10711	176	12	in	in	ADP
aiua-10711	176	13	counteracting	counteract	VERB
aiua-10711	176	14	lower	low	ADJ
aiua-10711	176	15	urinary	urinary	ADJ
aiua-10711	176	16	tract	tract	NOUN
aiua-10711	176	17	symptoms	symptom	NOUN
aiua-10711	176	18	associated	associate	VERB
aiua-10711	176	19	with	with	ADP
aiua-10711	176	20	benign	benign	ADJ
aiua-10711	176	21	prostatic	prostatic	ADJ
aiua-10711	176	22	hyperplasia	hyperplasia	NOUN
aiua-10711	176	23	(	(	PUNCT
aiua-10711	176	24	85	85	NUM
aiua-10711	176	25	,	,	PUNCT
aiua-10711	176	26	86	86	NUM
aiua-10711	176	27	)	)	PUNCT
aiua-10711	176	28	,	,	PUNCT
aiua-10711	176	29	as	as	ADV
aiua-10711	176	30	well	well	ADV
aiua-10711	176	31	as	as	ADP
aiua-10711	176	32	in	in	ADP
aiua-10711	176	33	facilitating	facilitate	VERB
aiua-10711	176	34	the	the	DET
aiua-10711	176	35	spontaneous	spontaneous	ADJ
aiua-10711	176	36	passage	passage	NOUN
aiua-10711	176	37	of	of	ADP
aiua-10711	176	38	stones	stone	NOUN
aiua-10711	176	39	from	from	ADP
aiua-10711	176	40	the	the	DET
aiua-10711	176	41	distal	distal	ADJ
aiua-10711	176	42	ureter	ureter	NOUN
aiua-10711	176	43	(	(	PUNCT
aiua-10711	176	44	87	87	NUM
aiua-10711	176	45	,	,	PUNCT
aiua-10711	176	46	88	88	NUM
aiua-10711	176	47	)	)	PUNCT
aiua-10711	176	48	.	.	PUNCT
aiua-10711	177	1	however	however	ADV
aiua-10711	177	2	,	,	PUNCT
aiua-10711	177	3	this	this	DET
aiua-10711	177	4	class	class	NOUN
aiua-10711	177	5	of	of	ADP
aiua-10711	177	6	drugs	drug	NOUN
aiua-10711	177	7	can	can	AUX
aiua-10711	177	8	lead	lead	VERB
aiua-10711	177	9	to	to	ADP
aiua-10711	177	10	cardiovascular	cardiovascular	ADJ
aiua-10711	177	11	side	side	NOUN
aiua-10711	177	12	effects	effect	NOUN
aiua-10711	177	13	and	and	CCONJ
aiua-10711	177	14	sexual	sexual	ADJ
aiua-10711	177	15	dysfunction	dysfunction	NOUN
aiua-10711	177	16	,	,	PUNCT
aiua-10711	177	17	thus	thus	ADV
aiua-10711	177	18	potentially	potentially	ADV
aiua-10711	177	19	worsening	worsen	VERB
aiua-10711	177	20	the	the	DET
aiua-10711	177	21	quality	quality	NOUN
aiua-10711	177	22	of	of	ADP
aiua-10711	177	23	life	life	NOUN
aiua-10711	177	24	of	of	ADP
aiua-10711	177	25	patients	patient	NOUN
aiua-10711	177	26	and	and	CCONJ
aiua-10711	177	27	possibly	possibly	ADV
aiua-10711	177	28	causing	cause	VERB
aiua-10711	177	29	a	a	DET
aiua-10711	177	30	reduction	reduction	NOUN
aiua-10711	177	31	in	in	ADP
aiua-10711	177	32	the	the	DET
aiua-10711	177	33	compliance	compliance	NOUN
aiua-10711	177	34	to	to	ADP
aiua-10711	177	35	long	long	ADJ
aiua-10711	177	36	-	-	PUNCT
aiua-10711	177	37	term	term	NOUN
aiua-10711	177	38	treatment	treatment	NOUN
aiua-10711	177	39	.	.	PUNCT
aiua-10711	178	1	since	since	SCONJ
aiua-10711	178	2	alpha	alpha	NOUN
aiua-10711	178	3	-	-	PUNCT
aiua-10711	178	4	adrenergic	adrenergic	ADJ
aiua-10711	178	5	receptors	receptor	NOUN
aiua-10711	178	6	are	be	AUX
aiua-10711	178	7	highly	highly	ADV
aiua-10711	178	8	expressed	express	VERB
aiua-10711	178	9	in	in	ADP
aiua-10711	178	10	male	male	ADJ
aiua-10711	178	11	genital	genital	ADJ
aiua-10711	178	12	organs	organ	NOUN
aiua-10711	178	13	,	,	PUNCT
aiua-10711	178	14	adrenergic	adrenergic	ADJ
aiua-10711	178	15	blockade	blockade	NOUN
aiua-10711	178	16	can	can	AUX
aiua-10711	178	17	potentially	potentially	ADV
aiua-10711	178	18	affect	affect	VERB
aiua-10711	178	19	erection	erection	NOUN
aiua-10711	178	20	,	,	PUNCT
aiua-10711	178	21	ejaculation	ejaculation	NOUN
aiua-10711	178	22	,	,	PUNCT
aiua-10711	178	23	and	and	CCONJ
aiua-10711	178	24	sexual	sexual	ADJ
aiua-10711	178	25	desire	desire	NOUN
aiua-10711	178	26	.	.	PUNCT
aiua-10711	179	1	ejaculation	ejaculation	NOUN
aiua-10711	179	2	the	the	DET
aiua-10711	179	3	influence	influence	NOUN
aiua-10711	179	4	of	of	ADP
aiua-10711	179	5	alpha	alpha	NOUN
aiua-10711	179	6	-	-	PUNCT
aiua-10711	179	7	blockers	blocker	NOUN
aiua-10711	179	8	on	on	ADP
aiua-10711	179	9	ejaculation	ejaculation	NOUN
aiua-10711	179	10	is	be	AUX
aiua-10711	179	11	well	well	ADV
aiua-10711	179	12	known	know	VERB
aiua-10711	179	13	,	,	PUNCT
aiua-10711	179	14	although	although	SCONJ
aiua-10711	179	15	the	the	DET
aiua-10711	179	16	underlying	underlie	VERB
aiua-10711	179	17	physiological	physiological	ADJ
aiua-10711	179	18	mechanism	mechanism	NOUN
aiua-10711	179	19	for	for	ADP
aiua-10711	179	20	such	such	ADJ
aiua-10711	179	21	effect	effect	NOUN
aiua-10711	179	22	is	be	AUX
aiua-10711	179	23	not	not	PART
aiua-10711	179	24	yet	yet	ADV
aiua-10711	179	25	well	well	ADV
aiua-10711	179	26	defined	define	VERB
aiua-10711	179	27	.	.	PUNCT
aiua-10711	180	1	our	our	PRON
aiua-10711	180	2	analysis	analysis	NOUN
aiua-10711	180	3	confirms	confirm	VERB
aiua-10711	180	4	that	that	SCONJ
aiua-10711	180	5	the	the	DET
aiua-10711	180	6	odds	odd	NOUN
aiua-10711	180	7	for	for	ADP
aiua-10711	180	8	ejaculation	ejaculation	NOUN
aiua-10711	180	9	disorders	disorder	NOUN
aiua-10711	180	10	are	be	AUX
aiua-10711	180	11	greater	great	ADJ
aiua-10711	180	12	in	in	ADP
aiua-10711	180	13	patients	patient	NOUN
aiua-10711	180	14	taking	take	VERB
aiua-10711	180	15	alpha	alpha	NOUN
aiua-10711	180	16	-	-	PUNCT
aiua-10711	180	17	blockers	blocker	NOUN
aiua-10711	180	18	of	of	ADP
aiua-10711	180	19	any	any	DET
aiua-10711	180	20	kind	kind	NOUN
aiua-10711	180	21	,	,	PUNCT
aiua-10711	180	22	compared	compare	VERB
aiua-10711	180	23	to	to	ADP
aiua-10711	180	24	placebo	placebo	NOUN
aiua-10711	180	25	.	.	PUNCT
aiua-10711	181	1	moreover	moreover	ADV
aiua-10711	181	2	,	,	PUNCT
aiua-10711	181	3	when	when	SCONJ
aiua-10711	181	4	the	the	DET
aiua-10711	181	5	effects	effect	NOUN
aiua-10711	181	6	of	of	ADP
aiua-10711	181	7	different	different	ADJ
aiua-10711	181	8	alpha	alpha	NOUN
aiua-10711	181	9	-	-	PUNCT
aiua-10711	181	10	blocking	block	VERB
aiua-10711	181	11	agents	agent	NOUN
aiua-10711	181	12	are	be	AUX
aiua-10711	181	13	analyzed	analyze	VERB
aiua-10711	181	14	separately	separately	ADV
aiua-10711	181	15	,	,	PUNCT
aiua-10711	181	16	the	the	DET
aiua-10711	181	17	odds	odd	NOUN
aiua-10711	181	18	for	for	ADP
aiua-10711	181	19	abnormal	abnormal	ADJ
aiua-10711	181	20	ejaculation	ejaculation	NOUN
aiua-10711	181	21	are	be	AUX
aiua-10711	181	22	greater	great	ADJ
aiua-10711	181	23	upon	upon	SCONJ
aiua-10711	181	24	administration	administration	NOUN
aiua-10711	181	25	of	of	ADP
aiua-10711	181	26	uroselective	uroselective	ADJ
aiua-10711	181	27	alpha	alpha	NOUN
aiua-10711	181	28	blockers	blocker	NOUN
aiua-10711	181	29	(	(	PUNCT
aiua-10711	181	30	tamsulosin	tamsulosin	NOUN
aiua-10711	181	31	and	and	CCONJ
aiua-10711	181	32	silodosin	silodosin	NOUN
aiua-10711	181	33	)	)	PUNCT
aiua-10711	181	34	.	.	PUNCT
aiua-10711	182	1	conversely	conversely	ADV
aiua-10711	182	2	,	,	PUNCT
aiua-10711	182	3	comparison	comparison	NOUN
aiua-10711	182	4	between	between	ADP
aiua-10711	182	5	alfuzosin	alfuzosin	NOUN
aiua-10711	182	6	and	and	CCONJ
aiua-10711	182	7	placebo	placebo	NOUN
aiua-10711	182	8	does	do	AUX
aiua-10711	182	9	not	not	PART
aiua-10711	182	10	result	result	VERB
aiua-10711	182	11	in	in	ADP
aiua-10711	182	12	statistically	statistically	ADV
aiua-10711	182	13	significant	significant	ADJ
aiua-10711	182	14	results	result	NOUN
aiua-10711	182	15	.	.	PUNCT
aiua-10711	183	1	the	the	DET
aiua-10711	183	2	comparison	comparison	NOUN
aiua-10711	183	3	between	between	ADP
aiua-10711	183	4	different	different	ADJ
aiua-10711	183	5	alpha	alpha	NOUN
aiua-10711	183	6	-	-	PUNCT
aiua-10711	183	7	blocking	block	VERB
aiua-10711	183	8	agents	agent	NOUN
aiua-10711	183	9	showed	show	VERB
aiua-10711	183	10	that	that	SCONJ
aiua-10711	183	11	silodosin	silodosin	NOUN
aiua-10711	183	12	and	and	CCONJ
aiua-10711	183	13	tamsulosin	tamsulosin	NOUN
aiua-10711	183	14	were	be	AUX
aiua-10711	183	15	more	more	ADV
aiua-10711	183	16	frequently	frequently	ADV
aiua-10711	183	17	associated	associate	VERB
aiua-10711	183	18	with	with	ADP
aiua-10711	183	19	ejaculation	ejaculation	NOUN
aiua-10711	183	20	disorders	disorder	NOUN
aiua-10711	183	21	when	when	SCONJ
aiua-10711	183	22	compared	compare	VERB
aiua-10711	183	23	to	to	ADP
aiua-10711	183	24	non	non	ADJ
aiua-10711	183	25	-	-	ADJ
aiua-10711	183	26	selective	selective	ADJ
aiua-10711	183	27	alpha	alpha	NOUN
aiua-10711	183	28	-	-	PUNCT
aiua-10711	183	29	blockers	blocker	NOUN
aiua-10711	183	30	.	.	PUNCT
aiua-10711	184	1	tamsulosin	tamsulosin	NOUN
aiua-10711	184	2	and	and	CCONJ
aiua-10711	184	3	,	,	PUNCT
aiua-10711	184	4	to	to	ADP
aiua-10711	184	5	a	a	DET
aiua-10711	184	6	greater	great	ADJ
aiua-10711	184	7	extent	extent	NOUN
aiua-10711	184	8	,	,	PUNCT
aiua-10711	184	9	silodosin	silodosin	NOUN
aiua-10711	184	10	,	,	PUNCT
aiua-10711	184	11	show	show	VERB
aiua-10711	184	12	super	super	ADJ
aiua-10711	184	13	-	-	ADJ
aiua-10711	184	14	selective	selective	ADJ
aiua-10711	184	15	binding	binding	NOUN
aiua-10711	184	16	with	with	ADP
aiua-10711	184	17	the	the	DET
aiua-10711	184	18	alpha1a	alpha1a	NOUN
aiua-10711	184	19	receptor	receptor	NOUN
aiua-10711	184	20	,	,	PUNCT
aiua-10711	184	21	while	while	SCONJ
aiua-10711	184	22	alfuzosin	alfuzosin	NOUN
aiua-10711	184	23	,	,	PUNCT
aiua-10711	184	24	doxazosin	doxazosin	VERB
aiua-10711	184	25	and	and	CCONJ
aiua-10711	184	26	terazosin	terazosin	NOUN
aiua-10711	184	27	show	show	VERB
aiua-10711	184	28	comparable	comparable	ADJ
aiua-10711	184	29	affinity	affinity	NOUN
aiua-10711	184	30	with	with	ADP
aiua-10711	184	31	the	the	DET
aiua-10711	184	32	three	three	NUM
aiua-10711	184	33	subtypes	subtype	NOUN
aiua-10711	184	34	of	of	ADP
aiua-10711	184	35	alpha1	alpha1	NOUN
aiua-10711	184	36	-	-	PUNCT
aiua-10711	184	37	adrenergic	adrenergic	ADJ
aiua-10711	184	38	receptors	receptor	NOUN
aiua-10711	184	39	.	.	PUNCT
aiua-10711	185	1	naftopidil	naftopidil	NOUN
aiua-10711	185	2	on	on	ADP
aiua-10711	185	3	the	the	DET
aiua-10711	185	4	other	other	ADJ
aiua-10711	185	5	hand	hand	NOUN
aiua-10711	185	6	exhibits	exhibit	VERB
aiua-10711	185	7	a	a	DET
aiua-10711	185	8	unique	unique	ADJ
aiua-10711	185	9	selectivity	selectivity	NOUN
aiua-10711	185	10	for	for	ADP
aiua-10711	185	11	alpha1b	alpha1b	NOUN
aiua-10711	185	12	receptors	receptor	NOUN
aiua-10711	185	13	.	.	PUNCT
aiua-10711	186	1	the	the	DET
aiua-10711	186	2	different	different	ADJ
aiua-10711	186	3	binding	bind	VERB
aiua-10711	186	4	affinity	affinity	NOUN
aiua-10711	186	5	(	(	PUNCT
aiua-10711	186	6	or	or	CCONJ
aiua-10711	186	7	selectivity	selectivity	NOUN
aiua-10711	186	8	)	)	PUNCT
aiua-10711	186	9	for	for	ADP
aiua-10711	186	10	alpha1	alpha1	NOUN
aiua-10711	186	11	-	-	PUNCT
aiua-10711	186	12	adrenergic	adrenergic	ADJ
aiua-10711	186	13	receptor	receptor	NOUN
aiua-10711	186	14	subtypes	subtype	NOUN
aiua-10711	186	15	explains	explain	VERB
aiua-10711	186	16	the	the	DET
aiua-10711	186	17	different	different	ADJ
aiua-10711	186	18	effects	effect	NOUN
aiua-10711	186	19	of	of	ADP
aiua-10711	186	20	alpha	alpha	NOUN
aiua-10711	186	21	-	-	PUNCT
aiua-10711	186	22	blockers	blocker	NOUN
aiua-10711	186	23	on	on	ADP
aiua-10711	186	24	ejaculation	ejaculation	NOUN
aiua-10711	186	25	.	.	PUNCT
aiua-10711	187	1	ejaculatory	ejaculatory	ADJ
aiua-10711	187	2	disorders	disorder	NOUN
aiua-10711	187	3	associated	associate	VERB
aiua-10711	187	4	with	with	ADP
aiua-10711	187	5	administration	administration	NOUN
aiua-10711	187	6	of	of	ADP
aiua-10711	187	7	alpha-1	alpha-1	PROPN
aiua-10711	187	8	blockers	blocker	NOUN
aiua-10711	187	9	were	be	AUX
aiua-10711	187	10	initially	initially	ADV
aiua-10711	187	11	thought	think	VERB
aiua-10711	187	12	to	to	PART
aiua-10711	187	13	be	be	AUX
aiua-10711	187	14	a	a	DET
aiua-10711	187	15	consequence	consequence	NOUN
aiua-10711	187	16	of	of	ADP
aiua-10711	187	17	bladder	bladder	NOUN
aiua-10711	187	18	neck	neck	NOUN
aiua-10711	187	19	relaxation	relaxation	NOUN
aiua-10711	187	20	,	,	PUNCT
aiua-10711	187	21	causing	cause	VERB
aiua-10711	187	22	in	in	ADP
aiua-10711	187	23	turn	turn	NOUN
aiua-10711	187	24	retrograde	retrograde	ADJ
aiua-10711	187	25	ejaculation	ejaculation	NOUN
aiua-10711	187	26	.	.	PUNCT
aiua-10711	188	1	further	further	ADJ
aiua-10711	188	2	studies	study	NOUN
aiua-10711	188	3	clarified	clarify	VERB
aiua-10711	188	4	the	the	DET
aiua-10711	188	5	mechanisms	mechanism	NOUN
aiua-10711	188	6	whereby	whereby	SCONJ
aiua-10711	188	7	ejaculation	ejaculation	NOUN
aiua-10711	188	8	disorders	disorder	NOUN
aiua-10711	188	9	occur	occur	VERB
aiua-10711	188	10	following	follow	VERB
aiua-10711	188	11	the	the	DET
aiua-10711	188	12	use	use	NOUN
aiua-10711	188	13	of	of	ADP
aiua-10711	188	14	uroselective	uroselective	ADJ
aiua-10711	188	15	alpha	alpha	NOUN
aiua-10711	188	16	-	-	PUNCT
aiua-10711	188	17	blockers	blocker	NOUN
aiua-10711	188	18	.	.	PUNCT
aiua-10711	189	1	disorders	disorder	NOUN
aiua-10711	189	2	of	of	ADP
aiua-10711	189	3	ejaculation	ejaculation	NOUN
aiua-10711	189	4	after	after	ADP
aiua-10711	189	5	tamsulosin	tamsulosin	NOUN
aiua-10711	189	6	and	and	CCONJ
aiua-10711	189	7	silodosin	silodosin	NOUN
aiua-10711	189	8	have	have	AUX
aiua-10711	189	9	been	be	AUX
aiua-10711	189	10	related	relate	VERB
aiua-10711	189	11	to	to	ADP
aiua-10711	189	12	both	both	DET
aiua-10711	189	13	a	a	DET
aiua-10711	189	14	peripheral	peripheral	ADJ
aiua-10711	189	15	effect	effect	NOUN
aiua-10711	189	16	on	on	ADP
aiua-10711	189	17	the	the	DET
aiua-10711	189	18	vas	vas	X
aiua-10711	189	19	deferens	deferens	NOUN
aiua-10711	189	20	and/or	and/or	CCONJ
aiua-10711	189	21	seminal	seminal	ADJ
aiua-10711	189	22	vesicles	vesicle	NOUN
aiua-10711	189	23	and	and	CCONJ
aiua-10711	189	24	a	a	DET
aiua-10711	189	25	central	central	ADJ
aiua-10711	189	26	effect	effect	NOUN
aiua-10711	189	27	in	in	ADP
aiua-10711	189	28	the	the	DET
aiua-10711	189	29	coordination	coordination	NOUN
aiua-10711	189	30	of	of	ADP
aiua-10711	189	31	ejaculation	ejaculation	NOUN
aiua-10711	189	32	(	(	PUNCT
aiua-10711	189	33	89	89	NUM
aiua-10711	189	34	)	)	PUNCT
aiua-10711	189	35	.	.	PUNCT
aiua-10711	190	1	at	at	ADP
aiua-10711	190	2	the	the	DET
aiua-10711	190	3	peripheral	peripheral	ADJ
aiua-10711	190	4	level	level	NOUN
aiua-10711	190	5	,	,	PUNCT
aiua-10711	190	6	ejaculation	ejaculation	NOUN
aiua-10711	190	7	disorders	disorder	NOUN
aiua-10711	190	8	have	have	AUX
aiua-10711	190	9	been	be	AUX
aiua-10711	190	10	related	relate	VERB
aiua-10711	190	11	to	to	ADP
aiua-10711	190	12	the	the	DET
aiua-10711	190	13	decreased	decrease	VERB
aiua-10711	190	14	capacity	capacity	NOUN
aiua-10711	190	15	of	of	ADP
aiua-10711	190	16	contraction	contraction	NOUN
aiua-10711	190	17	of	of	ADP
aiua-10711	190	18	the	the	DET
aiua-10711	190	19	seminal	seminal	ADJ
aiua-10711	190	20	vesicles	vesicle	NOUN
aiua-10711	190	21	and	and	CCONJ
aiua-10711	190	22	of	of	ADP
aiua-10711	190	23	the	the	DET
aiua-10711	190	24	vas	vas	X
aiua-10711	190	25	deferens	deferens	PROPN
aiua-10711	190	26	.	.	PUNCT
aiua-10711	191	1	this	this	PRON
aiua-10711	191	2	is	be	AUX
aiua-10711	191	3	supported	support	VERB
aiua-10711	191	4	by	by	ADP
aiua-10711	191	5	the	the	DET
aiua-10711	191	6	evidence	evidence	NOUN
aiua-10711	191	7	that	that	SCONJ
aiua-10711	191	8	alpha-1a	alpha-1a	DET
aiua-10711	191	9	adrenoceptor	adrenoceptor	NOUN
aiua-10711	191	10	subtype	subtype	NOUN
aiua-10711	191	11	mrna	mrna	NOUN
aiua-10711	191	12	is	be	AUX
aiua-10711	191	13	predominant	predominant	ADJ
aiua-10711	191	14	in	in	ADP
aiua-10711	191	15	human	human	ADJ
aiua-10711	191	16	seminal	seminal	ADJ
aiua-10711	191	17	vesicles	vesicle	NOUN
aiua-10711	191	18	,	,	PUNCT
aiua-10711	191	19	and	and	CCONJ
aiua-10711	191	20	that	that	SCONJ
aiua-10711	191	21	spermatic	spermatic	ADJ
aiua-10711	191	22	cells	cell	NOUN
aiua-10711	191	23	are	be	AUX
aiua-10711	191	24	not	not	PART
aiua-10711	191	25	detected	detect	VERB
aiua-10711	191	26	in	in	ADP
aiua-10711	191	27	the	the	DET
aiua-10711	191	28	urine	urine	NOUN
aiua-10711	191	29	after	after	ADP
aiua-10711	191	30	ejaculation	ejaculation	NOUN
aiua-10711	191	31	following	follow	VERB
aiua-10711	191	32	silodosin	silodosin	PROPN
aiua-10711	191	33	administration	administration	PROPN
aiua-10711	191	34	.	.	PUNCT
aiua-10711	192	1	this	this	PRON
aiua-10711	192	2	shows	show	VERB
aiua-10711	192	3	that	that	SCONJ
aiua-10711	192	4	ejaculatory	ejaculatory	ADJ
aiua-10711	192	5	dysfunction	dysfunction	NOUN
aiua-10711	192	6	caused	cause	VERB
aiua-10711	192	7	by	by	ADP
aiua-10711	192	8	silodosin	silodosin	NOUN
aiua-10711	192	9	is	be	AUX
aiua-10711	192	10	not	not	PART
aiua-10711	192	11	related	relate	VERB
aiua-10711	192	12	to	to	PART
aiua-10711	192	13	retrograde	retrograde	VERB
aiua-10711	192	14	ejaculation	ejaculation	NOUN
aiua-10711	192	15	but	but	CCONJ
aiua-10711	192	16	rather	rather	ADV
aiua-10711	192	17	to	to	ADP
aiua-10711	192	18	a	a	DET
aiua-10711	192	19	loss	loss	NOUN
aiua-10711	192	20	of	of	ADP
aiua-10711	192	21	seminal	seminal	ADJ
aiua-10711	192	22	emission	emission	NOUN
aiua-10711	192	23	(	(	PUNCT
aiua-10711	192	24	90	90	NUM
aiua-10711	192	25	,	,	PUNCT
aiua-10711	192	26	91	91	NUM
aiua-10711	192	27	)	)	PUNCT
aiua-10711	192	28	.	.	PUNCT
aiua-10711	193	1	similarly	similarly	ADV
aiua-10711	193	2	,	,	PUNCT
aiua-10711	193	3	administration	administration	NOUN
aiua-10711	193	4	of	of	ADP
aiua-10711	193	5	0.8	0.8	NUM
aiua-10711	193	6	mg	mg	PROPN
aiua-10711	193	7	tamsulosin	tamsulosin	NOUN
aiua-10711	193	8	to	to	ADP
aiua-10711	193	9	healthy	healthy	ADJ
aiua-10711	193	10	volunteers	volunteer	NOUN
aiua-10711	193	11	resulted	result	VERB
aiua-10711	193	12	in	in	ADP
aiua-10711	193	13	reduction	reduction	NOUN
aiua-10711	193	14	of	of	ADP
aiua-10711	193	15	the	the	DET
aiua-10711	193	16	ejaculatory	ejaculatory	ADJ
aiua-10711	193	17	volume	volume	NOUN
aiua-10711	193	18	in	in	ADP
aiua-10711	193	19	almost	almost	ADV
aiua-10711	193	20	all	all	PRON
aiua-10711	193	21	subjects	subject	NOUN
aiua-10711	193	22	,	,	PUNCT
aiua-10711	193	23	without	without	ADP
aiua-10711	193	24	causing	cause	VERB
aiua-10711	193	25	a	a	DET
aiua-10711	193	26	significant	significant	ADJ
aiua-10711	193	27	difference	difference	NOUN
aiua-10711	193	28	in	in	ADP
aiua-10711	193	29	post	post	ADJ
aiua-10711	193	30	-	-	ADJ
aiua-10711	193	31	ejaculation	ejaculation	ADJ
aiua-10711	193	32	urinary	urinary	ADJ
aiua-10711	193	33	sperm	sperm	NOUN
aiua-10711	193	34	concentrations	concentration	NOUN
aiua-10711	193	35	when	when	SCONJ
aiua-10711	193	36	compared	compare	VERB
aiua-10711	193	37	to	to	ADP
aiua-10711	193	38	placebo	placebo	NOUN
aiua-10711	193	39	or	or	CCONJ
aiua-10711	193	40	alfuzosin	alfuzosin	NOUN
aiua-10711	193	41	(	(	PUNCT
aiua-10711	193	42	92	92	NUM
aiua-10711	193	43	)	)	PUNCT
aiua-10711	193	44	.	.	PUNCT
aiua-10711	194	1	unlike	unlike	ADP
aiua-10711	194	2	other	other	ADJ
aiua-10711	194	3	alpha1	alpha1	NOUN
aiua-10711	194	4	-	-	PUNCT
aiua-10711	194	5	blockers	blocker	NOUN
aiua-10711	194	6	,	,	PUNCT
aiua-10711	194	7	tamsulosin	tamsulosin	NOUN
aiua-10711	194	8	can	can	AUX
aiua-10711	194	9	cross	cross	VERB
aiua-10711	194	10	the	the	DET
aiua-10711	194	11	bloodbrain	bloodbrain	NOUN
aiua-10711	194	12	barrier	barrier	NOUN
aiua-10711	194	13	and	and	CCONJ
aiua-10711	194	14	bind	bind	VERB
aiua-10711	194	15	to	to	ADP
aiua-10711	194	16	dopaminergic	dopaminergic	ADJ
aiua-10711	194	17	and/or	and/or	CCONJ
aiua-10711	194	18	serotonergic	serotonergic	ADJ
aiua-10711	194	19	receptors	receptor	NOUN
aiua-10711	194	20	that	that	PRON
aiua-10711	194	21	are	be	AUX
aiua-10711	194	22	involved	involve	VERB
aiua-10711	194	23	in	in	ADP
aiua-10711	194	24	the	the	DET
aiua-10711	194	25	central	central	ADJ
aiua-10711	194	26	coordination	coordination	NOUN
aiua-10711	194	27	of	of	ADP
aiua-10711	194	28	ejaculation	ejaculation	NOUN
aiua-10711	194	29	(	(	PUNCT
aiua-10711	194	30	93	93	NUM
aiua-10711	194	31	)	)	PUNCT
aiua-10711	194	32	.	.	PUNCT
aiua-10711	195	1	a	a	DET
aiua-10711	195	2	strong	strong	ADJ
aiua-10711	195	3	affinity	affinity	NOUN
aiua-10711	195	4	of	of	ADP
aiua-10711	195	5	alpha1	alpha1	NOUN
aiua-10711	195	6	-	-	PUNCT
aiua-10711	195	7	adrenoceptor	adrenoceptor	NOUN
aiua-10711	195	8	antagonists	antagonist	NOUN
aiua-10711	195	9	for	for	ADP
aiua-10711	195	10	d2and	d2and	PROPN
aiua-10711	195	11	5ht1a	5ht1a	NUM
aiua-10711	195	12	-	-	PUNCT
aiua-10711	195	13	like	like	ADJ
aiua-10711	195	14	receptors	receptor	NOUN
aiua-10711	195	15	for	for	ADP
aiua-10711	195	16	has	have	AUX
aiua-10711	195	17	been	be	AUX
aiua-10711	195	18	demonstrated	demonstrate	VERB
aiua-10711	195	19	,	,	PUNCT
aiua-10711	195	20	suggesting	suggest	VERB
aiua-10711	195	21	that	that	SCONJ
aiua-10711	195	22	these	these	DET
aiua-10711	195	23	drugs	drug	NOUN
aiua-10711	195	24	may	may	AUX
aiua-10711	195	25	act	act	VERB
aiua-10711	195	26	as	as	ADP
aiua-10711	195	27	antagonists	antagonist	NOUN
aiua-10711	195	28	of	of	ADP
aiua-10711	195	29	dopaminergic	dopaminergic	ADJ
aiua-10711	195	30	receptors	receptor	NOUN
aiua-10711	195	31	mediating	mediate	VERB
aiua-10711	195	32	the	the	DET
aiua-10711	195	33	contraction	contraction	NOUN
aiua-10711	195	34	of	of	ADP
aiua-10711	195	35	the	the	DET
aiua-10711	195	36	vas	vas	X
aiua-10711	195	37	deferens	deferens	PROPN
aiua-10711	195	38	(	(	PUNCT
aiua-10711	195	39	94	94	NUM
aiua-10711	195	40	)	)	PUNCT
aiua-10711	195	41	.	.	PUNCT
aiua-10711	196	1	erection	erection	NOUN
aiua-10711	196	2	there	there	PRON
aiua-10711	196	3	are	be	VERB
aiua-10711	196	4	conflicting	conflicting	ADJ
aiua-10711	196	5	data	datum	NOUN
aiua-10711	196	6	about	about	ADP
aiua-10711	196	7	the	the	DET
aiua-10711	196	8	effect	effect	NOUN
aiua-10711	196	9	of	of	ADP
aiua-10711	196	10	alpha	alpha	NOUN
aiua-10711	196	11	-	-	PUNCT
aiua-10711	196	12	blockers	blocker	NOUN
aiua-10711	196	13	on	on	ADP
aiua-10711	196	14	erection	erection	NOUN
aiua-10711	196	15	,	,	PUNCT
aiua-10711	196	16	mainly	mainly	ADV
aiua-10711	196	17	because	because	SCONJ
aiua-10711	196	18	the	the	DET
aiua-10711	196	19	erectile	erectile	NOUN
aiua-10711	196	20	function	function	NOUN
aiua-10711	196	21	is	be	AUX
aiua-10711	196	22	the	the	DET
aiua-10711	196	23	result	result	NOUN
aiua-10711	196	24	of	of	ADP
aiua-10711	196	25	a	a	DET
aiua-10711	196	26	complex	complex	ADJ
aiua-10711	196	27	interplay	interplay	NOUN
aiua-10711	196	28	between	between	ADP
aiua-10711	196	29	multiple	multiple	ADJ
aiua-10711	196	30	biochemical	biochemical	ADJ
aiua-10711	196	31	signals	signal	NOUN
aiua-10711	196	32	responding	respond	VERB
aiua-10711	196	33	to	to	ADP
aiua-10711	196	34	several	several	ADJ
aiua-10711	196	35	neurotransmitters	neurotransmitter	NOUN
aiua-10711	196	36	and	and	CCONJ
aiua-10711	196	37	vasoactive	vasoactive	ADJ
aiua-10711	196	38	agents	agent	NOUN
aiua-10711	196	39	.	.	PUNCT
aiua-10711	197	1	basically	basically	ADV
aiua-10711	197	2	,	,	PUNCT
aiua-10711	197	3	penile	penile	ADJ
aiua-10711	197	4	tumescence	tumescence	NOUN
aiua-10711	197	5	is	be	AUX
aiua-10711	197	6	associated	associate	VERB
aiua-10711	197	7	with	with	ADP
aiua-10711	197	8	relaxation	relaxation	NOUN
aiua-10711	197	9	of	of	ADP
aiua-10711	197	10	the	the	DET
aiua-10711	197	11	erectile	erectile	ADJ
aiua-10711	197	12	tissue	tissue	NOUN
aiua-10711	197	13	whereas	whereas	SCONJ
aiua-10711	197	14	detumescence	detumescence	NOUN
aiua-10711	197	15	is	be	AUX
aiua-10711	197	16	caused	cause	VERB
aiua-10711	197	17	by	by	ADP
aiua-10711	197	18	contraction	contraction	NOUN
aiua-10711	197	19	of	of	ADP
aiua-10711	197	20	the	the	DET
aiua-10711	197	21	erectile	erectile	ADJ
aiua-10711	197	22	tissue	tissue	NOUN
aiua-10711	197	23	.	.	PUNCT
aiua-10711	198	1	postsynaptic	postsynaptic	ADJ
aiua-10711	198	2	alpha1	alpha1	NOUN
aiua-10711	198	3	-	-	PUNCT
aiua-10711	198	4	adrenoceptor	adrenoceptor	NOUN
aiua-10711	198	5	activation	activation	NOUN
aiua-10711	198	6	causes	cause	VERB
aiua-10711	198	7	the	the	DET
aiua-10711	198	8	contraction	contraction	NOUN
aiua-10711	198	9	of	of	ADP
aiua-10711	198	10	the	the	DET
aiua-10711	198	11	erectile	erectile	NOUN
aiua-10711	198	12	tissue	tissue	NOUN
aiua-10711	198	13	,	,	PUNCT
aiua-10711	198	14	leading	lead	VERB
aiua-10711	198	15	to	to	ADP
aiua-10711	198	16	penile	penile	NOUN
aiua-10711	198	17	flaccidity	flaccidity	NOUN
aiua-10711	198	18	and	and	CCONJ
aiua-10711	198	19	detumescence	detumescence	NOUN
aiua-10711	198	20	.	.	PUNCT
aiua-10711	199	1	for	for	ADP
aiua-10711	199	2	this	this	DET
aiua-10711	199	3	reason	reason	NOUN
aiua-10711	199	4	,	,	PUNCT
aiua-10711	199	5	alphaadrenoceptor	alphaadrenoceptor	NOUN
aiua-10711	199	6	antagonists	antagonist	NOUN
aiua-10711	199	7	can	can	AUX
aiua-10711	199	8	promote	promote	VERB
aiua-10711	199	9	the	the	DET
aiua-10711	199	10	relaxation	relaxation	NOUN
aiua-10711	199	11	of	of	ADP
aiua-10711	199	12	the	the	DET
aiua-10711	199	13	muscles	muscle	NOUN
aiua-10711	199	14	of	of	ADP
aiua-10711	199	15	the	the	DET
aiua-10711	199	16	trabeculae	trabeculae	NOUN
aiua-10711	199	17	of	of	ADP
aiua-10711	199	18	the	the	DET
aiua-10711	199	19	corpora	corpora	NOUN
aiua-10711	199	20	cavernosa	cavernosa	NOUN
aiua-10711	199	21	and	and	CCONJ
aiua-10711	199	22	induce	induce	VERB
aiua-10711	199	23	erection	erection	NOUN
aiua-10711	199	24	,	,	PUNCT
aiua-10711	199	25	as	as	SCONJ
aiua-10711	199	26	demonstrated	demonstrate	VERB
aiua-10711	199	27	by	by	ADP
aiua-10711	199	28	erection	erection	NOUN
aiua-10711	199	29	induced	induce	VERB
aiua-10711	199	30	by	by	ADP
aiua-10711	199	31	intra	intra	ADJ
aiua-10711	199	32	-	-	ADJ
aiua-10711	199	33	cavernous	cavernous	ADJ
aiua-10711	199	34	injection	injection	NOUN
aiua-10711	199	35	of	of	ADP
aiua-10711	199	36	alpha	alpha	NOUN
aiua-10711	199	37	-	-	PUNCT
aiua-10711	199	38	adrenoceptor	adrenoceptor	NOUN
aiua-10711	199	39	antagonists	antagonist	NOUN
aiua-10711	199	40	(	(	PUNCT
aiua-10711	199	41	95	95	NUM
aiua-10711	199	42	,	,	PUNCT
aiua-10711	199	43	96	96	NUM
aiua-10711	199	44	)	)	PUNCT
aiua-10711	199	45	.	.	PUNCT
aiua-10711	200	1	in	in	ADP
aiua-10711	200	2	addition	addition	NOUN
aiua-10711	200	3	,	,	PUNCT
aiua-10711	200	4	alpha	alpha	NOUN
aiua-10711	200	5	-	-	PUNCT
aiua-10711	200	6	blocker	blocker	NOUN
aiua-10711	200	7	-	-	PUNCT
aiua-10711	200	8	induced	induce	VERB
aiua-10711	200	9	priapism	priapism	NOUN
aiua-10711	200	10	is	be	AUX
aiua-10711	200	11	a	a	DET
aiua-10711	200	12	rare	rare	ADJ
aiua-10711	200	13	but	but	CCONJ
aiua-10711	200	14	well	well	ADV
aiua-10711	200	15	documented	document	VERB
aiua-10711	200	16	side	side	ADJ
aiua-10711	200	17	effect	effect	NOUN
aiua-10711	200	18	of	of	ADP
aiua-10711	200	19	treatment	treatment	NOUN
aiua-10711	200	20	(	(	PUNCT
aiua-10711	200	21	97	97	NUM
aiua-10711	200	22	)	)	PUNCT
aiua-10711	200	23	.	.	PUNCT
aiua-10711	201	1	at	at	ADP
aiua-10711	201	2	the	the	DET
aiua-10711	201	3	systemic	systemic	ADJ
aiua-10711	201	4	level	level	NOUN
aiua-10711	201	5	,	,	PUNCT
aiua-10711	201	6	blockage	blockage	NOUN
aiua-10711	201	7	of	of	ADP
aiua-10711	201	8	adrenergic	adrenergic	ADJ
aiua-10711	201	9	receptors	receptor	NOUN
aiua-10711	201	10	has	have	VERB
aiua-10711	201	11	a	a	DET
aiua-10711	201	12	more	more	ADV
aiua-10711	201	13	complex	complex	ADJ
aiua-10711	201	14	effect	effect	NOUN
aiua-10711	201	15	on	on	ADP
aiua-10711	201	16	the	the	DET
aiua-10711	201	17	regulation	regulation	NOUN
aiua-10711	201	18	of	of	ADP
aiua-10711	201	19	erectile	erectile	ADJ
aiua-10711	201	20	function	function	NOUN
aiua-10711	201	21	because	because	SCONJ
aiua-10711	201	22	it	it	PRON
aiua-10711	201	23	can	can	AUX
aiua-10711	201	24	occur	occur	VERB
aiua-10711	201	25	at	at	ADP
aiua-10711	201	26	both	both	CCONJ
aiua-10711	201	27	peripheral	peripheral	ADJ
aiua-10711	201	28	and	and	CCONJ
aiua-10711	201	29	central	central	ADJ
aiua-10711	201	30	levels	level	NOUN
aiua-10711	201	31	(	(	PUNCT
aiua-10711	201	32	through	through	ADP
aiua-10711	201	33	ascending	ascend	VERB
aiua-10711	201	34	pathways	pathway	NOUN
aiua-10711	201	35	to	to	ADP
aiua-10711	201	36	the	the	DET
aiua-10711	201	37	brain	brain	NOUN
aiua-10711	201	38	and	and	CCONJ
aiua-10711	201	39	descending	descend	VERB
aiua-10711	201	40	pathways	pathway	NOUN
aiua-10711	201	41	to	to	ADP
aiua-10711	201	42	the	the	DET
aiua-10711	201	43	spinal	spinal	NOUN
aiua-10711	201	44	cord	cord	NOUN
aiua-10711	201	45	)	)	PUNCT
aiua-10711	201	46	and	and	CCONJ
aiua-10711	201	47	involve	involve	VERB
aiua-10711	201	48	various	various	ADJ
aiua-10711	201	49	alpha1or	alpha1or	PROPN
aiua-10711	201	50	alpha2	alpha2	NOUN
aiua-10711	201	51	-	-	PUNCT
aiua-10711	201	52	adrenoceptor	adrenoceptor	NOUN
aiua-10711	201	53	subtypes	subtype	NOUN
aiua-10711	201	54	.	.	PUNCT
aiua-10711	202	1	the	the	DET
aiua-10711	202	2	effect	effect	NOUN
aiua-10711	202	3	of	of	ADP
aiua-10711	202	4	each	each	DET
aiua-10711	202	5	drug	drug	NOUN
aiua-10711	202	6	will	will	AUX
aiua-10711	202	7	depend	depend	VERB
aiua-10711	202	8	on	on	ADP
aiua-10711	202	9	the	the	DET
aiua-10711	202	10	central	central	ADJ
aiua-10711	202	11	and	and	CCONJ
aiua-10711	202	12	peripheral	peripheral	ADJ
aiua-10711	202	13	effects	effect	NOUN
aiua-10711	202	14	exerted	exert	VERB
aiua-10711	202	15	on	on	ADP
aiua-10711	202	16	the	the	DET
aiua-10711	202	17	different	different	ADJ
aiua-10711	202	18	receptors	receptor	NOUN
aiua-10711	202	19	,	,	PUNCT
aiua-10711	202	20	causing	cause	VERB
aiua-10711	202	21	in	in	ADP
aiua-10711	202	22	turn	turn	NOUN
aiua-10711	202	23	specific	specific	ADJ
aiua-10711	202	24	effects	effect	NOUN
aiua-10711	202	25	on	on	ADP
aiua-10711	202	26	erectile	erectile	ADJ
aiua-10711	202	27	function	function	NOUN
aiua-10711	202	28	(	(	PUNCT
aiua-10711	202	29	98	98	NUM
aiua-10711	202	30	)	)	PUNCT
aiua-10711	202	31	.	.	PUNCT
aiua-10711	203	1	finally	finally	ADV
aiua-10711	203	2	,	,	PUNCT
aiua-10711	203	3	hemodynamic	hemodynamic	ADJ
aiua-10711	203	4	effects	effect	NOUN
aiua-10711	203	5	of	of	ADP
aiua-10711	203	6	non	non	ADJ
aiua-10711	203	7	-	-	ADJ
aiua-10711	203	8	selective	selective	ADJ
aiua-10711	203	9	alpha	alpha	NOUN
aiua-10711	203	10	-	-	PUNCT
aiua-10711	203	11	blockers	blocker	NOUN
aiua-10711	203	12	may	may	AUX
aiua-10711	203	13	harm	harm	VERB
aiua-10711	203	14	erectile	erectile	NOUN
aiua-10711	203	15	function	function	NOUN
aiua-10711	203	16	because	because	SCONJ
aiua-10711	203	17	of	of	ADP
aiua-10711	203	18	symptomatic	symptomatic	ADJ
aiua-10711	203	19	hypotension	hypotension	NOUN
aiua-10711	203	20	side	side	NOUN
aiua-10711	203	21	effects	effect	NOUN
aiua-10711	203	22	(	(	PUNCT
aiua-10711	203	23	99	99	NUM
aiua-10711	203	24	)	)	PUNCT
aiua-10711	203	25	.	.	PUNCT
aiua-10711	204	1	our	our	PRON
aiua-10711	204	2	meta	meta	ADJ
aiua-10711	204	3	-	-	PUNCT
aiua-10711	204	4	analysis	analysis	NOUN
aiua-10711	204	5	demonstrated	demonstrate	VERB
aiua-10711	204	6	neither	neither	CCONJ
aiua-10711	204	7	greater	great	ADJ
aiua-10711	204	8	odds	odd	NOUN
aiua-10711	204	9	of	of	ADP
aiua-10711	204	10	erectile	erectile	ADJ
aiua-10711	204	11	dysfunction	dysfunction	NOUN
aiua-10711	204	12	or	or	CCONJ
aiua-10711	204	13	impotence	impotence	NOUN
aiua-10711	204	14	upon	upon	SCONJ
aiua-10711	204	15	exposure	exposure	NOUN
aiua-10711	204	16	to	to	ADP
aiua-10711	204	17	alpha	alpha	NOUN
aiua-10711	204	18	-	-	PUNCT
aiua-10711	204	19	blockers	blocker	NOUN
aiua-10711	204	20	,	,	PUNCT
aiua-10711	204	21	nor	nor	CCONJ
aiua-10711	204	22	differences	difference	NOUN
aiua-10711	204	23	of	of	ADP
aiua-10711	204	24	odds	odd	NOUN
aiua-10711	204	25	of	of	ADP
aiua-10711	204	26	erectile	erectile	ADJ
aiua-10711	204	27	dysfunction	dysfunction	NOUN
aiua-10711	204	28	evoked	evoke	VERB
aiua-10711	204	29	by	by	ADP
aiua-10711	204	30	treatment	treatment	NOUN
aiua-10711	204	31	with	with	ADP
aiua-10711	204	32	uroselective	uroselective	ADJ
aiua-10711	204	33	or	or	CCONJ
aiua-10711	204	34	nonselective	nonselective	ADJ
aiua-10711	204	35	alpha	alpha	NOUN
aiua-10711	204	36	-	-	PUNCT
aiua-10711	204	37	blockers	blocker	NOUN
aiua-10711	204	38	compared	compare	VERB
aiua-10711	204	39	to	to	ADP
aiua-10711	204	40	placebo	placebo	NOUN
aiua-10711	204	41	.	.	PUNCT
aiua-10711	205	1	thus	thus	ADV
aiua-10711	205	2	,	,	PUNCT
aiua-10711	205	3	the	the	DET
aiua-10711	205	4	potential	potential	ADJ
aiua-10711	205	5	effect	effect	NOUN
aiua-10711	205	6	of	of	ADP
aiua-10711	205	7	alpha	alpha	NOUN
aiua-10711	205	8	-	-	PUNCT
aiua-10711	205	9	blockers	blocker	NOUN
aiua-10711	205	10	on	on	ADP
aiua-10711	205	11	erectile	erectile	ADJ
aiua-10711	205	12	archivio	archivio	NOUN
aiua-10711	205	13	italiano	italiano	X
aiua-10711	205	14	di	di	X
aiua-10711	205	15	urologia	urologia	PROPN
aiua-10711	205	16	e	e	PROPN
aiua-10711	205	17	andrologia	andrologia	PROPN
aiua-10711	205	18	2022	2022	NUM
aiua-10711	205	19	;	;	PUNCT
aiua-10711	205	20	94	94	NUM
aiua-10711	205	21	,	,	PUNCT
aiua-10711	205	22	2	2	NUM
aiua-10711	205	23	r.	r.	NOUN
aiua-10711	205	24	bapir	bapir	NOUN
aiua-10711	205	25	,	,	PUNCT
aiua-10711	205	26	k.	k.	PROPN
aiua-10711	205	27	hassan	hassan	PROPN
aiua-10711	205	28	bhatti	bhatti	PROPN
aiua-10711	205	29	,	,	PUNCT
aiua-10711	205	30	a	a	PRON
aiua-10711	205	31	,	,	PUNCT
aiua-10711	205	32	eliwa	eliwa	NOUN
aiua-10711	205	33	,	,	PUNCT
aiua-10711	205	34	et	et	PROPN
aiua-10711	205	35	al	al	PROPN
aiua-10711	205	36	.	.	PROPN
aiua-10711	205	37	260	260	NUM
aiua-10711	205	38	function	function	NOUN
aiua-10711	205	39	therefore	therefore	ADV
aiua-10711	205	40	remains	remain	VERB
aiua-10711	205	41	unknown	unknown	ADJ
aiua-10711	205	42	.	.	PUNCT
aiua-10711	206	1	in	in	ADP
aiua-10711	206	2	our	our	PRON
aiua-10711	206	3	analysis	analysis	NOUN
aiua-10711	206	4	we	we	PRON
aiua-10711	206	5	excluded	exclude	VERB
aiua-10711	206	6	studies	study	NOUN
aiua-10711	206	7	that	that	PRON
aiua-10711	206	8	evaluated	evaluate	VERB
aiua-10711	206	9	the	the	DET
aiua-10711	206	10	effects	effect	NOUN
aiua-10711	206	11	of	of	ADP
aiua-10711	206	12	combination	combination	NOUN
aiua-10711	206	13	therapy	therapy	NOUN
aiua-10711	206	14	with	with	ADP
aiua-10711	206	15	alpha-1	alpha-1	NUM
aiua-10711	206	16	adrenergic	adrenergic	ADJ
aiua-10711	206	17	antagonists	antagonist	NOUN
aiua-10711	206	18	and	and	CCONJ
aiua-10711	206	19	phosphodiesterase-5	phosphodiesterase-5	NUM
aiua-10711	206	20	(	(	PUNCT
aiua-10711	206	21	pde5	pde5	NOUN
aiua-10711	206	22	)	)	PUNCT
aiua-10711	206	23	inhibitors	inhibitor	NOUN
aiua-10711	206	24	on	on	ADP
aiua-10711	206	25	sexual	sexual	ADJ
aiua-10711	206	26	function	function	NOUN
aiua-10711	206	27	.	.	PUNCT
aiua-10711	207	1	interestingly	interestingly	ADV
aiua-10711	207	2	,	,	PUNCT
aiua-10711	207	3	some	some	DET
aiua-10711	207	4	studies	study	NOUN
aiua-10711	207	5	have	have	AUX
aiua-10711	207	6	shown	show	VERB
aiua-10711	207	7	an	an	DET
aiua-10711	207	8	additive	additive	ADJ
aiua-10711	207	9	favorable	favorable	ADJ
aiua-10711	207	10	effect	effect	NOUN
aiua-10711	207	11	of	of	ADP
aiua-10711	207	12	the	the	DET
aiua-10711	207	13	combined	combine	VERB
aiua-10711	207	14	use	use	NOUN
aiua-10711	207	15	of	of	ADP
aiua-10711	207	16	alpha	alpha	NOUN
aiua-10711	207	17	-	-	PUNCT
aiua-10711	207	18	blockers	blocker	NOUN
aiua-10711	207	19	and	and	CCONJ
aiua-10711	207	20	pde5	pde5	NOUN
aiua-10711	207	21	inhibitors	inhibitor	NOUN
aiua-10711	207	22	on	on	ADP
aiua-10711	207	23	erectile	erectile	ADJ
aiua-10711	207	24	dysfunction	dysfunction	NOUN
aiua-10711	207	25	(	(	PUNCT
aiua-10711	207	26	100	100	NUM
aiua-10711	207	27	)	)	PUNCT
aiua-10711	207	28	.	.	PUNCT
aiua-10711	208	1	in	in	ADP
aiua-10711	208	2	2014	2014	NUM
aiua-10711	208	3	,	,	PUNCT
aiua-10711	208	4	a	a	DET
aiua-10711	208	5	meta	meta	ADJ
aiua-10711	208	6	-	-	PUNCT
aiua-10711	208	7	analysis	analysis	NOUN
aiua-10711	208	8	demonstrated	demonstrate	VERB
aiua-10711	208	9	that	that	SCONJ
aiua-10711	208	10	alpha	alpha	NOUN
aiua-10711	208	11	-	-	PUNCT
aiua-10711	208	12	blockers	blocker	NOUN
aiua-10711	208	13	may	may	AUX
aiua-10711	208	14	enhance	enhance	VERB
aiua-10711	208	15	the	the	DET
aiua-10711	208	16	efficacy	efficacy	NOUN
aiua-10711	208	17	of	of	ADP
aiua-10711	208	18	pde5	pde5	NOUN
aiua-10711	208	19	inhibitors	inhibitor	NOUN
aiua-10711	208	20	on	on	ADP
aiua-10711	208	21	erectile	erectile	ADJ
aiua-10711	208	22	dysfunction	dysfunction	NOUN
aiua-10711	208	23	in	in	ADP
aiua-10711	208	24	men	man	NOUN
aiua-10711	208	25	with	with	ADP
aiua-10711	208	26	luts	luts	PROPN
aiua-10711	208	27	suggestive	suggestive	ADJ
aiua-10711	208	28	of	of	ADP
aiua-10711	208	29	bph	bph	NOUN
aiua-10711	208	30	(	(	PUNCT
aiua-10711	208	31	101	101	NUM
aiua-10711	208	32	)	)	PUNCT
aiua-10711	208	33	.	.	PUNCT
aiua-10711	209	1	however	however	ADV
aiua-10711	209	2	,	,	PUNCT
aiua-10711	209	3	a	a	DET
aiua-10711	209	4	more	more	ADV
aiua-10711	209	5	recent	recent	ADJ
aiua-10711	209	6	review	review	NOUN
aiua-10711	209	7	found	find	VERB
aiua-10711	209	8	no	no	DET
aiua-10711	209	9	significant	significant	ADJ
aiua-10711	209	10	difference	difference	NOUN
aiua-10711	209	11	of	of	ADP
aiua-10711	209	12	the	the	DET
aiua-10711	209	13	mean	mean	ADJ
aiua-10711	209	14	change	change	NOUN
aiua-10711	209	15	of	of	ADP
aiua-10711	209	16	iief	iief	NOUN
aiua-10711	209	17	between	between	ADP
aiua-10711	209	18	combination	combination	NOUN
aiua-10711	209	19	therapy	therapy	NOUN
aiua-10711	209	20	and	and	CCONJ
aiua-10711	209	21	pde5	pde5	NOUN
aiua-10711	209	22	inhibitors	inhibitor	NOUN
aiua-10711	209	23	-	-	PUNCT
aiua-10711	209	24	monotherapy	monotherapy	NOUN
aiua-10711	209	25	concluding	concluding	NOUN
aiua-10711	209	26	that	that	SCONJ
aiua-10711	209	27	benefits	benefit	NOUN
aiua-10711	209	28	regarding	regard	VERB
aiua-10711	209	29	the	the	DET
aiua-10711	209	30	treatment	treatment	NOUN
aiua-10711	209	31	of	of	ADP
aiua-10711	209	32	ed	ed	NOUN
aiua-10711	209	33	are	be	AUX
aiua-10711	209	34	not	not	PART
aiua-10711	209	35	clear	clear	ADJ
aiua-10711	209	36	(	(	PUNCT
aiua-10711	209	37	102	102	NUM
aiua-10711	209	38	)	)	PUNCT
aiua-10711	209	39	.	.	PUNCT
aiua-10711	210	1	limitations	limitation	NOUN
aiua-10711	210	2	a	a	DET
aiua-10711	210	3	limitation	limitation	NOUN
aiua-10711	210	4	of	of	ADP
aiua-10711	210	5	this	this	DET
aiua-10711	210	6	meta	meta	ADJ
aiua-10711	210	7	-	-	PUNCT
aiua-10711	210	8	analysis	analysis	NOUN
aiua-10711	210	9	is	be	AUX
aiua-10711	210	10	the	the	DET
aiua-10711	210	11	disparity	disparity	NOUN
aiua-10711	210	12	of	of	ADP
aiua-10711	210	13	assessment	assessment	NOUN
aiua-10711	210	14	criteria	criterion	NOUN
aiua-10711	210	15	and	and	CCONJ
aiua-10711	210	16	definitions	definition	NOUN
aiua-10711	210	17	used	use	VERB
aiua-10711	210	18	to	to	PART
aiua-10711	210	19	describe	describe	VERB
aiua-10711	210	20	sexual	sexual	ADJ
aiua-10711	210	21	dysfunction	dysfunction	NOUN
aiua-10711	210	22	associated	associate	VERB
aiua-10711	210	23	with	with	ADP
aiua-10711	210	24	alpha	alpha	NOUN
aiua-10711	210	25	-	-	PUNCT
aiua-10711	210	26	blockers	blocker	NOUN
aiua-10711	210	27	.	.	PUNCT
aiua-10711	211	1	ejaculation	ejaculation	NOUN
aiua-10711	211	2	disorders	disorder	NOUN
aiua-10711	211	3	have	have	AUX
aiua-10711	211	4	been	be	AUX
aiua-10711	211	5	defined	define	VERB
aiua-10711	211	6	indifferently	indifferently	ADV
aiua-10711	211	7	as	as	ADP
aiua-10711	211	8	abnormal	abnormal	ADJ
aiua-10711	211	9	ejaculation	ejaculation	NOUN
aiua-10711	211	10	,	,	PUNCT
aiua-10711	211	11	ejaculatory	ejaculatory	NOUN
aiua-10711	211	12	disorders	disorder	NOUN
aiua-10711	211	13	,	,	PUNCT
aiua-10711	211	14	decreased	decrease	VERB
aiua-10711	211	15	ejaculatory	ejaculatory	ADJ
aiua-10711	211	16	volume	volume	NOUN
aiua-10711	211	17	,	,	PUNCT
aiua-10711	211	18	anejaculation	anejaculation	NOUN
aiua-10711	211	19	,	,	PUNCT
aiua-10711	211	20	and	and	CCONJ
aiua-10711	211	21	retrograde	retrograde	ADJ
aiua-10711	211	22	ejaculation	ejaculation	NOUN
aiua-10711	211	23	.	.	PUNCT
aiua-10711	212	1	some	some	PRON
aiua-10711	212	2	of	of	ADP
aiua-10711	212	3	these	these	DET
aiua-10711	212	4	terms	term	NOUN
aiua-10711	212	5	are	be	AUX
aiua-10711	212	6	generic	generic	ADJ
aiua-10711	212	7	,	,	PUNCT
aiua-10711	212	8	others	other	NOUN
aiua-10711	212	9	imply	imply	VERB
aiua-10711	212	10	specific	specific	ADJ
aiua-10711	212	11	pathophysiological	pathophysiological	ADJ
aiua-10711	212	12	alterations	alteration	NOUN
aiua-10711	212	13	that	that	PRON
aiua-10711	212	14	may	may	AUX
aiua-10711	212	15	not	not	PART
aiua-10711	212	16	correspond	correspond	VERB
aiua-10711	212	17	to	to	ADP
aiua-10711	212	18	clinically	clinically	ADV
aiua-10711	212	19	observable	observable	ADJ
aiua-10711	212	20	manifestations	manifestation	NOUN
aiua-10711	212	21	.	.	PUNCT
aiua-10711	213	1	the	the	DET
aiua-10711	213	2	presence	presence	NOUN
aiua-10711	213	3	of	of	ADP
aiua-10711	213	4	retrograde	retrograde	ADJ
aiua-10711	213	5	ejaculation	ejaculation	NOUN
aiua-10711	213	6	has	have	AUX
aiua-10711	213	7	been	be	AUX
aiua-10711	213	8	questioned	question	VERB
aiua-10711	213	9	by	by	ADP
aiua-10711	213	10	recent	recent	ADJ
aiua-10711	213	11	studies	study	NOUN
aiua-10711	213	12	which	which	PRON
aiua-10711	213	13	have	have	AUX
aiua-10711	213	14	shown	show	VERB
aiua-10711	213	15	that	that	SCONJ
aiua-10711	213	16	the	the	DET
aiua-10711	213	17	ejaculatory	ejaculatory	PROPN
aiua-10711	213	18	alterations	alteration	NOUN
aiua-10711	213	19	caused	cause	VERB
aiua-10711	213	20	by	by	ADP
aiua-10711	213	21	alpha	alpha	NOUN
aiua-10711	213	22	-	-	PUNCT
aiua-10711	213	23	blockers	blocker	NOUN
aiua-10711	213	24	are	be	AUX
aiua-10711	213	25	due	due	ADJ
aiua-10711	213	26	to	to	ADP
aiua-10711	213	27	a	a	DET
aiua-10711	213	28	lack	lack	NOUN
aiua-10711	213	29	of	of	ADP
aiua-10711	213	30	semen	semen	NOUN
aiua-10711	213	31	emission	emission	NOUN
aiua-10711	213	32	,	,	PUNCT
aiua-10711	213	33	that	that	PRON
aiua-10711	213	34	should	should	AUX
aiua-10711	213	35	be	be	AUX
aiua-10711	213	36	better	well	ADV
aiua-10711	213	37	defined	define	VERB
aiua-10711	213	38	as	as	ADP
aiua-10711	213	39	anejaculation	anejaculation	NOUN
aiua-10711	213	40	.	.	PUNCT
aiua-10711	214	1	the	the	DET
aiua-10711	214	2	different	different	ADJ
aiua-10711	214	3	physiological	physiological	ADJ
aiua-10711	214	4	mechanisms	mechanism	NOUN
aiua-10711	214	5	that	that	PRON
aiua-10711	214	6	are	be	AUX
aiua-10711	214	7	at	at	ADP
aiua-10711	214	8	the	the	DET
aiua-10711	214	9	origin	origin	NOUN
aiua-10711	214	10	of	of	ADP
aiua-10711	214	11	failure	failure	NOUN
aiua-10711	214	12	of	of	ADP
aiua-10711	214	13	semen	semen	NOUN
aiua-10711	214	14	emission	emission	NOUN
aiua-10711	214	15	,	,	PUNCT
aiua-10711	214	16	or	or	CCONJ
aiua-10711	214	17	of	of	ADP
aiua-10711	214	18	retrograde	retrograde	ADJ
aiua-10711	214	19	ejaculation	ejaculation	NOUN
aiua-10711	214	20	,	,	PUNCT
aiua-10711	214	21	can	can	AUX
aiua-10711	214	22	be	be	AUX
aiua-10711	214	23	associated	associate	VERB
aiua-10711	214	24	with	with	ADP
aiua-10711	214	25	different	different	ADJ
aiua-10711	214	26	orgasmic	orgasmic	ADJ
aiua-10711	214	27	dysfunctions	dysfunction	NOUN
aiua-10711	214	28	.	.	PUNCT
aiua-10711	215	1	on	on	ADP
aiua-10711	215	2	the	the	DET
aiua-10711	215	3	other	other	ADJ
aiua-10711	215	4	hand	hand	NOUN
aiua-10711	215	5	,	,	PUNCT
aiua-10711	215	6	ejaculation	ejaculation	NOUN
aiua-10711	215	7	disorders	disorder	NOUN
aiua-10711	215	8	have	have	AUX
aiua-10711	215	9	rarely	rarely	ADV
aiua-10711	215	10	been	be	AUX
aiua-10711	215	11	evaluated	evaluate	VERB
aiua-10711	215	12	with	with	ADP
aiua-10711	215	13	specific	specific	ADJ
aiua-10711	215	14	questionnaires	questionnaire	NOUN
aiua-10711	215	15	such	such	ADJ
aiua-10711	215	16	as	as	ADP
aiua-10711	215	17	dan	dan	PROPN
aiua-10711	215	18	-	-	PUNCT
aiua-10711	215	19	pss	pss	PROPN
aiua-10711	215	20	or	or	CCONJ
aiua-10711	215	21	msqh	msqh	NOUN
aiua-10711	215	22	.	.	PUNCT
aiua-10711	216	1	erectile	erectile	ADJ
aiua-10711	216	2	dysfunction	dysfunction	NOUN
aiua-10711	216	3	was	be	AUX
aiua-10711	216	4	also	also	ADV
aiua-10711	216	5	not	not	PART
aiua-10711	216	6	uniquely	uniquely	ADV
aiua-10711	216	7	defined	define	VERB
aiua-10711	216	8	in	in	ADP
aiua-10711	216	9	the	the	DET
aiua-10711	216	10	different	different	ADJ
aiua-10711	216	11	studies	study	NOUN
aiua-10711	216	12	that	that	PRON
aiua-10711	216	13	used	use	VERB
aiua-10711	216	14	both	both	DET
aiua-10711	216	15	the	the	DET
aiua-10711	216	16	term	term	NOUN
aiua-10711	216	17	impotence	impotence	NOUN
aiua-10711	216	18	and	and	CCONJ
aiua-10711	216	19	erectile	erectile	NOUN
aiua-10711	216	20	dysfunction	dysfunction	NOUN
aiua-10711	216	21	,	,	PUNCT
aiua-10711	216	22	with	with	ADP
aiua-10711	216	23	only	only	ADV
aiua-10711	216	24	a	a	DET
aiua-10711	216	25	few	few	ADJ
aiua-10711	216	26	studies	study	NOUN
aiua-10711	216	27	assessing	assess	VERB
aiua-10711	216	28	the	the	DET
aiua-10711	216	29	latter	latter	ADJ
aiua-10711	216	30	with	with	ADP
aiua-10711	216	31	the	the	DET
aiua-10711	216	32	iief	iief	ADJ
aiua-10711	216	33	questionnaire	questionnaire	NOUN
aiua-10711	216	34	.	.	PUNCT
aiua-10711	217	1	in	in	ADP
aiua-10711	217	2	order	order	NOUN
aiua-10711	217	3	to	to	PART
aiua-10711	217	4	take	take	VERB
aiua-10711	217	5	into	into	ADP
aiua-10711	217	6	account	account	NOUN
aiua-10711	217	7	the	the	DET
aiua-10711	217	8	diversity	diversity	NOUN
aiua-10711	217	9	of	of	ADP
aiua-10711	217	10	diagnostic	diagnostic	ADJ
aiua-10711	217	11	methods	method	NOUN
aiua-10711	217	12	and	and	CCONJ
aiua-10711	217	13	tools	tool	NOUN
aiua-10711	217	14	used	use	VERB
aiua-10711	217	15	to	to	PART
aiua-10711	217	16	ascertain	ascertain	VERB
aiua-10711	217	17	ejaculatory	ejaculatory	NOUN
aiua-10711	217	18	or	or	CCONJ
aiua-10711	217	19	erectile	erectile	ADJ
aiua-10711	217	20	dysfunction	dysfunction	NOUN
aiua-10711	217	21	in	in	ADP
aiua-10711	217	22	included	include	VERB
aiua-10711	217	23	studies	study	NOUN
aiua-10711	217	24	,	,	PUNCT
aiua-10711	217	25	we	we	PRON
aiua-10711	217	26	have	have	AUX
aiua-10711	217	27	used	use	VERB
aiua-10711	217	28	in	in	ADP
aiua-10711	217	29	all	all	DET
aiua-10711	217	30	metanalyses	metanalyse	NOUN
aiua-10711	217	31	a	a	DET
aiua-10711	217	32	random	random	ADJ
aiua-10711	217	33	-	-	PUNCT
aiua-10711	217	34	effect	effect	NOUN
aiua-10711	217	35	model	model	NOUN
aiua-10711	217	36	(	(	PUNCT
aiua-10711	217	37	103	103	NUM
aiua-10711	217	38	)	)	PUNCT
aiua-10711	217	39	.	.	PUNCT
aiua-10711	218	1	conclusions	conclusion	NOUN
aiua-10711	218	2	in	in	ADP
aiua-10711	218	3	conclusion	conclusion	NOUN
aiua-10711	218	4	,	,	PUNCT
aiua-10711	218	5	because	because	SCONJ
aiua-10711	218	6	of	of	ADP
aiua-10711	218	7	the	the	DET
aiua-10711	218	8	different	different	ADJ
aiua-10711	218	9	effects	effect	NOUN
aiua-10711	218	10	of	of	ADP
aiua-10711	218	11	alpha1adrenergic	alpha1adrenergic	ADJ
aiua-10711	218	12	antagonists	antagonist	NOUN
aiua-10711	218	13	on	on	ADP
aiua-10711	218	14	sexuality	sexuality	NOUN
aiua-10711	218	15	,	,	PUNCT
aiua-10711	218	16	the	the	DET
aiua-10711	218	17	sexual	sexual	ADJ
aiua-10711	218	18	function	function	NOUN
aiua-10711	218	19	of	of	ADP
aiua-10711	218	20	each	each	DET
aiua-10711	218	21	patient	patient	NOUN
aiua-10711	218	22	should	should	AUX
aiua-10711	218	23	be	be	AUX
aiua-10711	218	24	assessed	assess	VERB
aiua-10711	218	25	and	and	CCONJ
aiua-10711	218	26	discussed	discuss	VERB
aiua-10711	218	27	when	when	SCONJ
aiua-10711	218	28	alpha	alpha	NOUN
aiua-10711	218	29	-	-	PUNCT
aiua-10711	218	30	blocker	blocker	NOUN
aiua-10711	218	31	therapy	therapy	NOUN
aiua-10711	218	32	is	be	AUX
aiua-10711	218	33	planned	plan	VERB
aiua-10711	218	34	,	,	PUNCT
aiua-10711	218	35	and	and	CCONJ
aiua-10711	218	36	patients	patient	NOUN
aiua-10711	218	37	should	should	AUX
aiua-10711	218	38	be	be	AUX
aiua-10711	218	39	informed	inform	VERB
aiua-10711	218	40	about	about	ADP
aiua-10711	218	41	the	the	DET
aiua-10711	218	42	potential	potential	ADJ
aiua-10711	218	43	side	side	NOUN
aiua-10711	218	44	effects	effect	NOUN
aiua-10711	218	45	of	of	ADP
aiua-10711	218	46	such	such	ADJ
aiua-10711	218	47	treatment	treatment	NOUN
aiua-10711	218	48	.	.	PUNCT
aiua-10711	219	1	when	when	SCONJ
aiua-10711	219	2	prescribing	prescribe	VERB
aiua-10711	219	3	a	a	DET
aiua-10711	219	4	specific	specific	ADJ
aiua-10711	219	5	alpha	alpha	NOUN
aiua-10711	219	6	-	-	PUNCT
aiua-10711	219	7	blocker	blocker	NOUN
aiua-10711	219	8	,	,	PUNCT
aiua-10711	219	9	the	the	DET
aiua-10711	219	10	specialist	specialist	NOUN
aiua-10711	219	11	should	should	AUX
aiua-10711	219	12	consider	consider	VERB
aiua-10711	219	13	the	the	DET
aiua-10711	219	14	needs	need	NOUN
aiua-10711	219	15	and	and	CCONJ
aiua-10711	219	16	expectations	expectation	NOUN
aiua-10711	219	17	of	of	ADP
aiua-10711	219	18	the	the	DET
aiua-10711	219	19	patient	patient	NOUN
aiua-10711	219	20	,	,	PUNCT
aiua-10711	219	21	to	to	PART
aiua-10711	219	22	ensure	ensure	VERB
aiua-10711	219	23	the	the	DET
aiua-10711	219	24	best	good	ADJ
aiua-10711	219	25	possible	possible	ADJ
aiua-10711	219	26	quality	quality	NOUN
aiua-10711	219	27	of	of	ADP
aiua-10711	219	28	life	life	NOUN
aiua-10711	219	29	.	.	PUNCT
aiua-10711	220	1	references	reference	NOUN
aiua-10711	220	2	1	1	NUM
aiua-10711	220	3	.	.	PUNCT
aiua-10711	220	4	frishman	frishman	PROPN
aiua-10711	220	5	wh	wh	PROPN
aiua-10711	220	6	,	,	PUNCT
aiua-10711	220	7	kotob	kotob	PROPN
aiua-10711	220	8	f.	f.	PROPN
aiua-10711	220	9	alpha	alpha	PROPN
aiua-10711	220	10	-	-	PUNCT
aiua-10711	220	11	adrenergic	adrenergic	ADJ
aiua-10711	220	12	blocking	block	VERB
aiua-10711	220	13	drugs	drug	NOUN
aiua-10711	220	14	in	in	ADP
aiua-10711	220	15	clinical	clinical	ADJ
aiua-10711	220	16	medicine	medicine	NOUN
aiua-10711	220	17	.	.	PUNCT
aiua-10711	221	1	j	j	PROPN
aiua-10711	221	2	clin	clin	PROPN
aiua-10711	221	3	pharmacol	pharmacol	PROPN
aiua-10711	221	4	.	.	PUNCT
aiua-10711	221	5	1999	1999	NUM
aiua-10711	221	6	;	;	PUNCT
aiua-10711	221	7	39:7	39:7	NUM
aiua-10711	221	8	-	-	SYM
aiua-10711	221	9	16	16	NUM
aiua-10711	221	10	.	.	PUNCT
aiua-10711	222	1	2	2	X
aiua-10711	222	2	.	.	X
aiua-10711	222	3	civantos	civantos	PROPN
aiua-10711	222	4	calzada	calzada	PROPN
aiua-10711	222	5	b	b	PROPN
aiua-10711	222	6	,	,	PUNCT
aiua-10711	222	7	aleixandre	aleixandre	PROPN
aiua-10711	222	8	de	de	PROPN
aiua-10711	222	9	artiñano	artiñano	PROPN
aiua-10711	222	10	a.	a.	PROPN
aiua-10711	222	11	alpha	alpha	PROPN
aiua-10711	222	12	-	-	PUNCT
aiua-10711	222	13	adrenoceptor	adrenoceptor	NOUN
aiua-10711	222	14	subtypes	subtype	NOUN
aiua-10711	222	15	.	.	PUNCT
aiua-10711	223	1	pharmacol	pharmacol	NOUN
aiua-10711	223	2	res	re	NOUN
aiua-10711	223	3	.	.	PUNCT
aiua-10711	223	4	2001	2001	NUM
aiua-10711	223	5	;	;	PUNCT
aiua-10711	223	6	44:195	44:195	NUM
aiua-10711	223	7	-	-	SYM
aiua-10711	223	8	208	208	NUM
aiua-10711	223	9	.	.	PUNCT
aiua-10711	224	1	3	3	X
aiua-10711	224	2	.	.	PUNCT
aiua-10711	224	3	graham	graham	PROPN
aiua-10711	224	4	rm	rm	PROPN
aiua-10711	224	5	.	.	PROPN
aiua-10711	224	6	selective	selective	ADJ
aiua-10711	224	7	alpha	alpha	ADJ
aiua-10711	224	8	1	1	NUM
aiua-10711	224	9	-	-	PUNCT
aiua-10711	224	10	adrenergic	adrenergic	ADJ
aiua-10711	224	11	antagonists	antagonist	NOUN
aiua-10711	224	12	:	:	PUNCT
aiua-10711	224	13	therapeutically	therapeutically	ADV
aiua-10711	224	14	relevant	relevant	ADJ
aiua-10711	224	15	antihypertensive	antihypertensive	ADJ
aiua-10711	224	16	agents	agent	NOUN
aiua-10711	224	17	.	.	PUNCT
aiua-10711	224	18	am	be	AUX
aiua-10711	224	19	j	j	PROPN
aiua-10711	224	20	cardiol	cardiol	NOUN
aiua-10711	224	21	.	.	PUNCT
aiua-10711	224	22	1984	1984	NUM
aiua-10711	224	23	;	;	PUNCT
aiua-10711	225	1	53:16a-20a	53:16a-20a	X
aiua-10711	225	2	.	.	NOUN
aiua-10711	225	3	4	4	NUM
aiua-10711	225	4	.	.	X
aiua-10711	225	5	heran	heran	PROPN
aiua-10711	225	6	bs	bs	PROPN
aiua-10711	225	7	,	,	PUNCT
aiua-10711	225	8	galm	galm	PROPN
aiua-10711	225	9	bp	bp	PROPN
aiua-10711	225	10	,	,	PUNCT
aiua-10711	225	11	wright	wright	PROPN
aiua-10711	225	12	jm	jm	PROPN
aiua-10711	225	13	.	.	PROPN
aiua-10711	225	14	blood	blood	NOUN
aiua-10711	225	15	pressure	pressure	NOUN
aiua-10711	225	16	lowering	lower	VERB
aiua-10711	225	17	efficacy	efficacy	NOUN
aiua-10711	225	18	of	of	ADP
aiua-10711	225	19	alpha	alpha	NOUN
aiua-10711	225	20	blockers	blocker	NOUN
aiua-10711	225	21	for	for	ADP
aiua-10711	225	22	primary	primary	ADJ
aiua-10711	225	23	hypertension	hypertension	NOUN
aiua-10711	225	24	.	.	PUNCT
aiua-10711	226	1	cochrane	cochrane	PROPN
aiua-10711	226	2	database	database	PROPN
aiua-10711	226	3	syst	syst	PROPN
aiua-10711	226	4	rev	rev	PROPN
aiua-10711	226	5	.	.	PROPN
aiua-10711	226	6	2012	2012	NUM
aiua-10711	226	7	;	;	PUNCT
aiua-10711	226	8	(	(	PUNCT
aiua-10711	226	9	8):cd004643	8):cd004643	NUM
aiua-10711	226	10	.	.	NOUN
aiua-10711	226	11	5	5	NUM
aiua-10711	226	12	.	.	X
aiua-10711	226	13	lepor	lepor	PROPN
aiua-10711	226	14	h.	h.	PROPN
aiua-10711	226	15	alpha	alpha	PROPN
aiua-10711	226	16	-	-	PUNCT
aiua-10711	226	17	blockers	blocker	NOUN
aiua-10711	226	18	for	for	ADP
aiua-10711	226	19	the	the	DET
aiua-10711	226	20	treatment	treatment	NOUN
aiua-10711	226	21	of	of	ADP
aiua-10711	226	22	benign	benign	ADJ
aiua-10711	226	23	prostatic	prostatic	ADJ
aiua-10711	226	24	hyperplasia	hyperplasia	NOUN
aiua-10711	226	25	.	.	PUNCT
aiua-10711	227	1	urol	urol	PROPN
aiua-10711	227	2	clin	clin	PROPN
aiua-10711	227	3	north	north	PROPN
aiua-10711	227	4	am	am	PROPN
aiua-10711	227	5	.	.	PUNCT
aiua-10711	228	1	2016	2016	NUM
aiua-10711	228	2	;	;	PUNCT
aiua-10711	228	3	43:311	43:311	NUM
aiua-10711	228	4	-	-	SYM
aiua-10711	228	5	23	23	NUM
aiua-10711	228	6	.	.	NOUN
aiua-10711	229	1	6	6	NUM
aiua-10711	229	2	.	.	X
aiua-10711	229	3	ishihama	ishihama	PROPN
aiua-10711	229	4	h	h	NOUN
aiua-10711	229	5	,	,	PUNCT
aiua-10711	229	6	momota	momota	PROPN
aiua-10711	229	7	y	y	NOUN
aiua-10711	229	8	,	,	PUNCT
aiua-10711	229	9	yanase	yanase	NOUN
aiua-10711	229	10	h	h	NOUN
aiua-10711	229	11	,	,	PUNCT
aiua-10711	229	12	et	et	PROPN
aiua-10711	229	13	al	al	PROPN
aiua-10711	229	14	.	.	PUNCT
aiua-10711	230	1	activation	activation	NOUN
aiua-10711	230	2	of	of	ADP
aiua-10711	230	3	alpha1d	alpha1d	NOUN
aiua-10711	230	4	adrenergic	adrenergic	ADJ
aiua-10711	230	5	receptors	receptor	NOUN
aiua-10711	230	6	in	in	ADP
aiua-10711	230	7	the	the	DET
aiua-10711	230	8	rat	rat	NOUN
aiua-10711	230	9	urothelium	urothelium	NOUN
aiua-10711	230	10	facilitates	facilitate	VERB
aiua-10711	230	11	the	the	DET
aiua-10711	230	12	micturition	micturition	NOUN
aiua-10711	230	13	reflex	reflex	NOUN
aiua-10711	230	14	.	.	PUNCT
aiua-10711	231	1	j	j	PROPN
aiua-10711	231	2	urol	urol	PROPN
aiua-10711	231	3	.	.	PUNCT
aiua-10711	232	1	2006	2006	NUM
aiua-10711	232	2	;	;	PUNCT
aiua-10711	232	3	175:358	175:358	NOUN
aiua-10711	232	4	-	-	SYM
aiua-10711	232	5	64	64	NUM
aiua-10711	232	6	.	.	PUNCT
aiua-10711	233	1	7	7	X
aiua-10711	233	2	.	.	PUNCT
aiua-10711	234	1	hwang	hwang	PROPN
aiua-10711	234	2	ec	ec	PROPN
aiua-10711	234	3	,	,	PUNCT
aiua-10711	234	4	gandhi	gandhi	PROPN
aiua-10711	234	5	s	s	PROPN
aiua-10711	234	6	,	,	PUNCT
aiua-10711	234	7	jung	jung	PROPN
aiua-10711	234	8	jh	jh	PROPN
aiua-10711	234	9	,	,	PUNCT
aiua-10711	234	10	et	et	PROPN
aiua-10711	234	11	al	al	PROPN
aiua-10711	234	12	.	.	PROPN
aiua-10711	234	13	naftopidil	naftopidil	PROPN
aiua-10711	234	14	for	for	ADP
aiua-10711	234	15	the	the	DET
aiua-10711	234	16	treatment	treatment	NOUN
aiua-10711	234	17	of	of	ADP
aiua-10711	234	18	lower	low	ADJ
aiua-10711	234	19	urinary	urinary	ADJ
aiua-10711	234	20	tract	tract	NOUN
aiua-10711	234	21	symptoms	symptom	NOUN
aiua-10711	234	22	compatible	compatible	ADJ
aiua-10711	234	23	with	with	ADP
aiua-10711	234	24	benign	benign	ADJ
aiua-10711	234	25	prostatic	prostatic	ADJ
aiua-10711	234	26	hyperplasia	hyperplasia	NOUN
aiua-10711	234	27	.	.	PUNCT
aiua-10711	235	1	cochrane	cochrane	PROPN
aiua-10711	235	2	database	database	PROPN
aiua-10711	235	3	syst	syst	PROPN
aiua-10711	235	4	rev	rev	PROPN
aiua-10711	235	5	.	.	PROPN
aiua-10711	235	6	2018	2018	NUM
aiua-10711	235	7	;	;	PUNCT
aiua-10711	235	8	10	10	NUM
aiua-10711	235	9	:	:	PUNCT
aiua-10711	235	10	cd007360	cd007360	NOUN
aiua-10711	235	11	.	.	PUNCT
aiua-10711	236	1	8	8	NUM
aiua-10711	236	2	.	.	PUNCT
aiua-10711	237	1	moher	moher	PROPN
aiua-10711	237	2	d	d	PROPN
aiua-10711	237	3	,	,	PUNCT
aiua-10711	237	4	liberati	liberati	PROPN
aiua-10711	237	5	a	a	PRON
aiua-10711	237	6	,	,	PUNCT
aiua-10711	237	7	tetzlaff	tetzlaff	PROPN
aiua-10711	237	8	j	j	PROPN
aiua-10711	237	9	,	,	PUNCT
aiua-10711	237	10	et	et	PROPN
aiua-10711	237	11	al	al	PROPN
aiua-10711	237	12	.	.	PROPN
aiua-10711	237	13	preferred	preferred	ADJ
aiua-10711	237	14	reporting	reporting	NOUN
aiua-10711	237	15	items	item	NOUN
aiua-10711	237	16	for	for	ADP
aiua-10711	237	17	systematic	systematic	ADJ
aiua-10711	237	18	reviews	review	NOUN
aiua-10711	237	19	and	and	CCONJ
aiua-10711	237	20	meta	meta	NOUN
aiua-10711	237	21	-	-	PUNCT
aiua-10711	237	22	analyses	analysis	NOUN
aiua-10711	237	23	:	:	PUNCT
aiua-10711	237	24	the	the	DET
aiua-10711	237	25	prisma	prisma	PROPN
aiua-10711	237	26	statement	statement	NOUN
aiua-10711	237	27	.	.	PUNCT
aiua-10711	238	1	plos	plos	PROPN
aiua-10711	238	2	med	med	PROPN
aiua-10711	238	3	.	.	PROPN
aiua-10711	238	4	2009	2009	NUM
aiua-10711	238	5	;	;	PUNCT
aiua-10711	238	6	6	6	NUM
aiua-10711	238	7	:	:	SYM
aiua-10711	238	8	e1000097	e1000097	PROPN
aiua-10711	238	9	.	.	PROPN
aiua-10711	238	10	9	9	NUM
aiua-10711	238	11	.	.	PUNCT
aiua-10711	239	1	sterne	sterne	PROPN
aiua-10711	239	2	jac	jac	PROPN
aiua-10711	239	3	,	,	PUNCT
aiua-10711	239	4	savovic	savovic	PROPN
aiua-10711	239	5	j	j	PROPN
aiua-10711	239	6	,	,	PUNCT
aiua-10711	239	7	page	page	NOUN
aiua-10711	239	8	mj	mj	PROPN
aiua-10711	239	9	,	,	PUNCT
aiua-10711	239	10	et	et	PROPN
aiua-10711	239	11	al	al	PROPN
aiua-10711	239	12	.	.	PROPN
aiua-10711	239	13	rob	rob	PROPN
aiua-10711	240	1	2	2	NUM
aiua-10711	240	2	:	:	PUNCT
aiua-10711	240	3	a	a	DET
aiua-10711	240	4	revised	revise	VERB
aiua-10711	240	5	tool	tool	NOUN
aiua-10711	240	6	for	for	ADP
aiua-10711	240	7	assessing	assess	VERB
aiua-10711	240	8	risk	risk	NOUN
aiua-10711	240	9	of	of	ADP
aiua-10711	240	10	bias	bias	NOUN
aiua-10711	240	11	in	in	ADP
aiua-10711	240	12	randomised	randomised	ADJ
aiua-10711	240	13	trials	trial	NOUN
aiua-10711	240	14	.	.	PUNCT
aiua-10711	241	1	bmj	bmj	PROPN
aiua-10711	241	2	2019	2019	NUM
aiua-10711	241	3	;	;	PUNCT
aiua-10711	241	4	366	366	NUM
aiua-10711	241	5	:	:	PUNCT
aiua-10711	241	6	l4898	l4898	ADJ
aiua-10711	241	7	.	.	PUNCT
aiua-10711	242	1	10	10	NUM
aiua-10711	242	2	.	.	PUNCT
aiua-10711	242	3	chapple	chapple	PROPN
aiua-10711	242	4	cr	cr	PROPN
aiua-10711	242	5	,	,	PUNCT
aiua-10711	242	6	al	al	PROPN
aiua-10711	242	7	-	-	PUNCT
aiua-10711	242	8	shukri	shukri	NOUN
aiua-10711	242	9	sh	sh	PROPN
aiua-10711	242	10	,	,	PUNCT
aiua-10711	242	11	gattegno	gattegno	PROPN
aiua-10711	242	12	b	b	PROPN
aiua-10711	242	13	,	,	PUNCT
aiua-10711	242	14	et	et	PROPN
aiua-10711	242	15	al	al	PROPN
aiua-10711	242	16	.	.	PROPN
aiua-10711	242	17	tamsulosin	tamsulosin	PROPN
aiua-10711	242	18	oral	oral	PROPN
aiua-10711	242	19	controlled	control	VERB
aiua-10711	242	20	absorption	absorption	NOUN
aiua-10711	242	21	system	system	NOUN
aiua-10711	242	22	(	(	PUNCT
aiua-10711	242	23	ocas	ocas	PROPN
aiua-10711	242	24	)	)	PUNCT
aiua-10711	242	25	in	in	ADP
aiua-10711	242	26	patients	patient	NOUN
aiua-10711	242	27	with	with	ADP
aiua-10711	242	28	lower	low	ADJ
aiua-10711	242	29	urinary	urinary	ADJ
aiua-10711	242	30	tract	tract	NOUN
aiua-10711	242	31	symptoms	symptom	NOUN
aiua-10711	242	32	suggestive	suggestive	ADJ
aiua-10711	242	33	of	of	ADP
aiua-10711	242	34	benign	benign	ADJ
aiua-10711	242	35	prostatic	prostatic	ADJ
aiua-10711	242	36	hyperplasia	hyperplasia	NOUN
aiua-10711	242	37	(	(	PUNCT
aiua-10711	242	38	luts	luts	PROPN
aiua-10711	242	39	/	/	SYM
aiua-10711	242	40	bph	bph	PROPN
aiua-10711	242	41	):	):	PUNCT
aiua-10711	242	42	efficacy	efficacy	NOUN
aiua-10711	242	43	and	and	CCONJ
aiua-10711	242	44	tolerability	tolerability	NOUN
aiua-10711	242	45	in	in	ADP
aiua-10711	242	46	a	a	DET
aiua-10711	242	47	placebo	placebo	NOUN
aiua-10711	242	48	and	and	CCONJ
aiua-10711	242	49	active	active	ADJ
aiua-10711	242	50	comparator	comparator	NOUN
aiua-10711	242	51	controlled	control	VERB
aiua-10711	242	52	phase	phase	NOUN
aiua-10711	242	53	3a	3a	NUM
aiua-10711	242	54	study	study	VERB
aiua-10711	242	55	eur	eur	PROPN
aiua-10711	242	56	urol	urol	PROPN
aiua-10711	242	57	.	.	PUNCT
aiua-10711	243	1	(	(	PUNCT
aiua-10711	243	2	supplements	supplement	NOUN
aiua-10711	243	3	)	)	PUNCT
aiua-10711	243	4	2005	2005	NUM
aiua-10711	243	5	;	;	PUNCT
aiua-10711	243	6	4:33	4:33	NUM
aiua-10711	243	7	-	-	SYM
aiua-10711	243	8	44	44	NUM
aiua-10711	243	9	.	.	PUNCT
aiua-10711	243	10	11	11	NUM
aiua-10711	243	11	.	.	PUNCT
aiua-10711	244	1	chapple	chapple	PROPN
aiua-10711	244	2	cr	cr	PROPN
aiua-10711	244	3	,	,	PUNCT
aiua-10711	244	4	montorsi	montorsi	NOUN
aiua-10711	244	5	f	f	NOUN
aiua-10711	244	6	,	,	PUNCT
aiua-10711	244	7	tammela	tammela	PROPN
aiua-10711	244	8	tl	tl	PROPN
aiua-10711	244	9	,	,	PUNCT
aiua-10711	244	10	et	et	PROPN
aiua-10711	244	11	al	al	PROPN
aiua-10711	244	12	.	.	PROPN
aiua-10711	244	13	european	european	PROPN
aiua-10711	244	14	silodosin	silodosin	PROPN
aiua-10711	244	15	study	study	PROPN
aiua-10711	244	16	group	group	NOUN
aiua-10711	244	17	.	.	PUNCT
aiua-10711	245	1	silodosin	silodosin	NOUN
aiua-10711	245	2	therapy	therapy	NOUN
aiua-10711	245	3	for	for	ADP
aiua-10711	245	4	lower	low	ADJ
aiua-10711	245	5	urinary	urinary	ADJ
aiua-10711	245	6	tract	tract	NOUN
aiua-10711	245	7	symptoms	symptom	NOUN
aiua-10711	245	8	in	in	ADP
aiua-10711	245	9	men	man	NOUN
aiua-10711	245	10	with	with	ADP
aiua-10711	245	11	suspected	suspect	VERB
aiua-10711	245	12	benign	benign	ADJ
aiua-10711	245	13	prostatic	prostatic	ADJ
aiua-10711	245	14	hyperplasia	hyperplasia	NOUN
aiua-10711	245	15	:	:	PUNCT
aiua-10711	245	16	results	result	NOUN
aiua-10711	245	17	of	of	ADP
aiua-10711	245	18	an	an	DET
aiua-10711	245	19	international	international	ADJ
aiua-10711	245	20	,	,	PUNCT
aiua-10711	245	21	randomized	randomize	VERB
aiua-10711	245	22	,	,	PUNCT
aiua-10711	245	23	double	double	ADJ
aiua-10711	245	24	-	-	PUNCT
aiua-10711	245	25	blind	blind	ADJ
aiua-10711	245	26	,	,	PUNCT
aiua-10711	245	27	placeboand	placeboand	VERB
aiua-10711	245	28	active	active	ADV
aiua-10711	245	29	-	-	PUNCT
aiua-10711	245	30	controlled	control	VERB
aiua-10711	245	31	clinical	clinical	ADJ
aiua-10711	245	32	trial	trial	NOUN
aiua-10711	245	33	performed	perform	VERB
aiua-10711	245	34	in	in	ADP
aiua-10711	245	35	europe	europe	PROPN
aiua-10711	245	36	.	.	PUNCT
aiua-10711	246	1	eur	eur	PROPN
aiua-10711	246	2	urol	urol	PROPN
aiua-10711	246	3	.	.	PUNCT
aiua-10711	247	1	2011	2011	NUM
aiua-10711	247	2	;	;	PUNCT
aiua-10711	247	3	59:342	59:342	NUM
aiua-10711	247	4	-	-	SYM
aiua-10711	247	5	52	52	NUM
aiua-10711	247	6	.	.	PUNCT
aiua-10711	248	1	12	12	NUM
aiua-10711	248	2	.	.	PUNCT
aiua-10711	249	1	homma	homma	PROPN
aiua-10711	249	2	y	y	PROPN
aiua-10711	249	3	,	,	PUNCT
aiua-10711	249	4	kawabe	kawabe	PROPN
aiua-10711	249	5	k	k	PROPN
aiua-10711	249	6	,	,	PUNCT
aiua-10711	249	7	takeda	takeda	PROPN
aiua-10711	249	8	m	m	PROPN
aiua-10711	249	9	,	,	PUNCT
aiua-10711	249	10	yoshida	yoshida	PROPN
aiua-10711	249	11	m.	m.	PROPN
aiua-10711	249	12	ejaculation	ejaculation	NOUN
aiua-10711	249	13	disorder	disorder	NOUN
aiua-10711	249	14	is	be	AUX
aiua-10711	249	15	associated	associate	VERB
aiua-10711	249	16	with	with	ADP
aiua-10711	249	17	increased	increase	VERB
aiua-10711	249	18	efficacy	efficacy	NOUN
aiua-10711	249	19	of	of	ADP
aiua-10711	249	20	silodosin	silodosin	NOUN
aiua-10711	249	21	for	for	ADP
aiua-10711	249	22	benign	benign	ADJ
aiua-10711	249	23	prostatic	prostatic	ADJ
aiua-10711	249	24	hyperplasia	hyperplasia	NOUN
aiua-10711	249	25	.	.	PUNCT
aiua-10711	250	1	urology	urology	NOUN
aiua-10711	250	2	2010	2010	NUM
aiua-10711	250	3	;	;	PUNCT
aiua-10711	250	4	76:1446	76:1446	NOUN
aiua-10711	250	5	-	-	SYM
aiua-10711	250	6	1450	1450	NUM
aiua-10711	250	7	.	.	PUNCT
aiua-10711	251	1	13	13	NUM
aiua-10711	251	2	.	.	PUNCT
aiua-10711	252	1	kawabe	kawabe	PROPN
aiua-10711	252	2	k	k	PROPN
aiua-10711	252	3	,	,	PUNCT
aiua-10711	252	4	yoshida	yoshida	PROPN
aiua-10711	252	5	m	m	PROPN
aiua-10711	252	6	,	,	PUNCT
aiua-10711	252	7	homma	homma	PROPN
aiua-10711	252	8	y	y	PROPN
aiua-10711	252	9	,	,	PUNCT
aiua-10711	252	10	silodosin	silodosin	VERB
aiua-10711	252	11	clinical	clinical	ADJ
aiua-10711	252	12	study	study	NOUN
aiua-10711	252	13	group	group	NOUN
aiua-10711	252	14	.	.	PUNCT
aiua-10711	253	1	silodosin	silodosin	PROPN
aiua-10711	253	2	,	,	PUNCT
aiua-10711	253	3	a	a	DET
aiua-10711	253	4	new	new	ADJ
aiua-10711	253	5	alpha1a	alpha1a	NOUN
aiua-10711	253	6	-	-	PUNCT
aiua-10711	253	7	adrenoceptor	adrenoceptor	NOUN
aiua-10711	253	8	-	-	PUNCT
aiua-10711	253	9	selective	selective	ADJ
aiua-10711	253	10	antagonist	antagonist	NOUN
aiua-10711	253	11	for	for	ADP
aiua-10711	253	12	treating	treat	VERB
aiua-10711	253	13	benign	benign	ADJ
aiua-10711	253	14	prostatic	prostatic	ADJ
aiua-10711	253	15	hyperplasia	hyperplasia	NOUN
aiua-10711	253	16	:	:	PUNCT
aiua-10711	253	17	results	result	NOUN
aiua-10711	253	18	of	of	ADP
aiua-10711	253	19	a	a	DET
aiua-10711	253	20	phase	phase	NOUN
aiua-10711	253	21	iii	iii	NOUN
aiua-10711	253	22	randomized	randomize	VERB
aiua-10711	253	23	,	,	PUNCT
aiua-10711	253	24	placebo	placebo	NOUN
aiua-10711	253	25	-	-	PUNCT
aiua-10711	253	26	controlled	control	VERB
aiua-10711	253	27	,	,	PUNCT
aiua-10711	253	28	double	double	ADJ
aiua-10711	253	29	-	-	PUNCT
aiua-10711	253	30	blind	blind	ADJ
aiua-10711	253	31	study	study	NOUN
aiua-10711	253	32	in	in	ADP
aiua-10711	253	33	japanese	japanese	ADJ
aiua-10711	253	34	men	man	NOUN
aiua-10711	253	35	.	.	PUNCT
aiua-10711	254	1	bju	bju	NOUN
aiua-10711	254	2	int	int	PROPN
aiua-10711	254	3	.	.	PUNCT
aiua-10711	255	1	2006	2006	NUM
aiua-10711	255	2	;	;	PUNCT
aiua-10711	255	3	98:1019	98:1019	NUM
aiua-10711	255	4	-	-	SYM
aiua-10711	255	5	24	24	NUM
aiua-10711	255	6	.	.	PUNCT
aiua-10711	256	1	14	14	NUM
aiua-10711	256	2	.	.	PUNCT
aiua-10711	257	1	lepor	lepor	PROPN
aiua-10711	257	2	h.	h.	PROPN
aiua-10711	257	3	phase	phase	PROPN
aiua-10711	257	4	iii	iii	NUM
aiua-10711	257	5	multicenter	multicenter	NOUN
aiua-10711	257	6	placebo	placebo	NOUN
aiua-10711	257	7	-	-	PUNCT
aiua-10711	257	8	controlled	control	VERB
aiua-10711	257	9	study	study	NOUN
aiua-10711	257	10	of	of	ADP
aiua-10711	257	11	tamsulosin	tamsulosin	NOUN
aiua-10711	257	12	in	in	ADP
aiua-10711	257	13	benign	benign	ADJ
aiua-10711	257	14	prostatic	prostatic	ADJ
aiua-10711	257	15	hyperplasia	hyperplasia	NOUN
aiua-10711	257	16	.	.	PUNCT
aiua-10711	258	1	tamsulosin	tamsulosin	NOUN
aiua-10711	258	2	investigator	investigator	NOUN
aiua-10711	258	3	group	group	NOUN
aiua-10711	258	4	.	.	PUNCT
aiua-10711	259	1	urology	urology	NOUN
aiua-10711	259	2	.	.	PUNCT
aiua-10711	260	1	1998	1998	NUM
aiua-10711	260	2	;	;	PUNCT
aiua-10711	260	3	51:892	51:892	NUM
aiua-10711	260	4	-	-	SYM
aiua-10711	260	5	900	900	NUM
aiua-10711	260	6	.	.	PUNCT
aiua-10711	261	1	15	15	NUM
aiua-10711	261	2	.	.	PUNCT
aiua-10711	262	1	marks	marks	PROPN
aiua-10711	262	2	ls	ls	PROPN
aiua-10711	262	3	,	,	PUNCT
aiua-10711	262	4	gittelman	gittelman	PROPN
aiua-10711	262	5	mc	mc	PROPN
aiua-10711	262	6	,	,	PUNCT
aiua-10711	262	7	hill	hill	PROPN
aiua-10711	262	8	la	la	PROPN
aiua-10711	262	9	,	,	PUNCT
aiua-10711	262	10	et	et	PROPN
aiua-10711	262	11	al	al	PROPN
aiua-10711	262	12	.	.	PROPN
aiua-10711	263	1	rapid	rapid	ADJ
aiua-10711	263	2	efficacy	efficacy	NOUN
aiua-10711	263	3	of	of	ADP
aiua-10711	263	4	the	the	DET
aiua-10711	263	5	highly	highly	ADV
aiua-10711	263	6	selective	selective	ADJ
aiua-10711	263	7	alpha(1a)-adrenoceptor	alpha(1a)-adrenoceptor	NOUN
aiua-10711	263	8	antagonist	antagonist	NOUN
aiua-10711	263	9	silodosin	silodosin	NOUN
aiua-10711	263	10	in	in	ADP
aiua-10711	263	11	men	man	NOUN
aiua-10711	263	12	with	with	ADP
aiua-10711	263	13	signs	sign	NOUN
aiua-10711	263	14	and	and	CCONJ
aiua-10711	263	15	symptoms	symptom	NOUN
aiua-10711	263	16	of	of	ADP
aiua-10711	263	17	benign	benign	ADJ
aiua-10711	263	18	prostatic	prostatic	ADJ
aiua-10711	263	19	hyperplasia	hyperplasia	NOUN
aiua-10711	263	20	:	:	PUNCT
aiua-10711	263	21	pooled	pool	VERB
aiua-10711	263	22	results	result	NOUN
aiua-10711	263	23	of	of	ADP
aiua-10711	263	24	2	2	NUM
aiua-10711	263	25	phase	phase	NOUN
aiua-10711	263	26	3	3	NUM
aiua-10711	263	27	studies	study	NOUN
aiua-10711	263	28	.	.	PUNCT
aiua-10711	264	1	j	j	PROPN
aiua-10711	264	2	urol	urol	PROPN
aiua-10711	264	3	.	.	PUNCT
aiua-10711	265	1	2013	2013	NUM
aiua-10711	265	2	;	;	PUNCT
aiua-10711	265	3	189(1	189(1	NUM
aiua-10711	265	4	suppl):s122	suppl):s122	NOUN
aiua-10711	265	5	-	-	PUNCT
aiua-10711	265	6	8	8	NUM
aiua-10711	265	7	.	.	PUNCT
aiua-10711	266	1	16	16	NUM
aiua-10711	266	2	.	.	PUNCT
aiua-10711	267	1	mehik	mehik	PROPN
aiua-10711	267	2	a	a	PRON
aiua-10711	267	3	,	,	PUNCT
aiua-10711	267	4	alas	alas	INTJ
aiua-10711	267	5	p	p	X
aiua-10711	267	6	,	,	PUNCT
aiua-10711	267	7	nickel	nickel	PROPN
aiua-10711	267	8	jc	jc	PROPN
aiua-10711	267	9	,	,	PUNCT
aiua-10711	267	10	et	et	PROPN
aiua-10711	267	11	al	al	PROPN
aiua-10711	267	12	.	.	PROPN
aiua-10711	267	13	alfuzosin	alfuzosin	PROPN
aiua-10711	267	14	treatment	treatment	NOUN
aiua-10711	267	15	for	for	ADP
aiua-10711	267	16	chronic	chronic	ADJ
aiua-10711	267	17	prostatitis	prostatitis	NOUN
aiua-10711	267	18	/	/	SYM
aiua-10711	267	19	chronic	chronic	ADJ
aiua-10711	267	20	pelvic	pelvic	ADJ
aiua-10711	267	21	pain	pain	NOUN
aiua-10711	267	22	syndrome	syndrome	NOUN
aiua-10711	267	23	:	:	PUNCT
aiua-10711	267	24	a	a	DET
aiua-10711	267	25	prospective	prospective	ADJ
aiua-10711	267	26	,	,	PUNCT
aiua-10711	267	27	randomized	randomize	VERB
aiua-10711	267	28	,	,	PUNCT
aiua-10711	267	29	double	double	ADJ
aiua-10711	267	30	-	-	PUNCT
aiua-10711	267	31	blind	blind	ADJ
aiua-10711	267	32	,	,	PUNCT
aiua-10711	267	33	placebo	placebo	NOUN
aiua-10711	267	34	-	-	PUNCT
aiua-10711	267	35	controlled	control	VERB
aiua-10711	267	36	,	,	PUNCT
aiua-10711	267	37	pilot	pilot	NOUN
aiua-10711	267	38	study	study	NOUN
aiua-10711	267	39	.	.	PUNCT
aiua-10711	268	1	urology	urology	NOUN
aiua-10711	268	2	.	.	PUNCT
aiua-10711	269	1	2003	2003	NUM
aiua-10711	269	2	;	;	PUNCT
aiua-10711	269	3	62:425	62:425	NUM
aiua-10711	269	4	-	-	SYM
aiua-10711	269	5	9	9	NUM
aiua-10711	269	6	.	.	NOUN
aiua-10711	269	7	17	17	NUM
aiua-10711	269	8	.	.	PUNCT
aiua-10711	270	1	mohanty	mohanty	PROPN
aiua-10711	270	2	nk	nk	PROPN
aiua-10711	270	3	,	,	PUNCT
aiua-10711	270	4	nayak	nayak	PROPN
aiua-10711	270	5	rl	rl	PROPN
aiua-10711	270	6	,	,	PUNCT
aiua-10711	270	7	malhotra	malhotra	PROPN
aiua-10711	270	8	v	v	PROPN
aiua-10711	270	9	,	,	PUNCT
aiua-10711	270	10	arora	arora	PROPN
aiua-10711	270	11	rp	rp	PROPN
aiua-10711	270	12	.	.	PUNCT
aiua-10711	271	1	a	a	DET
aiua-10711	271	2	double	double	ADJ
aiua-10711	271	3	-	-	PUNCT
aiua-10711	271	4	blind	blind	ADJ
aiua-10711	271	5	placebo	placebo	NOUN
aiua-10711	271	6	controlled	control	VERB
aiua-10711	271	7	study	study	NOUN
aiua-10711	271	8	of	of	ADP
aiua-10711	271	9	tamsulosin	tamsulosin	NOUN
aiua-10711	271	10	in	in	ADP
aiua-10711	271	11	the	the	DET
aiua-10711	271	12	management	management	NOUN
aiua-10711	271	13	of	of	ADP
aiua-10711	271	14	benign	benign	ADJ
aiua-10711	271	15	prostatic	prostatic	ADJ
aiua-10711	271	16	hyperplasia	hyperplasia	NOUN
aiua-10711	271	17	in	in	ADP
aiua-10711	271	18	an	an	DET
aiua-10711	271	19	indian	indian	ADJ
aiua-10711	271	20	population	population	NOUN
aiua-10711	271	21	.	.	PUNCT
aiua-10711	272	1	ann	ann	PROPN
aiua-10711	272	2	college	college	PROPN
aiua-10711	272	3	of	of	ADP
aiua-10711	272	4	surgeons	surgeon	NOUN
aiua-10711	272	5	of	of	ADP
aiua-10711	272	6	hong	hong	PROPN
aiua-10711	272	7	kong	kong	PROPN
aiua-10711	272	8	.	.	PUNCT
aiua-10711	273	1	2003	2003	NUM
aiua-10711	273	2	;	;	PUNCT
aiua-10711	273	3	7:88	7:88	NUM
aiua-10711	273	4	-	-	SYM
aiua-10711	273	5	93	93	NUM
aiua-10711	273	6	.	.	PUNCT
aiua-10711	274	1	18	18	NUM
aiua-10711	274	2	.	.	PUNCT
aiua-10711	275	1	roehrborn	roehrborn	ADJ
aiua-10711	275	2	cg	cg	PROPN
aiua-10711	275	3	,	,	PUNCT
aiua-10711	275	4	kaplan	kaplan	PROPN
aiua-10711	275	5	sa	sa	PROPN
aiua-10711	275	6	,	,	PUNCT
aiua-10711	275	7	lepor	lepor	ADJ
aiua-10711	275	8	h	h	NOUN
aiua-10711	275	9	,	,	PUNCT
aiua-10711	275	10	volinn	volinn	PROPN
aiua-10711	275	11	w.	w.	PROPN
aiua-10711	275	12	symptomatic	symptomatic	ADJ
aiua-10711	275	13	and	and	CCONJ
aiua-10711	275	14	urodynamic	urodynamic	ADJ
aiua-10711	275	15	responses	response	NOUN
aiua-10711	275	16	in	in	ADP
aiua-10711	275	17	patients	patient	NOUN
aiua-10711	275	18	with	with	ADP
aiua-10711	275	19	reduced	reduced	ADJ
aiua-10711	275	20	or	or	CCONJ
aiua-10711	275	21	no	no	DET
aiua-10711	275	22	seminal	seminal	ADJ
aiua-10711	275	23	emission	emission	NOUN
aiua-10711	275	24	during	during	ADP
aiua-10711	275	25	silodosin	silodosin	ADJ
aiua-10711	275	26	treatment	treatment	NOUN
aiua-10711	275	27	for	for	ADP
aiua-10711	275	28	luts	luts	PROPN
aiua-10711	275	29	and	and	CCONJ
aiua-10711	275	30	bph	bph	NOUN
aiua-10711	275	31	.	.	PUNCT
aiua-10711	276	1	prostate	prostate	NOUN
aiua-10711	276	2	cancer	cancer	NOUN
aiua-10711	276	3	prostatic	prostatic	ADJ
aiua-10711	276	4	dis	dis	PROPN
aiua-10711	276	5	.	.	PUNCT
aiua-10711	277	1	2011	2011	NUM
aiua-10711	277	2	;	;	PUNCT
aiua-10711	277	3	14:143	14:143	NUM
aiua-10711	277	4	-	-	SYM
aiua-10711	277	5	8	8	NUM
aiua-10711	277	6	.	.	NOUN
aiua-10711	277	7	19	19	NUM
aiua-10711	277	8	.	.	PUNCT
aiua-10711	278	1	singh	singh	PROPN
aiua-10711	278	2	p	p	PROPN
aiua-10711	278	3	,	,	PUNCT
aiua-10711	278	4	singh	singh	PROPN
aiua-10711	278	5	a	a	X
aiua-10711	278	6	,	,	PUNCT
aiua-10711	278	7	indurkar	indurkar	PROPN
aiua-10711	278	8	m	m	PROPN
aiua-10711	278	9	,	,	PUNCT
aiua-10711	278	10	raj	raj	PROPN
aiua-10711	278	11	b.	b.	PROPN
aiua-10711	278	12	efficacy	efficacy	PROPN
aiua-10711	278	13	and	and	CCONJ
aiua-10711	278	14	safety	safety	NOUN
aiua-10711	278	15	of	of	ADP
aiua-10711	278	16	tamsulosin	tamsulosin	NOUN
aiua-10711	278	17	(	(	PUNCT
aiua-10711	278	18	0.4	0.4	NUM
aiua-10711	278	19	mg	mg	NOUN
aiua-10711	278	20	)	)	PUNCT
aiua-10711	278	21	once	once	ADV
aiua-10711	278	22	daily	daily	ADV
aiua-10711	278	23	for	for	ADP
aiua-10711	278	24	treating	treat	VERB
aiua-10711	278	25	symptomatic	symptomatic	ADJ
aiua-10711	278	26	benign	benign	ADJ
aiua-10711	278	27	prostatic	prostatic	NOUN
aiua-10711	278	28	261archivio	261archivio	PROPN
aiua-10711	278	29	italiano	italiano	NOUN
aiua-10711	278	30	di	di	X
aiua-10711	278	31	urologia	urologia	PROPN
aiua-10711	278	32	e	e	PROPN
aiua-10711	278	33	andrologia	andrologia	PROPN
aiua-10711	278	34	2022	2022	NUM
aiua-10711	278	35	;	;	PUNCT
aiua-10711	278	36	94	94	NUM
aiua-10711	278	37	,	,	PUNCT
aiua-10711	278	38	2	2	NUM
aiua-10711	278	39	sexual	sexual	ADJ
aiua-10711	278	40	function	function	NOUN
aiua-10711	278	41	and	and	CCONJ
aiua-10711	278	42	alpha	alpha	NOUN
aiua-10711	278	43	-	-	PUNCT
aiua-10711	278	44	blockers	blocker	NOUN
aiua-10711	278	45	hyperplasia	hyperplasia	NOUN
aiua-10711	278	46	.	.	PUNCT
aiua-10711	279	1	asian	asian	ADJ
aiua-10711	279	2	journal	journal	PROPN
aiua-10711	279	3	of	of	ADP
aiua-10711	279	4	pharmaceutical	pharmaceutical	NOUN
aiua-10711	279	5	and	and	CCONJ
aiua-10711	279	6	clinical	clinical	ADJ
aiua-10711	279	7	research	research	NOUN
aiua-10711	279	8	2012	2012	NUM
aiua-10711	279	9	;	;	PUNCT
aiua-10711	279	10	5(suppl	5(suppl	PROPN
aiua-10711	279	11	4):87	4):87	PROPN
aiua-10711	279	12	-	-	PUNCT
aiua-10711	279	13	91	91	NUM
aiua-10711	279	14	.	.	PUNCT
aiua-10711	279	15	20	20	NUM
aiua-10711	279	16	.	.	PUNCT
aiua-10711	280	1	al	al	PROPN
aiua-10711	280	2	-	-	PUNCT
aiua-10711	280	3	ansari	ansari	PROPN
aiua-10711	280	4	a	a	PROPN
aiua-10711	280	5	,	,	PUNCT
aiua-10711	280	6	al	al	PROPN
aiua-10711	280	7	-	-	PROPN
aiua-10711	280	8	naimi	naimi	PROPN
aiua-10711	280	9	a	a	PROPN
aiua-10711	280	10	,	,	PUNCT
aiua-10711	280	11	alobaidy	alobaidy	ADJ
aiua-10711	280	12	a	a	DET
aiua-10711	280	13	,	,	PUNCT
aiua-10711	280	14	et	et	PROPN
aiua-10711	280	15	al	al	PROPN
aiua-10711	280	16	.	.	PROPN
aiua-10711	280	17	efficacy	efficacy	NOUN
aiua-10711	280	18	of	of	ADP
aiua-10711	280	19	tamsulosin	tamsulosin	NOUN
aiua-10711	280	20	in	in	ADP
aiua-10711	280	21	the	the	DET
aiua-10711	280	22	management	management	NOUN
aiua-10711	280	23	of	of	ADP
aiua-10711	280	24	lower	low	ADJ
aiua-10711	280	25	ureteral	ureteral	ADJ
aiua-10711	280	26	stones	stone	NOUN
aiua-10711	280	27	:	:	PUNCT
aiua-10711	280	28	a	a	DET
aiua-10711	280	29	randomized	randomized	ADJ
aiua-10711	280	30	double	double	ADJ
aiua-10711	280	31	-	-	PUNCT
aiua-10711	280	32	blind	blind	ADJ
aiua-10711	280	33	placebo	placebo	NOUN
aiua-10711	280	34	-	-	PUNCT
aiua-10711	280	35	controlled	control	VERB
aiua-10711	280	36	study	study	NOUN
aiua-10711	280	37	of	of	ADP
aiua-10711	280	38	100	100	NUM
aiua-10711	280	39	patients	patient	NOUN
aiua-10711	280	40	urology	urology	NOUN
aiua-10711	280	41	.	.	PUNCT
aiua-10711	281	1	2010	2010	NUM
aiua-10711	281	2	;	;	PUNCT
aiua-10711	281	3	75:4	75:4	X
aiua-10711	281	4	-	-	SYM
aiua-10711	281	5	7	7	NUM
aiua-10711	281	6	.	.	NUM
aiua-10711	281	7	21	21	NUM
aiua-10711	281	8	.	.	PUNCT
aiua-10711	282	1	meltzer	meltzer	PROPN
aiua-10711	282	2	ac	ac	PROPN
aiua-10711	282	3	,	,	PUNCT
aiua-10711	282	4	burrows	burrow	NOUN
aiua-10711	282	5	pk	pk	PROPN
aiua-10711	282	6	,	,	PUNCT
aiua-10711	282	7	wolfson	wolfson	PROPN
aiua-10711	282	8	ab	ab	PROPN
aiua-10711	282	9	,	,	PUNCT
aiua-10711	282	10	et	et	PROPN
aiua-10711	282	11	al	al	PROPN
aiua-10711	282	12	.	.	PROPN
aiua-10711	282	13	effect	effect	NOUN
aiua-10711	282	14	of	of	ADP
aiua-10711	282	15	tamsulosin	tamsulosin	NOUN
aiua-10711	282	16	on	on	ADP
aiua-10711	282	17	passage	passage	NOUN
aiua-10711	282	18	of	of	ADP
aiua-10711	282	19	symptomatic	symptomatic	ADJ
aiua-10711	282	20	ureteral	ureteral	ADJ
aiua-10711	282	21	stones	stone	NOUN
aiua-10711	282	22	:	:	PUNCT
aiua-10711	282	23	a	a	DET
aiua-10711	282	24	randomized	randomized	ADJ
aiua-10711	282	25	clinical	clinical	ADJ
aiua-10711	282	26	trial	trial	NOUN
aiua-10711	282	27	jama	jama	PROPN
aiua-10711	282	28	intern	intern	NOUN
aiua-10711	282	29	med	me	VERB
aiua-10711	282	30	.	.	PROPN
aiua-10711	282	31	2018	2018	NUM
aiua-10711	282	32	;	;	PUNCT
aiua-10711	282	33	178:1051	178:1051	NUM
aiua-10711	282	34	-	-	NOUN
aiua-10711	282	35	1057	1057	NUM
aiua-10711	282	36	.	.	PUNCT
aiua-10711	283	1	22	22	NUM
aiua-10711	283	2	.	.	PUNCT
aiua-10711	284	1	singh	singh	PROPN
aiua-10711	284	2	i	i	PRON
aiua-10711	284	3	,	,	PUNCT
aiua-10711	284	4	tripathy	tripathy	PROPN
aiua-10711	284	5	s	s	PROPN
aiua-10711	284	6	,	,	PUNCT
aiua-10711	284	7	agrawal	agrawal	PROPN
aiua-10711	284	8	v.	v.	CCONJ
aiua-10711	284	9	efficacy	efficacy	NOUN
aiua-10711	284	10	of	of	ADP
aiua-10711	284	11	tamsulosin	tamsulosin	NOUN
aiua-10711	284	12	hydrochloride	hydrochloride	NOUN
aiua-10711	284	13	in	in	ADP
aiua-10711	284	14	relieving	relieve	VERB
aiua-10711	284	15	"	"	PUNCT
aiua-10711	284	16	double	double	ADJ
aiua-10711	284	17	-	-	PUNCT
aiua-10711	284	18	j	j	NOUN
aiua-10711	284	19	ureteral	ureteral	ADJ
aiua-10711	284	20	stent	stent	NOUN
aiua-10711	284	21	-	-	PUNCT
aiua-10711	284	22	related	relate	VERB
aiua-10711	284	23	morbidity	morbidity	NOUN
aiua-10711	284	24	"	"	PUNCT
aiua-10711	284	25	:	:	PUNCT
aiua-10711	284	26	a	a	DET
aiua-10711	284	27	randomized	randomized	ADJ
aiua-10711	284	28	placebo	placebo	NOUN
aiua-10711	284	29	controlled	control	VERB
aiua-10711	284	30	clinical	clinical	ADJ
aiua-10711	284	31	study	study	NOUN
aiua-10711	284	32	.	.	PUNCT
aiua-10711	285	1	int	int	PROPN
aiua-10711	285	2	urol	urol	ADJ
aiua-10711	285	3	nephrol	nephrol	NOUN
aiua-10711	285	4	.	.	PUNCT
aiua-10711	286	1	2014	2014	NUM
aiua-10711	286	2	;	;	PUNCT
aiua-10711	286	3	46:2279	46:2279	NUM
aiua-10711	286	4	-	-	SYM
aiua-10711	286	5	83	83	NUM
aiua-10711	286	6	.	.	PUNCT
aiua-10711	287	1	23	23	NUM
aiua-10711	287	2	.	.	PUNCT
aiua-10711	287	3	sur	sur	PROPN
aiua-10711	287	4	rl	rl	PROPN
aiua-10711	287	5	,	,	PUNCT
aiua-10711	287	6	shore	shore	NOUN
aiua-10711	287	7	n	n	CCONJ
aiua-10711	287	8	,	,	PUNCT
aiua-10711	287	9	l'esperance	l'esperance	PROPN
aiua-10711	287	10	j	j	PROPN
aiua-10711	287	11	,	,	PUNCT
aiua-10711	287	12	et	et	PROPN
aiua-10711	287	13	al	al	PROPN
aiua-10711	287	14	.	.	PROPN
aiua-10711	287	15	silodosin	silodosin	PROPN
aiua-10711	287	16	to	to	PART
aiua-10711	287	17	facilitate	facilitate	VERB
aiua-10711	287	18	passage	passage	NOUN
aiua-10711	287	19	of	of	ADP
aiua-10711	287	20	ureteral	ureteral	ADJ
aiua-10711	287	21	stones	stone	NOUN
aiua-10711	287	22	:	:	PUNCT
aiua-10711	287	23	a	a	DET
aiua-10711	287	24	multi	multi	ADJ
aiua-10711	287	25	-	-	ADJ
aiua-10711	287	26	institutional	institutional	ADJ
aiua-10711	287	27	,	,	PUNCT
aiua-10711	287	28	randomized	randomize	VERB
aiua-10711	287	29	,	,	PUNCT
aiua-10711	287	30	doubleblinded	doubleblinde	VERB
aiua-10711	287	31	,	,	PUNCT
aiua-10711	287	32	placebo	placebo	NOUN
aiua-10711	287	33	-	-	PUNCT
aiua-10711	287	34	controlled	control	VERB
aiua-10711	287	35	trial	trial	NOUN
aiua-10711	287	36	.	.	PUNCT
aiua-10711	288	1	eur	eur	PROPN
aiua-10711	288	2	urol	urol	PROPN
aiua-10711	288	3	.	.	PUNCT
aiua-10711	288	4	2015	2015	NUM
aiua-10711	288	5	;	;	PUNCT
aiua-10711	288	6	67:959	67:959	NOUN
aiua-10711	288	7	-	-	SYM
aiua-10711	288	8	64	64	NUM
aiua-10711	288	9	.	.	PUNCT
aiua-10711	289	1	24	24	NUM
aiua-10711	289	2	.	.	PUNCT
aiua-10711	290	1	ye	ye	PRON
aiua-10711	290	2	z	z	PROPN
aiua-10711	290	3	,	,	PUNCT
aiua-10711	290	4	zeng	zeng	PROPN
aiua-10711	290	5	g	g	PROPN
aiua-10711	290	6	,	,	PUNCT
aiua-10711	290	7	yang	yang	PROPN
aiua-10711	290	8	h	h	PROPN
aiua-10711	290	9	,	,	PUNCT
aiua-10711	290	10	et	et	PROPN
aiua-10711	290	11	al	al	PROPN
aiua-10711	290	12	.	.	PROPN
aiua-10711	290	13	efficacy	efficacy	NOUN
aiua-10711	290	14	and	and	CCONJ
aiua-10711	290	15	safety	safety	NOUN
aiua-10711	290	16	of	of	ADP
aiua-10711	290	17	tamsulosin	tamsulosin	NOUN
aiua-10711	290	18	in	in	ADP
aiua-10711	290	19	medical	medical	ADJ
aiua-10711	290	20	expulsive	expulsive	NOUN
aiua-10711	290	21	therapy	therapy	NOUN
aiua-10711	290	22	for	for	ADP
aiua-10711	290	23	distal	distal	ADJ
aiua-10711	290	24	ureteral	ureteral	ADJ
aiua-10711	290	25	stones	stone	NOUN
aiua-10711	290	26	with	with	ADP
aiua-10711	290	27	renal	renal	ADJ
aiua-10711	290	28	colic	colic	NOUN
aiua-10711	290	29	:	:	PUNCT
aiua-10711	290	30	a	a	DET
aiua-10711	290	31	multicenter	multicenter	NOUN
aiua-10711	290	32	,	,	PUNCT
aiua-10711	290	33	randomized	randomize	VERB
aiua-10711	290	34	,	,	PUNCT
aiua-10711	290	35	double	double	ADJ
aiua-10711	290	36	-	-	PUNCT
aiua-10711	290	37	blind	blind	ADJ
aiua-10711	290	38	,	,	PUNCT
aiua-10711	290	39	placebo	placebo	NOUN
aiua-10711	290	40	-	-	PUNCT
aiua-10711	290	41	controlled	control	VERB
aiua-10711	290	42	trial	trial	NOUN
aiua-10711	290	43	.	.	PUNCT
aiua-10711	291	1	eur	eur	PROPN
aiua-10711	291	2	urol	urol	PROPN
aiua-10711	291	3	.	.	PUNCT
aiua-10711	291	4	2018	2018	NUM
aiua-10711	291	5	;	;	PUNCT
aiua-10711	291	6	73:385	73:385	PROPN
aiua-10711	291	7	-	-	SYM
aiua-10711	291	8	391	391	NUM
aiua-10711	291	9	.	.	PUNCT
aiua-10711	292	1	25	25	NUM
aiua-10711	292	2	.	.	PUNCT
aiua-10711	293	1	cho	cho	PROPN
aiua-10711	293	2	hj	hj	PROPN
aiua-10711	293	3	,	,	PUNCT
aiua-10711	293	4	shin	shin	PROPN
aiua-10711	293	5	sc	sc	PROPN
aiua-10711	293	6	,	,	PUNCT
aiua-10711	293	7	seo	seo	NOUN
aiua-10711	293	8	dy	dy	PROPN
aiua-10711	293	9	,	,	PUNCT
aiua-10711	293	10	et	et	PROPN
aiua-10711	293	11	al	al	PROPN
aiua-10711	293	12	.	.	PROPN
aiua-10711	293	13	efficacy	efficacy	NOUN
aiua-10711	293	14	of	of	ADP
aiua-10711	293	15	alfuzosin	alfuzosin	NOUN
aiua-10711	293	16	after	after	SCONJ
aiua-10711	293	17	shock	shock	NOUN
aiua-10711	293	18	wave	wave	NOUN
aiua-10711	293	19	lithotripsy	lithotripsy	VERB
aiua-10711	293	20	for	for	ADP
aiua-10711	293	21	the	the	DET
aiua-10711	293	22	treatment	treatment	NOUN
aiua-10711	293	23	of	of	ADP
aiua-10711	293	24	ureteral	ureteral	ADJ
aiua-10711	293	25	calculi	calculi	NOUN
aiua-10711	293	26	korean	korean	PROPN
aiua-10711	293	27	j	j	PROPN
aiua-10711	293	28	urol	urol	PROPN
aiua-10711	293	29	.	.	PUNCT
aiua-10711	294	1	2013	2013	NUM
aiua-10711	294	2	;	;	PUNCT
aiua-10711	294	3	54:106	54:106	NUM
aiua-10711	294	4	-	-	SYM
aiua-10711	294	5	110	110	NUM
aiua-10711	294	6	.	.	PUNCT
aiua-10711	295	1	26	26	NUM
aiua-10711	295	2	.	.	PUNCT
aiua-10711	296	1	el	el	PROPN
aiua-10711	296	2	said	say	VERB
aiua-10711	296	3	no	no	INTJ
aiua-10711	296	4	,	,	PUNCT
aiua-10711	296	5	el	el	PROPN
aiua-10711	296	6	wakeel	wakeel	PROPN
aiua-10711	296	7	l	l	PROPN
aiua-10711	296	8	,	,	PUNCT
aiua-10711	296	9	kamal	kamal	PROPN
aiua-10711	296	10	km	km	PROPN
aiua-10711	296	11	,	,	PUNCT
aiua-10711	296	12	morad	morad	PROPN
aiua-10711	296	13	ael	ael	PROPN
aiua-10711	296	14	r.	r.	PROPN
aiua-10711	296	15	alfuzosin	alfuzosin	PROPN
aiua-10711	296	16	treatment	treatment	NOUN
aiua-10711	296	17	improves	improve	VERB
aiua-10711	296	18	the	the	DET
aiua-10711	296	19	rate	rate	NOUN
aiua-10711	296	20	and	and	CCONJ
aiua-10711	296	21	time	time	NOUN
aiua-10711	296	22	for	for	ADP
aiua-10711	296	23	stone	stone	NOUN
aiua-10711	296	24	expulsion	expulsion	NOUN
aiua-10711	296	25	in	in	ADP
aiua-10711	296	26	patients	patient	NOUN
aiua-10711	296	27	with	with	ADP
aiua-10711	296	28	distal	distal	ADJ
aiua-10711	296	29	uretral	uretral	ADJ
aiua-10711	296	30	stones	stone	NOUN
aiua-10711	296	31	:	:	PUNCT
aiua-10711	296	32	a	a	DET
aiua-10711	296	33	prospective	prospective	ADJ
aiua-10711	296	34	randomized	randomized	ADJ
aiua-10711	296	35	controlled	control	VERB
aiua-10711	296	36	study	study	NOUN
aiua-10711	296	37	.	.	PUNCT
aiua-10711	297	1	pharmacotherapy	pharmacotherapy	NOUN
aiua-10711	297	2	.	.	PUNCT
aiua-10711	298	1	2015	2015	NUM
aiua-10711	298	2	;	;	PUNCT
aiua-10711	298	3	35:470	35:470	NUM
aiua-10711	298	4	-	-	SYM
aiua-10711	298	5	6	6	NUM
aiua-10711	298	6	.	.	NOUN
aiua-10711	298	7	27	27	NUM
aiua-10711	298	8	.	.	PUNCT
aiua-10711	299	1	ferre	ferre	PROPN
aiua-10711	299	2	rm	rm	PROPN
aiua-10711	299	3	,	,	PUNCT
aiua-10711	299	4	wasielewski	wasielewski	PROPN
aiua-10711	299	5	jn	jn	PROPN
aiua-10711	299	6	,	,	PUNCT
aiua-10711	299	7	strout	strout	PROPN
aiua-10711	299	8	td	td	PROPN
aiua-10711	299	9	,	,	PUNCT
aiua-10711	299	10	perron	perron	PROPN
aiua-10711	299	11	ad	ad	NOUN
aiua-10711	299	12	.	.	PUNCT
aiua-10711	299	13	tamsulosin	tamsulosin	NOUN
aiua-10711	299	14	for	for	ADP
aiua-10711	299	15	ureteral	ureteral	ADJ
aiua-10711	299	16	stones	stone	NOUN
aiua-10711	299	17	in	in	ADP
aiua-10711	299	18	the	the	DET
aiua-10711	299	19	emergency	emergency	NOUN
aiua-10711	299	20	department	department	NOUN
aiua-10711	299	21	:	:	PUNCT
aiua-10711	299	22	a	a	DET
aiua-10711	299	23	randomized	randomized	ADJ
aiua-10711	299	24	,	,	PUNCT
aiua-10711	299	25	controlled	control	VERB
aiua-10711	299	26	trial	trial	NOUN
aiua-10711	299	27	.	.	PUNCT
aiua-10711	300	1	ann	ann	PROPN
aiua-10711	300	2	emerg	emerg	PROPN
aiua-10711	300	3	med	med	PROPN
aiua-10711	300	4	.	.	PUNCT
aiua-10711	300	5	2009	2009	NUM
aiua-10711	300	6	;	;	PUNCT
aiua-10711	300	7	54:432	54:432	NUM
aiua-10711	300	8	-	-	SYM
aiua-10711	300	9	9	9	NUM
aiua-10711	300	10	,	,	PUNCT
aiua-10711	300	11	439.e1	439.e1	NUM
aiua-10711	300	12	-	-	SYM
aiua-10711	300	13	2	2	NUM
aiua-10711	300	14	.	.	NOUN
aiua-10711	300	15	28	28	NUM
aiua-10711	300	16	.	.	PUNCT
aiua-10711	301	1	itoh	itoh	PROPN
aiua-10711	301	2	y	y	PROPN
aiua-10711	301	3	,	,	PUNCT
aiua-10711	301	4	okada	okada	PROPN
aiua-10711	301	5	a	a	PROPN
aiua-10711	301	6	,	,	PUNCT
aiua-10711	301	7	yasui	yasui	PROPN
aiua-10711	301	8	t	t	PROPN
aiua-10711	301	9	,	,	PUNCT
aiua-10711	301	10	et	et	PROPN
aiua-10711	301	11	al	al	PROPN
aiua-10711	301	12	.	.	PROPN
aiua-10711	301	13	efficacy	efficacy	NOUN
aiua-10711	301	14	of	of	ADP
aiua-10711	301	15	selective	selective	ADJ
aiua-10711	301	16	alpha1a	alpha1a	NOUN
aiua-10711	301	17	adrenoceptor	adrenoceptor	NOUN
aiua-10711	301	18	antagonist	antagonist	NOUN
aiua-10711	301	19	silodosin	silodosin	NOUN
aiua-10711	301	20	in	in	ADP
aiua-10711	301	21	the	the	DET
aiua-10711	301	22	medical	medical	ADJ
aiua-10711	301	23	expulsive	expulsive	NOUN
aiua-10711	301	24	therapy	therapy	NOUN
aiua-10711	301	25	for	for	ADP
aiua-10711	301	26	ureteral	ureteral	ADJ
aiua-10711	301	27	stones	stone	NOUN
aiua-10711	301	28	.	.	PUNCT
aiua-10711	302	1	int	int	NOUN
aiua-10711	302	2	j	j	PROPN
aiua-10711	302	3	urol	urol	PROPN
aiua-10711	302	4	.	.	PUNCT
aiua-10711	303	1	2011	2011	NUM
aiua-10711	303	2	;	;	PUNCT
aiua-10711	303	3	18:672	18:672	NUM
aiua-10711	303	4	-	-	SYM
aiua-10711	303	5	4	4	NUM
aiua-10711	303	6	.	.	NOUN
aiua-10711	303	7	29	29	NUM
aiua-10711	303	8	.	.	PUNCT
aiua-10711	304	1	moursy	moursy	PROPN
aiua-10711	304	2	e	e	PROPN
aiua-10711	304	3	,	,	PUNCT
aiua-10711	304	4	gamal	gamal	PROPN
aiua-10711	304	5	wm	wm	PROPN
aiua-10711	304	6	,	,	PUNCT
aiua-10711	304	7	abuzeid	abuzeid	NOUN
aiua-10711	304	8	a.	a.	NOUN
aiua-10711	304	9	tamsulosin	tamsulosin	NOUN
aiua-10711	304	10	as	as	ADP
aiua-10711	304	11	an	an	DET
aiua-10711	304	12	expulsive	expulsive	NOUN
aiua-10711	304	13	therapy	therapy	NOUN
aiua-10711	304	14	for	for	ADP
aiua-10711	304	15	steinstrasse	steinstrasse	NOUN
aiua-10711	304	16	after	after	SCONJ
aiua-10711	304	17	extracorporeal	extracorporeal	NOUN
aiua-10711	304	18	shock	shock	NOUN
aiua-10711	304	19	wave	wave	NOUN
aiua-10711	304	20	lithotripsy	lithotripsy	NOUN
aiua-10711	304	21	:	:	PUNCT
aiua-10711	304	22	a	a	DET
aiua-10711	304	23	randomized	randomized	ADJ
aiua-10711	304	24	controlled	control	VERB
aiua-10711	304	25	study	study	NOUN
aiua-10711	304	26	.	.	PUNCT
aiua-10711	305	1	scand	scand	PROPN
aiua-10711	305	2	j	j	PROPN
aiua-10711	305	3	urol	urol	PROPN
aiua-10711	305	4	nephrol	nephrol	PROPN
aiua-10711	305	5	.	.	PUNCT
aiua-10711	306	1	2010	2010	NUM
aiua-10711	306	2	;	;	PUNCT
aiua-10711	306	3	44:315	44:315	NUM
aiua-10711	306	4	-	-	SYM
aiua-10711	306	5	9	9	NUM
aiua-10711	306	6	.	.	NOUN
aiua-10711	306	7	30	30	NUM
aiua-10711	306	8	.	.	PUNCT
aiua-10711	307	1	naja	naja	PROPN
aiua-10711	307	2	v	v	PROPN
aiua-10711	307	3	,	,	PUNCT
aiua-10711	307	4	agarwal	agarwal	PROPN
aiua-10711	307	5	mm	mm	PROPN
aiua-10711	307	6	,	,	PUNCT
aiua-10711	307	7	mandal	mandal	PROPN
aiua-10711	307	8	ak	ak	PROPN
aiua-10711	307	9	,	,	PUNCT
aiua-10711	307	10	et	et	PROPN
aiua-10711	307	11	al	al	PROPN
aiua-10711	307	12	.	.	PROPN
aiua-10711	307	13	tamsulosin	tamsulosin	PROPN
aiua-10711	307	14	facilitates	facilitate	VERB
aiua-10711	307	15	earlier	early	ADJ
aiua-10711	307	16	clearance	clearance	NOUN
aiua-10711	307	17	of	of	ADP
aiua-10711	307	18	stone	stone	NOUN
aiua-10711	307	19	fragments	fragment	NOUN
aiua-10711	307	20	and	and	CCONJ
aiua-10711	307	21	reduces	reduce	VERB
aiua-10711	307	22	pain	pain	NOUN
aiua-10711	307	23	after	after	ADP
aiua-10711	307	24	shockwave	shockwave	PROPN
aiua-10711	307	25	lithotripsy	lithotripsy	PROPN
aiua-10711	307	26	for	for	ADP
aiua-10711	307	27	renal	renal	ADJ
aiua-10711	307	28	calculi	calculi	NOUN
aiua-10711	307	29	:	:	PUNCT
aiua-10711	307	30	results	result	VERB
aiua-10711	307	31	from	from	ADP
aiua-10711	307	32	an	an	DET
aiua-10711	307	33	open	open	ADJ
aiua-10711	307	34	-	-	PUNCT
aiua-10711	307	35	label	label	NOUN
aiua-10711	307	36	randomized	randomized	ADJ
aiua-10711	307	37	study	study	NOUN
aiua-10711	307	38	.	.	PUNCT
aiua-10711	308	1	urology	urology	NOUN
aiua-10711	308	2	.	.	PUNCT
aiua-10711	308	3	2008	2008	NUM
aiua-10711	308	4	;	;	PUNCT
aiua-10711	308	5	72:1006	72:1006	NOUN
aiua-10711	308	6	-	-	X
aiua-10711	308	7	11	11	NUM
aiua-10711	308	8	.	.	PUNCT
aiua-10711	309	1	31	31	NUM
aiua-10711	309	2	.	.	PUNCT
aiua-10711	310	1	resim	resim	PROPN
aiua-10711	310	2	s	s	PROPN
aiua-10711	310	3	,	,	PUNCT
aiua-10711	310	4	ekerbicer	ekerbicer	NOUN
aiua-10711	310	5	hc	hc	PROPN
aiua-10711	310	6	,	,	PUNCT
aiua-10711	310	7	ciftci	ciftci	ADJ
aiua-10711	310	8	a.	a.	NOUN
aiua-10711	310	9	role	role	NOUN
aiua-10711	310	10	of	of	ADP
aiua-10711	310	11	tamsulosin	tamsulosin	NOUN
aiua-10711	310	12	in	in	ADP
aiua-10711	310	13	treatment	treatment	NOUN
aiua-10711	310	14	of	of	ADP
aiua-10711	310	15	patients	patient	NOUN
aiua-10711	310	16	with	with	ADP
aiua-10711	310	17	steinstrasse	steinstrasse	NOUN
aiua-10711	310	18	developing	develop	VERB
aiua-10711	310	19	after	after	ADP
aiua-10711	310	20	extracorporeal	extracorporeal	NOUN
aiua-10711	310	21	shock	shock	NOUN
aiua-10711	310	22	wave	wave	NOUN
aiua-10711	310	23	lithotripsy	lithotripsy	NOUN
aiua-10711	310	24	.	.	PUNCT
aiua-10711	311	1	urology	urology	NOUN
aiua-10711	311	2	.	.	PUNCT
aiua-10711	312	1	2005	2005	NUM
aiua-10711	312	2	;	;	PUNCT
aiua-10711	312	3	66:945	66:945	NUM
aiua-10711	312	4	-	-	SYM
aiua-10711	312	5	8	8	NUM
aiua-10711	312	6	.	.	X
aiua-10711	313	1	32	32	NUM
aiua-10711	313	2	.	.	PUNCT
aiua-10711	314	1	chung	chung	PROPN
aiua-10711	314	2	jh	jh	PROPN
aiua-10711	314	3	,	,	PUNCT
aiua-10711	314	4	oh	oh	INTJ
aiua-10711	314	5	cy	cy	PROPN
aiua-10711	314	6	,	,	PUNCT
aiua-10711	314	7	kim	kim	PROPN
aiua-10711	314	8	jh	jh	PROPN
aiua-10711	314	9	,	,	PUNCT
aiua-10711	314	10	et	et	PROPN
aiua-10711	314	11	al	al	PROPN
aiua-10711	314	12	.	.	PROPN
aiua-10711	314	13	efficacy	efficacy	NOUN
aiua-10711	314	14	and	and	CCONJ
aiua-10711	314	15	safety	safety	NOUN
aiua-10711	314	16	of	of	ADP
aiua-10711	314	17	tamsulosin	tamsulosin	NOUN
aiua-10711	314	18	0.4	0.4	NUM
aiua-10711	314	19	mg	mg	PROPN
aiua-10711	314	20	single	single	ADJ
aiua-10711	314	21	pills	pill	NOUN
aiua-10711	314	22	for	for	ADP
aiua-10711	314	23	treatment	treatment	NOUN
aiua-10711	314	24	of	of	ADP
aiua-10711	314	25	asian	asian	ADJ
aiua-10711	314	26	patients	patient	NOUN
aiua-10711	314	27	with	with	ADP
aiua-10711	314	28	symptomatic	symptomatic	ADJ
aiua-10711	314	29	benign	benign	ADJ
aiua-10711	314	30	prostatic	prostatic	ADJ
aiua-10711	314	31	hyperplasia	hyperplasia	NOUN
aiua-10711	314	32	with	with	ADP
aiua-10711	314	33	lower	low	ADJ
aiua-10711	314	34	urinary	urinary	ADJ
aiua-10711	314	35	tract	tract	NOUN
aiua-10711	314	36	symptoms	symptom	NOUN
aiua-10711	314	37	:	:	PUNCT
aiua-10711	314	38	a	a	DET
aiua-10711	314	39	randomized	randomized	ADJ
aiua-10711	314	40	,	,	PUNCT
aiua-10711	314	41	double	double	ADJ
aiua-10711	314	42	-	-	PUNCT
aiua-10711	314	43	blind	blind	ADJ
aiua-10711	314	44	,	,	PUNCT
aiua-10711	314	45	phase	phase	NOUN
aiua-10711	314	46	3	3	NUM
aiua-10711	314	47	trial	trial	NOUN
aiua-10711	314	48	.	.	PUNCT
aiua-10711	315	1	curr	curr	PROPN
aiua-10711	315	2	med	med	PROPN
aiua-10711	315	3	res	re	NOUN
aiua-10711	315	4	opin	opin	NOUN
aiua-10711	315	5	.	.	PUNCT
aiua-10711	316	1	2018	2018	NUM
aiua-10711	316	2	;	;	PUNCT
aiua-10711	316	3	34:1793	34:1793	NUM
aiua-10711	316	4	-	-	SYM
aiua-10711	316	5	1801	1801	NUM
aiua-10711	316	6	.	.	PUNCT
aiua-10711	317	1	33	33	NUM
aiua-10711	317	2	.	.	PUNCT
aiua-10711	318	1	höfner	höfner	PROPN
aiua-10711	318	2	k	k	PROPN
aiua-10711	318	3	,	,	PUNCT
aiua-10711	318	4	claes	claes	PROPN
aiua-10711	318	5	h	h	PROPN
aiua-10711	318	6	,	,	PUNCT
aiua-10711	318	7	de	de	PROPN
aiua-10711	318	8	reijke	reijke	PROPN
aiua-10711	318	9	tm	tm	PROPN
aiua-10711	318	10	,	,	PUNCT
aiua-10711	318	11	et	et	PROPN
aiua-10711	318	12	al	al	PROPN
aiua-10711	318	13	.	.	PROPN
aiua-10711	318	14	tamsulosin	tamsulosin	PROPN
aiua-10711	318	15	0.4	0.4	NUM
aiua-10711	318	16	mg	mg	ADP
aiua-10711	318	17	once	once	ADV
aiua-10711	318	18	daily	daily	ADV
aiua-10711	318	19	:	:	PUNCT
aiua-10711	318	20	effect	effect	NOUN
aiua-10711	318	21	on	on	ADP
aiua-10711	318	22	sexual	sexual	ADJ
aiua-10711	318	23	function	function	NOUN
aiua-10711	318	24	in	in	ADP
aiua-10711	318	25	patients	patient	NOUN
aiua-10711	318	26	with	with	ADP
aiua-10711	318	27	lower	low	ADJ
aiua-10711	318	28	urinary	urinary	ADJ
aiua-10711	318	29	tract	tract	NOUN
aiua-10711	318	30	symptoms	symptom	NOUN
aiua-10711	318	31	suggestive	suggestive	ADJ
aiua-10711	318	32	of	of	ADP
aiua-10711	318	33	benign	benign	ADJ
aiua-10711	318	34	prostatic	prostatic	ADJ
aiua-10711	318	35	obstruction	obstruction	NOUN
aiua-10711	318	36	.	.	PUNCT
aiua-10711	319	1	eur	eur	PROPN
aiua-10711	319	2	urol	urol	PROPN
aiua-10711	319	3	.	.	PUNCT
aiua-10711	319	4	1999	1999	NUM
aiua-10711	319	5	;	;	PUNCT
aiua-10711	319	6	36:335	36:335	NUM
aiua-10711	319	7	-	-	SYM
aiua-10711	319	8	41	41	NUM
aiua-10711	319	9	.	.	PUNCT
aiua-10711	320	1	34	34	NUM
aiua-10711	320	2	.	.	PUNCT
aiua-10711	321	1	kirby	kirby	PROPN
aiua-10711	321	2	rs	rs	PROPN
aiua-10711	321	3	,	,	PUNCT
aiua-10711	321	4	roehrborn	roehrborn	ADJ
aiua-10711	321	5	c	c	PROPN
aiua-10711	321	6	,	,	PUNCT
aiua-10711	321	7	boyle	boyle	PROPN
aiua-10711	321	8	p	p	PROPN
aiua-10711	321	9	,	,	PUNCT
aiua-10711	321	10	et	et	PROPN
aiua-10711	322	1	al	al	PROPN
aiua-10711	322	2	.	.	PROPN
aiua-10711	322	3	prospective	prospective	ADJ
aiua-10711	322	4	european	european	PROPN
aiua-10711	322	5	doxazosin	doxazosin	PROPN
aiua-10711	322	6	and	and	CCONJ
aiua-10711	322	7	combination	combination	NOUN
aiua-10711	322	8	therapy	therapy	NOUN
aiua-10711	322	9	study	study	NOUN
aiua-10711	322	10	investigators	investigator	NOUN
aiua-10711	322	11	.	.	PUNCT
aiua-10711	323	1	efficacy	efficacy	NOUN
aiua-10711	323	2	and	and	CCONJ
aiua-10711	323	3	tolerability	tolerability	NOUN
aiua-10711	323	4	of	of	ADP
aiua-10711	323	5	doxazosin	doxazosin	NOUN
aiua-10711	323	6	and	and	CCONJ
aiua-10711	323	7	finasteride	finasteride	ADJ
aiua-10711	323	8	,	,	PUNCT
aiua-10711	323	9	alone	alone	ADV
aiua-10711	323	10	or	or	CCONJ
aiua-10711	323	11	in	in	ADP
aiua-10711	323	12	combination	combination	NOUN
aiua-10711	323	13	,	,	PUNCT
aiua-10711	323	14	in	in	ADP
aiua-10711	323	15	treatment	treatment	NOUN
aiua-10711	323	16	of	of	ADP
aiua-10711	323	17	symptomatic	symptomatic	ADJ
aiua-10711	323	18	benign	benign	ADJ
aiua-10711	323	19	prostatic	prostatic	ADJ
aiua-10711	323	20	hyperplasia	hyperplasia	NOUN
aiua-10711	323	21	:	:	PUNCT
aiua-10711	323	22	the	the	DET
aiua-10711	323	23	prospective	prospective	ADJ
aiua-10711	323	24	european	european	ADJ
aiua-10711	323	25	doxazosin	doxazosin	NOUN
aiua-10711	323	26	and	and	CCONJ
aiua-10711	323	27	combination	combination	NOUN
aiua-10711	323	28	therapy	therapy	NOUN
aiua-10711	323	29	(	(	PUNCT
aiua-10711	323	30	predict	predict	VERB
aiua-10711	323	31	)	)	PUNCT
aiua-10711	323	32	trial	trial	NOUN
aiua-10711	323	33	.	.	PUNCT
aiua-10711	324	1	urology	urology	NOUN
aiua-10711	324	2	.	.	PUNCT
aiua-10711	325	1	2003	2003	NUM
aiua-10711	325	2	;	;	PUNCT
aiua-10711	325	3	61:119	61:119	NUM
aiua-10711	325	4	-	-	SYM
aiua-10711	325	5	26	26	NUM
aiua-10711	325	6	.	.	PUNCT
aiua-10711	325	7	35	35	NUM
aiua-10711	325	8	.	.	PUNCT
aiua-10711	326	1	nordling	nordle	VERB
aiua-10711	326	2	j.	j.	PROPN
aiua-10711	326	3	efficacy	efficacy	PROPN
aiua-10711	326	4	and	and	CCONJ
aiua-10711	326	5	safety	safety	NOUN
aiua-10711	326	6	of	of	ADP
aiua-10711	326	7	two	two	NUM
aiua-10711	326	8	doses	dose	NOUN
aiua-10711	326	9	(	(	PUNCT
aiua-10711	326	10	10	10	NUM
aiua-10711	326	11	and	and	CCONJ
aiua-10711	326	12	15	15	NUM
aiua-10711	326	13	mg	mg	NOUN
aiua-10711	326	14	)	)	PUNCT
aiua-10711	326	15	of	of	ADP
aiua-10711	326	16	alfuzosin	alfuzosin	NOUN
aiua-10711	326	17	or	or	CCONJ
aiua-10711	326	18	tamsulosin	tamsulosin	NOUN
aiua-10711	326	19	(	(	PUNCT
aiua-10711	326	20	0.4	0.4	NUM
aiua-10711	326	21	mg	mg	NOUN
aiua-10711	326	22	)	)	PUNCT
aiua-10711	326	23	once	once	ADV
aiua-10711	326	24	daily	daily	ADV
aiua-10711	326	25	for	for	ADP
aiua-10711	326	26	treating	treat	VERB
aiua-10711	326	27	symptomatic	symptomatic	ADJ
aiua-10711	326	28	benign	benign	ADJ
aiua-10711	326	29	prostatic	prostatic	ADJ
aiua-10711	326	30	hyperplasia	hyperplasia	NOUN
aiua-10711	326	31	.	.	PUNCT
aiua-10711	327	1	bju	bju	NOUN
aiua-10711	327	2	int	int	PROPN
aiua-10711	327	3	.	.	PUNCT
aiua-10711	328	1	2005	2005	NUM
aiua-10711	328	2	;	;	PUNCT
aiua-10711	328	3	95:1006	95:1006	NUM
aiua-10711	328	4	-	-	SYM
aiua-10711	328	5	12	12	NUM
aiua-10711	328	6	.	.	PUNCT
aiua-10711	329	1	36	36	NUM
aiua-10711	329	2	.	.	PUNCT
aiua-10711	330	1	roehrborn	roehrborn	ADJ
aiua-10711	330	2	cg	cg	NOUN
aiua-10711	330	3	.	.	PUNCT
aiua-10711	330	4	efficacy	efficacy	NOUN
aiua-10711	330	5	and	and	CCONJ
aiua-10711	330	6	safety	safety	NOUN
aiua-10711	330	7	of	of	ADP
aiua-10711	330	8	once	once	ADV
aiua-10711	330	9	-	-	PUNCT
aiua-10711	330	10	daily	daily	ADJ
aiua-10711	330	11	alfuzosin	alfuzosin	NOUN
aiua-10711	330	12	in	in	ADP
aiua-10711	330	13	the	the	DET
aiua-10711	330	14	treatment	treatment	NOUN
aiua-10711	330	15	of	of	ADP
aiua-10711	330	16	lower	low	ADJ
aiua-10711	330	17	urinary	urinary	ADJ
aiua-10711	330	18	tract	tract	NOUN
aiua-10711	330	19	symptoms	symptom	NOUN
aiua-10711	330	20	and	and	CCONJ
aiua-10711	330	21	clinical	clinical	ADJ
aiua-10711	330	22	benign	benign	ADJ
aiua-10711	330	23	prostatic	prostatic	ADJ
aiua-10711	330	24	hyperplasia	hyperplasia	NOUN
aiua-10711	330	25	:	:	PUNCT
aiua-10711	330	26	a	a	DET
aiua-10711	330	27	randomized	randomized	ADJ
aiua-10711	330	28	,	,	PUNCT
aiua-10711	330	29	placebo	placebo	NOUN
aiua-10711	330	30	-	-	PUNCT
aiua-10711	330	31	controlled	control	VERB
aiua-10711	330	32	trial	trial	NOUN
aiua-10711	330	33	.	.	PUNCT
aiua-10711	331	1	urology	urology	NOUN
aiua-10711	331	2	.	.	PUNCT
aiua-10711	332	1	2001	2001	NUM
aiua-10711	332	2	;	;	PUNCT
aiua-10711	332	3	58:953	58:953	NUM
aiua-10711	332	4	-	-	SYM
aiua-10711	332	5	9	9	NUM
aiua-10711	332	6	.	.	NOUN
aiua-10711	332	7	37	37	NUM
aiua-10711	332	8	.	.	PUNCT
aiua-10711	333	1	roehrborn	roehrborn	ADJ
aiua-10711	333	2	cg	cg	PROPN
aiua-10711	333	3	,	,	PUNCT
aiua-10711	333	4	van	van	PROPN
aiua-10711	333	5	kerrebroeck	kerrebroeck	PROPN
aiua-10711	333	6	p	p	X
aiua-10711	333	7	,	,	PUNCT
aiua-10711	333	8	nordling	nordling	ADJ
aiua-10711	333	9	j.	j.	PROPN
aiua-10711	333	10	safety	safety	PROPN
aiua-10711	333	11	and	and	CCONJ
aiua-10711	333	12	efficacy	efficacy	NOUN
aiua-10711	333	13	of	of	ADP
aiua-10711	333	14	alfuzosin	alfuzosin	NOUN
aiua-10711	333	15	10	10	NUM
aiua-10711	333	16	mg	mg	NOUN
aiua-10711	333	17	once	once	ADV
aiua-10711	333	18	-	-	PUNCT
aiua-10711	333	19	daily	daily	ADJ
aiua-10711	333	20	in	in	ADP
aiua-10711	333	21	the	the	DET
aiua-10711	333	22	treatment	treatment	NOUN
aiua-10711	333	23	of	of	ADP
aiua-10711	333	24	lower	low	ADJ
aiua-10711	333	25	urinary	urinary	ADJ
aiua-10711	333	26	tract	tract	NOUN
aiua-10711	333	27	symptoms	symptom	NOUN
aiua-10711	333	28	and	and	CCONJ
aiua-10711	333	29	clinical	clinical	ADJ
aiua-10711	333	30	benign	benign	ADJ
aiua-10711	333	31	prostatic	prostatic	ADJ
aiua-10711	333	32	hyperplasia	hyperplasia	NOUN
aiua-10711	333	33	:	:	PUNCT
aiua-10711	333	34	a	a	DET
aiua-10711	333	35	pooled	pool	VERB
aiua-10711	333	36	analysis	analysis	NOUN
aiua-10711	333	37	of	of	ADP
aiua-10711	333	38	three	three	NUM
aiua-10711	333	39	double	double	ADJ
aiua-10711	333	40	-	-	PUNCT
aiua-10711	333	41	blind	blind	ADJ
aiua-10711	333	42	,	,	PUNCT
aiua-10711	333	43	placebo	placebo	NOUN
aiua-10711	333	44	-	-	PUNCT
aiua-10711	333	45	controlled	control	VERB
aiua-10711	333	46	studies	study	NOUN
aiua-10711	333	47	.	.	PUNCT
aiua-10711	334	1	bju	bju	PROPN
aiua-10711	334	2	int	int	PROPN
aiua-10711	334	3	.	.	PUNCT
aiua-10711	335	1	2003	2003	NUM
aiua-10711	335	2	;	;	PUNCT
aiua-10711	335	3	92:257	92:257	NUM
aiua-10711	335	4	-	-	SYM
aiua-10711	335	5	61	61	NUM
aiua-10711	335	6	.	.	PUNCT
aiua-10711	336	1	38	38	NUM
aiua-10711	336	2	.	.	PUNCT
aiua-10711	337	1	roehrborn	roehrborn	ADJ
aiua-10711	337	2	c.g	c.g	PROPN
aiua-10711	337	3	.	.	PROPN
aiua-10711	337	4	alfuzosin	alfuzosin	PROPN
aiua-10711	337	5	10	10	NUM
aiua-10711	337	6	mg	mg	NOUN
aiua-10711	337	7	once	once	SCONJ
aiua-10711	337	8	daily	daily	ADV
aiua-10711	337	9	prevents	prevent	VERB
aiua-10711	337	10	overall	overall	ADJ
aiua-10711	337	11	clinical	clinical	ADJ
aiua-10711	337	12	progression	progression	NOUN
aiua-10711	337	13	of	of	ADP
aiua-10711	337	14	benign	benign	ADJ
aiua-10711	337	15	prostatic	prostatic	ADJ
aiua-10711	337	16	hyperplasia	hyperplasia	NOUN
aiua-10711	337	17	but	but	CCONJ
aiua-10711	337	18	not	not	PART
aiua-10711	337	19	acute	acute	ADJ
aiua-10711	337	20	urinary	urinary	ADJ
aiua-10711	337	21	retention	retention	NOUN
aiua-10711	337	22	:	:	PUNCT
aiua-10711	337	23	results	result	NOUN
aiua-10711	337	24	of	of	ADP
aiua-10711	337	25	a	a	DET
aiua-10711	337	26	2	2	NUM
aiua-10711	337	27	-	-	PUNCT
aiua-10711	337	28	year	year	NOUN
aiua-10711	337	29	placebo	placebo	NOUN
aiua-10711	337	30	-	-	PUNCT
aiua-10711	337	31	controlled	control	VERB
aiua-10711	337	32	study	study	NOUN
aiua-10711	337	33	bju	bju	NOUN
aiua-10711	337	34	int	int	NOUN
aiua-10711	337	35	.	.	PUNCT
aiua-10711	338	1	2006	2006	NUM
aiua-10711	338	2	;	;	PUNCT
aiua-10711	338	3	97:734	97:734	NUM
aiua-10711	338	4	-	-	SYM
aiua-10711	338	5	741	741	NUM
aiua-10711	338	6	.	.	NUM
aiua-10711	338	7	39	39	NUM
aiua-10711	338	8	.	.	PUNCT
aiua-10711	339	1	rosen	rosen	PROPN
aiua-10711	339	2	r	r	PROPN
aiua-10711	339	3	,	,	PUNCT
aiua-10711	339	4	seftel	seftel	NOUN
aiua-10711	339	5	a	a	DET
aiua-10711	339	6	,	,	PUNCT
aiua-10711	339	7	roehrborn	roehrborn	ADJ
aiua-10711	339	8	cg	cg	NOUN
aiua-10711	339	9	.	.	PUNCT
aiua-10711	340	1	effects	effect	NOUN
aiua-10711	340	2	of	of	ADP
aiua-10711	340	3	alfuzosin	alfuzosin	NOUN
aiua-10711	340	4	10	10	NUM
aiua-10711	340	5	mg	mg	ADP
aiua-10711	340	6	once	once	ADV
aiua-10711	340	7	daily	daily	ADV
aiua-10711	340	8	on	on	ADP
aiua-10711	340	9	sexual	sexual	ADJ
aiua-10711	340	10	function	function	NOUN
aiua-10711	340	11	in	in	ADP
aiua-10711	340	12	men	man	NOUN
aiua-10711	340	13	treated	treat	VERB
aiua-10711	340	14	for	for	ADP
aiua-10711	340	15	symptomatic	symptomatic	ADJ
aiua-10711	340	16	benign	benign	ADJ
aiua-10711	340	17	prostatic	prostatic	ADJ
aiua-10711	340	18	hyperplasia	hyperplasia	NOUN
aiua-10711	340	19	.	.	PUNCT
aiua-10711	341	1	int	int	PROPN
aiua-10711	341	2	j	j	PROPN
aiua-10711	341	3	impot	impot	NOUN
aiua-10711	341	4	res	re	NOUN
aiua-10711	341	5	.	.	PUNCT
aiua-10711	342	1	2007	2007	NUM
aiua-10711	342	2	;	;	PUNCT
aiua-10711	342	3	19:480	19:480	NUM
aiua-10711	342	4	-	-	SYM
aiua-10711	342	5	5	5	NUM
aiua-10711	342	6	.	.	NUM
aiua-10711	342	7	40	40	NUM
aiua-10711	342	8	.	.	PUNCT
aiua-10711	343	1	safarinejad	safarinejad	PROPN
aiua-10711	343	2	mr	mr	PROPN
aiua-10711	343	3	.	.	PROPN
aiua-10711	343	4	safety	safety	PROPN
aiua-10711	343	5	and	and	CCONJ
aiua-10711	343	6	efficacy	efficacy	NOUN
aiua-10711	343	7	of	of	ADP
aiua-10711	343	8	tamsulosin	tamsulosin	NOUN
aiua-10711	343	9	in	in	ADP
aiua-10711	343	10	the	the	DET
aiua-10711	343	11	treatment	treatment	NOUN
aiua-10711	343	12	of	of	ADP
aiua-10711	343	13	painful	painful	ADJ
aiua-10711	343	14	ejaculation	ejaculation	NOUN
aiua-10711	343	15	:	:	PUNCT
aiua-10711	343	16	a	a	DET
aiua-10711	343	17	randomized	randomized	ADJ
aiua-10711	343	18	,	,	PUNCT
aiua-10711	343	19	double	double	ADJ
aiua-10711	343	20	-	-	PUNCT
aiua-10711	343	21	blind	blind	ADJ
aiua-10711	343	22	,	,	PUNCT
aiua-10711	343	23	placebocontrolled	placebocontrolle	VERB
aiua-10711	343	24	study	study	NOUN
aiua-10711	343	25	.	.	PUNCT
aiua-10711	344	1	int	int	PROPN
aiua-10711	344	2	j	j	PROPN
aiua-10711	344	3	impot	impot	NOUN
aiua-10711	344	4	res	re	NOUN
aiua-10711	344	5	.	.	PUNCT
aiua-10711	345	1	2006	2006	NUM
aiua-10711	345	2	;	;	PUNCT
aiua-10711	345	3	18:527	18:527	NUM
aiua-10711	345	4	-	-	SYM
aiua-10711	345	5	33	33	NUM
aiua-10711	345	6	.	.	NOUN
aiua-10711	346	1	41	41	NUM
aiua-10711	346	2	.	.	PUNCT
aiua-10711	347	1	becker	becker	PROPN
aiua-10711	347	2	aj	aj	PROPN
aiua-10711	347	3	,	,	PUNCT
aiua-10711	347	4	stief	stief	PROPN
aiua-10711	347	5	cg	cg	PROPN
aiua-10711	347	6	,	,	PUNCT
aiua-10711	347	7	machtens	machten	VERB
aiua-10711	347	8	s	s	PART
aiua-10711	347	9	,	,	PUNCT
aiua-10711	347	10	et	et	PROPN
aiua-10711	347	11	al	al	PROPN
aiua-10711	347	12	.	.	PROPN
aiua-10711	347	13	oral	oral	ADJ
aiua-10711	347	14	phentolamine	phentolamine	NOUN
aiua-10711	347	15	as	as	ADP
aiua-10711	347	16	treatment	treatment	NOUN
aiua-10711	347	17	for	for	ADP
aiua-10711	347	18	erectile	erectile	ADJ
aiua-10711	347	19	dysfunction	dysfunction	NOUN
aiua-10711	347	20	.	.	PUNCT
aiua-10711	348	1	j	j	PROPN
aiua-10711	348	2	urol	urol	PROPN
aiua-10711	348	3	.	.	PUNCT
aiua-10711	349	1	1998	1998	NUM
aiua-10711	349	2	;	;	PUNCT
aiua-10711	349	3	159:1214	159:1214	NUM
aiua-10711	349	4	-	-	SYM
aiua-10711	349	5	6	6	NUM
aiua-10711	349	6	.	.	X
aiua-10711	349	7	42	42	NUM
aiua-10711	349	8	.	.	PUNCT
aiua-10711	350	1	choppin	choppin	NOUN
aiua-10711	350	2	a	a	PRON
aiua-10711	350	3	,	,	PUNCT
aiua-10711	350	4	blue	blue	PROPN
aiua-10711	350	5	dr	dr	PROPN
aiua-10711	350	6	,	,	PUNCT
aiua-10711	350	7	hegde	hegde	PROPN
aiua-10711	350	8	ss	ss	PROPN
aiua-10711	350	9	,	,	PUNCT
aiua-10711	350	10	et	et	PROPN
aiua-10711	350	11	al	al	PROPN
aiua-10711	350	12	.	.	PUNCT
aiua-10711	350	13	evaluation	evaluation	NOUN
aiua-10711	350	14	of	of	ADP
aiua-10711	350	15	oral	oral	ADJ
aiua-10711	350	16	ro700004/003	ro700004/003	PROPN
aiua-10711	350	17	,	,	PUNCT
aiua-10711	350	18	an	an	DET
aiua-10711	350	19	alpha1a	alpha1a	ADJ
aiua-10711	350	20	-	-	PUNCT
aiua-10711	350	21	adrenoceptor	adrenoceptor	NOUN
aiua-10711	350	22	antagonist	antagonist	NOUN
aiua-10711	350	23	,	,	PUNCT
aiua-10711	350	24	in	in	ADP
aiua-10711	350	25	the	the	DET
aiua-10711	350	26	treatment	treatment	NOUN
aiua-10711	350	27	of	of	ADP
aiua-10711	350	28	male	male	ADJ
aiua-10711	350	29	erectile	erectile	NOUN
aiua-10711	350	30	dysfunction	dysfunction	NOUN
aiua-10711	350	31	.	.	PUNCT
aiua-10711	351	1	int	int	NOUN
aiua-10711	351	2	j	j	PROPN
aiua-10711	351	3	impot	impot	NOUN
aiua-10711	351	4	res	re	NOUN
aiua-10711	351	5	.	.	PUNCT
aiua-10711	351	6	2001	2001	NUM
aiua-10711	351	7	;	;	PUNCT
aiua-10711	351	8	13:157	13:157	NUM
aiua-10711	351	9	-	-	SYM
aiua-10711	351	10	61	61	NUM
aiua-10711	351	11	.	.	PUNCT
aiua-10711	352	1	43	43	NUM
aiua-10711	352	2	.	.	PUNCT
aiua-10711	353	1	resnick	resnick	PROPN
aiua-10711	353	2	mi	mi	PROPN
aiua-10711	353	3	,	,	PUNCT
aiua-10711	353	4	roehrborn	roehrborn	ADJ
aiua-10711	353	5	cg	cg	NOUN
aiua-10711	353	6	.	.	PUNCT
aiua-10711	354	1	rapid	rapid	ADJ
aiua-10711	354	2	onset	onset	NOUN
aiua-10711	354	3	of	of	ADP
aiua-10711	354	4	action	action	NOUN
aiua-10711	354	5	with	with	ADP
aiua-10711	354	6	alfuzosin	alfuzosin	NOUN
aiua-10711	354	7	10	10	NUM
aiua-10711	354	8	mg	mg	ADP
aiua-10711	354	9	once	once	ADV
aiua-10711	354	10	daily	daily	ADV
aiua-10711	354	11	in	in	ADP
aiua-10711	354	12	men	man	NOUN
aiua-10711	354	13	with	with	ADP
aiua-10711	354	14	benign	benign	ADJ
aiua-10711	354	15	prostatic	prostatic	ADJ
aiua-10711	354	16	hyperplasia	hyperplasia	NOUN
aiua-10711	354	17	:	:	PUNCT
aiua-10711	354	18	a	a	DET
aiua-10711	354	19	randomized	randomized	ADJ
aiua-10711	354	20	,	,	PUNCT
aiua-10711	354	21	placebo	placebo	NOUN
aiua-10711	354	22	-	-	PUNCT
aiua-10711	354	23	controlled	control	VERB
aiua-10711	354	24	trial	trial	NOUN
aiua-10711	354	25	prostate	prostate	NOUN
aiua-10711	354	26	cancer	cancer	NOUN
aiua-10711	354	27	prostatic	prostatic	ADJ
aiua-10711	354	28	dis	dis	PROPN
aiua-10711	354	29	.	.	PUNCT
aiua-10711	355	1	2007	2007	NUM
aiua-10711	355	2	;	;	PUNCT
aiua-10711	355	3	10:155	10:155	NUM
aiua-10711	355	4	-	-	SYM
aiua-10711	355	5	159	159	NUM
aiua-10711	355	6	.	.	PUNCT
aiua-10711	356	1	44	44	NUM
aiua-10711	356	2	.	.	PUNCT
aiua-10711	357	1	shelbaia	shelbaia	PROPN
aiua-10711	357	2	a	a	DET
aiua-10711	357	3	,	,	PUNCT
aiua-10711	357	4	elsaied	elsaie	VERB
aiua-10711	357	5	wm	wm	PROPN
aiua-10711	357	6	,	,	PUNCT
aiua-10711	357	7	elghamrawy	elghamrawy	PROPN
aiua-10711	357	8	h	h	PROPN
aiua-10711	357	9	,	,	PUNCT
aiua-10711	357	10	et	et	PROPN
aiua-10711	357	11	al	al	PROPN
aiua-10711	357	12	.	.	PROPN
aiua-10711	357	13	effect	effect	NOUN
aiua-10711	357	14	of	of	ADP
aiua-10711	357	15	selective	selective	ADJ
aiua-10711	357	16	alpha	alpha	NOUN
aiua-10711	357	17	-	-	PUNCT
aiua-10711	357	18	blocker	blocker	NOUN
aiua-10711	357	19	tamsulosin	tamsulosin	NOUN
aiua-10711	357	20	on	on	ADP
aiua-10711	357	21	erectile	erectile	ADJ
aiua-10711	357	22	function	function	NOUN
aiua-10711	357	23	in	in	ADP
aiua-10711	357	24	patients	patient	NOUN
aiua-10711	357	25	with	with	ADP
aiua-10711	357	26	lower	low	ADJ
aiua-10711	357	27	urinary	urinary	ADJ
aiua-10711	357	28	tract	tract	NOUN
aiua-10711	357	29	symptoms	symptom	NOUN
aiua-10711	357	30	due	due	ADJ
aiua-10711	357	31	to	to	ADP
aiua-10711	357	32	benign	benign	ADJ
aiua-10711	357	33	prostatic	prostatic	ADJ
aiua-10711	357	34	hyperplasia	hyperplasia	NOUN
aiua-10711	357	35	.	.	PUNCT
aiua-10711	358	1	urology	urology	NOUN
aiua-10711	358	2	.	.	PUNCT
aiua-10711	359	1	2013	2013	NUM
aiua-10711	359	2	;	;	PUNCT
aiua-10711	359	3	82:130	82:130	NUM
aiua-10711	359	4	-	-	SYM
aiua-10711	359	5	5	5	NUM
aiua-10711	359	6	.	.	NOUN
aiua-10711	359	7	45	45	NUM
aiua-10711	359	8	.	.	PUNCT
aiua-10711	360	1	van	van	PROPN
aiua-10711	360	2	kerrebroeck	kerrebroeck	PROPN
aiua-10711	360	3	p	p	PROPN
aiua-10711	360	4	,	,	PUNCT
aiua-10711	360	5	jardin	jardin	VERB
aiua-10711	360	6	a	a	PRON
aiua-10711	360	7	,	,	PUNCT
aiua-10711	360	8	laval	laval	PROPN
aiua-10711	360	9	ku	ku	PROPN
aiua-10711	360	10	,	,	PUNCT
aiua-10711	360	11	van	van	PROPN
aiua-10711	360	12	cangh	cangh	PROPN
aiua-10711	360	13	p.	p.	PROPN
aiua-10711	360	14	efficacy	efficacy	NOUN
aiua-10711	360	15	and	and	CCONJ
aiua-10711	360	16	safety	safety	NOUN
aiua-10711	360	17	of	of	ADP
aiua-10711	360	18	a	a	DET
aiua-10711	360	19	new	new	ADJ
aiua-10711	360	20	prolonged	prolong	VERB
aiua-10711	360	21	release	release	NOUN
aiua-10711	360	22	formulation	formulation	NOUN
aiua-10711	360	23	of	of	ADP
aiua-10711	360	24	alfuzosin	alfuzosin	NOUN
aiua-10711	360	25	10	10	NUM
aiua-10711	360	26	mg	mg	ADP
aiua-10711	360	27	once	once	ADV
aiua-10711	360	28	daily	daily	ADV
aiua-10711	360	29	versus	versus	ADP
aiua-10711	360	30	alfuzosin	alfuzosin	VERB
aiua-10711	360	31	2.5	2.5	NUM
aiua-10711	360	32	mg	mg	PROPN
aiua-10711	360	33	thrice	thrice	PROPN
aiua-10711	360	34	daily	daily	ADV
aiua-10711	360	35	and	and	CCONJ
aiua-10711	360	36	placebo	placebo	NOUN
aiua-10711	360	37	in	in	ADP
aiua-10711	360	38	patients	patient	NOUN
aiua-10711	360	39	with	with	ADP
aiua-10711	360	40	symptomatic	symptomatic	ADJ
aiua-10711	360	41	benign	benign	ADJ
aiua-10711	360	42	prostatic	prostatic	ADJ
aiua-10711	360	43	hyperplasia	hyperplasia	NOUN
aiua-10711	360	44	.	.	PUNCT
aiua-10711	361	1	alforti	alforti	PROPN
aiua-10711	361	2	study	study	PROPN
aiua-10711	361	3	group	group	NOUN
aiua-10711	361	4	.	.	PUNCT
aiua-10711	362	1	eur	eur	PROPN
aiua-10711	362	2	urol	urol	PROPN
aiua-10711	362	3	.	.	PUNCT
aiua-10711	363	1	2000	2000	NUM
aiua-10711	363	2	;	;	PUNCT
aiua-10711	364	1	37:306	37:306	NUM
aiua-10711	364	2	-	-	SYM
aiua-10711	364	3	13	13	NUM
aiua-10711	364	4	.	.	PUNCT
aiua-10711	364	5	46	46	NUM
aiua-10711	364	6	.	.	PUNCT
aiua-10711	365	1	agrawal	agrawal	PROPN
aiua-10711	365	2	m	m	PROPN
aiua-10711	365	3	,	,	PUNCT
aiua-10711	365	4	gupta	gupta	PROPN
aiua-10711	365	5	m	m	PROPN
aiua-10711	365	6	,	,	PUNCT
aiua-10711	365	7	gupta	gupta	PROPN
aiua-10711	365	8	a	a	PRON
aiua-10711	365	9	,	,	PUNCT
aiua-10711	365	10	et	et	PROPN
aiua-10711	365	11	al	al	PROPN
aiua-10711	365	12	.	.	PROPN
aiua-10711	365	13	prospective	prospective	ADJ
aiua-10711	365	14	randomized	randomized	ADJ
aiua-10711	365	15	trial	trial	NOUN
aiua-10711	365	16	comparing	compare	VERB
aiua-10711	365	17	efficacy	efficacy	NOUN
aiua-10711	365	18	of	of	ADP
aiua-10711	365	19	alfuzosin	alfuzosin	NOUN
aiua-10711	365	20	and	and	CCONJ
aiua-10711	365	21	tamsulosin	tamsulosin	NOUN
aiua-10711	365	22	in	in	ADP
aiua-10711	365	23	management	management	NOUN
aiua-10711	365	24	of	of	ADP
aiua-10711	365	25	lower	low	ADJ
aiua-10711	365	26	ureteral	ureteral	ADJ
aiua-10711	365	27	stones	stone	NOUN
aiua-10711	365	28	.	.	PUNCT
aiua-10711	366	1	urology	urology	NOUN
aiua-10711	366	2	.	.	PUNCT
aiua-10711	367	1	2009	2009	NUM
aiua-10711	367	2	;	;	PUNCT
aiua-10711	367	3	73:706	73:706	PROPN
aiua-10711	367	4	-	-	SYM
aiua-10711	367	5	9	9	NUM
aiua-10711	367	6	.	.	X
aiua-10711	368	1	47	47	NUM
aiua-10711	368	2	.	.	PUNCT
aiua-10711	369	1	agrawal	agrawal	PROPN
aiua-10711	369	2	ms	ms	PROPN
aiua-10711	369	3	,	,	PUNCT
aiua-10711	369	4	yadav	yadav	PROPN
aiua-10711	369	5	a	a	PROPN
aiua-10711	369	6	,	,	PUNCT
aiua-10711	369	7	yadav	yadav	PROPN
aiua-10711	369	8	h	h	PROPN
aiua-10711	369	9	,	,	PUNCT
aiua-10711	369	10	et	et	PROPN
aiua-10711	369	11	al	al	PROPN
aiua-10711	369	12	.	.	PUNCT
aiua-10711	370	1	a	a	DET
aiua-10711	370	2	prospective	prospective	ADJ
aiua-10711	370	3	randomized	randomized	ADJ
aiua-10711	370	4	study	study	NOUN
aiua-10711	370	5	comparing	compare	VERB
aiua-10711	370	6	alfuzosin	alfuzosin	NOUN
aiua-10711	370	7	and	and	CCONJ
aiua-10711	370	8	tamsulosin	tamsulosin	NOUN
aiua-10711	370	9	in	in	ADP
aiua-10711	370	10	the	the	DET
aiua-10711	370	11	management	management	NOUN
aiua-10711	370	12	of	of	ADP
aiua-10711	370	13	patients	patient	NOUN
aiua-10711	370	14	suffering	suffer	VERB
aiua-10711	370	15	from	from	ADP
aiua-10711	370	16	acute	acute	ADJ
aiua-10711	370	17	urinary	urinary	ADJ
aiua-10711	370	18	retention	retention	NOUN
aiua-10711	370	19	caused	cause	VERB
aiua-10711	370	20	by	by	ADP
aiua-10711	370	21	benign	benign	ADJ
aiua-10711	370	22	prostatic	prostatic	ADJ
aiua-10711	370	23	hyperplasia	hyperplasia	NOUN
aiua-10711	370	24	.	.	PUNCT
aiua-10711	371	1	indian	indian	PROPN
aiua-10711	371	2	j	j	PROPN
aiua-10711	371	3	urol	urol	PROPN
aiua-10711	371	4	.	.	PUNCT
aiua-10711	371	5	2009	2009	NUM
aiua-10711	371	6	;	;	PUNCT
aiua-10711	371	7	25:474	25:474	PROPN
aiua-10711	371	8	-	-	SYM
aiua-10711	371	9	478	478	NUM
aiua-10711	371	10	.	.	PUNCT
aiua-10711	371	11	48	48	NUM
aiua-10711	371	12	.	.	PUNCT
aiua-10711	372	1	ahmed	ahmed	PROPN
aiua-10711	372	2	a.-f.a.-m	a.-f.a.-m	PROPN
aiua-10711	372	3	.	.	PROPN
aiua-10711	372	4	,	,	PUNCT
aiua-10711	372	5	al	al	PROPN
aiua-10711	372	6	-	-	PUNCT
aiua-10711	372	7	sayed	say	VERB
aiua-10711	372	8	a.-y.s	a.-y.s	PROPN
aiua-10711	372	9	.	.	PUNCT
aiua-10711	372	10	tamsulosin	tamsulosin	PROPN
aiua-10711	372	11	versus	versus	ADP
aiua-10711	372	12	alfuzosin	alfuzosin	NOUN
aiua-10711	372	13	in	in	ADP
aiua-10711	372	14	the	the	DET
aiua-10711	372	15	treatment	treatment	NOUN
aiua-10711	372	16	of	of	ADP
aiua-10711	372	17	patients	patient	NOUN
aiua-10711	372	18	with	with	ADP
aiua-10711	372	19	distal	distal	ADJ
aiua-10711	372	20	ureteral	ureteral	ADJ
aiua-10711	372	21	stones	stone	NOUN
aiua-10711	372	22	:	:	PUNCT
aiua-10711	372	23	prospective	prospective	ADJ
aiua-10711	372	24	,	,	PUNCT
aiua-10711	372	25	randomized	randomize	VERB
aiua-10711	372	26	,	,	PUNCT
aiua-10711	372	27	comparative	comparative	ADJ
aiua-10711	372	28	study	study	NOUN
aiua-10711	372	29	.	.	PUNCT
aiua-10711	373	1	korean	korean	PROPN
aiua-10711	373	2	j	j	PROPN
aiua-10711	373	3	urol	urol	PROPN
aiua-10711	373	4	.	.	PUNCT
aiua-10711	374	1	2010	2010	NUM
aiua-10711	374	2	;	;	PUNCT
aiua-10711	374	3	51:193	51:193	NUM
aiua-10711	374	4	-	-	SYM
aiua-10711	374	5	197	197	NUM
aiua-10711	374	6	.	.	PUNCT
aiua-10711	375	1	49	49	NUM
aiua-10711	375	2	.	.	PUNCT
aiua-10711	376	1	dell'atti	dell'atti	PROPN
aiua-10711	376	2	l.	l.	PROPN
aiua-10711	376	3	silodosin	silodosin	PROPN
aiua-10711	376	4	versus	versus	ADP
aiua-10711	376	5	tamsulosin	tamsulosin	NOUN
aiua-10711	376	6	as	as	ADP
aiua-10711	376	7	medical	medical	ADJ
aiua-10711	376	8	expulsive	expulsive	NOUN
aiua-10711	376	9	therapy	therapy	NOUN
aiua-10711	376	10	for	for	ADP
aiua-10711	376	11	distal	distal	ADJ
aiua-10711	376	12	ureteral	ureteral	ADJ
aiua-10711	376	13	stones	stone	NOUN
aiua-10711	376	14	:	:	PUNCT
aiua-10711	376	15	a	a	DET
aiua-10711	376	16	prospective	prospective	ADJ
aiua-10711	376	17	randomized	randomized	ADJ
aiua-10711	376	18	study	study	NOUN
aiua-10711	376	19	.	.	PUNCT
aiua-10711	377	1	urologia	urologia	PROPN
aiua-10711	377	2	.	.	PROPN
aiua-10711	378	1	2015	2015	NUM
aiua-10711	378	2	;	;	PUNCT
aiua-10711	378	3	82:54	82:54	NUM
aiua-10711	378	4	-	-	SYM
aiua-10711	378	5	7	7	NUM
aiua-10711	378	6	.	.	NOUN
aiua-10711	379	1	50	50	NUM
aiua-10711	379	2	.	.	X
aiua-10711	379	3	de	de	PROPN
aiua-10711	379	4	nunzio	nunzio	PROPN
aiua-10711	379	5	c	c	PROPN
aiua-10711	379	6	,	,	PUNCT
aiua-10711	379	7	brassetti	brassetti	X
aiua-10711	379	8	a	a	PRON
aiua-10711	379	9	,	,	PUNCT
aiua-10711	379	10	bellangino	bellangino	PROPN
aiua-10711	379	11	m	m	PROPN
aiua-10711	379	12	,	,	PUNCT
aiua-10711	379	13	et	et	PROPN
aiua-10711	379	14	al	al	PROPN
aiua-10711	379	15	.	.	PROPN
aiua-10711	379	16	tamsulosin	tamsulosin	PROPN
aiua-10711	379	17	or	or	CCONJ
aiua-10711	379	18	silodosin	silodosin	VERB
aiua-10711	379	19	adjuvant	adjuvant	ADJ
aiua-10711	379	20	treatment	treatment	NOUN
aiua-10711	379	21	is	be	AUX
aiua-10711	379	22	ineffective	ineffective	ADJ
aiua-10711	379	23	in	in	ADP
aiua-10711	379	24	improving	improve	VERB
aiua-10711	379	25	shockwave	shockwave	PROPN
aiua-10711	379	26	lithotripsy	lithotripsy	PROPN
aiua-10711	379	27	outcome	outcome	NOUN
aiua-10711	379	28	:	:	PUNCT
aiua-10711	379	29	a	a	DET
aiua-10711	379	30	short	short	ADJ
aiua-10711	379	31	-	-	PUNCT
aiua-10711	379	32	term	term	NOUN
aiua-10711	379	33	follow	follow	NOUN
aiua-10711	379	34	-	-	PUNCT
aiua-10711	379	35	up	up	NOUN
aiua-10711	379	36	randomized	randomize	VERB
aiua-10711	379	37	,	,	PUNCT
aiua-10711	379	38	placebocontrolled	placebocontrolle	VERB
aiua-10711	379	39	study	study	NOUN
aiua-10711	379	40	j	j	PROPN
aiua-10711	379	41	endourol	endourol	NOUN
aiua-10711	379	42	.	.	PUNCT
aiua-10711	380	1	2016	2016	NUM
aiua-10711	380	2	;	;	PUNCT
aiua-10711	380	3	30	30	NUM
aiua-10711	380	4	:	:	PUNCT
aiua-10711	380	5	817	817	NUM
aiua-10711	380	6	-	-	SYM
aiua-10711	380	7	821	821	NUM
aiua-10711	380	8	.	.	PUNCT
aiua-10711	381	1	51	51	NUM
aiua-10711	381	2	.	.	PUNCT
aiua-10711	382	1	elgalaly	elgalaly	PROPN
aiua-10711	382	2	h	h	PROPN
aiua-10711	382	3	,	,	PUNCT
aiua-10711	382	4	sakr	sakr	VERB
aiua-10711	382	5	a	a	PRON
aiua-10711	382	6	,	,	PUNCT
aiua-10711	382	7	fawzi	fawzi	NOUN
aiua-10711	382	8	a	a	X
aiua-10711	382	9	,	,	PUNCT
aiua-10711	382	10	et	et	PROPN
aiua-10711	382	11	al	al	PROPN
aiua-10711	382	12	.	.	PROPN
aiua-10711	382	13	silodosin	silodosin	PROPN
aiua-10711	382	14	vs	vs	ADP
aiua-10711	382	15	tamsulosin	tamsulosin	NOUN
aiua-10711	382	16	in	in	ADP
aiua-10711	382	17	the	the	DET
aiua-10711	382	18	management	management	NOUN
aiua-10711	382	19	of	of	ADP
aiua-10711	382	20	distal	distal	ADJ
aiua-10711	382	21	ureteric	ureteric	ADJ
aiua-10711	382	22	stones	stone	NOUN
aiua-10711	382	23	:	:	PUNCT
aiua-10711	382	24	a	a	DET
aiua-10711	382	25	prospective	prospective	ADJ
aiua-10711	382	26	randomised	randomise	VERB
aiua-10711	382	27	study.arab	study.arab	PROPN
aiua-10711	382	28	j	j	PROPN
aiua-10711	382	29	urol	urol	PROPN
aiua-10711	382	30	.	.	PROPN
aiua-10711	382	31	2016	2016	NUM
aiua-10711	382	32	;	;	PUNCT
aiua-10711	382	33	14:12	14:12	NUM
aiua-10711	382	34	-	-	SYM
aiua-10711	382	35	17	17	NUM
aiua-10711	382	36	.	.	PUNCT
aiua-10711	383	1	archivio	archivio	NOUN
aiua-10711	383	2	italiano	italiano	X
aiua-10711	383	3	di	di	X
aiua-10711	383	4	urologia	urologia	PROPN
aiua-10711	383	5	e	e	PROPN
aiua-10711	383	6	andrologia	andrologia	PROPN
aiua-10711	383	7	2022	2022	NUM
aiua-10711	383	8	;	;	PUNCT
aiua-10711	383	9	94	94	NUM
aiua-10711	383	10	,	,	PUNCT
aiua-10711	383	11	2	2	NUM
aiua-10711	383	12	r.	r.	NOUN
aiua-10711	383	13	bapir	bapir	NOUN
aiua-10711	383	14	,	,	PUNCT
aiua-10711	383	15	k.	k.	PROPN
aiua-10711	383	16	hassan	hassan	PROPN
aiua-10711	383	17	bhatti	bhatti	PROPN
aiua-10711	383	18	,	,	PUNCT
aiua-10711	383	19	a	a	PRON
aiua-10711	383	20	,	,	PUNCT
aiua-10711	383	21	eliwa	eliwa	NOUN
aiua-10711	383	22	,	,	PUNCT
aiua-10711	383	23	et	et	PROPN
aiua-10711	383	24	al	al	PROPN
aiua-10711	383	25	.	.	PROPN
aiua-10711	384	1	262	262	NUM
aiua-10711	384	2	52	52	NUM
aiua-10711	384	3	.	.	PUNCT
aiua-10711	385	1	georgescu	georgescu	PROPN
aiua-10711	385	2	d	d	NOUN
aiua-10711	385	3	,	,	PUNCT
aiua-10711	385	4	ionita	ionita	PROPN
aiua-10711	385	5	-	-	PUNCT
aiua-10711	385	6	radu	radu	PROPN
aiua-10711	385	7	f	f	PROPN
aiua-10711	385	8	,	,	PUNCT
aiua-10711	385	9	multescu	multescu	ADJ
aiua-10711	385	10	r	r	NOUN
aiua-10711	385	11	,	,	PUNCT
aiua-10711	385	12	et	et	PROPN
aiua-10711	385	13	al	al	PROPN
aiua-10711	385	14	.	.	PUNCT
aiua-10711	386	1	the	the	DET
aiua-10711	386	2	role	role	NOUN
aiua-10711	386	3	of	of	ADP
aiua-10711	386	4	alpha1	alpha1	NOUN
aiua-10711	386	5	-	-	PUNCT
aiua-10711	386	6	blockers	blocker	NOUN
aiua-10711	386	7	in	in	ADP
aiua-10711	386	8	the	the	DET
aiua-10711	386	9	medical	medical	ADJ
aiua-10711	386	10	expulsive	expulsive	NOUN
aiua-10711	386	11	therapy	therapy	NOUN
aiua-10711	386	12	for	for	ADP
aiua-10711	386	13	ureteral	ureteral	ADJ
aiua-10711	386	14	calculi	calculi	PROPN
aiua-10711	386	15	a	a	DET
aiua-10711	386	16	prospective	prospective	ADJ
aiua-10711	386	17	controlled	control	VERB
aiua-10711	386	18	randomized	randomized	ADJ
aiua-10711	386	19	study	study	NOUN
aiua-10711	386	20	comparing	compare	VERB
aiua-10711	386	21	tamsulosin	tamsulosin	NOUN
aiua-10711	386	22	and	and	CCONJ
aiua-10711	386	23	silodosin	silodosin	NOUN
aiua-10711	386	24	.	.	PUNCT
aiua-10711	387	1	farmacia	farmacia	PROPN
aiua-10711	387	2	2015	2015	NUM
aiua-10711	387	3	;	;	PUNCT
aiua-10711	387	4	63:184	63:184	X
aiua-10711	387	5	-	-	SYM
aiua-10711	387	6	188	188	NUM
aiua-10711	387	7	.	.	PUNCT
aiua-10711	388	1	53	53	NUM
aiua-10711	388	2	.	.	PUNCT
aiua-10711	389	1	gharib	gharib	PROPN
aiua-10711	389	2	t	t	PROPN
aiua-10711	389	3	,	,	PUNCT
aiua-10711	389	4	mohey	mohey	PROPN
aiua-10711	389	5	a	a	PROPN
aiua-10711	389	6	,	,	PUNCT
aiua-10711	389	7	fathi	fathi	PROPN
aiua-10711	389	8	a	a	X
aiua-10711	389	9	,	,	PUNCT
aiua-10711	389	10	et	et	PROPN
aiua-10711	389	11	al	al	PROPN
aiua-10711	389	12	.	.	PROPN
aiua-10711	389	13	comparative	comparative	ADJ
aiua-10711	389	14	study	study	NOUN
aiua-10711	389	15	between	between	ADP
aiua-10711	389	16	silodosin	silodosin	NOUN
aiua-10711	389	17	and	and	CCONJ
aiua-10711	389	18	tamsulosin	tamsulosin	NOUN
aiua-10711	389	19	in	in	ADP
aiua-10711	389	20	expectant	expectant	ADJ
aiua-10711	389	21	therapy	therapy	NOUN
aiua-10711	389	22	of	of	ADP
aiua-10711	389	23	distal	distal	ADJ
aiua-10711	389	24	ureteral	ureteral	ADJ
aiua-10711	389	25	stones	stone	NOUN
aiua-10711	389	26	.	.	PUNCT
aiua-10711	390	1	urol	urol	PROPN
aiua-10711	390	2	int	int	PROPN
aiua-10711	390	3	.	.	PUNCT
aiua-10711	391	1	2018	2018	NUM
aiua-10711	391	2	;	;	PUNCT
aiua-10711	391	3	101:161	101:161	NUM
aiua-10711	391	4	-	-	PUNCT
aiua-10711	391	5	166	166	NUM
aiua-10711	391	6	.	.	PUNCT
aiua-10711	392	1	54	54	NUM
aiua-10711	392	2	.	.	PUNCT
aiua-10711	393	1	gupta	gupta	PROPN
aiua-10711	393	2	s	s	PART
aiua-10711	393	3	,	,	PUNCT
aiua-10711	393	4	lodh	lodh	PROPN
aiua-10711	393	5	b	b	PROPN
aiua-10711	393	6	,	,	PUNCT
aiua-10711	393	7	kaku	kaku	PROPN
aiua-10711	393	8	singh	singh	PROPN
aiua-10711	393	9	a	a	PROPN
aiua-10711	393	10	,	,	PUNCT
aiua-10711	393	11	et	et	PROPN
aiua-10711	393	12	al	al	PROPN
aiua-10711	393	13	.	.	PROPN
aiua-10711	393	14	comparing	compare	VERB
aiua-10711	393	15	the	the	DET
aiua-10711	393	16	efficacy	efficacy	NOUN
aiua-10711	393	17	of	of	ADP
aiua-10711	393	18	tamsulosin	tamsulosin	NOUN
aiua-10711	393	19	and	and	CCONJ
aiua-10711	393	20	silodosin	silodosin	VERB
aiua-10711	393	21	in	in	ADP
aiua-10711	393	22	the	the	DET
aiua-10711	393	23	medical	medical	ADJ
aiua-10711	393	24	expulsion	expulsion	NOUN
aiua-10711	393	25	therapy	therapy	NOUN
aiua-10711	393	26	for	for	ADP
aiua-10711	393	27	ureteral	ureteral	ADJ
aiua-10711	393	28	calculi	calculi	NOUN
aiua-10711	393	29	.	.	PUNCT
aiua-10711	394	1	j	j	PROPN
aiua-10711	394	2	clin	clin	PROPN
aiua-10711	394	3	diagn	diagn	PROPN
aiua-10711	394	4	res	re	NOUN
aiua-10711	394	5	.	.	PUNCT
aiua-10711	394	6	2013	2013	NUM
aiua-10711	394	7	;	;	PUNCT
aiua-10711	394	8	7:1672	7:1672	NUM
aiua-10711	394	9	-	-	SYM
aiua-10711	394	10	1674	1674	NUM
aiua-10711	394	11	.	.	PUNCT
aiua-10711	395	1	55	55	NUM
aiua-10711	395	2	.	.	PUNCT
aiua-10711	396	1	hellstrom	hellstrom	PROPN
aiua-10711	396	2	wj	wj	PROPN
aiua-10711	396	3	,	,	PUNCT
aiua-10711	396	4	sikka	sikka	PROPN
aiua-10711	396	5	sc	sc	PROPN
aiua-10711	396	6	.	.	PUNCT
aiua-10711	397	1	effects	effect	NOUN
aiua-10711	397	2	of	of	ADP
aiua-10711	397	3	acute	acute	ADJ
aiua-10711	397	4	treatment	treatment	NOUN
aiua-10711	397	5	with	with	ADP
aiua-10711	397	6	tamsulosin	tamsulosin	NOUN
aiua-10711	397	7	versus	versus	ADP
aiua-10711	397	8	alfuzosin	alfuzosin	NOUN
aiua-10711	397	9	on	on	ADP
aiua-10711	397	10	ejaculatory	ejaculatory	ADJ
aiua-10711	397	11	function	function	NOUN
aiua-10711	397	12	in	in	ADP
aiua-10711	397	13	normal	normal	ADJ
aiua-10711	397	14	volunteers	volunteer	NOUN
aiua-10711	397	15	.	.	PUNCT
aiua-10711	398	1	j	j	PROPN
aiua-10711	398	2	urol	urol	PROPN
aiua-10711	398	3	.	.	PUNCT
aiua-10711	399	1	2006	2006	NUM
aiua-10711	399	2	;	;	PUNCT
aiua-10711	399	3	176:1529	176:1529	NUM
aiua-10711	399	4	-	-	SYM
aiua-10711	399	5	33	33	NUM
aiua-10711	399	6	.	.	PUNCT
aiua-10711	400	1	56	56	NUM
aiua-10711	400	2	.	.	PUNCT
aiua-10711	400	3	ibrahim	ibrahim	PROPN
aiua-10711	400	4	ak	ak	PROPN
aiua-10711	400	5	,	,	PUNCT
aiua-10711	400	6	mahmood	mahmood	PROPN
aiua-10711	400	7	ih	ih	PROPN
aiua-10711	400	8	,	,	PUNCT
aiua-10711	400	9	mahmood	mahmood	PROPN
aiua-10711	400	10	ns	ns	PROPN
aiua-10711	400	11	.	.	PROPN
aiua-10711	400	12	efficacy	efficacy	NOUN
aiua-10711	400	13	and	and	CCONJ
aiua-10711	400	14	safety	safety	NOUN
aiua-10711	400	15	of	of	ADP
aiua-10711	400	16	tamsulosin	tamsulosin	NOUN
aiua-10711	400	17	vs.	vs.	ADP
aiua-10711	400	18	alfuzosin	alfuzosin	NOUN
aiua-10711	400	19	as	as	ADP
aiua-10711	400	20	medical	medical	ADJ
aiua-10711	400	21	expulsive	expulsive	NOUN
aiua-10711	400	22	therapy	therapy	NOUN
aiua-10711	400	23	for	for	ADP
aiua-10711	400	24	ureteric	ureteric	ADJ
aiua-10711	400	25	stones	stone	NOUN
aiua-10711	400	26	.	.	PUNCT
aiua-10711	401	1	arab	arab	PROPN
aiua-10711	401	2	j	j	PROPN
aiua-10711	401	3	urol	urol	PROPN
aiua-10711	401	4	.	.	PUNCT
aiua-10711	402	1	2013	2013	NUM
aiua-10711	402	2	11:142	11:142	NUM
aiua-10711	402	3	-	-	SYM
aiua-10711	402	4	147	147	NUM
aiua-10711	402	5	.	.	PUNCT
aiua-10711	403	1	57	57	NUM
aiua-10711	403	2	.	.	PUNCT
aiua-10711	404	1	karadag	karadag	PROPN
aiua-10711	404	2	e	e	PROPN
aiua-10711	404	3	,	,	PUNCT
aiua-10711	404	4	öner	öner	NOUN
aiua-10711	404	5	s	s	PROPN
aiua-10711	404	6	,	,	PUNCT
aiua-10711	404	7	budak	budak	PROPN
aiua-10711	404	8	yu	yu	PROPN
aiua-10711	404	9	,	,	PUNCT
aiua-10711	404	10	atahan	atahan	PROPN
aiua-10711	404	11	o.	o.	PROPN
aiua-10711	404	12	randomized	randomize	VERB
aiua-10711	404	13	crossover	crossover	ADP
aiua-10711	404	14	comparison	comparison	NOUN
aiua-10711	404	15	of	of	ADP
aiua-10711	404	16	tamsulosin	tamsulosin	NOUN
aiua-10711	404	17	and	and	CCONJ
aiua-10711	404	18	alfuzosin	alfuzosin	VERB
aiua-10711	404	19	in	in	ADP
aiua-10711	404	20	patients	patient	NOUN
aiua-10711	404	21	with	with	ADP
aiua-10711	404	22	urinary	urinary	ADJ
aiua-10711	404	23	disturbances	disturbance	NOUN
aiua-10711	404	24	caused	cause	VERB
aiua-10711	404	25	by	by	ADP
aiua-10711	404	26	benign	benign	ADJ
aiua-10711	404	27	prostatic	prostatic	ADJ
aiua-10711	404	28	hyperplasia	hyperplasia	NOUN
aiua-10711	404	29	.	.	PUNCT
aiua-10711	405	1	int	int	PROPN
aiua-10711	405	2	urol	urol	ADJ
aiua-10711	405	3	nephrol	nephrol	NOUN
aiua-10711	405	4	.	.	PUNCT
aiua-10711	406	1	2011	2011	NUM
aiua-10711	406	2	;	;	PUNCT
aiua-10711	406	3	43:949	43:949	NUM
aiua-10711	406	4	-	-	SYM
aiua-10711	406	5	954	954	NUM
aiua-10711	406	6	.	.	PUNCT
aiua-10711	407	1	58	58	NUM
aiua-10711	407	2	.	.	PUNCT
aiua-10711	408	1	kirby	kirby	PROPN
aiua-10711	408	2	rs	rs	PROPN
aiua-10711	408	3	.	.	PUNCT
aiua-10711	409	1	a	a	DET
aiua-10711	409	2	randomized	randomized	ADJ
aiua-10711	409	3	,	,	PUNCT
aiua-10711	409	4	double	double	ADJ
aiua-10711	409	5	-	-	PUNCT
aiua-10711	409	6	blind	blind	ADJ
aiua-10711	409	7	crossover	crossover	NOUN
aiua-10711	409	8	study	study	NOUN
aiua-10711	409	9	of	of	ADP
aiua-10711	409	10	tamsulosin	tamsulosin	NOUN
aiua-10711	409	11	and	and	CCONJ
aiua-10711	409	12	controlled	control	VERB
aiua-10711	409	13	-	-	PUNCT
aiua-10711	409	14	release	release	NOUN
aiua-10711	409	15	doxazosin	doxazosin	NOUN
aiua-10711	409	16	in	in	ADP
aiua-10711	409	17	patients	patient	NOUN
aiua-10711	409	18	with	with	ADP
aiua-10711	409	19	benign	benign	ADJ
aiua-10711	409	20	prostatic	prostatic	ADJ
aiua-10711	409	21	hyperplasia	hyperplasia	NOUN
aiua-10711	409	22	.	.	PUNCT
aiua-10711	410	1	bju	bju	NOUN
aiua-10711	410	2	int	int	PROPN
aiua-10711	410	3	.	.	PUNCT
aiua-10711	411	1	2003	2003	NUM
aiua-10711	411	2	;	;	PUNCT
aiua-10711	411	3	91:41	91:41	NUM
aiua-10711	411	4	-	-	SYM
aiua-10711	411	5	4	4	NUM
aiua-10711	411	6	.	.	X
aiua-10711	412	1	59	59	NUM
aiua-10711	412	2	.	.	PUNCT
aiua-10711	413	1	kumar	kumar	PROPN
aiua-10711	413	2	s	s	PROPN
aiua-10711	413	3	,	,	PUNCT
aiua-10711	413	4	kurdia	kurdia	PROPN
aiua-10711	413	5	kc	kc	PROPN
aiua-10711	413	6	,	,	PUNCT
aiua-10711	413	7	ganesamoni	ganesamoni	PROPN
aiua-10711	413	8	r	r	PROPN
aiua-10711	413	9	,	,	PUNCT
aiua-10711	413	10	et	et	PROPN
aiua-10711	413	11	al	al	PROPN
aiua-10711	413	12	.	.	PROPN
aiua-10711	413	13	randomized	randomize	VERB
aiua-10711	413	14	controlled	control	VERB
aiua-10711	413	15	trial	trial	NOUN
aiua-10711	413	16	to	to	PART
aiua-10711	413	17	compare	compare	VERB
aiua-10711	413	18	the	the	DET
aiua-10711	413	19	safety	safety	NOUN
aiua-10711	413	20	and	and	CCONJ
aiua-10711	413	21	efficacy	efficacy	NOUN
aiua-10711	413	22	of	of	ADP
aiua-10711	413	23	naftopidil	naftopidil	NOUN
aiua-10711	413	24	and	and	CCONJ
aiua-10711	413	25	tamsulosin	tamsulosin	NOUN
aiua-10711	413	26	as	as	ADP
aiua-10711	413	27	medical	medical	ADJ
aiua-10711	413	28	expulsive	expulsive	NOUN
aiua-10711	413	29	therapy	therapy	NOUN
aiua-10711	413	30	in	in	ADP
aiua-10711	413	31	combination	combination	NOUN
aiua-10711	413	32	with	with	ADP
aiua-10711	413	33	prednisolone	prednisolone	PROPN
aiua-10711	413	34	for	for	ADP
aiua-10711	413	35	distal	distal	ADJ
aiua-10711	413	36	ureteral	ureteral	ADJ
aiua-10711	413	37	stones	stone	NOUN
aiua-10711	413	38	.	.	PUNCT
aiua-10711	414	1	korean	korean	PROPN
aiua-10711	414	2	j	j	PROPN
aiua-10711	414	3	urol	urol	PROPN
aiua-10711	414	4	.	.	PUNCT
aiua-10711	415	1	2013	2013	NUM
aiua-10711	415	2	;	;	PUNCT
aiua-10711	415	3	54:311	54:311	NUM
aiua-10711	415	4	-	-	SYM
aiua-10711	415	5	315	315	NUM
aiua-10711	415	6	.	.	PUNCT
aiua-10711	416	1	60	60	NUM
aiua-10711	416	2	.	.	PUNCT
aiua-10711	417	1	manohar	manohar	PROPN
aiua-10711	417	2	cms	cms	PROPN
aiua-10711	417	3	,	,	PUNCT
aiua-10711	417	4	nagabhushana	nagabhushana	PROPN
aiua-10711	417	5	m	m	PROPN
aiua-10711	417	6	,	,	PUNCT
aiua-10711	417	7	karthikeyan	karthikeyan	PROPN
aiua-10711	417	8	vs	vs	ADP
aiua-10711	417	9	,	,	PUNCT
aiua-10711	417	10	et	et	PROPN
aiua-10711	417	11	al	al	PROPN
aiua-10711	417	12	.	.	PROPN
aiua-10711	417	13	safety	safety	NOUN
aiua-10711	417	14	and	and	CCONJ
aiua-10711	417	15	efficacy	efficacy	NOUN
aiua-10711	417	16	of	of	ADP
aiua-10711	417	17	tamsulosin	tamsulosin	NOUN
aiua-10711	417	18	,	,	PUNCT
aiua-10711	417	19	alfuzosin	alfuzosin	VERB
aiua-10711	417	20	or	or	CCONJ
aiua-10711	417	21	silodosin	silodosin	VERB
aiua-10711	417	22	as	as	ADP
aiua-10711	417	23	monotherapy	monotherapy	NOUN
aiua-10711	417	24	for	for	ADP
aiua-10711	417	25	luts	luts	PROPN
aiua-10711	417	26	in	in	ADP
aiua-10711	417	27	bph	bph	NOUN
aiua-10711	417	28	a	a	DET
aiua-10711	417	29	double	double	ADJ
aiua-10711	417	30	-	-	PUNCT
aiua-10711	417	31	blind	blind	ADJ
aiua-10711	417	32	randomized	randomized	ADJ
aiua-10711	417	33	trial	trial	NOUN
aiua-10711	417	34	.	.	PUNCT
aiua-10711	418	1	cent	cent	NOUN
aiua-10711	418	2	european	european	PROPN
aiua-10711	418	3	j	j	PROPN
aiua-10711	418	4	urol	urol	PROPN
aiua-10711	418	5	.	.	PROPN
aiua-10711	419	1	2017	2017	NUM
aiua-10711	419	2	;	;	PUNCT
aiua-10711	419	3	70:148	70:148	NUM
aiua-10711	419	4	-	-	SYM
aiua-10711	419	5	153	153	NUM
aiua-10711	419	6	.	.	NOUN
aiua-10711	419	7	61	61	NUM
aiua-10711	419	8	.	.	NUM
aiua-10711	419	9	masumori	masumori	PROPN
aiua-10711	419	10	n	n	CCONJ
aiua-10711	419	11	,	,	PUNCT
aiua-10711	419	12	tsukamoto	tsukamoto	PROPN
aiua-10711	419	13	t	t	PROPN
aiua-10711	419	14	,	,	PUNCT
aiua-10711	419	15	iwasawa	iwasawa	PROPN
aiua-10711	419	16	a	a	PRON
aiua-10711	419	17	,	,	PUNCT
aiua-10711	419	18	et	et	PROPN
aiua-10711	419	19	al	al	PROPN
aiua-10711	419	20	.	.	PROPN
aiua-10711	420	1	hokkaido	hokkaido	PROPN
aiua-10711	420	2	urological	urological	ADJ
aiua-10711	420	3	disorders	disorder	NOUN
aiua-10711	420	4	conference	conference	NOUN
aiua-10711	420	5	writing	writing	NOUN
aiua-10711	420	6	group	group	NOUN
aiua-10711	420	7	.	.	PUNCT
aiua-10711	421	1	ejaculatory	ejaculatory	ADJ
aiua-10711	421	2	disorders	disorder	NOUN
aiua-10711	421	3	caused	cause	VERB
aiua-10711	421	4	by	by	ADP
aiua-10711	421	5	alpha-1	alpha-1	NUM
aiua-10711	421	6	blockers	blocker	NOUN
aiua-10711	421	7	for	for	ADP
aiua-10711	421	8	patients	patient	NOUN
aiua-10711	421	9	with	with	ADP
aiua-10711	421	10	lower	low	ADJ
aiua-10711	421	11	urinary	urinary	ADJ
aiua-10711	421	12	tract	tract	NOUN
aiua-10711	421	13	symptoms	symptom	NOUN
aiua-10711	421	14	suggestive	suggestive	ADJ
aiua-10711	421	15	of	of	ADP
aiua-10711	421	16	benign	benign	ADJ
aiua-10711	421	17	prostatic	prostatic	ADJ
aiua-10711	421	18	hyperplasia	hyperplasia	NOUN
aiua-10711	421	19	:	:	PUNCT
aiua-10711	421	20	comparison	comparison	NOUN
aiua-10711	421	21	of	of	ADP
aiua-10711	421	22	naftopidil	naftopidil	NOUN
aiua-10711	421	23	and	and	CCONJ
aiua-10711	421	24	tamsulosin	tamsulosin	NOUN
aiua-10711	421	25	in	in	ADP
aiua-10711	421	26	a	a	DET
aiua-10711	421	27	randomized	randomized	ADJ
aiua-10711	421	28	multicenter	multicenter	NOUN
aiua-10711	421	29	study	study	NOUN
aiua-10711	421	30	.	.	PUNCT
aiua-10711	422	1	urol	urol	PROPN
aiua-10711	422	2	int	int	PROPN
aiua-10711	422	3	.	.	PUNCT
aiua-10711	423	1	2009	2009	NUM
aiua-10711	423	2	;	;	PUNCT
aiua-10711	423	3	83:49	83:49	NUM
aiua-10711	423	4	-	-	SYM
aiua-10711	423	5	54	54	NUM
aiua-10711	423	6	.	.	PUNCT
aiua-10711	424	1	62	62	NUM
aiua-10711	424	2	.	.	PUNCT
aiua-10711	425	1	miyakita	miyakita	PROPN
aiua-10711	425	2	h	h	PROPN
aiua-10711	425	3	,	,	PUNCT
aiua-10711	425	4	yokoyama	yokoyama	PROPN
aiua-10711	425	5	e	e	PROPN
aiua-10711	425	6	,	,	PUNCT
aiua-10711	425	7	onodera	onodera	NOUN
aiua-10711	425	8	y	y	PROPN
aiua-10711	425	9	,	,	PUNCT
aiua-10711	425	10	et	et	PROPN
aiua-10711	425	11	al	al	PROPN
aiua-10711	425	12	.	.	PUNCT
aiua-10711	425	13	short	short	ADJ
aiua-10711	425	14	-	-	PUNCT
aiua-10711	425	15	term	term	NOUN
aiua-10711	425	16	effects	effect	NOUN
aiua-10711	425	17	of	of	ADP
aiua-10711	425	18	crossover	crossover	NOUN
aiua-10711	425	19	treatment	treatment	NOUN
aiua-10711	425	20	with	with	ADP
aiua-10711	425	21	silodosin	silodosin	NOUN
aiua-10711	425	22	and	and	CCONJ
aiua-10711	425	23	tamsulosin	tamsulosin	VERB
aiua-10711	425	24	hydrochloride	hydrochloride	NOUN
aiua-10711	425	25	for	for	ADP
aiua-10711	425	26	lower	low	ADJ
aiua-10711	425	27	urinary	urinary	ADJ
aiua-10711	425	28	tract	tract	NOUN
aiua-10711	425	29	symptoms	symptom	NOUN
aiua-10711	425	30	associated	associate	VERB
aiua-10711	425	31	with	with	ADP
aiua-10711	425	32	benign	benign	ADJ
aiua-10711	425	33	prostatic	prostatic	ADJ
aiua-10711	425	34	hyperplasia	hyperplasia	NOUN
aiua-10711	425	35	.	.	PUNCT
aiua-10711	426	1	int	int	PROPN
aiua-10711	426	2	j	j	PROPN
aiua-10711	426	3	urol	urol	PROPN
aiua-10711	426	4	.	.	PUNCT
aiua-10711	427	1	2010	2010	NUM
aiua-10711	427	2	;	;	PUNCT
aiua-10711	427	3	17:869	17:869	NUM
aiua-10711	427	4	-	-	SYM
aiua-10711	427	5	875	875	NUM
aiua-10711	427	6	.	.	PUNCT
aiua-10711	428	1	63	63	NUM
aiua-10711	428	2	.	.	PUNCT
aiua-10711	429	1	narayan	narayan	PROPN
aiua-10711	429	2	p	p	X
aiua-10711	429	3	,	,	PUNCT
aiua-10711	429	4	o'leary	o'leary	PROPN
aiua-10711	429	5	mp	mp	PROPN
aiua-10711	429	6	,	,	PUNCT
aiua-10711	429	7	davidai	davidai	PROPN
aiua-10711	429	8	g.	g.	PROPN
aiua-10711	429	9	early	early	ADJ
aiua-10711	429	10	efficacy	efficacy	NOUN
aiua-10711	429	11	of	of	ADP
aiua-10711	429	12	tamsulosin	tamsulosin	NOUN
aiua-10711	429	13	versus	versus	ADP
aiua-10711	429	14	terazosin	terazosin	NOUN
aiua-10711	429	15	in	in	ADP
aiua-10711	429	16	the	the	DET
aiua-10711	429	17	treatment	treatment	NOUN
aiua-10711	429	18	of	of	ADP
aiua-10711	429	19	men	man	NOUN
aiua-10711	429	20	with	with	ADP
aiua-10711	429	21	benign	benign	ADJ
aiua-10711	429	22	prostatic	prostatic	ADJ
aiua-10711	429	23	hyperplasia	hyperplasia	NOUN
aiua-10711	429	24	:	:	PUNCT
aiua-10711	429	25	a	a	DET
aiua-10711	429	26	randomized	randomized	ADJ
aiua-10711	429	27	,	,	PUNCT
aiua-10711	429	28	open	open	ADJ
aiua-10711	429	29	-	-	PUNCT
aiua-10711	429	30	label	label	NOUN
aiua-10711	429	31	trial	trial	NOUN
aiua-10711	429	32	.	.	PUNCT
aiua-10711	430	1	the	the	DET
aiua-10711	430	2	journal	journal	NOUN
aiua-10711	430	3	of	of	ADP
aiua-10711	430	4	applied	apply	VERB
aiua-10711	430	5	research	research	NOUN
aiua-10711	430	6	2005	2005	NUM
aiua-10711	430	7	;	;	PUNCT
aiua-10711	430	8	5:237	5:237	NUM
aiua-10711	430	9	-	-	SYM
aiua-10711	430	10	245	245	NUM
aiua-10711	430	11	.	.	NOUN
aiua-10711	430	12	64	64	NUM
aiua-10711	430	13	.	.	PUNCT
aiua-10711	431	1	pande	pande	PROPN
aiua-10711	431	2	s	s	PROPN
aiua-10711	431	3	,	,	PUNCT
aiua-10711	431	4	hazra	hazra	VERB
aiua-10711	431	5	a	a	DET
aiua-10711	431	6	,	,	PUNCT
aiua-10711	431	7	kundu	kundu	PROPN
aiua-10711	431	8	ak	ak	PROPN
aiua-10711	431	9	.	.	PROPN
aiua-10711	431	10	evaluation	evaluation	NOUN
aiua-10711	431	11	of	of	ADP
aiua-10711	431	12	silodosin	silodosin	NOUN
aiua-10711	431	13	in	in	ADP
aiua-10711	431	14	comparison	comparison	NOUN
aiua-10711	431	15	to	to	PART
aiua-10711	431	16	tamsulosin	tamsulosin	NOUN
aiua-10711	431	17	in	in	ADP
aiua-10711	431	18	benign	benign	ADJ
aiua-10711	431	19	prostatic	prostatic	ADJ
aiua-10711	431	20	hyperplasia	hyperplasia	NOUN
aiua-10711	431	21	:	:	PUNCT
aiua-10711	431	22	a	a	DET
aiua-10711	431	23	randomized	randomized	ADJ
aiua-10711	431	24	controlled	control	VERB
aiua-10711	431	25	trial	trial	NOUN
aiua-10711	431	26	indian	indian	PROPN
aiua-10711	431	27	j	j	PROPN
aiua-10711	431	28	pharmacol	pharmacol	PROPN
aiua-10711	431	29	2014	2014	NUM
aiua-10711	431	30	;	;	PUNCT
aiua-10711	431	31	46	46	NUM
aiua-10711	431	32	:	:	SYM
aiua-10711	431	33	601	601	NUM
aiua-10711	431	34	-	-	NUM
aiua-10711	431	35	607	607	NUM
aiua-10711	431	36	.	.	PUNCT
aiua-10711	431	37	65	65	NUM
aiua-10711	431	38	.	.	PUNCT
aiua-10711	432	1	patil	patil	PROPN
aiua-10711	432	2	sb	sb	PROPN
aiua-10711	432	3	,	,	PUNCT
aiua-10711	432	4	ranka	ranka	PROPN
aiua-10711	432	5	k	k	PROPN
aiua-10711	432	6	,	,	PUNCT
aiua-10711	432	7	kundargi	kundargi	NOUN
aiua-10711	432	8	vs	vs	ADP
aiua-10711	432	9	,	,	PUNCT
aiua-10711	432	10	guru	guru	ADJ
aiua-10711	432	11	n.	n.	PROPN
aiua-10711	432	12	comparison	comparison	NOUN
aiua-10711	432	13	of	of	ADP
aiua-10711	432	14	tamsulosin	tamsulosin	NOUN
aiua-10711	432	15	and	and	CCONJ
aiua-10711	432	16	silodosin	silodosin	NOUN
aiua-10711	432	17	in	in	ADP
aiua-10711	432	18	the	the	DET
aiua-10711	432	19	management	management	NOUN
aiua-10711	432	20	of	of	ADP
aiua-10711	432	21	acute	acute	ADJ
aiua-10711	432	22	urinary	urinary	ADJ
aiua-10711	432	23	retention	retention	NOUN
aiua-10711	432	24	secondary	secondary	ADJ
aiua-10711	432	25	to	to	ADP
aiua-10711	432	26	benign	benign	ADJ
aiua-10711	432	27	prostatic	prostatic	ADJ
aiua-10711	432	28	hyperplasia	hyperplasia	NOUN
aiua-10711	432	29	in	in	ADP
aiua-10711	432	30	patients	patient	NOUN
aiua-10711	432	31	planned	plan	VERB
aiua-10711	432	32	for	for	ADP
aiua-10711	432	33	trial	trial	NOUN
aiua-10711	432	34	without	without	ADP
aiua-10711	432	35	catheter	catheter	NOUN
aiua-10711	432	36	.	.	PUNCT
aiua-10711	433	1	a	a	DET
aiua-10711	433	2	prospective	prospective	ADJ
aiua-10711	433	3	randomized	randomized	ADJ
aiua-10711	433	4	study	study	NOUN
aiua-10711	433	5	cent	cent	NOUN
aiua-10711	433	6	european	european	PROPN
aiua-10711	433	7	j	j	PROPN
aiua-10711	433	8	urol	urol	PROPN
aiua-10711	433	9	.	.	PROPN
aiua-10711	433	10	2017	2017	NUM
aiua-10711	433	11	;	;	PUNCT
aiua-10711	433	12	70:259	70:259	NUM
aiua-10711	433	13	-	-	SYM
aiua-10711	433	14	263	263	NUM
aiua-10711	433	15	.	.	PUNCT
aiua-10711	434	1	66	66	NUM
aiua-10711	434	2	.	.	PUNCT
aiua-10711	435	1	pompeo	pompeo	PROPN
aiua-10711	435	2	ac	ac	PROPN
aiua-10711	435	3	,	,	PUNCT
aiua-10711	435	4	rosenblatt	rosenblatt	PROPN
aiua-10711	435	5	c	c	PROPN
aiua-10711	435	6	,	,	PUNCT
aiua-10711	435	7	bertero	bertero	NOUN
aiua-10711	435	8	e	e	NOUN
aiua-10711	435	9	,	,	PUNCT
aiua-10711	435	10	et	et	PROPN
aiua-10711	435	11	al	al	PROPN
aiua-10711	435	12	.	.	PROPN
aiua-10711	435	13	doxazosin	doxazosin	PROPN
aiua-10711	435	14	and	and	CCONJ
aiua-10711	435	15	tamsulosin	tamsulosin	NOUN
aiua-10711	435	16	study	study	NOUN
aiua-10711	435	17	investigator	investigator	NOUN
aiua-10711	435	18	group	group	NOUN
aiua-10711	435	19	.	.	PUNCT
aiua-10711	436	1	a	a	DET
aiua-10711	436	2	randomised	randomised	ADJ
aiua-10711	436	3	,	,	PUNCT
aiua-10711	436	4	double	double	ADJ
aiua-10711	436	5	-	-	PUNCT
aiua-10711	436	6	blind	blind	ADJ
aiua-10711	436	7	study	study	NOUN
aiua-10711	436	8	comparing	compare	VERB
aiua-10711	436	9	the	the	DET
aiua-10711	436	10	efficacy	efficacy	NOUN
aiua-10711	436	11	and	and	CCONJ
aiua-10711	436	12	tolerability	tolerability	NOUN
aiua-10711	436	13	of	of	ADP
aiua-10711	436	14	controlled	control	VERB
aiua-10711	436	15	-	-	PUNCT
aiua-10711	436	16	release	release	NOUN
aiua-10711	436	17	doxazosin	doxazosin	NOUN
aiua-10711	436	18	and	and	CCONJ
aiua-10711	436	19	tamsulosin	tamsulosin	NOUN
aiua-10711	436	20	in	in	ADP
aiua-10711	436	21	the	the	DET
aiua-10711	436	22	treatment	treatment	NOUN
aiua-10711	436	23	of	of	ADP
aiua-10711	436	24	benign	benign	ADJ
aiua-10711	436	25	prostatic	prostatic	ADJ
aiua-10711	436	26	hyperplasia	hyperplasia	NOUN
aiua-10711	436	27	in	in	ADP
aiua-10711	436	28	brazil	brazil	PROPN
aiua-10711	436	29	.	.	PUNCT
aiua-10711	437	1	int	int	PROPN
aiua-10711	438	1	j	j	PROPN
aiua-10711	438	2	clin	clin	PROPN
aiua-10711	438	3	pract	pract	PROPN
aiua-10711	438	4	.	.	PUNCT
aiua-10711	439	1	2006	2006	NUM
aiua-10711	439	2	;	;	PUNCT
aiua-10711	439	3	60:1172	60:1172	NUM
aiua-10711	439	4	-	-	SYM
aiua-10711	439	5	7	7	NUM
aiua-10711	439	6	.	.	NUM
aiua-10711	439	7	67	67	NUM
aiua-10711	439	8	.	.	PUNCT
aiua-10711	439	9	samli	samli	PROPN
aiua-10711	439	10	mm	mm	PROPN
aiua-10711	439	11	,	,	PUNCT
aiua-10711	439	12	dincel	dincel	PROPN
aiua-10711	439	13	c.terazosin	c.terazosin	PROPN
aiua-10711	439	14	and	and	CCONJ
aiua-10711	439	15	doxazosin	doxazosin	VERB
aiua-10711	439	16	in	in	ADP
aiua-10711	439	17	the	the	DET
aiua-10711	439	18	treatment	treatment	NOUN
aiua-10711	439	19	of	of	ADP
aiua-10711	439	20	bph	bph	NOUN
aiua-10711	439	21	:	:	PUNCT
aiua-10711	439	22	results	result	NOUN
aiua-10711	439	23	of	of	ADP
aiua-10711	439	24	a	a	DET
aiua-10711	439	25	randomized	randomized	ADJ
aiua-10711	439	26	study	study	NOUN
aiua-10711	439	27	with	with	ADP
aiua-10711	439	28	crossover	crossover	NOUN
aiua-10711	439	29	in	in	ADP
aiua-10711	439	30	non	non	NOUN
aiua-10711	439	31	-	-	NOUN
aiua-10711	439	32	responders	responder	NOUN
aiua-10711	439	33	.	.	PUNCT
aiua-10711	440	1	urol	urol	PROPN
aiua-10711	440	2	int	int	PROPN
aiua-10711	440	3	.	.	PUNCT
aiua-10711	441	1	2004	2004	NUM
aiua-10711	441	2	;	;	PUNCT
aiua-10711	441	3	73:125	73:125	NUM
aiua-10711	441	4	-	-	SYM
aiua-10711	441	5	129	129	NUM
aiua-10711	441	6	.	.	PUNCT
aiua-10711	442	1	68	68	NUM
aiua-10711	442	2	.	.	PUNCT
aiua-10711	443	1	shirakawa	shirakawa	PROPN
aiua-10711	443	2	t	t	PROPN
aiua-10711	443	3	,	,	PUNCT
aiua-10711	443	4	haraguchi	haraguchi	PROPN
aiua-10711	443	5	t	t	PROPN
aiua-10711	443	6	,	,	PUNCT
aiua-10711	443	7	shigemura	shigemura	PROPN
aiua-10711	443	8	k	k	PROPN
aiua-10711	443	9	,	,	PUNCT
aiua-10711	443	10	et	et	PROPN
aiua-10711	443	11	al	al	PROPN
aiua-10711	443	12	.	.	PROPN
aiua-10711	443	13	silodosin	silodosin	PROPN
aiua-10711	443	14	versus	versus	ADP
aiua-10711	443	15	naftopidil	naftopidil	PROPN
aiua-10711	443	16	in	in	ADP
aiua-10711	443	17	japanese	japanese	ADJ
aiua-10711	443	18	patients	patient	NOUN
aiua-10711	443	19	with	with	ADP
aiua-10711	443	20	lower	low	ADJ
aiua-10711	443	21	urinary	urinary	ADJ
aiua-10711	443	22	tract	tract	NOUN
aiua-10711	443	23	symptoms	symptom	NOUN
aiua-10711	443	24	associated	associate	VERB
aiua-10711	443	25	with	with	ADP
aiua-10711	443	26	benign	benign	ADJ
aiua-10711	443	27	prostatic	prostatic	ADJ
aiua-10711	443	28	hyperplasia	hyperplasia	NOUN
aiua-10711	443	29	:	:	PUNCT
aiua-10711	443	30	a	a	DET
aiua-10711	443	31	randomized	randomized	ADJ
aiua-10711	443	32	multicenter	multicenter	NOUN
aiua-10711	443	33	study	study	NOUN
aiua-10711	443	34	international	international	PROPN
aiua-10711	443	35	j	j	PROPN
aiua-10711	443	36	urol	urol	PROPN
aiua-10711	443	37	.	.	PUNCT
aiua-10711	443	38	2013	2013	NUM
aiua-10711	443	39	;	;	PUNCT
aiua-10711	443	40	20:903	20:903	NUM
aiua-10711	443	41	-	-	SYM
aiua-10711	443	42	910	910	NUM
aiua-10711	443	43	.	.	PUNCT
aiua-10711	444	1	69	69	NUM
aiua-10711	444	2	.	.	PUNCT
aiua-10711	445	1	takahashi	takahashi	PROPN
aiua-10711	445	2	s	s	PROPN
aiua-10711	445	3	,	,	PUNCT
aiua-10711	445	4	yamaguchi	yamaguchi	PROPN
aiua-10711	445	5	k.	k.	PROPN
aiua-10711	445	6	treatment	treatment	NOUN
aiua-10711	445	7	of	of	ADP
aiua-10711	445	8	benign	benign	ADJ
aiua-10711	445	9	prostatic	prostatic	ADJ
aiua-10711	445	10	hyperplasia	hyperplasia	NOUN
aiua-10711	445	11	and	and	CCONJ
aiua-10711	445	12	aging	aging	NOUN
aiua-10711	445	13	:	:	PUNCT
aiua-10711	445	14	impacts	impact	NOUN
aiua-10711	445	15	of	of	ADP
aiua-10711	445	16	alpha-1	alpha-1	NUM
aiua-10711	445	17	blockers	blocker	NOUN
aiua-10711	445	18	on	on	ADP
aiua-10711	445	19	sexual	sexual	ADJ
aiua-10711	445	20	function	function	NOUN
aiua-10711	445	21	.	.	PUNCT
aiua-10711	446	1	journal	journal	NOUN
aiua-10711	446	2	of	of	ADP
aiua-10711	446	3	men	man	NOUN
aiua-10711	446	4	's	's	PART
aiua-10711	446	5	health	health	NOUN
aiua-10711	446	6	.	.	PUNCT
aiua-10711	447	1	2011	2011	NUM
aiua-10711	447	2	;	;	PUNCT
aiua-10711	447	3	8	8	NUM
aiua-10711	447	4	(	(	PUNCT
aiua-10711	447	5	suppl	suppl	ADJ
aiua-10711	447	6	1):s25	1):s25	NUM
aiua-10711	447	7	-	-	PUNCT
aiua-10711	447	8	s28	s28	NOUN
aiua-10711	447	9	.	.	PUNCT
aiua-10711	448	1	70	70	NUM
aiua-10711	448	2	.	.	PUNCT
aiua-10711	449	1	takeshita	takeshita	PROPN
aiua-10711	449	2	h	h	PROPN
aiua-10711	449	3	,	,	PUNCT
aiua-10711	449	4	moriyama	moriyama	PROPN
aiua-10711	449	5	s	s	PROPN
aiua-10711	449	6	,	,	PUNCT
aiua-10711	449	7	arai	arai	PROPN
aiua-10711	449	8	y	y	PROPN
aiua-10711	449	9	,	,	PUNCT
aiua-10711	449	10	et	et	PROPN
aiua-10711	449	11	al	al	PROPN
aiua-10711	449	12	.	.	PROPN
aiua-10711	449	13	randomized	randomize	VERB
aiua-10711	449	14	crossover	crossover	ADP
aiua-10711	449	15	comparison	comparison	NOUN
aiua-10711	449	16	of	of	ADP
aiua-10711	449	17	the	the	DET
aiua-10711	449	18	short	short	ADJ
aiua-10711	449	19	-	-	PUNCT
aiua-10711	449	20	term	term	NOUN
aiua-10711	449	21	efficacy	efficacy	NOUN
aiua-10711	449	22	and	and	CCONJ
aiua-10711	449	23	safety	safety	NOUN
aiua-10711	449	24	of	of	ADP
aiua-10711	449	25	single	single	ADJ
aiua-10711	449	26	halfdose	halfdose	NOUN
aiua-10711	449	27	silodosin	silodosin	NOUN
aiua-10711	449	28	and	and	CCONJ
aiua-10711	449	29	tamsulosin	tamsulosin	VERB
aiua-10711	449	30	hydrochoride	hydrochoride	ADV
aiua-10711	449	31	in	in	ADP
aiua-10711	449	32	men	man	NOUN
aiua-10711	449	33	with	with	ADP
aiua-10711	449	34	lower	low	ADJ
aiua-10711	449	35	urinary	urinary	ADJ
aiua-10711	449	36	tract	tract	NOUN
aiua-10711	449	37	symptoms	symptom	NOUN
aiua-10711	449	38	secondary	secondary	ADJ
aiua-10711	449	39	to	to	ADP
aiua-10711	449	40	benign	benign	ADJ
aiua-10711	449	41	prostatic	prostatic	ADJ
aiua-10711	449	42	hyperplasia	hyperplasia	NOUN
aiua-10711	449	43	.	.	PUNCT
aiua-10711	450	1	low	low	ADJ
aiua-10711	450	2	urin	urin	PROPN
aiua-10711	450	3	tract	tract	NOUN
aiua-10711	450	4	symptoms	symptom	NOUN
aiua-10711	450	5	.	.	PUNCT
aiua-10711	451	1	2016	2016	NUM
aiua-10711	451	2	;	;	PUNCT
aiua-10711	451	3	8:38	8:38	NUM
aiua-10711	451	4	-	-	SYM
aiua-10711	451	5	43	43	NUM
aiua-10711	451	6	.	.	PUNCT
aiua-10711	452	1	71	71	NUM
aiua-10711	452	2	.	.	PUNCT
aiua-10711	453	1	watanabe	watanabe	PROPN
aiua-10711	453	2	t	t	PROPN
aiua-10711	453	3	,	,	PUNCT
aiua-10711	453	4	ozono	ozono	PROPN
aiua-10711	453	5	s	s	PROPN
aiua-10711	453	6	,	,	PUNCT
aiua-10711	453	7	kageyama	kageyama	PROPN
aiua-10711	453	8	s.	s.	PROPN
aiua-10711	453	9	a	a	DET
aiua-10711	453	10	randomized	randomized	ADJ
aiua-10711	453	11	crossover	crossover	NOUN
aiua-10711	453	12	study	study	NOUN
aiua-10711	453	13	comparing	compare	VERB
aiua-10711	453	14	patient	patient	NOUN
aiua-10711	453	15	preference	preference	NOUN
aiua-10711	453	16	for	for	ADP
aiua-10711	453	17	tamsulosin	tamsulosin	NOUN
aiua-10711	453	18	and	and	CCONJ
aiua-10711	453	19	silodosin	silodosin	VERB
aiua-10711	453	20	in	in	ADP
aiua-10711	453	21	patients	patient	NOUN
aiua-10711	453	22	with	with	ADP
aiua-10711	453	23	lower	low	ADJ
aiua-10711	453	24	urinary	urinary	ADJ
aiua-10711	453	25	tract	tract	NOUN
aiua-10711	453	26	symptoms	symptom	NOUN
aiua-10711	453	27	associated	associate	VERB
aiua-10711	453	28	with	with	ADP
aiua-10711	453	29	benign	benign	ADJ
aiua-10711	453	30	prostatic	prostatic	ADJ
aiua-10711	453	31	hyperplasia	hyperplasia	NOUN
aiua-10711	453	32	.	.	PUNCT
aiua-10711	454	1	j	j	PROPN
aiua-10711	454	2	int	int	PROPN
aiua-10711	454	3	med	med	PROPN
aiua-10711	454	4	res	re	NOUN
aiua-10711	454	5	.	.	PUNCT
aiua-10711	454	6	2011	2011	NUM
aiua-10711	454	7	;	;	PUNCT
aiua-10711	454	8	39:129	39:129	NUM
aiua-10711	454	9	-	-	SYM
aiua-10711	454	10	142	142	NUM
aiua-10711	454	11	.	.	PUNCT
aiua-10711	455	1	72	72	NUM
aiua-10711	455	2	.	.	PUNCT
aiua-10711	456	1	yamaguchi	yamaguchi	PROPN
aiua-10711	456	2	k	k	PROPN
aiua-10711	456	3	,	,	PUNCT
aiua-10711	456	4	aoki	aoki	PROPN
aiua-10711	456	5	y	y	PROPN
aiua-10711	456	6	,	,	PUNCT
aiua-10711	456	7	yoshikawa	yoshikawa	PROPN
aiua-10711	456	8	t	t	PROPN
aiua-10711	456	9	,	,	PUNCT
aiua-10711	456	10	et	et	PROPN
aiua-10711	456	11	al	al	PROPN
aiua-10711	456	12	.	.	PROPN
aiua-10711	456	13	silodosin	silodosin	PROPN
aiua-10711	456	14	versus	versus	ADP
aiua-10711	456	15	naftopidil	naftopidil	NOUN
aiua-10711	456	16	for	for	ADP
aiua-10711	456	17	the	the	DET
aiua-10711	456	18	treatment	treatment	NOUN
aiua-10711	456	19	of	of	ADP
aiua-10711	456	20	benign	benign	ADJ
aiua-10711	456	21	prostatic	prostatic	ADJ
aiua-10711	456	22	hyperplasia	hyperplasia	NOUN
aiua-10711	456	23	:	:	PUNCT
aiua-10711	456	24	a	a	DET
aiua-10711	456	25	multicenter	multicenter	NOUN
aiua-10711	456	26	randomized	randomize	VERB
aiua-10711	456	27	trial	trial	NOUN
aiua-10711	456	28	.	.	PUNCT
aiua-10711	457	1	int	int	NOUN
aiua-10711	457	2	j	j	PROPN
aiua-10711	457	3	urol	urol	PROPN
aiua-10711	457	4	.	.	PUNCT
aiua-10711	458	1	2013	2013	NUM
aiua-10711	458	2	;	;	PUNCT
aiua-10711	458	3	20:1234	20:1234	NOUN
aiua-10711	458	4	-	-	PUNCT
aiua-10711	458	5	8	8	NUM
aiua-10711	458	6	.	.	PUNCT
aiua-10711	459	1	73	73	NUM
aiua-10711	459	2	.	.	PUNCT
aiua-10711	460	1	yokoyama	yokoyama	PROPN
aiua-10711	460	2	t	t	PROPN
aiua-10711	460	3	,	,	PUNCT
aiua-10711	460	4	hara	hara	PROPN
aiua-10711	460	5	r	r	NOUN
aiua-10711	460	6	,	,	PUNCT
aiua-10711	460	7	fukumoto	fukumoto	PRON
aiua-10711	460	8	k	k	NOUN
aiua-10711	460	9	,	,	PUNCT
aiua-10711	460	10	et	et	PROPN
aiua-10711	460	11	al	al	PROPN
aiua-10711	460	12	.	.	PUNCT
aiua-10711	461	1	effects	effect	NOUN
aiua-10711	461	2	of	of	ADP
aiua-10711	461	3	three	three	NUM
aiua-10711	461	4	types	type	NOUN
aiua-10711	461	5	of	of	ADP
aiua-10711	461	6	alpha-1	alpha-1	NUM
aiua-10711	461	7	adrenoceptor	adrenoceptor	NOUN
aiua-10711	461	8	blocker	blocker	NOUN
aiua-10711	461	9	on	on	ADP
aiua-10711	461	10	lower	low	ADJ
aiua-10711	461	11	urinary	urinary	ADJ
aiua-10711	461	12	tract	tract	NOUN
aiua-10711	461	13	symptoms	symptom	NOUN
aiua-10711	461	14	and	and	CCONJ
aiua-10711	461	15	sexual	sexual	ADJ
aiua-10711	461	16	function	function	NOUN
aiua-10711	461	17	in	in	ADP
aiua-10711	461	18	males	male	NOUN
aiua-10711	461	19	with	with	ADP
aiua-10711	461	20	benign	benign	ADJ
aiua-10711	461	21	prostatic	prostatic	ADJ
aiua-10711	461	22	hyperplasia	hyperplasia	NOUN
aiua-10711	461	23	.	.	PUNCT
aiua-10711	462	1	int	int	PROPN
aiua-10711	462	2	j	j	PROPN
aiua-10711	462	3	urol	urol	PROPN
aiua-10711	462	4	.	.	PUNCT
aiua-10711	463	1	2011	2011	NUM
aiua-10711	463	2	;	;	PUNCT
aiua-10711	463	3	18:225	18:225	NUM
aiua-10711	463	4	-	-	SYM
aiua-10711	463	5	30	30	NUM
aiua-10711	463	6	.	.	PUNCT
aiua-10711	464	1	74	74	NUM
aiua-10711	464	2	.	.	PUNCT
aiua-10711	465	1	yokoyama	yokoyama	PROPN
aiua-10711	465	2	t	t	PROPN
aiua-10711	465	3	,	,	PUNCT
aiua-10711	465	4	hara	hara	PROPN
aiua-10711	465	5	r	r	PROPN
aiua-10711	465	6	,	,	PUNCT
aiua-10711	465	7	fujii	fujii	PROPN
aiua-10711	465	8	t	t	PROPN
aiua-10711	465	9	,	,	PUNCT
aiua-10711	465	10	et	et	PROPN
aiua-10711	465	11	al	al	PROPN
aiua-10711	465	12	.	.	PROPN
aiua-10711	465	13	comparison	comparison	NOUN
aiua-10711	465	14	of	of	ADP
aiua-10711	465	15	two	two	NUM
aiua-10711	465	16	different	different	ADJ
aiua-10711	465	17	alpha1	alpha1	NOUN
aiua-10711	465	18	-	-	PUNCT
aiua-10711	465	19	adrenoceptor	adrenoceptor	NOUN
aiua-10711	465	20	antagonists	antagonist	NOUN
aiua-10711	465	21	,	,	PUNCT
aiua-10711	465	22	tamsulosin	tamsulosin	NOUN
aiua-10711	465	23	and	and	CCONJ
aiua-10711	465	24	silodosin	silodosin	NOUN
aiua-10711	465	25	,	,	PUNCT
aiua-10711	465	26	in	in	ADP
aiua-10711	465	27	the	the	DET
aiua-10711	465	28	treatment	treatment	NOUN
aiua-10711	465	29	of	of	ADP
aiua-10711	465	30	male	male	NOUN
aiua-10711	465	31	lower	low	ADJ
aiua-10711	465	32	urinary	urinary	ADJ
aiua-10711	465	33	tract	tract	NOUN
aiua-10711	465	34	symptoms	symptom	NOUN
aiua-10711	465	35	suggestive	suggestive	ADJ
aiua-10711	465	36	of	of	ADP
aiua-10711	465	37	benign	benign	ADJ
aiua-10711	465	38	prostatic	prostatic	ADJ
aiua-10711	465	39	hyperplasia	hyperplasia	NOUN
aiua-10711	465	40	:	:	PUNCT
aiua-10711	465	41	a	a	DET
aiua-10711	465	42	prospective	prospective	ADJ
aiua-10711	465	43	randomized	randomize	VERB
aiua-10711	465	44	crossover	crossover	ADP
aiua-10711	465	45	study	study	NOUN
aiua-10711	465	46	luts	lut	NOUN
aiua-10711	465	47	:	:	PUNCT
aiua-10711	465	48	lower	low	ADJ
aiua-10711	465	49	urinary	urinary	ADJ
aiua-10711	465	50	tract	tract	NOUN
aiua-10711	465	51	symptoms	symptom	NOUN
aiua-10711	465	52	2012	2012	NUM
aiua-10711	465	53	;	;	PUNCT
aiua-10711	465	54	4:14	4:14	NUM
aiua-10711	465	55	-	-	SYM
aiua-10711	465	56	18	18	NUM
aiua-10711	465	57	.	.	PUNCT
aiua-10711	466	1	75	75	NUM
aiua-10711	466	2	.	.	PUNCT
aiua-10711	466	3	yu	yu	PROPN
aiua-10711	466	4	hj	hj	PROPN
aiua-10711	466	5	,	,	PUNCT
aiua-10711	466	6	lin	lin	PROPN
aiua-10711	466	7	at	at	ADP
aiua-10711	466	8	,	,	PUNCT
aiua-10711	466	9	yang	yang	PROPN
aiua-10711	466	10	ss	ss	PROPN
aiua-10711	466	11	,	,	PUNCT
aiua-10711	466	12	et	et	PROPN
aiua-10711	466	13	al	al	PROPN
aiua-10711	466	14	.	.	PUNCT
aiua-10711	467	1	non	non	ADJ
aiua-10711	467	2	-	-	NOUN
aiua-10711	467	3	inferiority	inferiority	NOUN
aiua-10711	467	4	of	of	ADP
aiua-10711	467	5	silodosin	silodosin	NOUN
aiua-10711	467	6	to	to	PART
aiua-10711	467	7	tamsulosin	tamsulosin	VERB
aiua-10711	467	8	in	in	ADP
aiua-10711	467	9	treating	treat	VERB
aiua-10711	467	10	patients	patient	NOUN
aiua-10711	467	11	with	with	ADP
aiua-10711	467	12	lower	low	ADJ
aiua-10711	467	13	urinary	urinary	ADJ
aiua-10711	467	14	tract	tract	NOUN
aiua-10711	467	15	symptoms	symptom	NOUN
aiua-10711	467	16	(	(	PUNCT
aiua-10711	467	17	luts	luts	PROPN
aiua-10711	467	18	)	)	PUNCT
aiua-10711	467	19	associated	associate	VERB
aiua-10711	467	20	with	with	ADP
aiua-10711	467	21	benign	benign	ADJ
aiua-10711	467	22	prostatic	prostatic	ADJ
aiua-10711	467	23	hyperplasia	hyperplasia	NOUN
aiua-10711	467	24	(	(	PUNCT
aiua-10711	467	25	bph	bph	NOUN
aiua-10711	467	26	)	)	PUNCT
aiua-10711	467	27	.	.	PUNCT
aiua-10711	468	1	bju	bju	NOUN
aiua-10711	468	2	int	int	PROPN
aiua-10711	468	3	.	.	PUNCT
aiua-10711	469	1	2011	2011	NUM
aiua-10711	469	2	;	;	PUNCT
aiua-10711	469	3	108:1843	108:1843	NUM
aiua-10711	469	4	-	-	SYM
aiua-10711	469	5	8	8	NUM
aiua-10711	469	6	.	.	NUM
aiua-10711	470	1	76	76	NUM
aiua-10711	470	2	.	.	PUNCT
aiua-10711	471	1	zaytoun	zaytoun	PROPN
aiua-10711	471	2	om	om	PROPN
aiua-10711	471	3	,	,	PUNCT
aiua-10711	471	4	yakoubi	yakoubi	ADJ
aiua-10711	471	5	r	r	NOUN
aiua-10711	471	6	,	,	PUNCT
aiua-10711	471	7	zahran	zahran	NOUN
aiua-10711	471	8	arm	arm	NOUN
aiua-10711	471	9	,	,	PUNCT
aiua-10711	471	10	et	et	PROPN
aiua-10711	471	11	al	al	PROPN
aiua-10711	471	12	.	.	PROPN
aiua-10711	471	13	tamsulosin	tamsulosin	PROPN
aiua-10711	471	14	and	and	CCONJ
aiua-10711	471	15	doxazosin	doxazosin	VERB
aiua-10711	471	16	as	as	ADP
aiua-10711	471	17	adjunctive	adjunctive	ADJ
aiua-10711	471	18	therapy	therapy	NOUN
aiua-10711	471	19	following	follow	VERB
aiua-10711	471	20	shock	shock	NOUN
aiua-10711	471	21	-	-	PUNCT
aiua-10711	471	22	wave	wave	NOUN
aiua-10711	471	23	lithotripsy	lithotripsy	NOUN
aiua-10711	471	24	of	of	ADP
aiua-10711	471	25	renal	renal	ADJ
aiua-10711	471	26	calculi	calculi	PROPN
aiua-10711	471	27	:	:	PUNCT
aiua-10711	471	28	randomized	randomize	VERB
aiua-10711	471	29	controlled	control	VERB
aiua-10711	471	30	trial	trial	NOUN
aiua-10711	471	31	.	.	PUNCT
aiua-10711	472	1	urological	urological	ADJ
aiua-10711	472	2	research	research	NOUN
aiua-10711	472	3	.	.	PUNCT
aiua-10711	473	1	2012	2012	NUM
aiua-10711	473	2	;	;	PUNCT
aiua-10711	473	3	40:327	40:327	NOUN
aiua-10711	473	4	-	-	PUNCT
aiua-10711	473	5	332	332	NUM
aiua-10711	473	6	.	.	PUNCT
aiua-10711	474	1	77	77	NUM
aiua-10711	474	2	.	.	PUNCT
aiua-10711	474	3	keten	keten	PROPN
aiua-10711	474	4	t	t	PROPN
aiua-10711	474	5	,	,	PUNCT
aiua-10711	474	6	aslan	aslan	PROPN
aiua-10711	474	7	y	y	PROPN
aiua-10711	474	8	,	,	PUNCT
aiua-10711	474	9	balci	balci	NOUN
aiua-10711	474	10	m	m	PROPN
aiua-10711	474	11	,	,	PUNCT
aiua-10711	474	12	et	et	PROPN
aiua-10711	474	13	al	al	PROPN
aiua-10711	474	14	.	.	PUNCT
aiua-10711	475	1	determination	determination	NOUN
aiua-10711	475	2	of	of	ADP
aiua-10711	475	3	the	the	DET
aiua-10711	475	4	efficiency	efficiency	NOUN
aiua-10711	475	5	of	of	ADP
aiua-10711	475	6	8	8	NUM
aiua-10711	475	7	mg	mg	NOUN
aiua-10711	475	8	doxazosin	doxazosin	PROPN
aiua-10711	475	9	xl	xl	PROPN
aiua-10711	475	10	treatment	treatment	NOUN
aiua-10711	475	11	in	in	ADP
aiua-10711	475	12	patients	patient	NOUN
aiua-10711	475	13	with	with	ADP
aiua-10711	475	14	an	an	DET
aiua-10711	475	15	inadequate	inadequate	ADJ
aiua-10711	475	16	response	response	NOUN
aiua-10711	475	17	to	to	ADP
aiua-10711	475	18	4	4	NUM
aiua-10711	475	19	mg	mg	NOUN
aiua-10711	475	20	doxazosin	doxazosin	PROPN
aiua-10711	476	1	xl	xl	PROPN
aiua-10711	476	2	treatment	treatment	NOUN
aiua-10711	476	3	for	for	ADP
aiua-10711	476	4	benign	benign	ADJ
aiua-10711	476	5	prostatic	prostatic	ADJ
aiua-10711	476	6	hyperplasia	hyperplasia	NOUN
aiua-10711	476	7	urology	urology	NOUN
aiua-10711	476	8	.	.	PUNCT
aiua-10711	477	1	2015	2015	NUM
aiua-10711	477	2	;	;	PUNCT
aiua-10711	477	3	85:189	85:189	NUM
aiua-10711	477	4	-	-	SYM
aiua-10711	477	5	194	194	NUM
aiua-10711	477	6	.	.	PUNCT
aiua-10711	478	1	78	78	NUM
aiua-10711	478	2	.	.	PUNCT
aiua-10711	479	1	kirby	kirby	PROPN
aiua-10711	479	2	rs	rs	PROPN
aiua-10711	479	3	,	,	PUNCT
aiua-10711	479	4	o'leary	o'leary	PROPN
aiua-10711	479	5	mp	mp	PROPN
aiua-10711	479	6	,	,	PUNCT
aiua-10711	479	7	carson	carson	PROPN
aiua-10711	479	8	c.	c.	PROPN
aiua-10711	479	9	efficacy	efficacy	PROPN
aiua-10711	479	10	of	of	ADP
aiua-10711	479	11	extended	extend	VERB
aiua-10711	479	12	-	-	PUNCT
aiua-10711	479	13	release	release	NOUN
aiua-10711	479	14	doxazosin	doxazosin	NOUN
aiua-10711	479	15	and	and	CCONJ
aiua-10711	479	16	doxazosin	doxazosin	VERB
aiua-10711	479	17	standard	standard	NOUN
aiua-10711	479	18	in	in	ADP
aiua-10711	479	19	patients	patient	NOUN
aiua-10711	479	20	with	with	ADP
aiua-10711	479	21	concomitant	concomitant	ADJ
aiua-10711	479	22	benign	benign	ADJ
aiua-10711	479	23	prostatic	prostatic	ADJ
aiua-10711	479	24	hyperplasia	hyperplasia	NOUN
aiua-10711	479	25	and	and	CCONJ
aiua-10711	479	26	sexual	sexual	ADJ
aiua-10711	479	27	dysfunction	dysfunction	NOUN
aiua-10711	479	28	.	.	PUNCT
aiua-10711	480	1	bju	bju	NOUN
aiua-10711	480	2	int	int	PROPN
aiua-10711	480	3	.	.	PUNCT
aiua-10711	481	1	2005	2005	NUM
aiua-10711	481	2	;	;	PUNCT
aiua-10711	481	3	95:103	95:103	NUM
aiua-10711	481	4	-	-	SYM
aiua-10711	481	5	9	9	NUM
aiua-10711	481	6	.	.	NOUN
aiua-10711	481	7	79	79	NUM
aiua-10711	481	8	.	.	PUNCT
aiua-10711	482	1	choo	choo	PROPN
aiua-10711	482	2	ms	ms	PROPN
aiua-10711	482	3	,	,	PUNCT
aiua-10711	482	4	song	song	NOUN
aiua-10711	482	5	m	m	PROPN
aiua-10711	482	6	,	,	PUNCT
aiua-10711	482	7	kim	kim	PROPN
aiua-10711	482	8	jh	jh	PROPN
aiua-10711	482	9	,	,	PUNCT
aiua-10711	482	10	et	et	PROPN
aiua-10711	482	11	al	al	PROPN
aiua-10711	482	12	.	.	PROPN
aiua-10711	482	13	safety	safety	NOUN
aiua-10711	482	14	and	and	CCONJ
aiua-10711	482	15	efficacy	efficacy	NOUN
aiua-10711	482	16	of	of	ADP
aiua-10711	482	17	8	8	NUM
aiua-10711	482	18	-	-	PUNCT
aiua-10711	482	19	mg	mg	NOUN
aiua-10711	482	20	once	once	ADV
aiua-10711	482	21	-	-	PUNCT
aiua-10711	482	22	daily	daily	ADJ
aiua-10711	482	23	vs	vs	ADP
aiua-10711	482	24	4	4	NUM
aiua-10711	482	25	-	-	PUNCT
aiua-10711	482	26	mg	mg	NOUN
aiua-10711	482	27	twice	twice	ADV
aiua-10711	482	28	-	-	PUNCT
aiua-10711	482	29	daily	daily	ADJ
aiua-10711	482	30	silodosin	silodosin	NOUN
aiua-10711	482	31	in	in	ADP
aiua-10711	482	32	patients	patient	NOUN
aiua-10711	482	33	with	with	ADP
aiua-10711	482	34	lower	low	ADJ
aiua-10711	482	35	urinary	urinary	ADJ
aiua-10711	482	36	tract	tract	NOUN
aiua-10711	482	37	symptoms	symptom	NOUN
aiua-10711	482	38	suggestive	suggestive	ADJ
aiua-10711	482	39	of	of	ADP
aiua-10711	482	40	benign	benign	ADJ
aiua-10711	482	41	prostatic	prostatic	ADJ
aiua-10711	482	42	hyperplasia	hyperplasia	NOUN
aiua-10711	482	43	(	(	PUNCT
aiua-10711	482	44	silver	silver	NOUN
aiua-10711	482	45	study	study	NOUN
aiua-10711	482	46	):	):	PUNCT
aiua-10711	482	47	a	a	DET
aiua-10711	482	48	12	12	NUM
aiua-10711	482	49	-	-	PUNCT
aiua-10711	482	50	week	week	NOUN
aiua-10711	482	51	,	,	PUNCT
aiua-10711	482	52	double	double	ADJ
aiua-10711	482	53	-	-	PUNCT
aiua-10711	482	54	blind	blind	ADJ
aiua-10711	482	55	,	,	PUNCT
aiua-10711	482	56	randomized	randomize	VERB
aiua-10711	482	57	,	,	PUNCT
aiua-10711	482	58	parallel	parallel	ADJ
aiua-10711	482	59	,	,	PUNCT
aiua-10711	482	60	multicenter	multicenter	ADJ
aiua-10711	482	61	study	study	NOUN
aiua-10711	482	62	.	.	PUNCT
aiua-10711	483	1	urology	urology	NOUN
aiua-10711	483	2	.	.	PUNCT
aiua-10711	484	1	2014	2014	NUM
aiua-10711	484	2	;	;	PUNCT
aiua-10711	484	3	83:875	83:875	NUM
aiua-10711	484	4	-	-	SYM
aiua-10711	484	5	81	81	NUM
aiua-10711	484	6	.	.	PUNCT
aiua-10711	484	7	80	80	NUM
aiua-10711	484	8	.	.	PUNCT
aiua-10711	485	1	seki	seki	PROPN
aiua-10711	485	2	n	n	CCONJ
aiua-10711	485	3	,	,	PUNCT
aiua-10711	485	4	takahashi	takahashi	PROPN
aiua-10711	485	5	r	r	PROPN
aiua-10711	485	6	,	,	PUNCT
aiua-10711	485	7	yamaguchi	yamaguchi	PROPN
aiua-10711	485	8	a	a	PROPN
aiua-10711	485	9	,	,	PUNCT
aiua-10711	485	10	et	et	PROPN
aiua-10711	485	11	al	al	PROPN
aiua-10711	485	12	.	.	PUNCT
aiua-10711	486	1	non	non	ADJ
aiua-10711	487	1	-	-	NOUN
aiua-10711	488	1	inferiority	inferiority	NOUN
aiua-10711	488	2	of	of	ADP
aiua-10711	488	3	silodosin	silodosin	NOUN
aiua-10711	488	4	4	4	NUM
aiua-10711	488	5	mg	mg	NOUN
aiua-10711	488	6	once	once	ADV
aiua-10711	488	7	daily	daily	ADV
aiua-10711	488	8	to	to	PART
aiua-10711	488	9	twice	twice	ADV
aiua-10711	488	10	daily	daily	ADV
aiua-10711	488	11	for	for	ADP
aiua-10711	488	12	storage	storage	NOUN
aiua-10711	488	13	symptoms	symptom	NOUN
aiua-10711	488	14	score	score	VERB
aiua-10711	488	15	evaluated	evaluate	VERB
aiua-10711	488	16	by	by	ADP
aiua-10711	488	17	the	the	DET
aiua-10711	488	18	international	international	ADJ
aiua-10711	488	19	prostate	prostate	NOUN
aiua-10711	488	20	symptom	symptom	NOUN
aiua-10711	488	21	score	score	NOUN
aiua-10711	488	22	in	in	ADP
aiua-10711	488	23	japanese	japanese	ADJ
aiua-10711	488	24	patients	patient	NOUN
aiua-10711	488	25	with	with	ADP
aiua-10711	488	26	benign	benign	ADJ
aiua-10711	488	27	prostatic	prostatic	ADJ
aiua-10711	488	28	hyperplasia	hyperplasia	NOUN
aiua-10711	488	29	:	:	PUNCT
aiua-10711	488	30	a	a	DET
aiua-10711	488	31	multicenter	multicenter	NOUN
aiua-10711	488	32	,	,	PUNCT
aiua-10711	488	33	randomized	randomize	VERB
aiua-10711	488	34	,	,	PUNCT
aiua-10711	488	35	parallel	parallel	ADJ
aiua-10711	488	36	-	-	PUNCT
aiua-10711	488	37	group	group	NOUN
aiua-10711	488	38	study	study	NOUN
aiua-10711	488	39	.	.	PUNCT
aiua-10711	489	1	int	int	PROPN
aiua-10711	489	2	j	j	PROPN
aiua-10711	489	3	urol	urol	PROPN
aiua-10711	489	4	.	.	PUNCT
aiua-10711	490	1	2015	2015	NUM
aiua-10711	490	2	;	;	PUNCT
aiua-10711	490	3	22:311	22:311	NUM
aiua-10711	490	4	-	-	SYM
aiua-10711	490	5	6	6	NUM
aiua-10711	490	6	.	.	NUM
aiua-10711	490	7	81	81	NUM
aiua-10711	490	8	.	.	PUNCT
aiua-10711	491	1	kim	kim	PROPN
aiua-10711	491	2	jj	jj	PROPN
aiua-10711	491	3	,	,	PUNCT
aiua-10711	491	4	han	han	PROPN
aiua-10711	491	5	dh	dh	PROPN
aiua-10711	491	6	,	,	PUNCT
aiua-10711	491	7	sung	sing	VERB
aiua-10711	491	8	hh	hh	PROPN
aiua-10711	491	9	,	,	PUNCT
aiua-10711	491	10	et	et	PROPN
aiua-10711	491	11	al	al	PROPN
aiua-10711	491	12	.	.	PROPN
aiua-10711	491	13	efficacy	efficacy	NOUN
aiua-10711	491	14	and	and	CCONJ
aiua-10711	491	15	tolerability	tolerability	NOUN
aiua-10711	491	16	of	of	ADP
aiua-10711	491	17	tamsulosin	tamsulosin	NOUN
aiua-10711	491	18	0.4	0.4	NUM
aiua-10711	491	19	mg	mg	NOUN
aiua-10711	491	20	in	in	ADP
aiua-10711	491	21	asian	asian	ADJ
aiua-10711	491	22	patients	patient	NOUN
aiua-10711	491	23	with	with	ADP
aiua-10711	491	24	lower	low	ADJ
aiua-10711	491	25	urinary	urinary	ADJ
aiua-10711	491	26	tract	tract	NOUN
aiua-10711	491	27	symptoms	symptom	NOUN
aiua-10711	491	28	secondary	secondary	ADJ
aiua-10711	491	29	to	to	ADP
aiua-10711	491	30	benign	benign	ADJ
aiua-10711	491	31	prostatic	prostatic	ADJ
aiua-10711	491	32	hyperplasia	hyperplasia	NOUN
aiua-10711	491	33	refractory	refractory	NOUN
aiua-10711	491	34	to	to	PART
aiua-10711	491	35	tamsulosin	tamsulosin	VERB
aiua-10711	491	36	0.2	0.2	NUM
aiua-10711	491	37	mg	mg	NUM
aiua-10711	491	38	:	:	PUNCT
aiua-10711	491	39	a	a	DET
aiua-10711	491	40	randomized	randomized	ADJ
aiua-10711	491	41	placebo	placebo	NOUN
aiua-10711	491	42	controlled	control	VERB
aiua-10711	491	43	trial	trial	NOUN
aiua-10711	491	44	.	.	PUNCT
aiua-10711	492	1	int	int	NOUN
aiua-10711	492	2	j	j	PROPN
aiua-10711	492	3	urol	urol	PROPN
aiua-10711	492	4	.	.	PUNCT
aiua-10711	493	1	2014	2014	NUM
aiua-10711	493	2	;	;	PUNCT
aiua-10711	493	3	21:677	21:677	NUM
aiua-10711	493	4	-	-	SYM
aiua-10711	493	5	82	82	NUM
aiua-10711	493	6	.	.	PUNCT
aiua-10711	494	1	263archivio	263archivio	NUM
aiua-10711	494	2	italiano	italiano	NOUN
aiua-10711	494	3	di	di	X
aiua-10711	494	4	urologia	urologia	PROPN
aiua-10711	494	5	e	e	PROPN
aiua-10711	494	6	andrologia	andrologia	PROPN
aiua-10711	494	7	2022	2022	NUM
aiua-10711	494	8	;	;	PUNCT
aiua-10711	494	9	94	94	NUM
aiua-10711	494	10	,	,	PUNCT
aiua-10711	494	11	2	2	NUM
aiua-10711	494	12	sexual	sexual	ADJ
aiua-10711	494	13	function	function	NOUN
aiua-10711	494	14	and	and	CCONJ
aiua-10711	494	15	alpha	alpha	NOUN
aiua-10711	494	16	-	-	PUNCT
aiua-10711	494	17	blockers	blocker	NOUN
aiua-10711	494	18	82	82	NUM
aiua-10711	494	19	.	.	PUNCT
aiua-10711	495	1	lojanapiwat	lojanapiwat	PROPN
aiua-10711	495	2	b	b	PROPN
aiua-10711	495	3	,	,	PUNCT
aiua-10711	495	4	kochakarn	kochakarn	VERB
aiua-10711	495	5	w	w	PROPN
aiua-10711	495	6	,	,	PUNCT
aiua-10711	495	7	suparatchatpan	suparatchatpan	NOUN
aiua-10711	495	8	n	n	CCONJ
aiua-10711	495	9	,	,	PUNCT
aiua-10711	495	10	lertwuttichaikul	lertwuttichaikul	PROPN
aiua-10711	495	11	k.	k.	PROPN
aiua-10711	495	12	effectiveness	effectiveness	PROPN
aiua-10711	495	13	of	of	ADP
aiua-10711	495	14	low	low	ADV
aiua-10711	495	15	-	-	PUNCT
aiua-10711	495	16	dose	dose	VERB
aiua-10711	495	17	and	and	CCONJ
aiua-10711	495	18	standard	standard	ADJ
aiua-10711	495	19	-	-	PUNCT
aiua-10711	495	20	dose	dose	NOUN
aiua-10711	495	21	tamsulosin	tamsulosin	NOUN
aiua-10711	495	22	in	in	ADP
aiua-10711	495	23	the	the	DET
aiua-10711	495	24	treatment	treatment	NOUN
aiua-10711	495	25	of	of	ADP
aiua-10711	495	26	distal	distal	ADJ
aiua-10711	495	27	ureteric	ureteric	ADJ
aiua-10711	495	28	stones	stone	NOUN
aiua-10711	495	29	:	:	PUNCT
aiua-10711	495	30	a	a	DET
aiua-10711	495	31	randomized	randomized	ADJ
aiua-10711	495	32	controlled	control	VERB
aiua-10711	495	33	study	study	NOUN
aiua-10711	495	34	.	.	PUNCT
aiua-10711	496	1	j	j	PROPN
aiua-10711	496	2	int	int	PROPN
aiua-10711	496	3	med	med	PROPN
aiua-10711	496	4	res	re	NOUN
aiua-10711	496	5	.	.	PUNCT
aiua-10711	496	6	2008	2008	NUM
aiua-10711	496	7	;	;	PUNCT
aiua-10711	497	1	36:529	36:529	NUM
aiua-10711	497	2	-	-	SYM
aiua-10711	497	3	36	36	NUM
aiua-10711	497	4	.	.	PUNCT
aiua-10711	497	5	83	83	NUM
aiua-10711	497	6	.	.	PUNCT
aiua-10711	498	1	yanardag	yanardag	PROPN
aiua-10711	498	2	h	h	PROPN
aiua-10711	498	3	,	,	PUNCT
aiua-10711	498	4	goktas	goktas	PROPN
aiua-10711	498	5	s	s	PROPN
aiua-10711	498	6	,	,	PUNCT
aiua-10711	498	7	kibar	kibar	PROPN
aiua-10711	498	8	y	y	PROPN
aiua-10711	498	9	,	,	PUNCT
aiua-10711	498	10	et	et	PROPN
aiua-10711	498	11	al	al	PROPN
aiua-10711	498	12	.	.	PROPN
aiua-10711	498	13	intermittent	intermittent	PROPN
aiua-10711	498	14	tamsulosin	tamsulosin	NOUN
aiua-10711	498	15	therapy	therapy	NOUN
aiua-10711	498	16	in	in	ADP
aiua-10711	498	17	men	man	NOUN
aiua-10711	498	18	with	with	ADP
aiua-10711	498	19	lower	low	ADJ
aiua-10711	498	20	urinary	urinary	ADJ
aiua-10711	498	21	tract	tract	NOUN
aiua-10711	498	22	symptoms	symptom	NOUN
aiua-10711	498	23	.	.	PUNCT
aiua-10711	499	1	j	j	PROPN
aiua-10711	499	2	urol	urol	PROPN
aiua-10711	499	3	.	.	PUNCT
aiua-10711	499	4	2005	2005	NUM
aiua-10711	499	5	;	;	PUNCT
aiua-10711	499	6	173:155	173:155	NOUN
aiua-10711	499	7	-	-	SYM
aiua-10711	499	8	7	7	NUM
aiua-10711	499	9	.	.	NOUN
aiua-10711	499	10	84	84	NUM
aiua-10711	499	11	.	.	PUNCT
aiua-10711	500	1	hareendran	hareendran	PROPN
aiua-10711	500	2	a	a	PRON
aiua-10711	500	3	,	,	PUNCT
aiua-10711	500	4	abraham	abraham	PROPN
aiua-10711	500	5	l.	l.	PROPN
aiua-10711	500	6	using	use	VERB
aiua-10711	500	7	a	a	DET
aiua-10711	500	8	treatment	treatment	NOUN
aiua-10711	500	9	satisfaction	satisfaction	NOUN
aiua-10711	500	10	measure	measure	NOUN
aiua-10711	500	11	in	in	ADP
aiua-10711	500	12	an	an	DET
aiua-10711	500	13	early	early	ADJ
aiua-10711	500	14	trial	trial	NOUN
aiua-10711	500	15	to	to	PART
aiua-10711	500	16	inform	inform	VERB
aiua-10711	500	17	the	the	DET
aiua-10711	500	18	evaluation	evaluation	NOUN
aiua-10711	500	19	of	of	ADP
aiua-10711	500	20	a	a	DET
aiua-10711	500	21	new	new	ADJ
aiua-10711	500	22	treatment	treatment	NOUN
aiua-10711	500	23	for	for	ADP
aiua-10711	500	24	benign	benign	ADJ
aiua-10711	500	25	prostatic	prostatic	ADJ
aiua-10711	500	26	hyperplasia	hyperplasia	NOUN
aiua-10711	500	27	.	.	PUNCT
aiua-10711	501	1	value	value	NOUN
aiua-10711	501	2	health	health	NOUN
aiua-10711	501	3	.	.	PUNCT
aiua-10711	502	1	2005	2005	NUM
aiua-10711	502	2	;	;	PUNCT
aiua-10711	502	3	8(suppl	8(suppl	PROPN
aiua-10711	502	4	1):s35	1):s35	NUM
aiua-10711	502	5	-	-	SYM
aiua-10711	502	6	40	40	NUM
aiua-10711	502	7	.	.	PUNCT
aiua-10711	502	8	85	85	NUM
aiua-10711	502	9	.	.	PUNCT
aiua-10711	503	1	lepor	lepor	PROPN
aiua-10711	503	2	h.	h.	PROPN
aiua-10711	503	3	alpha	alpha	PROPN
aiua-10711	503	4	-	-	PUNCT
aiua-10711	503	5	blockers	blocker	NOUN
aiua-10711	503	6	for	for	ADP
aiua-10711	503	7	the	the	DET
aiua-10711	503	8	treatment	treatment	NOUN
aiua-10711	503	9	of	of	ADP
aiua-10711	503	10	benign	benign	ADJ
aiua-10711	503	11	prostatic	prostatic	ADJ
aiua-10711	503	12	hyperplasia	hyperplasia	NOUN
aiua-10711	503	13	.	.	PUNCT
aiua-10711	504	1	urol	urol	PROPN
aiua-10711	504	2	clin	clin	PROPN
aiua-10711	504	3	north	north	PROPN
aiua-10711	504	4	am	am	PROPN
aiua-10711	504	5	.	.	PUNCT
aiua-10711	505	1	2016	2016	NUM
aiua-10711	505	2	;	;	PUNCT
aiua-10711	505	3	43:311	43:311	NUM
aiua-10711	505	4	-	-	SYM
aiua-10711	505	5	23	23	NUM
aiua-10711	505	6	.	.	PUNCT
aiua-10711	506	1	86	86	NUM
aiua-10711	506	2	.	.	PUNCT
aiua-10711	506	3	nickel	nickel	PROPN
aiua-10711	506	4	jc	jc	PROPN
aiua-10711	506	5	,	,	PUNCT
aiua-10711	506	6	sander	sander	PROPN
aiua-10711	506	7	s	s	PROPN
aiua-10711	506	8	,	,	PUNCT
aiua-10711	506	9	moon	moon	NOUN
aiua-10711	506	10	td	td	NOUN
aiua-10711	506	11	.	.	PUNCT
aiua-10711	507	1	a	a	DET
aiua-10711	507	2	meta	meta	ADJ
aiua-10711	507	3	-	-	PUNCT
aiua-10711	507	4	analysis	analysis	NOUN
aiua-10711	507	5	of	of	ADP
aiua-10711	507	6	the	the	DET
aiua-10711	507	7	vascularrelated	vascularrelate	VERB
aiua-10711	507	8	safety	safety	NOUN
aiua-10711	507	9	profile	profile	NOUN
aiua-10711	507	10	and	and	CCONJ
aiua-10711	507	11	efficacy	efficacy	NOUN
aiua-10711	507	12	of	of	ADP
aiua-10711	507	13	alpha	alpha	NOUN
aiua-10711	507	14	-	-	PUNCT
aiua-10711	507	15	adrenergic	adrenergic	ADJ
aiua-10711	507	16	blockers	blocker	NOUN
aiua-10711	507	17	for	for	ADP
aiua-10711	507	18	symptoms	symptom	NOUN
aiua-10711	507	19	related	relate	VERB
aiua-10711	507	20	to	to	ADP
aiua-10711	507	21	benign	benign	ADJ
aiua-10711	507	22	prostatic	prostatic	ADJ
aiua-10711	507	23	hyperplasia	hyperplasia	NOUN
aiua-10711	507	24	.	.	PUNCT
aiua-10711	508	1	int	int	PROPN
aiua-10711	509	1	j	j	PROPN
aiua-10711	509	2	clin	clin	PROPN
aiua-10711	509	3	pract	pract	PROPN
aiua-10711	509	4	.	.	PUNCT
aiua-10711	509	5	2008	2008	NUM
aiua-10711	509	6	;	;	PUNCT
aiua-10711	509	7	62:1547	62:1547	X
aiua-10711	509	8	-	-	SYM
aiua-10711	509	9	59	59	NUM
aiua-10711	509	10	.	.	PUNCT
aiua-10711	509	11	87	87	NUM
aiua-10711	509	12	.	.	PUNCT
aiua-10711	510	1	hollingsworth	hollingsworth	PROPN
aiua-10711	510	2	jm	jm	PROPN
aiua-10711	510	3	,	,	PUNCT
aiua-10711	510	4	canales	canale	NOUN
aiua-10711	510	5	bk	bk	PROPN
aiua-10711	510	6	,	,	PUNCT
aiua-10711	510	7	rogers	rogers	PROPN
aiua-10711	510	8	ma	ma	PROPN
aiua-10711	510	9	,	,	PUNCT
aiua-10711	510	10	et	et	PROPN
aiua-10711	510	11	al	al	PROPN
aiua-10711	510	12	.	.	PUNCT
aiua-10711	511	1	alpha	alpha	PROPN
aiua-10711	511	2	blockers	blocker	NOUN
aiua-10711	511	3	for	for	ADP
aiua-10711	511	4	treatment	treatment	NOUN
aiua-10711	511	5	of	of	ADP
aiua-10711	511	6	ureteric	ureteric	ADJ
aiua-10711	511	7	stones	stone	NOUN
aiua-10711	511	8	:	:	PUNCT
aiua-10711	511	9	systematic	systematic	ADJ
aiua-10711	511	10	review	review	NOUN
aiua-10711	511	11	and	and	CCONJ
aiua-10711	511	12	meta	meta	ADJ
aiua-10711	511	13	-	-	PUNCT
aiua-10711	511	14	analysis	analysis	NOUN
aiua-10711	511	15	.	.	PUNCT
aiua-10711	512	1	bmj	bmj	PROPN
aiua-10711	512	2	.	.	PROPN
aiua-10711	512	3	2016	2016	NUM
aiua-10711	512	4	;	;	PUNCT
aiua-10711	512	5	355	355	NUM
aiua-10711	512	6	:	:	PUNCT
aiua-10711	512	7	i6112	i6112	PROPN
aiua-10711	512	8	.	.	PUNCT
aiua-10711	512	9	88	88	NUM
aiua-10711	512	10	.	.	PUNCT
aiua-10711	513	1	sentürk	sentürk	PROPN
aiua-10711	513	2	ab	ab	PROPN
aiua-10711	513	3	,	,	PUNCT
aiua-10711	513	4	aydin	aydin	VERB
aiua-10711	513	5	c	c	NOUN
aiua-10711	513	6	,	,	PUNCT
aiua-10711	513	7	ekici	ekici	PROPN
aiua-10711	513	8	m	m	PROPN
aiua-10711	513	9	,	,	PUNCT
aiua-10711	513	10	et	et	PROPN
aiua-10711	513	11	al	al	PROPN
aiua-10711	513	12	.	.	PROPN
aiua-10711	513	13	comparison	comparison	NOUN
aiua-10711	513	14	of	of	ADP
aiua-10711	513	15	three	three	NUM
aiua-10711	513	16	most	most	ADV
aiua-10711	513	17	frequently	frequently	ADV
aiua-10711	513	18	used	use	VERB
aiua-10711	513	19	alpha	alpha	NOUN
aiua-10711	513	20	blocker	blocker	NOUN
aiua-10711	513	21	agents	agent	NOUN
aiua-10711	513	22	in	in	ADP
aiua-10711	513	23	medical	medical	ADJ
aiua-10711	513	24	expulsive	expulsive	NOUN
aiua-10711	513	25	therapy	therapy	NOUN
aiua-10711	513	26	for	for	ADP
aiua-10711	513	27	distal	distal	ADJ
aiua-10711	513	28	ureteral	ureteral	ADJ
aiua-10711	513	29	calculi	calculi	NOUN
aiua-10711	513	30	,	,	PUNCT
aiua-10711	513	31	result	result	NOUN
aiua-10711	513	32	of	of	ADP
aiua-10711	513	33	a	a	DET
aiua-10711	513	34	retrospective	retrospective	ADJ
aiua-10711	513	35	observational	observational	ADJ
aiua-10711	513	36	study	study	NOUN
aiua-10711	513	37	.	.	PUNCT
aiua-10711	514	1	arch	arch	PROPN
aiua-10711	514	2	ital	ital	PROPN
aiua-10711	514	3	urol	urol	PROPN
aiua-10711	514	4	androl	androl	PROPN
aiua-10711	514	5	.	.	PROPN
aiua-10711	514	6	2018	2018	NUM
aiua-10711	514	7	;	;	PUNCT
aiua-10711	514	8	90:25	90:25	NUM
aiua-10711	514	9	-	-	SYM
aiua-10711	514	10	28	28	NUM
aiua-10711	514	11	.	.	PUNCT
aiua-10711	514	12	89	89	NUM
aiua-10711	514	13	.	.	PUNCT
aiua-10711	515	1	giuliano	giuliano	PROPN
aiua-10711	515	2	f.	f.	PROPN
aiua-10711	515	3	impact	impact	PROPN
aiua-10711	515	4	of	of	ADP
aiua-10711	515	5	medical	medical	ADJ
aiua-10711	515	6	treatments	treatment	NOUN
aiua-10711	515	7	for	for	ADP
aiua-10711	515	8	benign	benign	ADJ
aiua-10711	515	9	prostatic	prostatic	ADJ
aiua-10711	515	10	hyperplasia	hyperplasia	NOUN
aiua-10711	515	11	on	on	ADP
aiua-10711	515	12	sexual	sexual	ADJ
aiua-10711	515	13	function	function	NOUN
aiua-10711	515	14	.	.	PUNCT
aiua-10711	516	1	bju	bju	NOUN
aiua-10711	516	2	int	int	PROPN
aiua-10711	516	3	.	.	PUNCT
aiua-10711	517	1	2006	2006	NUM
aiua-10711	517	2	;	;	PUNCT
aiua-10711	517	3	97	97	NUM
aiua-10711	517	4	(	(	PUNCT
aiua-10711	517	5	suppl	suppl	ADJ
aiua-10711	517	6	2):34	2):34	PROPN
aiua-10711	517	7	-	-	SYM
aiua-10711	517	8	8	8	NUM
aiua-10711	517	9	;	;	PUNCT
aiua-10711	517	10	discussion	discussion	NOUN
aiua-10711	517	11	44	44	NUM
aiua-10711	517	12	-	-	SYM
aiua-10711	517	13	5	5	NUM
aiua-10711	517	14	.	.	NOUN
aiua-10711	517	15	90	90	NUM
aiua-10711	517	16	.	.	PUNCT
aiua-10711	518	1	hisasue	hisasue	PROPN
aiua-10711	518	2	s	s	PROPN
aiua-10711	518	3	,	,	PUNCT
aiua-10711	518	4	furuya	furuya	NOUN
aiua-10711	518	5	r	r	NOUN
aiua-10711	518	6	,	,	PUNCT
aiua-10711	518	7	itoh	itoh	NOUN
aiua-10711	518	8	n	n	CCONJ
aiua-10711	518	9	,	,	PUNCT
aiua-10711	518	10	et	et	PROPN
aiua-10711	518	11	al	al	PROPN
aiua-10711	518	12	.	.	PUNCT
aiua-10711	519	1	ejaculatory	ejaculatory	ADJ
aiua-10711	519	2	disorder	disorder	NOUN
aiua-10711	519	3	caused	cause	VERB
aiua-10711	519	4	by	by	ADP
aiua-10711	519	5	alpha-1	alpha-1	PROPN
aiua-10711	519	6	adrenoceptor	adrenoceptor	NOUN
aiua-10711	519	7	antagonists	antagonist	NOUN
aiua-10711	519	8	is	be	AUX
aiua-10711	519	9	not	not	PART
aiua-10711	519	10	retrograde	retrograde	ADJ
aiua-10711	519	11	ejaculation	ejaculation	NOUN
aiua-10711	519	12	but	but	CCONJ
aiua-10711	519	13	a	a	DET
aiua-10711	519	14	loss	loss	NOUN
aiua-10711	519	15	of	of	ADP
aiua-10711	519	16	seminal	seminal	ADJ
aiua-10711	519	17	emission	emission	NOUN
aiua-10711	519	18	.	.	PUNCT
aiua-10711	520	1	int	int	PROPN
aiua-10711	520	2	j	j	PROPN
aiua-10711	520	3	urol	urol	PROPN
aiua-10711	520	4	.	.	PUNCT
aiua-10711	521	1	2006	2006	NUM
aiua-10711	521	2	;	;	PUNCT
aiua-10711	521	3	13:1311	13:1311	NUM
aiua-10711	521	4	-	-	SYM
aiua-10711	521	5	6	6	NUM
aiua-10711	521	6	.	.	NOUN
aiua-10711	521	7	91	91	NUM
aiua-10711	521	8	.	.	PUNCT
aiua-10711	522	1	kobayashi	kobayashi	PROPN
aiua-10711	522	2	k	k	PROPN
aiua-10711	522	3	,	,	PUNCT
aiua-10711	522	4	masumori	masumori	PROPN
aiua-10711	522	5	n	n	CCONJ
aiua-10711	522	6	,	,	PUNCT
aiua-10711	522	7	hisasue	hisasue	NOUN
aiua-10711	522	8	s	s	PROPN
aiua-10711	522	9	,	,	PUNCT
aiua-10711	522	10	et	et	PROPN
aiua-10711	522	11	al	al	PROPN
aiua-10711	522	12	.	.	PROPN
aiua-10711	523	1	inhibition	inhibition	NOUN
aiua-10711	523	2	of	of	ADP
aiua-10711	523	3	seminal	seminal	ADJ
aiua-10711	523	4	emission	emission	NOUN
aiua-10711	523	5	is	be	AUX
aiua-10711	523	6	the	the	DET
aiua-10711	523	7	main	main	ADJ
aiua-10711	523	8	cause	cause	NOUN
aiua-10711	523	9	of	of	ADP
aiua-10711	523	10	anejaculation	anejaculation	NOUN
aiua-10711	523	11	induced	induce	VERB
aiua-10711	523	12	by	by	ADP
aiua-10711	523	13	a	a	DET
aiua-10711	523	14	new	new	ADJ
aiua-10711	523	15	highly	highly	ADV
aiua-10711	523	16	selective	selective	ADJ
aiua-10711	523	17	alpha1a	alpha1a	NOUN
aiua-10711	523	18	-	-	PUNCT
aiua-10711	523	19	blocker	blocker	NOUN
aiua-10711	523	20	in	in	ADP
aiua-10711	523	21	normal	normal	ADJ
aiua-10711	523	22	volunteers	volunteer	NOUN
aiua-10711	523	23	.	.	PUNCT
aiua-10711	524	1	j	j	PROPN
aiua-10711	524	2	sex	sex	PROPN
aiua-10711	524	3	med	med	PROPN
aiua-10711	524	4	.	.	PUNCT
aiua-10711	524	5	2008	2008	NUM
aiua-10711	524	6	;	;	PUNCT
aiua-10711	525	1	5:2185	5:2185	NUM
aiua-10711	525	2	-	-	SYM
aiua-10711	525	3	90	90	NUM
aiua-10711	525	4	.	.	PUNCT
aiua-10711	526	1	92	92	NUM
aiua-10711	526	2	.	.	PUNCT
aiua-10711	527	1	hellstrom	hellstrom	NOUN
aiua-10711	527	2	wj	wj	PROPN
aiua-10711	527	3	,	,	PUNCT
aiua-10711	527	4	sikka	sikka	PROPN
aiua-10711	527	5	sc	sc	PROPN
aiua-10711	527	6	.	.	PUNCT
aiua-10711	528	1	effects	effect	NOUN
aiua-10711	528	2	of	of	ADP
aiua-10711	528	3	acute	acute	ADJ
aiua-10711	528	4	treatment	treatment	NOUN
aiua-10711	528	5	with	with	ADP
aiua-10711	528	6	tamsulosin	tamsulosin	NOUN
aiua-10711	528	7	versus	versus	ADP
aiua-10711	528	8	alfuzosin	alfuzosin	NOUN
aiua-10711	528	9	on	on	ADP
aiua-10711	528	10	ejaculatory	ejaculatory	ADJ
aiua-10711	528	11	function	function	NOUN
aiua-10711	528	12	in	in	ADP
aiua-10711	528	13	normal	normal	ADJ
aiua-10711	528	14	volunteers	volunteer	NOUN
aiua-10711	528	15	.	.	PUNCT
aiua-10711	529	1	j	j	PROPN
aiua-10711	529	2	urol	urol	PROPN
aiua-10711	529	3	.	.	PUNCT
aiua-10711	530	1	2006	2006	NUM
aiua-10711	530	2	;	;	PUNCT
aiua-10711	530	3	176:1529	176:1529	NUM
aiua-10711	530	4	-	-	SYM
aiua-10711	530	5	1533	1533	NUM
aiua-10711	530	6	.	.	PUNCT
aiua-10711	531	1	93	93	NUM
aiua-10711	531	2	.	.	PUNCT
aiua-10711	532	1	yeung	yeung	PROPN
aiua-10711	532	2	hel	hel	PROPN
aiua-10711	532	3	,	,	PUNCT
aiua-10711	532	4	sena	sena	PROPN
aiua-10711	532	5	sj	sj	PROPN
aiua-10711	532	6	,	,	PUNCT
aiua-10711	532	7	calopedos	calopedos	PROPN
aiua-10711	532	8	rj	rj	PROPN
aiua-10711	532	9	,	,	PUNCT
aiua-10711	532	10	woo	woo	PROPN
aiua-10711	532	11	hh	hh	PROPN
aiua-10711	532	12	.	.	PROPN
aiua-10711	532	13	alfuzosin	alfuzosin	PROPN
aiua-10711	532	14	and	and	CCONJ
aiua-10711	532	15	its	its	PRON
aiua-10711	532	16	effect	effect	NOUN
aiua-10711	532	17	on	on	ADP
aiua-10711	532	18	ejaculatory	ejaculatory	ADJ
aiua-10711	532	19	dysfunction	dysfunction	NOUN
aiua-10711	532	20	:	:	PUNCT
aiua-10711	532	21	a	a	DET
aiua-10711	532	22	systematic	systematic	ADJ
aiua-10711	532	23	review	review	NOUN
aiua-10711	532	24	.	.	PUNCT
aiua-10711	533	1	world	world	PROPN
aiua-10711	533	2	j	j	PROPN
aiua-10711	533	3	mens	mens	PROPN
aiua-10711	533	4	health	health	PROPN
aiua-10711	533	5	.	.	PUNCT
aiua-10711	533	6	2021	2021	NUM
aiua-10711	533	7	;	;	PUNCT
aiua-10711	533	8	39:186	39:186	NUM
aiua-10711	533	9	-	-	SYM
aiua-10711	533	10	194	194	NUM
aiua-10711	533	11	94	94	NUM
aiua-10711	533	12	.	.	PUNCT
aiua-10711	534	1	britto	britto	PROPN
aiua-10711	534	2	-	-	PUNCT
aiua-10711	534	3	júnior	júnior	PROPN
aiua-10711	534	4	j	j	PROPN
aiua-10711	534	5	,	,	PUNCT
aiua-10711	534	6	ribeiro	ribeiro	PROPN
aiua-10711	534	7	a	a	PROPN
aiua-10711	534	8	,	,	PUNCT
aiua-10711	534	9	ximenes	ximenes	PROPN
aiua-10711	534	10	l	l	NOUN
aiua-10711	534	11	,	,	PUNCT
aiua-10711	534	12	et	et	PROPN
aiua-10711	534	13	al	al	PROPN
aiua-10711	534	14	.	.	PUNCT
aiua-10711	535	1	alpha1	alpha1	NOUN
aiua-10711	535	2	-	-	PUNCT
aiua-10711	535	3	adrenergic	adrenergic	ADJ
aiua-10711	535	4	antagonists	antagonist	NOUN
aiua-10711	535	5	block	block	VERB
aiua-10711	535	6	6	6	NUM
aiua-10711	535	7	-	-	PUNCT
aiua-10711	535	8	nitrodopamine	nitrodopamine	NOUN
aiua-10711	535	9	contractions	contraction	NOUN
aiua-10711	535	10	on	on	ADP
aiua-10711	535	11	the	the	DET
aiua-10711	535	12	rat	rat	NOUN
aiua-10711	535	13	isolated	isolate	VERB
aiua-10711	535	14	epididymal	epididymal	ADJ
aiua-10711	535	15	vas	vas	X
aiua-10711	535	16	deferens	deferen	NOUN
aiua-10711	535	17	.	.	PUNCT
aiua-10711	536	1	eur	eur	PROPN
aiua-10711	536	2	j	j	PROPN
aiua-10711	536	3	pharmacol	pharmacol	PROPN
aiua-10711	536	4	.	.	PUNCT
aiua-10711	537	1	2022	2022	NUM
aiua-10711	537	2	;	;	PUNCT
aiua-10711	538	1	915:174716	915:174716	NUM
aiua-10711	538	2	.	.	NOUN
aiua-10711	538	3	95	95	NUM
aiua-10711	538	4	.	.	PUNCT
aiua-10711	539	1	blum	blum	PROPN
aiua-10711	539	2	md	md	PROPN
aiua-10711	539	3	,	,	PUNCT
aiua-10711	539	4	bahnson	bahnson	PROPN
aiua-10711	539	5	rr	rr	PROPN
aiua-10711	539	6	,	,	PUNCT
aiua-10711	539	7	porter	porter	PROPN
aiua-10711	539	8	tn	tn	PROPN
aiua-10711	539	9	,	,	PUNCT
aiua-10711	539	10	carter	carter	PROPN
aiua-10711	539	11	mf	mf	PROPN
aiua-10711	539	12	.	.	PROPN
aiua-10711	539	13	effect	effect	NOUN
aiua-10711	539	14	of	of	ADP
aiua-10711	539	15	local	local	ADJ
aiua-10711	539	16	alpha	alpha	NOUN
aiua-10711	539	17	-	-	PUNCT
aiua-10711	539	18	adrenergic	adrenergic	ADJ
aiua-10711	539	19	blockade	blockade	NOUN
aiua-10711	539	20	on	on	ADP
aiua-10711	539	21	human	human	ADJ
aiua-10711	539	22	penile	penile	ADJ
aiua-10711	539	23	erection	erection	NOUN
aiua-10711	539	24	.	.	PUNCT
aiua-10711	540	1	j	j	PROPN
aiua-10711	540	2	urol	urol	PROPN
aiua-10711	540	3	.	.	PUNCT
aiua-10711	541	1	1985	1985	NUM
aiua-10711	541	2	;	;	PUNCT
aiua-10711	541	3	134:479	134:479	PROPN
aiua-10711	541	4	-	-	SYM
aiua-10711	541	5	481	481	NUM
aiua-10711	541	6	.	.	PUNCT
aiua-10711	542	1	96	96	NUM
aiua-10711	542	2	.	.	PUNCT
aiua-10711	543	1	brindley	brindley	PROPN
aiua-10711	543	2	gs	gs	PROPN
aiua-10711	543	3	.	.	PUNCT
aiua-10711	544	1	pilot	pilot	NOUN
aiua-10711	544	2	experiments	experiment	NOUN
aiua-10711	544	3	on	on	ADP
aiua-10711	544	4	the	the	DET
aiua-10711	544	5	actions	action	NOUN
aiua-10711	544	6	of	of	ADP
aiua-10711	544	7	drugs	drug	NOUN
aiua-10711	544	8	injected	inject	VERB
aiua-10711	544	9	into	into	ADP
aiua-10711	544	10	the	the	DET
aiua-10711	544	11	human	human	PROPN
aiua-10711	544	12	corpus	corpus	PROPN
aiua-10711	544	13	cavernosum	cavernosum	NOUN
aiua-10711	544	14	penis	penis	NOUN
aiua-10711	544	15	.	.	PUNCT
aiua-10711	545	1	br	br	PROPN
aiua-10711	545	2	j	j	PROPN
aiua-10711	545	3	pharmacol	pharmacol	PROPN
aiua-10711	545	4	.	.	PUNCT
aiua-10711	546	1	1986	1986	NUM
aiua-10711	546	2	;	;	PUNCT
aiua-10711	546	3	87:495500	87:495500	NUM
aiua-10711	546	4	.	.	PUNCT
aiua-10711	547	1	97	97	NUM
aiua-10711	547	2	.	.	PUNCT
aiua-10711	548	1	marconi	marconi	PROPN
aiua-10711	548	2	m	m	PROPN
aiua-10711	548	3	,	,	PUNCT
aiua-10711	548	4	pavez	pavez	ADJ
aiua-10711	548	5	p	p	X
aiua-10711	548	6	,	,	PUNCT
aiua-10711	548	7	san	san	PROPN
aiua-10711	548	8	francisco	francisco	PROPN
aiua-10711	549	1	i	i	PROPN
aiua-10711	549	2	,	,	PUNCT
aiua-10711	549	3	narvaez	narvaez	PROPN
aiua-10711	549	4	p.	p.	PROPN
aiua-10711	549	5	priapism	priapism	NOUN
aiua-10711	549	6	induced	induce	VERB
aiua-10711	549	7	by	by	ADP
aiua-10711	549	8	use	use	NOUN
aiua-10711	549	9	of	of	ADP
aiua-10711	549	10	tamsulosin	tamsulosin	NOUN
aiua-10711	549	11	:	:	PUNCT
aiua-10711	549	12	a	a	DET
aiua-10711	549	13	case	case	NOUN
aiua-10711	549	14	report	report	NOUN
aiua-10711	549	15	and	and	CCONJ
aiua-10711	549	16	review	review	NOUN
aiua-10711	549	17	of	of	ADP
aiua-10711	549	18	the	the	DET
aiua-10711	549	19	literature	literature	NOUN
aiua-10711	549	20	.	.	PUNCT
aiua-10711	550	1	arch	arch	PROPN
aiua-10711	550	2	ital	ital	PROPN
aiua-10711	550	3	urol	urol	PROPN
aiua-10711	550	4	androl	androl	PROPN
aiua-10711	550	5	.	.	PROPN
aiua-10711	550	6	2019	2019	NUM
aiua-10711	550	7	;	;	PUNCT
aiua-10711	550	8	91:193	91:193	NUM
aiua-10711	550	9	.	.	NOUN
aiua-10711	551	1	98	98	NUM
aiua-10711	551	2	.	.	PUNCT
aiua-10711	551	3	rampin	rampin	NOUN
aiua-10711	551	4	o.	o.	PROPN
aiua-10711	551	5	pharmacology	pharmacology	NOUN
aiua-10711	551	6	of	of	ADP
aiua-10711	551	7	alpha	alpha	NOUN
aiua-10711	551	8	-	-	PUNCT
aiua-10711	551	9	adrenoceptors	adrenoceptor	NOUN
aiua-10711	551	10	in	in	ADP
aiua-10711	551	11	male	male	ADJ
aiua-10711	551	12	sexual	sexual	ADJ
aiua-10711	551	13	function	function	NOUN
aiua-10711	551	14	.	.	PUNCT
aiua-10711	552	1	eur	eur	PROPN
aiua-10711	552	2	urol	urol	PROPN
aiua-10711	552	3	.	.	PUNCT
aiua-10711	552	4	1999	1999	NUM
aiua-10711	552	5	;	;	PUNCT
aiua-10711	552	6	36	36	NUM
aiua-10711	552	7	suppl	suppl	ADJ
aiua-10711	552	8	1:103	1:103	NUM
aiua-10711	552	9	-	-	SYM
aiua-10711	552	10	6	6	NUM
aiua-10711	552	11	.	.	NUM
aiua-10711	552	12	99	99	NUM
aiua-10711	552	13	.	.	PUNCT
aiua-10711	553	1	van	van	PROPN
aiua-10711	553	2	dijk	dijk	PROPN
aiua-10711	553	3	mm	mm	PROPN
aiua-10711	553	4	,	,	PUNCT
aiua-10711	553	5	de	de	X
aiua-10711	553	6	la	la	PROPN
aiua-10711	553	7	rosette	rosette	PROPN
aiua-10711	553	8	jj	jj	PROPN
aiua-10711	553	9	,	,	PUNCT
aiua-10711	553	10	michel	michel	PROPN
aiua-10711	553	11	mc	mc	PROPN
aiua-10711	553	12	.	.	PROPN
aiua-10711	553	13	effects	effect	NOUN
aiua-10711	553	14	of	of	ADP
aiua-10711	553	15	alpha(1)adrenoceptor	alpha(1)adrenoceptor	PROPN
aiua-10711	553	16	antagonists	antagonist	NOUN
aiua-10711	553	17	on	on	ADP
aiua-10711	553	18	male	male	ADJ
aiua-10711	553	19	sexual	sexual	ADJ
aiua-10711	553	20	function	function	NOUN
aiua-10711	553	21	.	.	PUNCT
aiua-10711	554	1	drugs	drug	NOUN
aiua-10711	554	2	.	.	PUNCT
aiua-10711	555	1	2006	2006	NUM
aiua-10711	555	2	;	;	PUNCT
aiua-10711	555	3	66:287	66:287	NUM
aiua-10711	555	4	-	-	SYM
aiua-10711	555	5	301	301	NUM
aiua-10711	555	6	.	.	NOUN
aiua-10711	555	7	100	100	NUM
aiua-10711	555	8	.	.	PUNCT
aiua-10711	556	1	kaplan	kaplan	PROPN
aiua-10711	556	2	sa	sa	PROPN
aiua-10711	556	3	,	,	PUNCT
aiua-10711	556	4	gonzalez	gonzalez	PROPN
aiua-10711	556	5	rr	rr	PROPN
aiua-10711	556	6	,	,	PUNCT
aiua-10711	556	7	te	te	PROPN
aiua-10711	556	8	ae	ae	PROPN
aiua-10711	556	9	.	.	PUNCT
aiua-10711	556	10	combination	combination	NOUN
aiua-10711	556	11	of	of	ADP
aiua-10711	556	12	alfuzosin	alfuzosin	NOUN
aiua-10711	556	13	and	and	CCONJ
aiua-10711	556	14	sildenafil	sildenafil	NOUN
aiua-10711	556	15	is	be	AUX
aiua-10711	556	16	superior	superior	ADJ
aiua-10711	556	17	to	to	ADP
aiua-10711	556	18	monotherapy	monotherapy	NOUN
aiua-10711	556	19	in	in	ADP
aiua-10711	556	20	treating	treat	VERB
aiua-10711	556	21	lower	low	ADJ
aiua-10711	556	22	urinary	urinary	ADJ
aiua-10711	556	23	tract	tract	NOUN
aiua-10711	556	24	symptoms	symptom	NOUN
aiua-10711	556	25	and	and	CCONJ
aiua-10711	556	26	erectile	erectile	ADJ
aiua-10711	556	27	dysfunction	dysfunction	NOUN
aiua-10711	556	28	.	.	PUNCT
aiua-10711	557	1	eur	eur	PROPN
aiua-10711	557	2	urol	urol	PROPN
aiua-10711	557	3	.	.	PUNCT
aiua-10711	558	1	2007	2007	NUM
aiua-10711	558	2	;	;	PUNCT
aiua-10711	558	3	51:1717	51:1717	NOUN
aiua-10711	558	4	-	-	SYM
aiua-10711	558	5	1723	1723	NUM
aiua-10711	558	6	.	.	PUNCT
aiua-10711	559	1	101	101	NUM
aiua-10711	559	2	.	.	PUNCT
aiua-10711	559	3	yan	yan	PROPN
aiua-10711	559	4	h	h	PROPN
aiua-10711	559	5	,	,	PUNCT
aiua-10711	559	6	zong	zong	PROPN
aiua-10711	559	7	h	h	PROPN
aiua-10711	559	8	,	,	PUNCT
aiua-10711	559	9	cui	cui	PROPN
aiua-10711	559	10	y	y	PROPN
aiua-10711	559	11	,	,	PUNCT
aiua-10711	559	12	et	et	PROPN
aiua-10711	559	13	al	al	PROPN
aiua-10711	559	14	.	.	PUNCT
aiua-10711	560	1	the	the	DET
aiua-10711	560	2	efficacy	efficacy	NOUN
aiua-10711	560	3	of	of	ADP
aiua-10711	560	4	pde5	pde5	NOUN
aiua-10711	560	5	inhibitors	inhibitor	NOUN
aiua-10711	560	6	alone	alone	ADJ
aiua-10711	560	7	or	or	CCONJ
aiua-10711	560	8	in	in	ADP
aiua-10711	560	9	combination	combination	NOUN
aiua-10711	560	10	with	with	ADP
aiua-10711	560	11	alpha	alpha	NOUN
aiua-10711	560	12	-	-	PUNCT
aiua-10711	560	13	blockers	blocker	NOUN
aiua-10711	560	14	for	for	ADP
aiua-10711	560	15	the	the	DET
aiua-10711	560	16	treatment	treatment	NOUN
aiua-10711	560	17	of	of	ADP
aiua-10711	560	18	erectile	erectile	ADJ
aiua-10711	560	19	dysfunction	dysfunction	NOUN
aiua-10711	560	20	and	and	CCONJ
aiua-10711	560	21	lower	low	ADJ
aiua-10711	560	22	urinary	urinary	ADJ
aiua-10711	560	23	tract	tract	NOUN
aiua-10711	560	24	symptoms	symptom	NOUN
aiua-10711	560	25	due	due	ADJ
aiua-10711	560	26	to	to	ADP
aiua-10711	560	27	benign	benign	ADJ
aiua-10711	560	28	prostatic	prostatic	ADJ
aiua-10711	560	29	hyperplasia	hyperplasia	NOUN
aiua-10711	560	30	:	:	PUNCT
aiua-10711	560	31	a	a	DET
aiua-10711	560	32	systematic	systematic	ADJ
aiua-10711	560	33	review	review	NOUN
aiua-10711	560	34	and	and	CCONJ
aiua-10711	560	35	meta	meta	ADJ
aiua-10711	560	36	-	-	PUNCT
aiua-10711	560	37	analysis	analysis	NOUN
aiua-10711	560	38	.	.	PUNCT
aiua-10711	561	1	j	j	PROPN
aiua-10711	561	2	sex	sex	PROPN
aiua-10711	561	3	med	med	PROPN
aiua-10711	561	4	.	.	PUNCT
aiua-10711	561	5	2014	2014	NUM
aiua-10711	561	6	;	;	PUNCT
aiua-10711	561	7	11:1539	11:1539	X
aiua-10711	561	8	-	-	SYM
aiua-10711	561	9	45	45	NUM
aiua-10711	561	10	.	.	NOUN
aiua-10711	562	1	102	102	NUM
aiua-10711	562	2	.	.	PUNCT
aiua-10711	563	1	kallidonis	kallidonis	PROPN
aiua-10711	563	2	p	p	X
aiua-10711	563	3	,	,	PUNCT
aiua-10711	563	4	adamou	adamou	ADV
aiua-10711	563	5	c	c	NOUN
aiua-10711	563	6	,	,	PUNCT
aiua-10711	563	7	kotsiris	kotsiris	PROPN
aiua-10711	563	8	d	d	PROPN
aiua-10711	563	9	,	,	PUNCT
aiua-10711	563	10	et	et	PROPN
aiua-10711	563	11	al	al	PROPN
aiua-10711	563	12	.	.	PUNCT
aiua-10711	564	1	young	young	ADJ
aiua-10711	564	2	academic	academic	ADJ
aiua-10711	564	3	urologists	urologist	NOUN
aiua-10711	564	4	of	of	ADP
aiua-10711	564	5	the	the	DET
aiua-10711	564	6	european	european	PROPN
aiua-10711	564	7	association	association	PROPN
aiua-10711	564	8	of	of	ADP
aiua-10711	564	9	urology	urology	NOUN
aiua-10711	564	10	-	-	PUNCT
aiua-10711	564	11	endourology	endourology	NOUN
aiua-10711	564	12	working	work	VERB
aiua-10711	564	13	party	party	NOUN
aiua-10711	564	14	.	.	PUNCT
aiua-10711	565	1	combination	combination	NOUN
aiua-10711	565	2	therapy	therapy	NOUN
aiua-10711	565	3	with	with	ADP
aiua-10711	565	4	alpha	alpha	NOUN
aiua-10711	565	5	-	-	NOUN
aiua-10711	565	6	blocker	blocker	NOUN
aiua-10711	565	7	and	and	CCONJ
aiua-10711	565	8	phosphodiesterase-5	phosphodiesterase-5	NUM
aiua-10711	565	9	inhibitor	inhibitor	NOUN
aiua-10711	565	10	for	for	ADP
aiua-10711	565	11	improving	improve	VERB
aiua-10711	565	12	lower	low	ADJ
aiua-10711	565	13	urinary	urinary	ADJ
aiua-10711	565	14	tract	tract	NOUN
aiua-10711	565	15	symptoms	symptom	NOUN
aiua-10711	565	16	and	and	CCONJ
aiua-10711	565	17	erectile	erectile	ADJ
aiua-10711	565	18	dysfunction	dysfunction	NOUN
aiua-10711	565	19	in	in	ADP
aiua-10711	565	20	comparison	comparison	NOUN
aiua-10711	565	21	with	with	ADP
aiua-10711	565	22	monotherapy	monotherapy	NOUN
aiua-10711	565	23	:	:	PUNCT
aiua-10711	565	24	a	a	DET
aiua-10711	565	25	systematic	systematic	ADJ
aiua-10711	565	26	review	review	NOUN
aiua-10711	565	27	and	and	CCONJ
aiua-10711	565	28	meta	meta	ADJ
aiua-10711	565	29	-	-	PUNCT
aiua-10711	565	30	analysis	analysis	NOUN
aiua-10711	565	31	.	.	PUNCT
aiua-10711	566	1	eur	eur	PROPN
aiua-10711	566	2	urol	urol	ADJ
aiua-10711	566	3	focus	focus	NOUN
aiua-10711	566	4	.	.	PUNCT
aiua-10711	567	1	2020	2020	NUM
aiua-10711	567	2	;	;	PUNCT
aiua-10711	567	3	6:537	6:537	NUM
aiua-10711	567	4	-	-	SYM
aiua-10711	567	5	558	558	NUM
aiua-10711	567	6	.	.	PUNCT
aiua-10711	567	7	103	103	NUM
aiua-10711	567	8	.	.	PUNCT
aiua-10711	568	1	tufanaru	tufanaru	PROPN
aiua-10711	568	2	c	c	PROPN
aiua-10711	568	3	,	,	PUNCT
aiua-10711	568	4	munn	munn	PROPN
aiua-10711	568	5	z	z	PROPN
aiua-10711	568	6	,	,	PUNCT
aiua-10711	568	7	stephenson	stephenson	PROPN
aiua-10711	568	8	m	m	PROPN
aiua-10711	568	9	,	,	PUNCT
aiua-10711	568	10	aromataris	aromataris	PROPN
aiua-10711	568	11	e.	e.	PROPN
aiua-10711	568	12	fixed	fix	VERB
aiua-10711	568	13	or	or	CCONJ
aiua-10711	568	14	random	random	ADJ
aiua-10711	568	15	effects	effect	NOUN
aiua-10711	568	16	meta	meta	ADJ
aiua-10711	568	17	-	-	PUNCT
aiua-10711	568	18	analysis	analysis	NOUN
aiua-10711	568	19	?	?	PUNCT
aiua-10711	569	1	common	common	ADJ
aiua-10711	569	2	methodological	methodological	ADJ
aiua-10711	569	3	issues	issue	NOUN
aiua-10711	569	4	in	in	ADP
aiua-10711	569	5	systematic	systematic	ADJ
aiua-10711	569	6	reviews	review	NOUN
aiua-10711	569	7	of	of	ADP
aiua-10711	569	8	effectiveness	effectiveness	NOUN
aiua-10711	569	9	.	.	PUNCT
aiua-10711	570	1	int	int	PROPN
aiua-10711	570	2	j	j	PROPN
aiua-10711	570	3	evid	evid	PROPN
aiua-10711	570	4	based	base	VERB
aiua-10711	570	5	healthc	healthc	PROPN
aiua-10711	570	6	.	.	PROPN
aiua-10711	570	7	2015	2015	NUM
aiua-10711	570	8	;	;	PUNCT
aiua-10711	570	9	13:196	13:196	NUM
aiua-10711	570	10	-	-	SYM
aiua-10711	570	11	207	207	NUM
aiua-10711	570	12	.	.	PUNCT
aiua-10711	571	1	correspondence	correspondence	NOUN
aiua-10711	571	2	rawa	rawa	PROPN
aiua-10711	571	3	bapir	bapir	PROPN
aiua-10711	571	4	dr.rawa@yahoo.com	dr.rawa@yahoo.com	VERB
aiua-10711	571	5	smart	smart	ADJ
aiua-10711	571	6	health	health	NOUN
aiua-10711	571	7	tower	tower	NOUN
aiua-10711	571	8	,	,	PUNCT
aiua-10711	571	9	sulaymaniyah	sulaymaniyah	NOUN
aiua-10711	571	10	,	,	PUNCT
aiua-10711	571	11	kurdistan	kurdistan	ADJ
aiua-10711	571	12	region	region	NOUN
aiua-10711	571	13	,	,	PUNCT
aiua-10711	571	14	iraq	iraq	PROPN
aiua-10711	571	15	kamran	kamran	PROPN
aiua-10711	571	16	hassan	hassan	PROPN
aiua-10711	571	17	bhatti	bhatti	PROPN
aiua-10711	571	18	kamibhatti92@gmail.com	kamibhatti92@gmail.com	PROPN
aiua-10711	571	19	urology	urology	NOUN
aiua-10711	571	20	department	department	PROPN
aiua-10711	571	21	,	,	PUNCT
aiua-10711	571	22	hmc	hmc	PROPN
aiua-10711	571	23	,	,	PUNCT
aiua-10711	571	24	hamad	hamad	PROPN
aiua-10711	571	25	medical	medical	PROPN
aiua-10711	571	26	corporation	corporation	PROPN
aiua-10711	571	27	,	,	PUNCT
aiua-10711	571	28	qatar	qatar	PROPN
aiua-10711	571	29	.	.	PUNCT
aiua-10711	572	1	ahmed	ahmed	PROPN
aiua-10711	572	2	eliwa	eliwa	PROPN
aiua-10711	572	3	ahmedeliwafarag@gmail.com	ahmedeliwafarag@gmail.com	PROPN
aiua-10711	572	4	department	department	PROPN
aiua-10711	572	5	of	of	ADP
aiua-10711	572	6	urology	urology	NOUN
aiua-10711	572	7	,	,	PUNCT
aiua-10711	572	8	zagazig	zagazig	PROPN
aiua-10711	572	9	university	university	PROPN
aiua-10711	572	10	,	,	PUNCT
aiua-10711	572	11	zagazig	zagazig	PROPN
aiua-10711	572	12	,	,	PUNCT
aiua-10711	572	13	sharkia	sharkia	PROPN
aiua-10711	572	14	,	,	PUNCT
aiua-10711	572	15	egypt	egypt	PROPN
aiua-10711	572	16	.	.	PUNCT
aiua-10711	573	1	herney	herney	PROPN
aiua-10711	573	2	andrés	andrés	PROPN
aiua-10711	573	3	garcía	garcía	PROPN
aiua-10711	573	4	-	-	PUNCT
aiua-10711	573	5	perdomo	perdomo	NOUN
aiua-10711	573	6	herney.garcia@correounivalle.edu.co	herney.garcia@correounivalle.edu.co	PROPN
aiua-10711	573	7	universidad	universidad	PROPN
aiua-10711	573	8	del	del	PROPN
aiua-10711	573	9	valle	valle	PROPN
aiua-10711	573	10	,	,	PUNCT
aiua-10711	573	11	cali	cali	PROPN
aiua-10711	573	12	,	,	PUNCT
aiua-10711	573	13	colombia	colombia	PROPN
aiua-10711	573	14	nazim	nazim	PROPN
aiua-10711	573	15	gherabi	gherabi	PROPN
aiua-10711	573	16	,	,	PUNCT
aiua-10711	573	17	md	md	PROPN
aiua-10711	573	18	ngherabi@gmail.com	ngherabi@gmail.com	PROPN
aiua-10711	573	19	faculty	faculty	NOUN
aiua-10711	573	20	of	of	ADP
aiua-10711	573	21	medicine	medicine	NOUN
aiua-10711	573	22	algiers	algiers	PROPN
aiua-10711	573	23	1	1	NUM
aiua-10711	573	24	,	,	PUNCT
aiua-10711	573	25	algiers	algiers	PROPN
aiua-10711	573	26	,	,	PUNCT
aiua-10711	573	27	algeria	algeria	PROPN
aiua-10711	573	28	derek	derek	PROPN
aiua-10711	573	29	hennessey	hennessey	PROPN
aiua-10711	573	30	,	,	PUNCT
aiua-10711	573	31	md	md	PROPN
aiua-10711	573	32	derek.hennessey@gmail.com	derek.hennessey@gmail.com	PROPN
aiua-10711	573	33	department	department	PROPN
aiua-10711	573	34	of	of	ADP
aiua-10711	573	35	urology	urology	NOUN
aiua-10711	573	36	,	,	PUNCT
aiua-10711	573	37	mercy	mercy	NOUN
aiua-10711	573	38	university	university	NOUN
aiua-10711	573	39	hospital	hospital	NOUN
aiua-10711	573	40	,	,	PUNCT
aiua-10711	573	41	cork	cork	NOUN
aiua-10711	573	42	,	,	PUNCT
aiua-10711	573	43	ireland	ireland	PROPN
aiua-10711	573	44	vittorio	vittorio	PROPN
aiua-10711	573	45	magri	magri	PROPN
aiua-10711	573	46	,	,	PUNCT
aiua-10711	573	47	md	md	PROPN
aiua-10711	573	48	vittorio.magri@virgilio.it	vittorio.magri@virgilio.it	PROPN
aiua-10711	573	49	asst	asst	PROPN
aiua-10711	573	50	nord	nord	PROPN
aiua-10711	573	51	milano	milano	PROPN
aiua-10711	573	52	,	,	PUNCT
aiua-10711	573	53	milan	milan	PROPN
aiua-10711	573	54	,	,	PUNCT
aiua-10711	573	55	italy	italy	PROPN
aiua-10711	573	56	panagiotis	panagiotis	PROPN
aiua-10711	573	57	mourmouris	mourmouris	PROPN
aiua-10711	573	58	,	,	PUNCT
aiua-10711	573	59	md	md	PROPN
aiua-10711	573	60	thodoros13@yahoo.com	thodoros13@yahoo.com	PROPN
aiua-10711	573	61	2nd	2nd	PROPN
aiua-10711	573	62	department	department	PROPN
aiua-10711	573	63	of	of	ADP
aiua-10711	573	64	urology	urology	NOUN
aiua-10711	573	65	,	,	PUNCT
aiua-10711	573	66	national	national	ADJ
aiua-10711	573	67	and	and	CCONJ
aiua-10711	573	68	kapodistrian	kapodistrian	ADJ
aiua-10711	573	69	university	university	PROPN
aiua-10711	573	70	of	of	ADP
aiua-10711	573	71	athens	athens	PROPN
aiua-10711	573	72	,	,	PUNCT
aiua-10711	573	73	sismanoglio	sismanoglio	PROPN
aiua-10711	573	74	hospital	hospital	PROPN
aiua-10711	573	75	,	,	PUNCT
aiua-10711	573	76	athens	athens	PROPN
aiua-10711	573	77	,	,	PUNCT
aiua-10711	573	78	greece	greece	PROPN
aiua-10711	573	79	adama	adama	PROPN
aiua-10711	573	80	ouattara	ouattara	PROPN
aiua-10711	573	81	,	,	PUNCT
aiua-10711	573	82	md	md	PROPN
aiua-10711	573	83	adamsouat1@hotmail.com	adamsouat1@hotmail.com	X
aiua-10711	573	84	division	division	NOUN
aiua-10711	573	85	of	of	ADP
aiua-10711	573	86	urology	urology	NOUN
aiua-10711	573	87	,	,	PUNCT
aiua-10711	573	88	souro	souro	NOUN
aiua-10711	573	89	sanou	sanou	PROPN
aiua-10711	573	90	university	university	NOUN
aiua-10711	573	91	teaching	teaching	NOUN
aiua-10711	573	92	hospital	hospital	NOUN
aiua-10711	573	93	,	,	PUNCT
aiua-10711	573	94	bobo	bobo	NOUN
aiua-10711	573	95	-	-	PUNCT
aiua-10711	573	96	dioulasso	dioulasso	PROPN
aiua-10711	573	97	,	,	PUNCT
aiua-10711	573	98	burkina	burkina	PROPN
aiua-10711	573	99	faso	faso	PROPN
aiua-10711	573	100	gianpaolo	gianpaolo	PROPN
aiua-10711	573	101	perletti	perletti	PROPN
aiua-10711	573	102	gianpaolo.perletti@uninsubria.it	gianpaolo.perletti@uninsubria.it	PROPN
aiua-10711	573	103	department	department	PROPN
aiua-10711	573	104	of	of	ADP
aiua-10711	573	105	biotechnology	biotechnology	NOUN
aiua-10711	573	106	and	and	CCONJ
aiua-10711	573	107	life	life	NOUN
aiua-10711	573	108	sciences	science	NOUN
aiua-10711	573	109	,	,	PUNCT
aiua-10711	573	110	section	section	NOUN
aiua-10711	573	111	of	of	ADP
aiua-10711	573	112	medical	medical	ADJ
aiua-10711	573	113	and	and	CCONJ
aiua-10711	573	114	surgical	surgical	ADJ
aiua-10711	573	115	sciences	science	NOUN
aiua-10711	573	116	,	,	PUNCT
aiua-10711	573	117	university	university	NOUN
aiua-10711	573	118	of	of	ADP
aiua-10711	573	119	insubria	insubria	PROPN
aiua-10711	573	120	,	,	PUNCT
aiua-10711	573	121	varese	varese	PROPN
aiua-10711	573	122	,	,	PUNCT
aiua-10711	573	123	italy	italy	PROPN
aiua-10711	573	124	joseph	joseph	PROPN
aiua-10711	573	125	philipraj	philipraj	PROPN
aiua-10711	573	126	,	,	PUNCT
aiua-10711	573	127	md	md	PROPN
aiua-10711	573	128	josephphilipraj@gmail.com	josephphilipraj@gmail.com	PROPN
aiua-10711	573	129	department	department	PROPN
aiua-10711	573	130	of	of	ADP
aiua-10711	573	131	urology	urology	NOUN
aiua-10711	573	132	,	,	PUNCT
aiua-10711	573	133	mahatma	mahatma	PROPN
aiua-10711	573	134	gandhi	gandhi	PROPN
aiua-10711	573	135	medical	medical	PROPN
aiua-10711	573	136	college	college	PROPN
aiua-10711	573	137	and	and	CCONJ
aiua-10711	573	138	research	research	PROPN
aiua-10711	573	139	institute	institute	PROPN
aiua-10711	573	140	,	,	PUNCT
aiua-10711	573	141	sri	sri	PROPN
aiua-10711	573	142	balaji	balaji	PROPN
aiua-10711	573	143	vidyapeeth	vidyapeeth	PROPN
aiua-10711	573	144	,	,	PUNCT
aiua-10711	573	145	puducherry	puducherry	PROPN
aiua-10711	573	146	,	,	PUNCT
aiua-10711	573	147	india	india	PROPN
aiua-10711	573	148	.	.	PUNCT
aiua-10711	574	1	alberto	alberto	PROPN
aiua-10711	574	2	trinchieri	trinchieri	PROPN
aiua-10711	574	3	,	,	PUNCT
aiua-10711	574	4	md	md	PROPN
aiua-10711	574	5	(	(	PUNCT
aiua-10711	574	6	corresponding	correspond	VERB
aiua-10711	574	7	author	author	NOUN
aiua-10711	574	8	)	)	PUNCT
aiua-10711	574	9	alberto.trinchieri@gmail.com	alberto.trinchieri@gmail.com	X
aiua-10711	574	10	urology	urology	NOUN
aiua-10711	574	11	school	school	NOUN
aiua-10711	574	12	,	,	PUNCT
aiua-10711	574	13	university	university	PROPN
aiua-10711	574	14	of	of	ADP
aiua-10711	574	15	milan	milan	PROPN
aiua-10711	574	16	,	,	PUNCT
aiua-10711	574	17	milan	milan	PROPN
aiua-10711	574	18	(	(	PUNCT
aiua-10711	574	19	italy	italy	PROPN
aiua-10711	574	20	)	)	PUNCT
aiua-10711	575	1	noor	noor	PROPN
aiua-10711	575	2	buchholz	buchholz	PROPN
aiua-10711	575	3	noor.buchholz@gmail.com	noor.buchholz@gmail.com	PROPN
aiua-10711	575	4	sobeh	sobeh	NOUN
aiua-10711	575	5	's	's	PART
aiua-10711	575	6	vascular	vascular	ADJ
aiua-10711	575	7	and	and	CCONJ
aiua-10711	575	8	medical	medical	ADJ
aiua-10711	575	9	center	center	NOUN
aiua-10711	575	10	,	,	PUNCT
aiua-10711	575	11	dubai	dubai	PROPN
aiua-10711	575	12	health	health	PROPN
aiua-10711	575	13	care	care	PROPN
aiua-10711	575	14	city	city	PROPN
aiua-10711	575	15	,	,	PUNCT
aiua-10711	575	16	dubai	dubai	PROPN
aiua-10711	575	17	,	,	PUNCT
aiua-10711	575	18	united	united	PROPN
aiua-10711	575	19	arab	arab	PROPN
aiua-10711	575	20	emirates	emirates	PROPN